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PREFACE
TOBY ZIEGLER: “We have honest disagreements. Arguments are good.”
LEO McGARRY: “Only when they lead to statemanship.  
Or it is just theater. And statemanship is compromise.”
TOBY ZIEGLER: “What about persuasion?”
West Wing  season 2, episode 11
“The Leadership Breakfast” 
From a dramaturgical perspective, the scientific report you are about to read 
can be considered as my front stage performance as an academic scholar in the 
interdisciplinary and “multi-staged” field of Science and Technology Studies. As some 
scholars in this field have noted, scientific texts, and particularly reports of qualitative 
research, are not only rhetorical devices to persuade critical audiences but they are 
also a means for self-presentation that “the performer uses to project his or her 
‘voice’ and create the desired impression on the audience: the production, editing, 
and presentation of written texts become means of impression management,” as 
Stephen Hilgartner (2000) writes about scientists who are on stage. The impression 
junior scientists on stage ought to convey is that of independence, creativity, 
autonomy and wit. On stage the candidate’s act is one of soliloquy.
 One of the dangers of comparing social practices – such as doing science – with 
staged performances and drama is that it tends to neglect the endless search, the 
hard work and the almost insurmountable dissensus between actors, directors 
and producers behind the scenes. Behind this printed dissertation the discord and 
despair remain hidden from the audience. As with the many public discussions I have 
organized in the last decade (some of which were chosen to be put center stage in 
this study) the production of this book contains the – more and less visible – work 
of many. Although it is custom to theatrical productions to acknowledge the people 
behind the scenes after the performance, to me the beginning of this book seems 
the proper place to offer them a stage.
Prize winning actors always start their acknowlegment speeches thanking their 
directors. I make no exception. Dear Tsjalling, I am truly grateful for adopting me as a 
PhD student from almost the very first moments I started staggering on the academic 
stage. Without your discernment to reduce matters to the heart, your frankness 
about your own struggles as an author, your hospitality, culinary art and strictness 
that kept me focused on my writing, and finally your commitment, I simply would not 
have passed auditions.  
Without suggesting that I committed the deadly academic sin of plagiarism, 
I thank you, dear Maud, for your solid role as prompter who accompanied me on a 
daily basis. I could always rely on your meticulous reading of substantial pieces of 
text. Your comments rendered my words into a considerably more readible version 
so that I was able to understand again what I was trying to say. I also thank you so 
Preface
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much for your commitment after you had to continue your career elsewhere when 
the CSG Next program had finished.
 Directors, actors, promters etcetera depend on the unremitting work of 
producers. Without a stable financial basis, the casting of a good team and the 
promotion of the project, these professionals cannot even think about starting their 
work. Special thanks I owe to Annemiek Nelis, former director of CSG who acted as 
the producer of the research project.
 Much gratitude I also owe to the people who have been starring in the public 
deliberations described and analyzed in this book, first and foremost the life scientists 
who were willing to act not only as protagonists of new and emerging life sciences 
and biotechnologies, but also as research subjects. I admire your dedication with 
which you perform in the scientific community. I am thankful for your willingness 
to interrupt the demanding work in your research labs to engage with society. 
Unfortunately, the codes of conduct prescribing ethical research restrain me from 
mentioning your names, but it is beyond doubt that you all deserve a red-carpet 
treatment.
 I would also like to thank my colleagues at the Department of Philosophy and 
Science Studies at Radboud University, particularly Meggie Pijnappel, Erwin van 
Rijswoud en Sanne van der Hout. Inge Mutsaers, thank you for our moments of 
reflection on supervision. I particularly thank my former roommates: Jan van Baren 
(I hope you will celebrate your moment of personal victory soon), Jochem Zwier 
(God, how much I miss your don’t-mention-the-war jokes) and Martin Ruivenkamp 
(thank you for your vivid narratives that remind me of the excitement of the life 
outside academia …). Also thanks to my colleagues at the Center for Society and the 
Life Sciences (CSG), particularly Maria Cantore, Marjolein Schrauwen, Frans van Dam, 
Gijs van der Starre and principal investigator of the Education and Communication 
program Arend Jan Waarlo. 
 For the solid introduction into the fluidities of Science and Technology Studies 
I very much thank Willem Halffman, Teun Zuiderent-Jerak en Sally Wyatt for 
coordinating the workshops and summerschools. I also thank all my fellow WTMC-
students I met at the bar of the Soeterbeeck convent or elsewhere in Ravenstein, 
particularly Yvonne Cuijpers and Dirk de Haen for appreciating my facilitation skills I 
was asked to demonstrate in their workshops on responsible innovation. And I thank 
WTMC for financially supporting the printing of this dissertation.
 The members of the supervisory committee also need to be mentioned for the 
fruitful and enjoyable discussions in the early stages of the project: Huub Dijstelbloem, 
Jessica Mesman, Hans Harbers, Pieter Leroy, Jos Kessels, Jacqueline Broerse. Many 
thanks of course to the manuscript committee – Hub Zwart, Hedwig te Molder, 
Jacqueline Broerse – for approving the text and their constructive criticism. The last 
academic network worth mentioning in these acknowledgments is the Center of 
Ethics and Politics of Emerging Technologies (EPET) particularly Simone van de Burg 
and Marianne Boenink. Thank you for the informal and fruitful academic discussions 
on emerging technologies. 
 This research project started at the hey-day of the department of public 
discussions of the LUX. I sometimes nostalgically think back about the most 
interesting part of our work as dramaturgists of public debate: the conversations we 
had with Dutch opinion leaders and politicians  after the show was over, our Tuesday 
meetings, our reflections on our profession. Allard Koers, Hedzerd de Boer, Piet-Hein 
Peeters, and of course Michel Schemkes, I will always cherish these memories.
 I would also like to thank the members of the crew without whose helpfulness 
the production of this book would have gone far less smoothly. Inge de Weerdt en 
Herman Balkenende of the Nederlandse Diabetesfederatie (NDF), thank you for 
co-producing the last deliberative production on emerging technologies and the 
preventive care for diabetes. Pieter van Terheijde, dramaturgical advisor, thank you 
for your help with becoming familiar with dramaturgical jargon of scripting, staging 
and setting as well as your refined observation. Sheile van de Sande, personal coach, 
how much I appreciate your personal involvement and professionalism. Els Brevink, 
text editor, thanks so much for your accuracy and punctiality in your translation and 
transcription work. Also many thanks for the numerous location managers who were 
willing to put their comfortable houses to the mercy of my untidy writing habits: 
Marieke en Jeroen, Remco en Sabine, Gonny.
 I would also like to thank my colleagues of the Institute Applied Sciences of HAN 
University of Applied Sciences for a warm welcome, the financial support and editing 
work: Kelly Vellinga-Chan, Beatrijs Linford, Pedro Hermkens and Michiel Geursen.
Fortunately, I am in the position to be surrounded by supportive friends and family. 
Gerald, I hope to continue our always amusing Huttenheugte Conferences. Dear 
Kelme-cyclists, I am looking forward to future explorations of the world by bike, 
following in the green train’s wake, panting for breath. Thank you dear indoor soccer 
friends, Bas, Eric, Erwin, Remco, Remy, Theo, Wil, for always giving me a hearty 
welcome after weeks and weeks of absence. And of course thank you Jeroen, Brabant 
buddy, I love you, man. And Antoon, remote friend, hopefully my dissertation is a 
hand that helps you stepping out of the proverbial “same boat” we have been in for 
far too long. 
 Dear Mom and Dad, although life scientists couldn’t quite convince me of 
the heridity of human behavior, I am grateful that somehow you succeeded in 
transferring an unhealthy amount of perseverance I admire you for. I also thank you 
for the many encouraging postcards and later on, as you smoothly switched to more 
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modern communication technologies, Whatsapp messages. And what is more, it 
is always a consolation to know that during insomnia you know that someone out 
there is sharing your useless staring at ceilings.
 Cathalijne, dear sister. Our trip to Washington DC and our visit to the Library of 
Congress to immortalize this piece of work came too early (or was I late? I just can’t 
remember which ;-). But I am more than willing to return to Hollywood for Ugly 
People for a second attempt. I promise you to do all of my West Wing homework this 
time! Apart from your material support – your house in The Hague, your Van Dale 
dictionary, your West Wing DVDs – I am so happy to have you as my companion in 
our absurd human existence littered with “gedoe.” Remember, we must imagine us 
happy.
 And to sweet little Moos, I want to say that from now on I will be a father in 
holiday times and weekends again so that we can dive for as many golf balls at the 
bottom of swimming pools as we want and that we can stroke iguanas anytime we 
feel like it.
 And last but not least, dearly beloved Esther. Most authors keep their words to 
their loved ones private. I refuse that because everyone has to know how much I 
owe to you. Most of all, thank you for enduring my poor back stage performances 
at home (that indeed better remain concealed from any audience altogether). A few 
times Tsjalling said to me: “Tell Esther she is about to get you back.” Now that this 
thesis has been finished I will again rehearse my interpretation of the Good Husband. 
I will even be open to (OK, only some of) your director notes. Dear Esther, rather than 
my director you are my ghost light, the dim light at the center of our stage modestly 
shining to prevent me from falling into orchestra pits or tripping over the set pieces 
of life. You are the light that appeases the many ghosts cursing the performances of 
a poor player like me who struts and frets his hour upon this stage. And then is heard 
no more… 
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INTRODUCTION
1.1 Scientists engaging with society
“Citizens will participate in decisions on academic research.” Thus read the headline 
on the front page of a national Dutch newspaper on 25 November 2014. The article 
highlights one of the spearheads of the new science policy as presented in a report by 
the Dutch Ministry of Education, Culture and Science. To set a new National Research 
Agenda, academic scientists and researchers will have to engage with society, 
because, as the report states, “[s]cience and society are increasingly interwoven. On 
the one hand there is an increasing social need of science contributing to the solution 
of problems. […] On the other we see that scientific findings will fundamentally 
change society in the upcoming years” (Ministry of Education, Culture and Science 
2014: 46).
 The new policy plans proved controversial within the academic community. 
Scientists and academic researchers sought out the spotlight of the public sphere 
to argue for or against the new political plans. Opponents of the plan feared a 
reduction of academic autonomy. A prominent Dutch astrophysicist and columnist 
wrote that the new policy “with its emphasis on social relevance, valorization and 
collaboration” is “an attempt to tie the hands of science under the veil of efficiency” 
(Icke, December 6 2014). Academic freedom is “important because arguments can 
be provided to change a situation. Science has to produce a lot of critical knowledge,” 
as other critics argued (Bartl and De Ruiter, December 6 2014). Again others asserted 
that it is dangerous to presume that “the contribution of citizens […] will give us a 
complete picture of the research worth producing” (Jongepier, December 6 2014).
 At the same time there were prominent scientists that also supported the 
new policy of the Ministry. “If scientists cannot convincingly show that they are 
investigating issues that people worry about (health care, climate) or [issues] that 
increase the quality of life (history, art) the social legitimacy of scientific research is 
under pressure” (Abma, December 30 2014). “There is no single other social sector 
that can spend other people’s money freely and at the same time can determine 
present and future of other people. […] As a tax payer […] I am pleased with one 
chapter 1
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aspect [of the new policy] in particular: the government supports the internationally 
increasing understanding that the exceptional position of the scientific sector can no 
longer be justified” (Dehue, December 27 2014).
 Indeed, the new Dutch science policy is in line with a recent trend in the 
European governance of science. The report of the Dutch ministry explicitly refers to 
the concept of Responsible Research and Innovation (RRI) that is prevailing in today’s 
European science policy context. On the European Commission’s website, the 
concept of RRI is described as a process where “societal actors (researchers, citizens, 
policy makers, business, third sector organizations, etc.) work together during the 
whole research and innovation process in order to better align both the process and 
its outcomes with the values, needs and expectations of society.”1
 Despite the resistance of scientists and researchers, public engagement with 
science has by now become central in European science policy.2 As an integral part of 
RRI, public engagement is firmly-rooted in the Horizon2020 framework, the funding 
program of the European Commission to invest nearly 80 billion Euros in research 
and innovation to address the so-called Seven Grand Challenges, cross-border social 
problems such as climate change, secure and clean energy, health and wellbeing and 
secure societies. European as well as Dutch administrators increasingly expect that 
scientists and researchers engage with (civil) society “to gear their research projects 
to the needs and the potential concerns of citizens and stakeholders” (Ministry of 
Education: 44).
This thesis is about the practice of facilitating the engagement of scientists with society. 
As its title suggests, I compare public engagement with theater. This metaphor allows 
me to spotlight two aspects of how public engagement is enacted that are mainly 
overlooked by scholars but that are crucial for its quality. The first aspect concerns 
the front stage performances of scientists performing public engagement as well 
1 http://ec.europa.eu/programmes/horizon2020/en/h2020-section/responsible-
research-innovation, 25 Feb 2015
2 Public engagement is an ambiguous concept. Rowe and Frewer (2005), for example, 
use public engagement as a generic concept to refer to different modes of how 
information flows from one party to the other. In public communication the public is 
involved to listen to one-way information. In public consultation, on the other hand, 
information flows from the public to the sponsors of the engagement activity, whereas 
in public participation information flows in both directions (Rowe and Frewer 2005). 
I use public engagement in the last sense, as public participation, where publics and 
(life) scientists exchange their views on (ethical) issues.
as facilitators directing the discussion process towards deliberation (engagement 
as public performance). As I will explain below, deliberation refers to the particular 
normative quality of reasonableness of a discussion or dialogue.3 The second aspect 
is about the back stage process of how professional organizers of public engagement 
set the scenes of public deliberation in their role of dramaturgist (dramaturgy of 
public engagement).
 In this dissertation I investigate these two aspects of public engagement with 
science from the vantage point of facilitator of public dialogue. For I argue that 
combining the roles of analyst and facilitator of public engagement improves the 
knowledge about the quality of the deliberative process.
In this introductory chapter I explain first why an increased understanding of 
these two aspects is relevant in the context of public engagement with science 
(Section 1.2). Secondly, I present the problem definition that constitutes the starting 
point of my research project (Section 1.3). Next, I formulate the research questions 
that guided my investigation. In the presentation of these questions, I integrate the 
methodological approaches I adopt to investigate these questions (Section 1.4). 
Finally, I will provide an outline of the book (Section 1.5).
1.2 The importance of process: lessons from the past
Why do European policymakers and political administrators attach great importance 
to involving the public in science? Andy Stirling, Professor of Science and Technology 
Policy at the University of Sussex in the UK, has distinguished three different types 
of arguments or “types of imperatives” (Stirling 2008) that indicate the motivations, 
intentions or justifications underlying the increasing demand for more public 
engagement with science. Firstly, citizens should participate in decisions on research 
3 It is important to distinguish between discussion, debate, dialogue and deliberation. 
I use the concept of discussion as a generic concept (or genus) to refer to different, 
specific forms of discussion: debate, dialogue and deliberation. I understand debate 
as an oppositional discussion where two or more parties attempt to prove each other 
wrong. Well known examples of debates are the public debates on television during 
elections. Dialogue on the other hand, refers to the type of discussion where two or 
more parties collaboratively work together toward a common understanding of the 
issue at hand. Deliberation is the concept I use to refer to the specific normative quality 
of a discussion in which reasonable arguments are used to resolve differences of 
opinion (see Section 1.2 and Chapter 2).
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agendas for normative reasons. It is simply the right thing to do from a democratic 
perspective. Tax payers should have more control over how their money used to fund 
scientific research and technological innovation is spent. As Tineke Abma, Professor 
of Participation and Diversity at the Free University of Amsterdam stated in the 
discussion on the new Dutch science policy: “Dutch citizens are increasingly highly 
educated, critical and articulate. They do not accept anymore that scientists can just 
go their own way” (Abma, December 30 2014). All the more, since technoscientific 
research encroaches deeply on society at large and people’s individual lives in 
particular as the Dutch minister indicated. According to democratic ideals people 
should be able to influence collective decisions that affect them.
 However, the new Dutch science policy to promote more public participation 
in science rather seems to reflect the other two imperatives: the instrumental and 
the substantive. Whereas normative imperatives concentrate on the process of 
public participation, the focus of instrumental and substantive imperatives is on the 
outcomes. On the one hand, the Dutch science policy is instrumental since engaging 
the public serves specific favored outcomes, particularly restoring public trust. “The 
big impact science can have on society can put pressure on the [public] trust in 
science” (Ministry of Education 2014: 43). Indeed, for today’s academic scientists, 
researchers and engineers unconditional support of the public is not self-evident. 
Even though hardly anyone questions the public value of new scientific knowledge 
for economic growth, well-being and the quality of life, public controversies in the 
past also indicate the reverse effects of new technological innovations. History shows 
that new science and technology can also produce devastating environmental effects 
(e.g. the insecticide dichlorophenyltrichloroethane  or DDT), life threatening risks 
on a global scale (nuclear energy) and genetically modified organisms (GMOs) or 
“monsters” (e.g. Roundup Ready Corn and Herman the Bull).
 On the other hand, the new Dutch vision on science is substantive. According to 
Andy Stirling, who has analyzed public participation initiatives in the UK, the focus of 
the substantive imperative, “lies on general qualities such as environmental quality, 
public health or broader human well-being”, “rather than aiming instrumentally to 
yield specific forms of acceptance or trust” (Stirling 2008: 271). It holds that engaging 
stakeholders, patients, end-users and citizens in setting research agendas will 
produce better science. “Interaction with users urges researchers to reflect on the 
opportunities and risks of the products that can result from their research” (Ministry 
of Education 2014: 44).
More public involvement is increasingly regarded as a necessary condition 
for instrumental ends (restoring public trust, increasing public acceptance) or 
substantive ends (improving the quality of health care). However, simply increasing 
public participation is not sufficient, as has been demonstrated in the past. Indeed, 
it turned out that the process matters significantly. Even though events to engage 
public discussion about genetically modified crops in the Netherlands (Eten en 
Genen, 2001) as well as in the United Kingdom (GM Nation? 2003) were innovative, 
evaluators assert that these initiatives suffered from serious flaws (Horlick-Jones et 
al. 2006; Gutteling and Hanssen 2001). In the Dutch case, sixteen non-governmental 
organizations (NGOs) that were involved in organizing Eten en Genen terminated 
their collaboration through an announcement placed in a national newspaper, 
complaining that not only the organisms at issue, but the national public debate itself 
was “manipulated.”4
 Several lessons about the process of public engagement have been drawn 
from these and other past examples. First, the discussion of public issues was 
narrowly framed in terms of the undesirable impact of new science and technology: 
unsafe food and, to a lesser extent, decrease of biodiversity and loss of traditional 
forms of agriculture. However, the public resistance towards genetically modified 
organisms did not only originate from these undesirable consequences, as I will 
discuss extensively in Chapter 2. Because of this narrow framing a variety of other 
ethical issues inextricably bound up with modern knowledge production that the 
public articulated were ignored. Can we interfere with natural order? Who will 
benefit from these new developments and who will not? What is the purpose of 
new scientific knowledge and new technological innovations? How desirable are 
these ends? Where do we invest our financial resources for scientific research in? 
Public engagement also has to address this wider spectrum of possible ethical issues 
concerning the purposes, needs and expected benefits, i.e. the moral desirability of 
new and emerging science and technology (or NEST) as imagined or envisioned by 
scientists and technology developers.
 The second lesson is closely related to the first. It is important to involve the public 
as early as possible to anticipate potential benefits and harms as well as openly discuss 
the research priorities that are set (where do we invest money?) and the moral visions 
that drive scientific developments so that the contribution of participants can have 
an impact on innovation trajectories (How desirable is the purpose of new science?). 
The biggest complaint of Non-Governmental Organizations (NGOs) about Eten en 
Genen and GM Nation was that the discussion came too late in the process. Even if 
governments had used the results in political decision-making, these NGOs thought 
4 http://www.platformgentechnologie.nl/genetech/index_nl.shtml, accessed March 14, 
2015
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that there was no reason to believe that the outcome still could have been able to 
influence the direction of biotechnological research and innovation. In the 1990s, a 
boycott against GMOs was felt to be the only option that consumers had to refuse 
this new technology while its developers wanted to recover the costs of the research 
and development of these new products. This explains the entrenched positions in 
the GMO controversy. So, public engagement with science also has to take place 
upstream in the process of scientific and technological development and not merely 
downstream where technologies are finalized and ready to hit the market.
 Third, public engagement with science needs a deliberative turn as some 
commentators assert (Felt et al. 2007). As I will also elaborate extensively in 
Chapter 2, this line of argument resonates with a body of thought within political 
theory called deliberative democracy that has become influential since the early 
1990s. According to deliberative democrats, public deliberation is an approach to 
decision-making based on reasonable political judgment. This means that citizens 
who morally disagree on issues (e.g. emerging from new science and technology) 
do not settle these issues on the basis of power, majority rule (voting) or rhetoric 
and strategic communication in public debate.5 Instead, citizens can enter freely 
in a deliberation where individual views and perspectives are called into question. 
These views need to be justified with good reasons that are acceptable to the people 
who think differently. Deliberation is an informed debate where views of others are 
both taken seriously and are critically tested in social interaction, just like one’s own 
perspectives. According to deliberative democracy theory, the preferences of citizens 
on collective problems (e.g. secure and green energy, sustainable agriculture) are not 
the fixed input of decision-making (e.g. by voting). Instead, people’s perspectives on 
issues are the output of a learning process in which reasonable critics can, in the end, 
revise their opinions.
 Deliberative democrats argue that only collective decisions (on moral issues) made 
as a result of such a deliberative process of reason-giving are mutually acceptable 
and therefore legitimate (according to the normative imperative) and effective 
(according to the instrumental and substantive imperative). Public deliberation is a 
concept referring to a good discussion. It refers to particular norms of the public 
engagement process that are necessary conditions for legitimate outcomes, be they 
instrumental or substantive.
 The fourth lesson that can be drawn from past experiences with public engagement 
with science relates to the facilitation process itself. Some commentators have argued 
5 See footnote 3
that how public engagement is organized has contributed considerably to the public 
uneasiness with new science and technology (Felt et al. 2007). In their analysis the 
methodologies used in public engagement – consensus conferences, citizen’s juries 
etc. – are overstressed. Facilitators adopt, in their view, a kind of “mechanistic” view 
on public engagement: as long as the protocols and guidelines of these methodologies 
are correctly applied a legitimate outcome will automatically be generated. In this 
narrow focus on the “hardware of public engagement” (Wilsdon et al. 2005) the 
experimental and hence unruly character of public deliberation is neglected. Since 
the facilitation process itself influences the outcome, these commentators also call 
the form of deliberative mechanisms into question.
1.3 Omitted aspects in evaluating upstream public deliberation
Thus, proponents consider upstream public deliberation on the moral desirability of 
NEST to be a necessary condition for democratic, widely supported decisions on the 
direction of techno-scientific innovation for normative (deliberative and democratic), 
instrumental (restoring trust, increasing acceptance, minimizing controversy) 
or substantive (improved quality of life, better environment) reasons. Public 
engagement has been a popular topic of academic analysis and evaluation, mainly 
in the fields of Science and Technology Studies (STS) and political sciences. However, 
scholars in these fields have paid scant attention to the deliberative process itself and 
the effects of facilitation on this process and its quality. On the one hand, evaluative 
research in STS is mainly concerned with providing normative conceptual frameworks 
for assessing the conditions of a valuable outcome of public engagement. Which 
criteria need to be used for evaluating the quality of public participation exercises 
(such as representativeness, transparency, impact on policy etc.), how must these 
criteria be operationalized and measured and how can concrete public engagement 
events be evaluated with respect to these criteria? Yet, this approach to evaluation 
of (upstream) public deliberation on NEST fails to acknowledge how the deliberative 
process influences the outcome and hence, the legitimacy, of public engagement.
 David Ryfe, scholar of political communication, who wrote one of the few reviews 
on empirical research on public deliberation states: “theorists remain silent about 
what deliberation looks like on the ground, where real people discuss concrete issues. 
Perhaps more surprisingly, the empirical literature has not addressed the issue either. 
Researchers have been less interested in deliberation itself than in measuring its 
effects” Ryfe (2005: 54).  As I will argue in Chapter 2, the few attempts to investigate 
the quality of reasoning in deliberation in empirical deliberative democracy literature 
are methodologically problematic and empirically inaccurate.
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 On the other hand, the question how a “particular setting influence[s] what 
is said, what can be said and what can be said with influence” (Hajer 2005) is, as 
far as I am aware, subject of discussion in only one study, that deals with a public 
participation process in regional planning in the Netherlands (cf. Gomart and Hajer 
2003; Hajer 2005). The few studies in STS that are focused on deliberation in action 
do not take the effect of settings on this process into account (cf. Felt et al. 2009; 
Kerr et al. 2008; Karner and Wieser 2010).
The main concern in this book is the facilitation of quality upstream public 
engagement with science. The main question reads: How to facilitate quality face-to-
face upstream public deliberation between life scientists and citizens on the ethical 
issues emerging from the new life sciences and biotechnologies? Facilitation is usually 
referred to as the practice of conducting discussions on stage. Facilitation, according 
to this view, comprises the elicitation of viewpoints from all participants without 
hinting at own opinions, the encouragement of participation, the enhancement of 
mutual understanding, the management of time and the help offered to groups to 
work toward its objectives (De Vries et al. 2011; Quick and Sandfort 2014). Of course, 
these aspects are part and parcel of the facilitation process and key to implementing 
deliberative processes. Facilitation in this study, however, particularly refers to the 
interventions on stage to maintain the reasonableness of the discussion among 
participants, i.e. to enhance the quality of argumentation which is quintessential to 
deliberation (as I argue below and in Chapter 2). In my view, this aspect of facilitating 
deliberation has mainly been overlooked in the literature.
 The same applies to the efforts of professional organizers of public dialogue 
behind the scenes to set the conditions for a fruitful discussion. Indeed, facilitating 
deliberation also refers to the process of designing public engagement. As John 
Forrester (2013) argues, skilled facilitators are doing “not just the pragmatic work 
of facilitating a discussion, but the critical pragmatic work of thinking through the 
procedural design, thinking through the politics and ethics, the normative structuring, 
of that discussion in the first place” (p. 19; original italics).
In the last decade I have attempted as a facilitator in a Dutch debating center (the 
LUX) to organize and study face-to-face upstream public deliberation on the moral 
desirability of NEST in the life sciences. In close collaboration with the Center for 
Society and the Life Sciences (CSG) we invited key players in (inter)national life 
sciences research to engage in a dialogue with the public. Using a learning-by-doing 
or interventionist approach (see Section 1.4), my aim is to unravel the process of 
deliberation in order to improve its quality.
 I concentrate on face-to-face social interaction, even though the public sphere 
where open and reasoned discussion takes place also comprises media discussions on 
the internet, in newspapers and television broadcasts, as the controversy on the new 
Dutch science policy demonstrates. Many of the public engagement methodologies 
that have been developed over the last decades, however, are based on face-to-face 
deliberation as the most ideal form of reason-giving debate (Engage2020 2014).
 Secondly, I particularly focus on the public performances of life scientists. How 
do these participating researchers do public deliberation? Despite the increasing 
influence of governments and industry on the research agendas and the daily practice 
of science, life scientists and biotech engineers remain key players in the actual 
production of new knowledge and technologies as well as the setting of research 
agendas. Particularly now that European policy makers demand a different role as 
active participants in upstream public engagement with society, it is important to 
understand how they actually do public deliberation.
 Finally, I focus on participating researchers in the life sciences, the broad field of 
science that involve the scientific study of living organisms – such as microorganisms, 
plants, animals, and human beings – mainly on a molecular level (DNA, RNA etc.). 
Since the 1970s, advances in the life sciences such as recombinant DNA techniques, 
GMOs and the human genome project have been the subject of public discussion 
and controversy;6 continuing developments in life sciences ensure this interest will 
remain relevant.
1.4 Research questions and methodological approach
As the title of this thesis suggests, I draw on the metaphor of the theater to highlight 
the deliberative process and its facilitation “on the ground.” I am not the first to 
compare public engagement with theater. In fact, its advocates themselves use the 
metaphor of the theater to draw a parallel with upstream public deliberation. “In the 
theater of science and technology, the time has come to dismantle the proscenium 
arch and begin performing in the round” (Wilsdon and Willis: 24).
 The theatrical metaphor allows me to spotlight the two aspects of the facilitation 
6 Recombinant DNA techniques enable the implantation of pieces of hereditary material 
from one organism in the DNA of another to evoke the production of proteins that 
do not naturally occur in these cells. These techniques were also used to develop 
genetically modified crops that sparked the public controversy over GMOs in the 1990s.
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of upstream public deliberation that have been largely “underexposed” in the public 
engagement literature: engagement as public performance and the dramaturgy of 
public deliberation. To analyze these two aspects I draw on two theoretical frameworks 
that make use of the metaphor of the theater. First, in dramaturgical analysis in social 
sciences interaction among people – such as deliberating ethical issues of NEST – is 
studied in terms of public performances. So, how do life scientists perform in the 
public sphere while doing public engagement? The second theoretical framework 
also draws a parallel with theater to analyze how the dramaturgical process behind 
the scenes affects the performances on stage. I first discuss the performance of life 
scientists and subsequently the dramaturgy of public deliberation. I conclude this 
section with a description of my methodological approach.
— Life scientists as public performers
Introduced in The Presentation of Life Itself (1959), the sociologist Erving Goffman 
developed an analytical approach to study face-to-face everyday human interactions 
in terms of a staged performance. Within this sociological perspective theatrical 
concepts are used to describe and analyze the behavior of people – the actors – in 
social interaction. To complement the existing literature on the evaluation of public 
engagement, Harvey (2009) indicates that dramaturgy, as a sociological perspective, 
is a valuable tool for understanding face-to-face deliberative action, for “[i]t is 
particularly important for such actors to manage and turn in their ‘best performance,’ 
appropriate to their individual (or institutional) goals” (Harvey 2009: 150).
 Drawing on the work of Goffman in his work on scientific advisors as performers 
in a public drama, STS scholar Steven Hilgartner (2000) refers to two important 
theatrical techniques scientific advisors use to perform as credible experts: persuasive 
rhetoric and impression management. First, I discuss persuasive rhetoric. I return to 
impression management later.
 Similar to Hilgartner’s scientific experts presenting their advice to policy makers, 
my hypothesis in this study is that scientists and researchers in the life sciences 
use a variety of rhetorical strategies to persuade their publics of the benefits of 
their scientific endeavors. Indeed, as Harvey notes, in their close inspection of the 
deliberative process researchers will undoubtedly find “strategic, success-oriented 
speech” aimed to “achieve an ulterior purpose and influence others” (Harvey 2009: 
148).
 In this book the strategic maneuvers that life scientists use in upstream public 
deliberation in order to be credible, are an important focus. I borrow the theoretical 
concept of strategic maneuvering from the pragma-dialectical argumentation 
theory, developed at the University of Amsterdam, to reconstruct, analyze and 
evaluate argumentative discourse. I use this concept to study argumentation of 
life scientists. Whereas sociologists and STS scholars such as Harvey and Hilgartner 
confine themselves to analyzing the persuasive rhetoric in the public performances 
of scientists and scientific advisors, pragma-dialecticians not only empirically study 
argumentative discourse as a phenomenon of ordinary language use, but they are 
also aiming at critically evaluating the soundness of argumentation. Not every move 
in a discussion is allowed; participants are bound by a set of discussion rules that can 
be violated.
 In pragma-dialectics the concept of strategic maneuvering was developed to 
draw attention to the delicate balance which participants in public deliberation have 
to observe between on the one hand the rhetorical aim of effectiveness (having 
their important claims accepted) and the dialectical aim of reasonableness (sound 
reasoning) on the other.
 The dialectical dimension of argumentation refers to the reasonable resolution 
of differences of opinion. Pragma-dialecticians have developed a model of critical 
discussion which stipulates a set of norms discussants agree to observe in order 
to resolve their difference of opinion. As I have discussed above, deliberation is a 
normative concept indicating the quality of the discussion process. It refers to a 
good discussion. For a proper evaluation of the deliberative process, the articulation 
of rules that define appropriate deliberative behavior is paramount. The pragma-
dialectical model of critical discussion provides a code of conduct for participants of 
public deliberation. The first set of research questions read:
What are the pragma-dialectical norms for upstream public deliberation 
on NEST-ethical issues emerging from the life sciences? What dialectical 
instruments can be derived from pragma-dialectics to direct the discussion 
towards deliberation?
The pragma-dialectical model of critical discussion reflects an idealized discussion 
situation. Since everyday discussions will hardly follow the model’s stages and rules 
for the resolution of differences of opinion, it is not a means to empirically describe 
actual deliberation. Rather, it is a normative framework to evaluate argumentative 
discourse for its soundness.
 Moreover, pragma-dialecticians stress that these norms are not carved in stone. 
The rules themselves can (and must) be subject of discussion since all discussants 
have to accept them. What is more, the norms of a critical discussion allow for 
rhetorical effectiveness. In addition to convincing reasonable critics discussants also 
attempt to have their standpoints accepted preferably without violating the rules 
of a critical discussion. “[P]eople are also, and perhaps even primarily, interested in 
resolving the difference of opinion effectively in favor of their case, i.e. in agreement 
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with their own standpoint or the position of those they represent” (Van Eemeren 
2010: 39). In their attempt to be effective, discussants can violate the norms of a 
critical discussion. In that case, their strategic maneuvering has derailed. If persuasive 
rhetoric is an important technique in their public performance, the question is:
How do life scientists’ strategic maneuvers in upstream public deliberation 
NEST-ethical issues relate to the pragma-dialectical discussion norms?
In addition to persuasive rhetoric, Hilgartner draws attention to a second technique 
used in the dramaturgical analysis: impression management. As Goffman defines, 
impression management is about how people present themselves to the public in 
an attempt to get the public to see them as they want to be seen. It refers to “the 
ways in which he [!] guides and controls the impression [the public] form[s] of him 
and the kind of things he may or may not do while sustaining his performance before 
them” (Goffman 1959: ix). This concept has also been used in sociological studies of 
scientific advisory bodies (Hilgartner 2000; Bijker et al. 2009).
 To get a hold on how participants of upstream public deliberation control 
information and how they constitute a public character or persona, studying the 
behavior of participants on stage does not suffice. To understand the goals and 
strategies in deliberative settings that drive their contributions, one needs to relate 
the discourse participants produce with their off stage behavior. Thus, one can learn 
how life scientists manage their impressions on stage by looking behind the scenes 
as well.
How do life scientists participating in upstream public engagement on NEST 
present themselves as dramatic personae?
— Facilitators of upstream public deliberation as dramaturgist
The theatrical metaphor also sheds light on a second aspect of the production 
process behind the scenes of upstream public engagement: its dramaturgy. Calling 
attention to the dramaturgical work of facilitators of public engagement puts the 
work of practitioners, social scientists and philosophers in the spotlight. As some 
have argued, social scientists and philosophers have a robust role to play in the 
production process of public engagement with science and technology. “Potentially 
this would involve social sciences becoming, modestly, actors in those worlds and 
not only observers and commentators of them” (MacNaghten et al 2005: 287).
 However, when social scientists and philosophers claim their part in organizing 
upstream public engagement perhaps they are dramaturgists rather than actors. 
Indeed, as Maarten Hajer writes, public deliberation is a form of dramaturgy and 
the scripting, staging and setting of a deliberative event affects the performance of 
deliberators (Hajer, 2005). How to do deliberative democracy is not a settled issue. 
This prompts a reflective turn that is addressed in the last research question of this 
thesis:
How does the dramaturgy (its scripting, staging and setting) of upstream 
public deliberation affect the performances of participants and the quality of 
deliberation?
— Methodological approach
To study deliberative action I organized two deliberative events at the LUX that I present 
as case studies in this book. The first case study is a series of three public discussions 
on behavioral genetics/genomics, each of which had a particular psychiatric disorder 
(Attention Deficit Hyperactivity Disorder (ADHD), delinquency and Autism Spectrum 
Disorder (ASD) as its focus. Behavioral genomics was considered to be a controversial 
field of biomedical research that could spark discussion. Similarly, the second case 
study is a public deliberation on the moral desirability of new omics technologies 
in the early detection and prevention of type two diabetes. In all of these public 
discussions life scientists were invited to engage into dialogue with representatives 
of the public and the public itself (people visiting LUX). In the table below, more 
details about the discussions are presented (see Table 1.1).
 To find answers to the abovementioned research questions, I employ a range of 
both quantitative and qualitative research methods for data collection and analysis: 
questionnaires, interviews, document analysis, discourse and argumentative analysis 
and ethnography. Discourse analysis is a diverse and complex field in the social 
sciences that is difficult to grasp. Discourse analysis can be defined loosely as the 
qualitative study of language use (both spoken and written) in social interaction. 
It is concerned with how people act as they speak (or write). In addition to a 
communicative goal, language allows us to do things and to be things (cf. Gee 2010). 
As I will argue in Chapter 4, in my view discourse analysis also comprises the study 
and analysis of argumentation as part of everday discourse, even though the fields of 
argumentation theory and discourse analysis are separated. The empirical object of 
study of discourse analysts is written or spoken discourses that can be preliminarily 
defined as particular ways of talking about and understanding the world (or an 
aspect of the world; cf. Jørgensen and Phillips 2002; see also Chapter 4). In Chapters 
3 and 4 I will present a more detailed framework of analysis.
 Since its history and origins are too complex to provide a conclusive definition 
of what ethnography entails, I follow the strategy of Hammersley and Atkinson 
(2007) to describe the term based on what ethnographers do. One of the most 
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important features of ethnographic work is to study people’s actions in everyday 
situations and their accounts thereof. Originally used to study foreign cultures in 
cultural anthropology, ethnography is by now widely used to study communities, 
(sub)cultures and practices on site such as scientific laboratories (e.g. Latour and 
Woolgar 1979, Gilbert and Mulkay 1984), hospitals (e.g. Mesman 2008) etcetera. 
Unstructured and semi-structured interviews, informal conversations, field notes, 
memory and participant observation are typical research methodologies that 
ethnographers employ. Participant observation is a method of data collection that 
is used through a close and intensive, long-term involvement in the social practices 
in which the people ethnographers study interact. Recordings of the observations as 
written field notes are important empirical data. Participant observation is typically 
used to gain access to practices that normally remain unaccessible; to reduce the 
people’s reactivity as a result of being observed; to better understand what really 
happens in certain practices (Kawulich 2005). The vantage point of a facilitator 
working as a dramaturgist of upstream public deliberation enables such a close 
examination of the practice of upstream public deliberation and the people who 
enact it.
In this study, I adopt the following research design (see Figure 1.1). This figures 
depicts the different moments of data collection and data analysis and their 
interrelationships during the organization process of the deliberative events at the 
LUX from the very start (doing research for finding a suitable issue for discussion) 
to the very end (the closing remarks of the facilitator of the deliberation). As I will 
discuss in the conclusion section of Chapter 5, I added a few elements to extend 
data gathering and analysis (indicated in green). Together, the collected data and the 
analysis thereof results in the reconstruction (“thick description” of you will) of the 
deliberations at the LUX, which I present in Chapters 5, 6 and 7 (see below for a short 
introduction into these chapters).
To study life scientists’ strategic maneuvers in upstream public deliberation, I use first 
and foremost transcriptions of the texts produced during the deliberative events at the 
LUX as empirical data. To reconcile the methodological differences between pragma-
dialectics and most branches of discourse analysis, I have decided to represent the 
texts ad verbatim.7 For a proper reconstruction of the discourse, other empirical 
sources were added: interviews after the events at the LUX (to clarify occasional 
ambiguities), video-recordings (to analyze non-verbal communication) and written 
documents (scientific articles, newspaper articles or philosophical literature) that 
were explicitly referred to during the discussions (intertextuality) or that constituted 
the macro-context. Subsequently, these transcriptions were systematically analyzed 
in terms of strategic maneuvering. I also use additional ethnographical material (in 
particular interviews) to study life scientists’ own reflections on their performances, 
intentions, rhetorical aims and experience. After the public engagement activity, I 
conducted interviews with the participating scientists in which we discussed selected 
passages of the video-recordings that were shown to them. The transcripts of the 
deliberative events at the LUX were analyzed using the framework developed in 
Chapters 3 and 4.
 To study the impression management of the life scientists, I compared 
the discourse analysis of the transcribed public deliberations (particularly the 
constructions of their identity) with the analysis of the preparatory interviews I 
conducted with every participating scientist. Ethnographic material (interviews 
afterwards, personal observations and the notes of several observers) was 
additionally analyzed and coded to investigate the differences between backstage 
and front stage behavior.
 The effects of the dramaturgical work behind the scenes were studied in two 
steps. Firstly, the organizational process was reconstructed by means of a document 
study. I closely examined all the documents that were produced directly or indirectly 
in the course of the organization of the deliberative events: draft versions of scripts; 
briefings for participants; promotional texts; e-mail correspondence; journalistic 
accounts of the events published on the website of the LUX. Secondly, questionnaires 
as well as interviews with participants and members of the public were used as a 
7 Pragma-dialectical argumentation theory and for example discourse psychology differ 
considerably as far as empirical data are concerned. Pragma-dialectics offers four 
different transformations that are used to reconstruct the argumentative discourse. 
Text can be deleted when considered irrelevant, added when relevant parts remain 
implicit, substituted by unambiguous text or parts of the text can be rearranged 
(permutation) in order to prepare the discourse for analysis and evaluation (see 
Van Eemeren and Grootendorst 2004: 100-110). In discursive psychology, on the 
other hand, recordings of conversations and discussions are transcribed following 
sophisticated notation conventions so as to include overlapping text, (micro)pauses, 
pitch and emphasis, laughter, error corrections and even unclear speech (cf. Veen et al. 
2013).
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source to study the effects of the dramaturgical work For a more detailed and 
quantified overview of the data collected in the two case studies, I refer to Appendix 
A. For the details of the questionnaires, see Appendices B, G and H. In Appendix D 
the interview guide with one of the participating life scientists is demonstrated.
The final remark about my methodological approach is about the iterative research 
design I chose. This means that the results of the evaluation of one deliberative event 
inform the design process of the next. So, I first reconstruct, analyze and evaluate 
the deliberative process. Subsequently, I develop strategies to improve the next 
upstream public deliberation. Finally, the effects of these interventions – both front 
stage and backstage – are closely examined. The analysis and evaluation of this 
second round constitute the basis for new interventions. In this dissertation I present 
one complete “loop.”
1.5 Outline of the thesis
In Chapter 2 I explore the problem setting in depth. I develop two perspectives 
on the quality of upstream public deliberation on ethical issues emerging from 
NEST. First, I discuss the discursive perspective. Drawing on the theoretical work of 
deliberative democracy (esp. the work of Gutmann and Thompson), I argue that 
the central procedural principle of reciprocity indicates an important direction for 
a conception of discursive quality. According to the principle of reciprocity people 
who morally disagree have to find mutually acceptable reasons to justify a mutually 
binding decision. As deliberative democrats hold, the quality of deliberation is about 
the quality of the reasons given to defend a particular (science) policy. However, the 
theories of deliberative democracy do not elaborate a theory how to analyze and 
evaluate everyday argumentative discourse.
 As I will argue, literature in STS on the evaluation of public participation with 
science is not helpful either. Dominant evaluative frameworks have an eye for the 
input quality criteria of public engagement (e.g. inclusiveness and representativeness) 
and output quality criteria (e.g. influence on policy agendas) but fail to address 
the throughput quality of public deliberation, i.e. the quality of the deliberative 
process itself. Furthermore, I assert that the few attempts to develop instruments to 
determine the quality of deliberation within political sciences are methodologically 
problematic and/or are hardly useful for the task of facilitators to direct the discussion 
towards deliberation.
 Secondly, I discuss the performative perspective on quality public deliberation. 
Drawing on Actor Network Theory (esp. the work of Gomart and Hajer), I argue that 
methodologies or “technologies of community” used for facilitating upstream public 
deliberation on NEST are not neutral instruments that only produce an unbiased 
representation of consensus. Just like other technologies, these methodologies affect 
the outcome. Using the work of Hajer (2005), I elaborate the dramaturgical concepts 
scripting, staging and setting introduced to analyze how the work behind the scenes 
affects the public deliberation process. I use the example of the widely applied 
consensus conference to illustrate how the role of scientists as neutral, distanced 
information provider is scripted in this public engagement methodology. Empirical 
research demonstrates, however, that some scientists feel restricted in this role as 
information provider. They also wanted to act as an issue advocate (Burchell et al. 
2009), but the format of the consensus conference does not allow scientists to play 
this role. So, the dramaturgical setting of the consensus conference co-determines 
what can be said. Furthermore, I argue that this role as information provider does 
not concur with the characteristics of modern knowledge production.
In the next two chapters, I introduce the pragma-dialectical argumentation theory 
that provides a normative framework to reconstruct, analyze and evaluate everyday 
argumentative discourse to complement existing evaluative frameworks of public 
participation. In Chapter 3, I investigate the first set of research questions: what 
are the pragma-dialectical norms for upstream public deliberation on NEST-ethical 
issues emerging from the life sciences? What dialectical instruments can be derived 
from pragma-dialectics to direct the discussion towards deliberation? First, I focus on 
the dialectical dimension of argumentative discourse in general. Using the pragma-
dialectical model of critical discussion that serves as a normative framework to 
evaluate argumentative discourse, I discuss the norms of a reasonable discussion, 
a set of norms discussants have to observe in order to resolve their difference of 
opinion. I particularly pay attention to the quality of the reasons that people give 
to substantiate their claims. As pragma-dialecticians hold, argumentation needs to 
be confronted with a maximum of doubt. This means that standpoints can only be 
deemed conclusively defended when the protagonist has satisfactorily answered a 
set of critical questions that different argumentation schemes raise.
 Second, I focus on the dialectical quality of argumentative discourse in public 
discussions and controversies on the ethical issues emerging from NEST in particular. 
Since pragma-dialectics is not particularly concerned with these NEST-ethical 
discussions, I draw on Swierstra and Rip’s so-called NEST-ethics, a description of 
recurring moral argumentation patterns in public debates on NEST. I subject these 
argumentation schemes – particularly pragmatic argumentation, deontological and 
justice argumentation – to the norms of critical discussion to derive a set of critical 
questions that need to be satisfactorily answered in order to conclusively defend 
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claims based on these argumentation schemes. Together, these critical questions (or 
stock topics) constitute a taxonomy of matters of concern that can be at issue in a 
public controversy on NEST. This taxonomy, I argue, is an instrument to increase the 
quality of public deliberation on NEST. I illustrate the conceptual work in this chapter 
with a recent public controversy on a new biotechnological innovation: the genetic 
modification of agricultural products using genetic material from biologically related 
species (cisgenesis).
In Chapter 4, I focus on the rhetorical dimension of argumentation. First, I explore 
the first part of the second research question doing a literature review: how do (life) 
scientists strategically maneuver in public discussions on NEST based on discourse 
analytical studies in STS? To investigate this research question, I discuss the pragma-
dialectical concept of strategic maneuvering that is central to pragma-dialectical 
argumentation theory. Strategic maneuvering is defined as keeping the delicate 
balance between the rhetorical aim for effectiveness in argumentative discourse 
and the dialectical aim of maintaining reasonableness as discussed in the previous 
Chapter 3. To have their standpoints accepted, participants in discussions can employ 
several discursive strategies in addition to argumentation as pragma-dialecticians 
define it.
 Since pragma-dialectics is not specifically concerned with public discussions 
on NEST, I present the results of a literature review of studies that have rhetorical 
devices that advocates and opponents of NEST use as their focus. These studies use 
Discourse Analysis (or DA for short) and, as I will argue, these studies in DA are useful 
because of their focus on a) the rhetorical function of constructed versions of the 
(social) world and b) other discursive strategies than argumentation (in the pragma-
dialectical sense) alone. From these studies in DA I identify three types of strategic 
maneuvers that frequently recur in public discussions on NEST and can be expected 
to be utilized: boundary work, subject positioning and future expectations. Next, I 
investigate the second part of research question 2: how these strategic maneuvers 
relate to the dialectical dimension of reasonableness, as discussed in Chapter 3. 
Again, I illustrate how these strategic maneuvers were used in the Dutch public 
controversy on cisgenesis.
In the next three chapters I present the empirical analyses and evaluations of the 
face-to-face upstream public deliberation on ethical issues emerging from new 
life sciences and biotechnologies I have facilitated. Using a) Hajer’s dramaturgical 
concepts of scripting, staging and setting as discussed in Chapter 2, b) the pragma-
dialectical model of critical discussion, elaborated in Chapter 3 and c) the strategic 
maneuvers in NEST-ethical discussions as identified in Chapter 4, in Chapter 5 I 
analyze three public deliberations on the ethical implications of behavioral genomics. 
The analysis of these deliberative events is chronological to demonstrate how the 
experiences after one event informed the interventions of the next.
 First, the performances of the life scientists on stage are reconstructed and 
analyzed in terms of strategic maneuvering and evaluated according to the model of 
critical discussion (Research Question 2). As I will demonstrate, future expectations 
concerning the technological feasibility of applications of behavioral genomics (e.g. 
genetic tests for autism, risk assessment tools for measuring recidivism) proved to be 
an effective strategic maneuver in these deliberative events. The future visions that 
scientists constructed closed down critical discussions on the moral desirability of 
these new technological innovations.
 Second, the influence of the dramaturgy of these public deliberations in terms 
of scripting, staging and setting is investigated (Research Question 4). The empirical 
analysis of the events in LUX shows that casting (choosing the characters in the 
play), scripting (who is to speak first) and staging (the public as active participants) 
influence the course of the discussion.
Finally, I discuss two strategies that can help facilitators to open up a more meaningful 
deliberation on the moral desirability of NEST.
Chapter 6 is a detailed description of the dramaturgical work performed behind the 
scenes of an upstream public deliberation event on new knowledge and technologies 
in molecular biomedicine (in particular, integrative personalized omics profiles or 
iPOPs). Firstly, I present how I implemented the two strategies identified in Chapter 
5 as an attempt to improve the quality of the discussion. During preparation, I 
used the stock topics derived in Chapter 3 as well as the rhetorical parameters for 
constructing the future as discussed in Chapter 4, to systematically and critically 
assess the argumentation advocates advance to defend the moral desirability of 
these new biomedical technologies based on the literature and on interviews with 
participants. In addition, I applied the critical questions that pertain to appeals to 
authority to assess claims about the technological feasibility of iPOPs. Both these 
assessments were used in the information package to prepare the panelists in the 
forum discussion.
 Secondly, I describe the dramaturgy of the deliberative setting (the framing of 
the issue, the casting of participants, the scripting and staging of the event) and 
how it affected the performance of participants (Research Question 4). This detailed 
description demonstrates the practical entanglements of facilitators of upstream 
public deliberation: the tradeoffs as a result of  the application of abstract normative 
criterions concerning the quality of public participation.
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In the final empirical chapter, Chapter 7, I turn the spotlight again to the stage 
performance of the life scientists participating in the public deliberation the ethical 
issues concerning the introduction of the iPOP to the preventive care of type 2 
diabetes. In this Chapter, I investigate again how the life scientists strategically 
maneuvered in this public discussion and how these maneuvers relate to the pragma-
dialectical model of critical discussion (Research Question 2). The reconstruction, 
analysis and evaluation of the public dialogue in LUX demonstrate, first, that my 
dramaturgical and dialectical interventions as facilitator positively affected the 
deliberative quality. The moral desirability of iPOPs was discussed.
 Secondly, I closely examine the strategic maneuvers the participating life 
scientists used to manage the public’s impressions (Research Question 3). The 
analysis of the argumentative discourse also shows that all three participating life 
scientists employed the theatrical technique of impression management to position 
themselves as advocates in the discussion without having to publicly divulge their 
personal convictions that corresponds to the views of their opponents. Even though 
the dialectical dimension of a reasonable discussion was respected, their impression 
management does not fully accord with the principles of deliberative democracy 
discussants have to respect when moral disagreement is deliberated, I argue. Finally, 
I also discuss how the deliberative setting contributed to their behavior, addressing 
Research Question 4.
In Chapter 8, I reflect on how the main research findings of this study can be used 
to intervene in public discussions on the moral desirability of NEST to realize, 
improve or maintain the quality of deliberation. I also reflect on the requirements for 
professionalizing facilitators of upstream public deliberation on NEST.
2
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2.1 Introduction
“Put simply, we recommend the introduction of structured ways of appraising the 
projected benefits of innovation. This means […] a shift from expert-dominated to 
more open deliberative science-informed institutions on ethics, risk and innovation” 
(Felt et al. 2007: 11; italics KD). This was one of the main conclusions from the 
report Taking European Knowledge Society Seriously (2007), published by a group 
of authoritative scholars in the field of Science and Technology Studies (STS).1 Their 
research expertise lies in public controversies involving science and technology and 
the questions that scientific and technological innovation poses for democracy. The 
European Commission had appointed them to “analyze the growing uneasiness 
which affects the relations between science and society and to explore ways to 
develop constructive interactions between techno-scientific expertise and public 
concerns” (Felt et al 2007: 14). The main conclusion of the expert group illustrates a 
commitment to the theoretical conception of deliberative democracy and its central 
principle of reciprocity (see Section 2.3.2). Not only does the public need to be 
engaged with science, but in turn, the scientific community has to engage with the 
public (cf. Borchelt and Hudson 2008; Gibbons 1999).
 This adage of more public deliberation had already resonated in governance 
circles as well as the scientific community. In 2000, the House of Lords already 
observed in their Third Report on Science and Society, that “science is beginning […] 
to move out of the laboratory and into the community to engage in dialogue aimed 
at mutual understanding” (House of Lords 2000: 5.1). And in 2004, the editors of 
Nature argued that the image of the public as a “babbling hag” has become obsolete. 
1 Sheila Jasanoff (Jasanoff 2003, 2004, 2005), Ulrike Felt (Felt et al. 2008, 2009), Brian 
Wynne (2001, 2005, 2006, 2007), Michel Callon (Callon et al. 2009), Andy Stirling 
(2008) among others.
chapter 2
See-through public engagement
A discursive and a performative perspective on the 
quality of upstream public deliberation
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They enthusiastically endorsed the need to engage the public as soon as possible 
even though the numerous mechanisms have not yet been properly evaluated 
(Anon. Nature 2004: 883).
 However, as the authors of the EC report observe, the effectiveness of all these 
engagement endeavors is poor, or at least uncertain. They rhetorically ask: “how if 
at all [has] this momentous collective effort on public engagement [with science] 
helped – or hindered – its various sponsors and users, including policy-makers, 
innovators and scientists, to better understand ‘the public’ in such issues?” (Felt et 
al. 2007: 56). How public participation has been  performed has counter-productively 
added to the public unease it was supposed to reduce, the members of the EC 
advisory group indicate. Simply involving the public is not enough. Rather, a more 
meaningful interaction between science and society is needed. As one of the authors 
had written earlier, “technologies of humility” are needed for a “richer deliberation” 
(Jasanoff 2003: 240). This call for “humility” is also directed towards practitioners 
and social scientists who are in favor of more public deliberation, but who have 
been focusing too much on the “hardware” of deliberative methodologies, such as 
consensus conferences and citizens’ juries (Wilsdon et al. 2005: 19).
In this chapter I use the problem analysis of the EC report as the foundation to 
present the main research aims of this dissertation. To address the issue of more 
meaningful public deliberation on new and emerging science and technology 
(NEST) as articulated in the EC report, I elaborate two perspectives on the quality of 
deliberation. Both perspectives are crucial in the work of organizing public dialogue 
off stage as well as the work of facilitating dialogue on stage: a discursive and a 
performative perspective.
 Before elucidating the discursive perspective, I first explicate the principally 
implicit link between STS literature on upstream public engagement and particular 
conceptions of deliberative democracy. More specifically, I claim that the problem 
analysis of (European) science and technology governance, as developed in the work 
of Brian Wynne and others (Section 2.2), is reverberated in the work of Gutmann 
and Thompson who have developed a problem analysis of economic conceptions 
of democracy (Section 2.3.1). However, whereas the normative position of public 
engagement literature in which the democratization of science is advocated 
or presupposed remains mainly unarticulated, the conception of deliberative 
democracy of Gutmann and Thompson indicates a valuable criterion of quality of 
deliberation: reciprocity. Since this procedural principle pertains to the “process of 
seeking […] mutually justifiable reasons and reaching mutually binding decisions on 
the basis of those reasons” (Gutmann and Thompson 2004: 134), deliberative quality 
is about the quality of argumentation and reasons advanced to defend particular 
(science) policy (Section 2.3.2).
 In Section 2.4, I argue that this discursive perspective on quality is omitted in 
dominant evaluative frameworks of public participation in STS literature (esp. 
Rowe and Frewer 2004). Attempts to investigate the quality of argumentation 
in deliberation in empirical deliberative democracy literature, on the other hand, 
are methodologically problematic and empirically inaccurate. I illustrate this claim 
drawing on the Discourse Quality Index (DQI) developed by Steenbergen et al. 
(2003). My claim is that both shortcomings indicate that developing a conception of 
quality of deliberation as quality of argumentation is needed.
 In Section 2.5, I discuss the performative perspective on public deliberation. 
Whereas most attention in the little STS literature on the process of deliberation 
is devoted to the action – (argumentative) discourse – the “dramaturgy of public 
deliberation” (Hajer 2005) is mostly overlooked. Drawing on the work of Emilie 
Gomart and Maarten Hajer, I emphasize the experimental character of public 
deliberation events (and its unpredictable outcomes) and the effects of the script, 
staging and setting of deliberation on the performance of its participants. Using 
examples from empirical studies in STS on how public deliberation is performed, I 
illustrate that the way public engagement with science is enacted affects the quality 
of the deliberation. Particularly, I use the example of the consensus conference to 
indicate how the staging of scientists exclusively as distanced and disinterested 
experts also determines what can and cannot be said. Therefore, I emphasize the 
importance of including the organizational process and its effects in the analysis of 
deliberative sessions. It is also time to look behind the scenes of what practitioners 
and social scientists who act as dramaturgist in public deliberation settings do. In 
Section 2.6, I formulate the two central research aims of this dissertation.
2.2 STS normative commitment to public deliberation
In the EC report, STS scholars Ulrike Felt, Brian Wynne, Sheila Jasanoff, Michel Callon 
and others offer an alternative analysis of the underlying problem behind public 
controversies on science and technology, which builds on prior academic work within 
STS which is referred to extensively. How can the public unease, resistance or even 
hostility towards science and technological innovations be explained, the authors 
ask? The problem is not as is often suggested the public who are frequently portrayed 
as being generally anti-science mainly because of their scientific illiteracy. Large 
surveys indicate, oppositely, that the European public is quite enthusiastic about 
science in general. This so-called deficit model came to be the dominant paradigm for 
understanding public controversy. If the public’s understanding of science is improved, 
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the resistance towards science and technology will decrease, the general line of 
argument was. This thinking was effectuated in policy (see e.g. Bodmer report 1985). 
As social scientific research in the public understanding of science has indicated, this 
public deficit paradigm has proven to be problematic. More public understanding of 
science does not automatically result in less uneasiness. Furthermore, in particular 
scientific contexts, citizens have proven to possess valuable sources of knowledge 
and information (Irwin and Wynne 1996).
 Contrary to this explanation, Felt et al. argue that the dual-track governance of 
science and technological innovation in most European countries is problematic. 
On the one hand, there are investments in scientific research and technological 
innovation that should stimulate national and European knowledge economies 
(governance of science). On the other hand, there is scientific expertise which is 
called in for assessing and calculating the risks resulting from these new technological 
innovations, to address and reassure public concerns (science for governance). Thus, 
a particular problem framing is imposed as Wynne has repeatedly argued (Wynne 
2001, 2003, 2006; Leach, Scoones and Wynne 2005): policy makers perceive the 
possible negative effects of technological innovation as constitutive for the main 
public concern. These effects are reduced to scientifically predictable and calculable 
variables: risks.
 The reduction of public concern to scientific risks is problematic for two reasons, 
Felt et al. argue. First, risk is an equivocal concept: risks cannot be scientifically 
objectified, they are uncertain and even embody normative values. Subdividing risks 
analytically into simple, complex, uncertain and ambiguous risks (cf. Bijker et al. 2009), 
even supposedly simple risks do not meet the cognitive values of predictability and 
control, as Wynne has shown in his famous Cumbrian sheep farmers case study 
(Wynne 1992). Complex risks, such as the effects of the introduction of genetically 
modified crops in developing countries on sustainability or economic growth, are 
even more difficult to assess. Should these effects count as risk in the first place?2 
What the risks are cannot be solely determined on scientific standards alone. Neither 
can the issue of acceptability. Here too, normative considerations are decisive in 
defining the level at which risks are acceptable. Uncertain risks, such as the health 
effects of nanoparticles, are unknown by definition, because assessment frameworks 
are still lacking or scientifically controversial at best. In sum, questions such as “What 
are the risks?”, “Are GMOs crops safe for food consumption?” and “What are the 
2 In Chapter 6 and 7 I demonstrate the different perspectives on the ethical issues 
concerning predictive and preventive biomedical technologies.
health risks of nanotubes?” are difficult to answer.
 What is more, a scientific definition of these risks frames the issue, which is the 
second reason why this science for governance is problematic. Framing entails the 
selection of “some aspects of a perceived reality and make them more salient [..] in 
such a way as to promote a particular problem definition […] [and] moral evaluation” 
(Entman 1993: 52). It limits the perspective on public issues concerning science 
and technology to “downstream” effects or output. This reflects the technological 
deterministic purport of the linear argument which prevails as master narrative in 
European science governance culture, Felt et al write. It presupposes that scientific 
and technological developments are autonomous, indifferent towards social 
influence, but with serious societal impacts (see Section 4.2.2 for an elaboration of 
technological determinism as a rhetorical device). Regulation and policy are directed 
towards prevention or mitigation of potential negative consequences. Scholars in 
STS, however, have made an effort to demonstrate that, contrary to technological 
determinism, science and technology are also the result of social work. This is 
captured in the idiom of co-production (Jasanoff 2004; Harbers 2005; Rip et al. 1995). 
“Briefly stated, co-production is shorthand for the proposition that the ways in which 
we know and represent the world (both nature and society) are inseparable from the 
ways in which we choose to live in it. Knowledge and its material embodiments are 
at once products of social work and constitutive of forms of social life; society cannot 
function without knowledge any more than knowledge can exist without appropriate 
social supports” (Jasanoff 2004: 2-3).
 The effects of science and technology are also intended even though not all 
consequences can be anticipated in advance. A technological artifact embodies 
particular values and beliefs. In terms of Actor Network Theory, it contains a 
script, a particular “vision of (or prediction about) the world” (Akrich 1992: 208) 
that innovators inscribe in their products even though anti-programs reflect the 
conflicts between intended use and actual use. The design of technologies (Winner 
1986; Bijker and Law 1992), their proper functioning (Akrich 1992) and their use 
(Oudshoorn and Pinch 2003) cannot be understood apart from society. “Scientific 
knowledge […] both embeds and is embedded in social practices, identities, norms, 
conventions, discourses, instruments and institutions – in short, in all the building 
block of what we term the social. The same can be said even more forcefully of 
technology” (Jasanoff 2004: 3).
 Thus, the making of science is also political (ibid. p. 21). It is the result of a 
complex and contingent social process in which eventually certain values come to 
prevail over others. The public unease with scientific and technological innovation, 
the authors of the EC report argue, has its origins in the way this process is governed. 
The public is not only concerned with the output of science and technology (as policy 
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makers think), but also with the “inputs (such as imagined social purposes, needs, 
benefits and priorities) that drive innovation research in the first place” (Felt et al. 
2007: 11). The authors of the report dispute the strict separation between science 
for governance and the governance of science. The former is wrongfully based on the 
belief of objective risk assessment. The latter is dominantly based on the no harm 
principle: as long as a new technology is expected to do no evident damage (hard 
impacts), “policy and technology actors” (Swierstra and Te Molder 2012: 1052) are 
autonomous. The causality between new technology and soft impacts – according 
to Swierstra and Te Molder often the cause of public unease with new technological 
developments – is less evident. According to this liberal discourse, the technology 
developers are not accountable for that. These soft impacts, then, are not something 
they have to publicly account for.
 The classic example that demonstrates this problematic dual-track governance of 
science is the European controversy over genetically modified crops (GMOs). Social 
scientists found a large discrepancy between public perceptions on GMOs and policy 
responses (Marris et al. 2001). In a large essay drawing on the results of this study, 
Wynne (2001) argues how governmental institutions on food safety frame ethical 
public concerns about the possible consequences of GMOs as risks: are GMOs safe? 
In addition, he demonstrates how ethical advisory bodies (e.g. the Nuffield Council 
on Bioethics), in a similar vein as scientific regulatory actors, reduced deontological 
ethical issues (e.g. are GMOs unnatural?) to issues of labeling which empowers 
people to make well informed consumer choices (see Chapter 3 for a discussion of 
consequentialist and deontological moral argumentation patterns).
 These framings are in sharp contrast to the wider public issues citizens had raised 
in the focus groups study. The public challenges the tacit presumption that science is 
capable of foreseeing all possible risks and predicting them accurately. Furthermore, 
they articulated issues which cannot simply be settled in liberal terms of consumer 
choice: public accountability (“Who will be responsible in case of unforeseen 
harm?”), distributive justice (“Who will benefit from the use of GMOs?”), the politics 
of scientific innovation (“Who decided that GMOs should be developed and how?”) 
and public participation and control (“Why were we not better informed about their 
use in our food, before their arrival on the market?”).3
 Wynne comes to conclude – in his (characteristically) slightly activist language 
– that public alienation or distrust is also a result of the failure of governments and 
the scientific community to address these public issues, mostly due to a lack of 
3 These questions are reported in Marris et al. 2001.
transparency in both policy and science culture. Wynne stresses (2006) that scientists 
and policy makers themselves contribute to the problem by reinventing public deficit 
models which reflects a “lack of open institutional selfreflection” (212). Therefore, 
there is a need to “dig out the implicit human values and ethical pre-commitments 
which those cultures (including scientific culture) unaccountably reproduce and 
impose. Our task is to render the very fabric of [this] culture transparent and explicit, 
open to rational and reflexive public deliberation” (Wynne 2001: 473).
 In a similar vein, De Vries and Horstman (2007) have critically analyzed public 
discussions on innovations in biomedical technologies, particularly in predictive 
medicine. After the 1980s, in which “untenable claims” and “exaggerated 
expectations” (ibid. 6) resulted in unrealistic debate, a piecemeal approach became 
dominant: every new technology is ethically assessed separately. Based on the ideal 
of a physician-patient relationship, a liberal ethics perspective was guiding, too. Issues 
were displaced to the private sphere and reduced to matters of informed consent, 
the equal of consumer choice in medical ethics. The individual patient, equipped 
with reliable and complete information, must make his or her own decision. Liberal 
ethics has the advantage that it provides a “political solution in situations where 
general consensus […] may not be expected” (ibid. 10), but important secondary or 
indirect public issues are neglected. And since health care consumers have only the 
exit option, only hard lessons are learnt, De Vries and Horstman argue. Therefore, 
they argue in favor of the organization of voice to stimulate (soft) social learning 
processes.
Opening up the process of defining problems – be it in terms of risks or in terms 
of ethics – for public deliberation is the main message of the 2007 EC report. Even 
more so, since scientific innovation is likely to intensify as it is the ambition of the 
European Union to become the most competitive knowledge economy. If public 
unease with science and technology is also and perhaps even primarily rooted in 
the input, then the governance of science must be opened up for civic involvement. 
Public deliberation has to move upstream so as to include a critical reflection on the 
social needs, benefits and priorities of scientific and technological innovation. “In the 
theatre of science and technology the time has come to dismantle the proscenium 
arch and begin performing in the round” (Wilsdon and Willis 2004: 24), so as to 
render publicly visible the backstage process of scientific and technological activity 
which is now hidden from a public view. This reflects, as I argue below, one of the 
main three procedural principles of deliberative democracy: publicity.
 Despite their commitment to the normative political theory of deliberative 
democracy, Felt cum suis do not articulate elaborate ideas of public deliberation. Nor 
do they address important questions such as why public deliberation is to be preferred 
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over other forms of political action (e.g. demonstrations, economic boycotts etc.). As 
Lövbrand et al. (2011) write: “Although the concept and ideal of public deliberation 
has gained widespread resonance in the science and society literature, few [STS] 
scholars have to date specified how their normative visions of public engagement 
with science relate to the deliberative ideals advanced in democratic theory” (487).
 My question therefore is: what is deliberative democratic theory and what does 
this theory have to offer for STS scholars who are in favor of more upstream public 
deliberation (and vice versa)? In the next section, I elaborate on the main ideas of 
deliberative democracy and I argue that advocates provide a philosophical argument 
as to why governance, as reflected in European science policy, is democratically 
problematic.
2.3 Upstream public deliberation and the principles of
 deliberative democracy
It is not self-evident to connect the work of Felt, Wynne and others with deliberative 
democracy theory. First of all, there are hardly explicit links between STS literature 
and deliberative democracy, except for the work of Hamlett (2003) and Lövbrand 
et al. (2011); Brian Wynne (2007) refers to the literature only to indicate the 
limitations of deliberation (see Section 2.4). Furthermore, the authors of the EC 
report do not explicitly refer to authoritative adherents of deliberative democracy. 
Additionally, as I will elaborate below (Section 2.4), the deliberative perspective is 
missing in dominant evaluative frameworks of public participation in STS literature, 
particularly the work of Rowe and Frewer (2000, 2004).
 To answer the question of what deliberative democratic theory entails and 
what it has to offer STS, I use the work of Amy Gutmann and Dennis Thompson 
(1996, 2004). Not only are they authoritative theorists, but they have been actively 
engaged in academic discussion with critics within deliberative democracy theory 
(e.g. Macebo 1999 which contains a set of essays in response of Democracy and 
Disagreement). Furthermore, Gutmann and Thompson offer in Why Deliberative 
Democracy (2004) a thorough elaboration in which they explicitly take position in the 
discussions between deliberative democracy and rival political theories as well as the 
main issues within deliberative democracy theory (its value, status, aims and scope). 
Finally, I show that there is no paradox between STS conceptions of democracy and 
Gutmann and Thompson’s conception of deliberative democracy, as Lövbrand et al. 
(2011) argue.
2.3.1 Linking STS to Deliberative Democracy
Deliberative democracy theory can be positioned as a response to minimally liberal 
or economic conceptions of democracy.4 According to these conceptions citizens 
have the democratic right to vote for representatives who will make decisions about 
legislation and public policy on behalf of their constituents in the usual political 
forums (parliaments). According to Gutmann and Thompson, persons in these 
conceptions of democracy are treated as “passive subjects to be ruled” instead of 
“autonomous agents who take part in the governance of their own society, directly 
or through their representatives” (Gutmann and Thompson 2004: 3).
 Three criticisms towards these conceptions, which deliberative democrats have 
advanced, can link this normative political theory to upstream public engagement. 
Deliberative democrats a) denounce the liberal preclusion of moral disagreement, 
b) reject the idea of preference (towards moral disagreement) as fixed and some of 
them – like Gutmann and Thompson – are in favor of c) extending the scope of public 
deliberation beyond usual governmental structures so as to include organizations in 
civil society (including universities and corporations).
 The first criticism is directed towards impartial principles that are currently often 
invoked to remove moral issues off the agenda of public discussion. These principles of 
preclusion, as Gutmann and Thompson call them, are originally proposed by liberals 
as a solution to religious conflict but are assumed to dispose of moral disagreements 
in pluralist societies as well. These principles constitute the foundation for the 
liberal call for toleration. As these liberals hold, there are no, and cannot be any, 
true moral beliefs (skeptical premise), and therefore the state should stay neutral 
towards any such belief (neutrality premise) and therefore, should not act (inaction 
premise). Every free individual should decide for him- or herself according to their 
own morality. Here, we recognize the criticisms of STS scholars towards the liberal 
governance of science and technological innovation. Whereas Wynne and De Vries 
et al. provide more empirically-informed reasons to challenge these principles of 
preclusion, Gutmann and Thompson advance a philosophical argumentation why 
more moral issues should be publicly discussed.
 Drawing on an alternative and, in their view, more plausible set of principles of 
4 It is important to note that deliberative democracy theory is sometimes characterized 
as liberal, too. As Mouffe (1999) writes deliberative democracy is “the most recent 
paradigm of liberal democratic theory” (745). Gutmann and Thompson adhere 
to a version of deliberative democracy which is liberal pluralist as opposed to a 
communitarian variant. Therefore, I chose to define aggregative forms of democratic 
theory as “minimally liberal”.
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preclusion (based on the work of John Locke) to decide which moral issues belong 
to the political agenda, Gutmann and Thompson conclude that these Lockean 
principles are more adequate than the aforementioned modern version but they 
“will not preclude as much nonreligious moral conflict as contemporary liberals claim 
to exclude” (Gutmann and Thompson 2004: 70). According to these principles, many 
moral positions should not (only) be tolerated, but should be subject to collective 
moral deliberation. Gutmann and Thompson illustrate their position using the 
example of abortion, but their argument also works well when applied to cases of 
NEST which evoke religiously inspired counterarguments (GMOs, stem cell research 
and pre-implantation genetic diagnosis to name a few).
 The second criticism concerns how moral disagreement is dealt with once it 
appears on the political agenda. Deliberative democrats favor public deliberation 
among free and equal citizens (and their representatives) which is considered to 
be a condition sine qua non for a legitimate resolution of moral disagreement. It 
performs better than so-called first-order theories of justice (utilitarianism, liberal 
egalitarianism, communitarianism) or second-order theories which are purely 
procedural in nature, such as aggregative conceptions of democracy.
 Common theories of justice are (first-order) moral theories about how to deal 
with moral disagreement, each of which “individually claims to resolve moral conflict 
or at least to provide a basis for resolving moral conflict” (ibid. 126). Some proponents 
of genetically modified crops, for instance, argue in utilitarian terms that it is unjust 
not to use GMOs in developing countries because the benefits of improving food 
production to alleviate hunger outweighs the (potential) risks of GMOs and thus, 
maximizes utility. Since risk is an ambiguous concept, the calculation of benefits 
and costs is a delicate matter. Moreover, deontological arguments do not fit in this 
reasoning as different analyses of the GM debate demonstrate (see also Chapter 
3). As Gutmann and Thompson argue, utilitarianism and other first order theories 
of justice render the problem less complex but “each does so in ways that require 
rejecting those substantive principles of its rivals that conflict with its own. But taken 
together, they are manifestations of the problem of moral disagreement, rather than 
resolutions of it” (ibid.).
 Deliberative democracy, on the other hand, presents itself as a second-order 
theory which accommodates conflicting first-order theories. As opposed to other 
theories of the second order – mainly procedural such as majoritarianism, which 
states that the majority should decide by voting – deliberative democrats do not take 
the preferences of people as fixed or given. Majority rule and similar supposedly 
neutral procedural principles, which aggregates the preferences of people, have the 
advantage of producing determinate outcomes and contain relatively uncontroversial 
procedures, but they might produce unjust outcomes and reinforce power balances. 
Deliberative theorists assume that preferences are not given, but are constructed 
as the result of a reasonable, well-informed deliberation process. Initial preferences 
can (and will) be revised during such processes. Here, some suggest an explicit 
overlap between deliberative democrats and (social) constructivists: “The literature 
on deliberative practices […] shows clear affinities to social constructivism” 
(Hamlett 2003: 134).
 The third criticism deals with the fact that many important decisions that affect 
people’s lives are taken outside the usual political arena. Even though the theory of 
deliberative democracy that Gutmann and Thompson developed applies primarily 
to the usual political contexts (national parliaments and comparable more or less 
representative governmental bodies), Gutmann and Thompson are proponents 
of broadening the scope of their conception of deliberative democracy beyond 
the realm of “ordinary politics” so as to include civil society organizations such as 
corporations and universities for which “deliberation still may be desirable” too 
(Gutmann and Thompson 2004: 35).
 This reflects the ideas of the STS scholars of the EC report who recommend 
stimulating public deliberation in innovation trajectories. Their idea of governance 
includes not only “formal ‘policy’ performed by ‘policy institutions’” but also “agents, 
collectives and networks of civil society” (Felt et al 2007: 14-5). Crucial decisions in 
the governance of science and technology are frequently made outside the domain 
of democratically elected, representative and accountable politicians. Empirical 
studies in STS have demonstrated that national governments sometimes have to deal 
with the politics of science and technology as loci of displaced or dispersed politics 
(Bovens et al. 1995) or sub-politics (Beck 1997). In the Netherlands, for example, the 
minister of health was left little room for maneuvering in the political debate about 
the legislation for regulating prenatal screening because it was already established 
as a practice. In a large clinical trial to obtain relevant statistical data for scientific 
research to improve prenatal screening, scientists recruited many women to 
participate. What initated as a scientific experiment gradually evolved into standard 
medical practice before public issues such as the medicalization of pregnancy were 
addressed (Popkema and Harbers 2005).
 To conclude, I have argued that there are good reasons to link deliberative 
democracy theory and STS. Gutmann and Thompson’s alternative to economic 
conceptions of democracy –  with its tendency to privatize public moral issues and to 
consider individual preferences as fixed –  and their advocacy to broaden the scope 
of deliberation so as to include dispersed political “arenas” (such as industry and 
universities), shows what they have in common with the authors of the EC report. 
Nevertheless, Felt and other STS scholars, who are in favor of upstream public 
deliberation, give only scarce clues as to why deliberation is to be preferred and 
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what public deliberation entails. In the next subsection, I elaborate on the central 
concepts that Gutmann and Thompson develop, why deliberative democracy is to be 
preferred and how these concepts indicate the direction of quality assessment.
2.3.2 The quality of argumentation as quality of deliberation
Primarily, deliberative democracy is a theory about a fair process of decision-making, 
although Gutmann and Thompson hold the view that apart from procedural principles 
substantive principles are also needed (in their case: basic liberty, basic opportunity 
and fair opportunities). The principle of reciprocity is the primary prerequisite of 
fairness. This principle holds that, “citizens owe one another justifications for the 
mutually binding laws and public policies they collectively enact” (Gutmann and 
Thompson 2004: 98). This also applies to the mutual acceptability of the principles 
themselves that guide the process of political agreement seeking; these principles 
are both morally and politically provisional. Deliberative democracy prescribes how 
people who morally disagree should engage in a discussion and test the reasons 
they give and revise their opinions and preferences in the light of new information 
and arguments that others advance (principles of accomodation). Firstly, citizens 
should follow the principle of civic integrity with respect to their own position. 
Citizens demonstrate civic integrity by a) consistency of speech (espousal of moral 
positions independently of the circumstances), b) consistency between speech 
and action, and c) integrity of principle (accepting the broader implications of the 
principles presupposed by one’s moral positions). Secondly, citizens should adhere to 
the principle of civic magnanimity with respect to the moral position of others they 
oppose which means a) acknowledging the position of others as moral instead of 
political or strategic, b) demonstrating open-mindedness and c) actively seeking an 
economy of moral disagreement, i.e. a minimum of disagreement (see Gutmann and 
Thompson 1996: 81-91). Thus, practicing these civic virtues, people attest to mutual 
respect which is more active than toleration as liberals argue.  As Michael Gibbons, 
argues in his commentary in Nature, reciprocity is a requirement of a new social 
contract between science and society: “[A] reciprocity is required in which not only 
does the public understand how science works but, equally, science understands 
how its publics work” (Gibbons 1999: C83-C84).
 Additionally, reasons should be accessible to anyone to whom they are 
addressed. This means first and foremost, that the process of reason-giving must be 
public. Publicity therefore is a second major principle, which is for instance reflected 
in the motto of Demos’ pamphlet “See-through science”: “the task is to make visible 
the invisible, to expose to public scrutiny the assumptions, values and visions that 
drive science” (Wilsdon and Willis 2004: 24). According to deliberative democrats, 
publicity has certain salutary effects because people are encouraged to carefully 
articulate one’s claims and to provide reasons, to take opposing views into account 
and to adopt a public reason that is acceptable to everybody (Chambers 2003).
 The final procedural principle is accountability which mainly applies to people 
who represent constituencies or say that they speak on behalf of other people. 
Politicians, policy makers, corporate business men/women, engineers and scientists, 
representing the public interest or patients consumers’ needs, who make decisions 
that affect the lives of fellow citizens, should account for their policy choices, i.e to 
publicly explain these decisions. Therefore, Brian Wynne considers upstream public 
engagement as an “accountable process of debate over driving interests, purposes 
and expectations shaping innovation” (Wynne 2006: 216). In sum, Gutmann and 
Thompson typify deliberative democracy as an accessible process of reason-giving, 
which is aimed at producing a binding decision and which is dynamic in the sense 
that these decisions can be revised when new situations arise.
 Although deliberation is concerned with the legitimacy of collective decisions 
and its primary purpose is to reach a (provisionally) binding and mutually acceptable 
decision through a process of reason-giving, Gutmann and Thompson emphasize 
that is not realistic to expect a rational consensus over moral issues in a pluralist 
society. In this sense, they adhere to a pluralist conception of deliberative democracy 
as opposed to alternative republican or communitarian conceptions, who argue in 
favor of a comprehensive notion of the common good, which “fulfills the deepest 
moral promise of […] a form of cooperation that all citizens could accept despite their 
deep differences of identity” (Gutmann and Thompson 2004: 27). Instead, Gutmann 
and Thompson believe there are irreconcilable moral beliefs, but deliberative 
citizens should practice an “economy of moral disagreement” which means publicly 
investigate moral disagreement to minimize the rejection of opposed positions.
 Some have argued that STS scholars of the EC report which is constructivist in 
nature, and deliberative democrats are uneasy bedfellows (Lövbrand et al. 2011) since 
the aim for rational consensus is incompatible with the “the virtue of disagreement 
and dissensus (p. 479),” emphasized by the STS scholars in the EC report. There is 
a democratic paradox, Lövbrand et al. claim, for if STS scholars do not endorse the 
central principle of reason, how can they justify public deliberation as a legitimate 
form of politics? “If we do not accept reasoned consensus as the final decision rule 
for citizen-driven engagement with specialists, there is no obvious end point to the 
discursive process” (ibid. 485).
 Here, it is important to differentiate between different theories, instead of 
Lövbrand et al.’s rather monolithic account of deliberative democracy theory in 
general. Gutmann and Thompson’s pluralist understanding exhibits no claims of 
“Enlightenment-type rationalism, essentialism and universalism” (ibid. 476) as 
Lövbrand et al. (2011) state. Reaching consensus is not the only purpose of public 
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deliberation. Other purposes of deliberative democracy are to “encourage public-
spirited perspectives on public issues” (without completely giving up own interests 
or positions); “to promote mutually respectful processes of decision-making”; and 
“to help correct mistakes” (Gutmann and Thompson 2004: 10-3). Since incomplete 
understanding is one of the sources of moral disagreement, moral learning is an 
important element of deliberation. To obtain a better understanding of opposing 
views or even to acquire an overview of differences of opinion is an important 
purpose of public dialogue, that match well with Felt et al. understanding of 
deliberation, who reject forms of consensus for its own sake, that are fabricated in 
consensus conferences (Felt et al. 2007: 61).
An essential aspect of deliberative democracy therefore, is reason-giving. Hence, 
an important aspect of the work of political theorists is “to critically investigate the 
quality, substance, and rationality of the arguments and reasons brought to defend 
policy and law” (Chambers 2003: 309). So, someone who is concerned with the 
quality of public deliberation over moral and social issues in the life sciences could 
benefit from studying (moral) argumentative patterns in public discussions on (new 
and) controversial science and technology (cf. Swierstra and Rip 2007; see Chapter 
3). This thesis takes the reasonableness of argumentative discourse in upstream 
public deliberation on NEST as a starting point. What reasons do participants give 
in defense of their (moral) position? Can these reasons be assessed on their quality 
and if so, how?
 Studying the justification of reasons is an important addition to the (critical) 
discourse analytical perspective of empirical studies on public dialogue in STS 
literature (Kerr et al. 2007; Felt et al. 2009; O’Doherty and Davidson 2010; 
Wieser and Karner 2010). As I argue in the next section, influential STS literature 
on evaluative frameworks of public participation does not include the quality of 
deliberation. Suggestions from literature that does include deliberative quality, are 
methodologically problematic and empirically inaccurate and therefore cannot serve 
as a handle to answer these questions properly.
2.4 Determining the quality of deliberation
2.4.1 The quality of public deliberation as omitted evaluation criterion
With the increased interest in public engagement with science and technology, 
the awareness of the necessity to assess its quality has increased simultaneously. 
However, evaluating quality is difficult. One important reason, Rowe et al. (2004) 
indicate, is the value-ladenness of the concept of participation.5 Therefore, there 
is hardly any consensus on a set of evaluation criteria.  Indeed, there even is no 
agreement on how to call that which is being assessed. I prefer and use the notion 
of quality, but other scholars use different notions, reflecting different political-
theoretical discourses. As I explain below, this is due to the particular normative 
political theory and its premises, on which the evaluation is theoretically grounded.
 For instance Rowe and Frewer (2004), whose efforts to systematically investigate 
evaluation practices have become considerably influential in public engagement with 
science literature, talk about the effectiveness of public participation, which in my 
view is problematically narrowing quality in terms of outcomes. After their attempt to 
formulate a clear, concise but comprehensive list of criteria in 2000, Rowe and Frewer 
have adopted a different approach to the “problem of evaluation.” They propose 
a research agenda for evaluation (Rowe and Frewer 2004) which circumvents the 
difficulties concerning rigid and schematic taxonomies, leaving room for more local 
and contextualized analyses.
 Their agenda comprises a guideline of three steps to follow in the evaluation 
process. First, one has to define effectiveness – “or success, quality, or whatever 
synonym one wishes to use” (517) –  and one has to determine a) its range (universal vs. 
local), b) its users (so: whose definition is it, the sponsors’, the participants’ etc.?) and 
c) its object (process vs. outcome). Second, the definition has to be operationalized, 
i.e. measurable with social scientific instruments that are valid, reliable and usable. 
Third, the evaluation has to be conducted and the results interpreted.
 Rowe and Frewer conducted a large literature review to investigate how different 
scholars have defined effectiveness of participatory exercises. Besides the relative 
lack of systematic evaluation practices, they observe that most of the participation 
studies focus on (what Rowe and Frewer call) outcome criteria or a combination 
of outcome and process. However, inquiring into their systematic review, I think 
that the two categories they use – process and outcome – in their classification is 
problematic. It is too crude and therefore, it leaves an essential element of quality 
out of consideration: the quality of deliberation.
 I prefer the more refined quality classification that Papadopoulos and Warin 
(2007) propose. Besides input legitimacy (openness and accessibility) and output 
legitimacy (efficiency and effectiveness), their classification makes visible an 
5 As I will argue below, participation and deliberation are not necessary synonymous. I 
prefer the concept of deliberation, but I adopt here the concepts used by the authors I 
discuss.
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essential aspect according to deliberative democrats: throughput legitimacy 
(quality of deliberation).6 This classification is more sensitive to the different 
normative political theories different sets of evaluation criteria are grounded on. 
Papadopoulos and Warin emphasize the difference between “participationist” 
and “deliberationist” perspectives on quality. Although often used synonymously 
– also in the evaluation literature – public participation and public deliberation 
are not synonyms and in some readings even contradictory. Whereas deliberative 
democrats “are more attentive to the ‘throughput’ dimension of policy making”, they 
“pay less attention to practical obstacles to inclusion, problems of representation” 
(Papadopoulos and Warin 2007: 450). Participationists, on the other hand, “favor 
questions of open access and care less about the refinement of preferences likely 
to occur among participants through the deliberation process” (ibid.). For instance, 
national referenda are participatory, since they promote direct mass participation to 
important decisions, but they are, from a deliberative perspective, not satisfactory 
democratic instruments.7 Some deliberationists, on the other hand, think there is a 
trade-off between the amount of participants and the quality of deliberation. For this 
reason, some advocates of deliberative democracy have concentrated on small-scale 
projects revolving around mini-publics in order to improve the quality of the public 
sphere (Fung 2003).
 While this evaluative criteria triptych of Papadopoulos and Warin is sensitive to 
the distinction between participatory and deliberative democracy, the influential 
evaluation study of Rowe and Frewer shows that most quality criteria are in fact 
concerned with input or output and therefore they are participationist in character. 
Their own set of criteria, for example, which was adjusted after having utilized 
it for the assessment of a deliberative conference on food in the UK (Rowe et al. 
2004), are clearly evaluation criteria of public participation. Their use of the concept 
of effectiveness, with its emphasis on outcomes, is telling in this sense. “In many 
ways,” they write, “the assessment of outcomes is preferable because these will 
correspond more directly to the desired aims of the exercise. However, these may 
be difficult to ascertain in a timely manner, and outcomes may to some extent 
6 Besides these three dimensions of quality of public participation, Papadopoulos and 
Warin discern two overarching criteria disctinct from those exclusively connected to a 
certain stage of the participation process: transparency and accountability.
7 Although the announcement of a referendum will undoubtedly spark public debate, as 
for example happened in the Netherlands in 2005, when the Dutch people could vote 
in a consulting referendum on the Treaty establishing a Constitution for Europe.
also be due to other variables, such as the occurrence of simultaneous events or 
externally mediated pressures influencing policy processes. As such, evaluation of 
exercise processes must often serve as surrogate to the outcomes of the exercise” 
(Rowe and Frewer 2004: 520; italics KD). Their “dichotomy between outcome and 
process” is problematic in two ways. First, deliberative democrats do not consider 
the distinction between deliberative process and outcome as a dichotomy. The 
possibly revised preferences are an important outcome of quality deliberation. Thus, 
throughput legitimacy is no surrogate, but an essential aspect of public deliberation. 
Moreover, what Rowe and Frewer subsume under the category of “process”, such as 
representativeness and inclusion, most often concern input legitimacy. Therefore, 
deliberative quality disappears from sight in their review and research agenda.
How to determine the quality of the deliberation processes? In the next subsection, 
I will discuss a few options from scholars in the field of empirical political sciences, 
who argue that the normative presumptions of deliberative democracy should be 
tested in order to settle the academic disputes of deliberationist political theory. 
Subsequently, I will argue that these methods measuring the quality of (public) 
deliberation passes over its main characteristic: the quality of reason-giving.
2.4.2 Methods for assessing deliberative quality
A first strategy to assess the quality of public deliberation that is common in the 
literature is to enlarge and to refine the set of criteria so as to incorporate throughput 
legitimacy (De Vries et al. 2011; Edwards et al. 2008; Goodin 2005; Timotijevic and 
Raats 2007; Webler 1995; Webler and Tuler 2000; Webler et al. 2001). Drawing on 
different theoretical frameworks, there is no complete consensus on these criteria, 
although there exists a considerable overlap in criteria, as the theoretical comparison 
of “standards of good discursive practice” of Goodin (2005) shows. However, the 
operationalization of these sets of criteria – the second step of Rowe and Frewer’s 
evaluation research agenda – the practical difficulties it entails and the different 
methodological approaches scatter the consensual idea of deliberative quality. 
Whereas in some studies, evaluators used the criteria to observe the deliberation 
process (Edwards et al. 2008), others obtain self-reported perceptions of participants 
using questionnaires (Timotijevic and Raats 2007) or interviews (Webler et al. 2001) 
or a combination of these (De Vries et al. 2011). Some present their results in 
qualitative terms (quotes from interviews indicating that the standards are met or 
not), others use (quasi-) quantitative methods (Likert-scales) or counting (turns taken 
or words spoken) to indicate quality deliberation. Although most of these studies 
consider reasoning (De Vries et al. 2011), advancement of critical reasons (Edwards 
et al. 2008) or redemption of validity claims (Webler 1995) essential to public 
deliberation, the quality of reason-giving itself, however remains unquestioned. 
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Edwards et al. do not report any evaluation result regarding reasoning. De Vries et 
al. indicate that some participants did advance argumentation to substantiate their 
position. And Webler emphasizes the importance of a consensually chosen “method 
to resolve validity claim redemption disputes” but provides no suggestion what 
method could be used. To conclude, the strategy of using criteria for quantitative or 
qualitative provides important results regarding the theoretical norms and concepts 
of deliberation, but fail to provide valuable insights into quality of reason-giving.
A second strategy which reflects a more general and sophisticated approach to 
measuring the quality of deliberation, are coding strategies (Steenbergen et al. 2003; 
Stromer-Galley 2007). Both methods, although adopting different parameters, do 
not simply indicate reason-giving, the degree of engagement or respect, but try to 
indicate the deliberative quality of an entire discussion by systematically coding the 
transcribed discourse or text. These coding methods are confined to an evaluator 
perspective and leave no room for self-reported perceptions of participants. 
Steenbergen et al. (2003) developed what they termed the Discourse Quality Index 
(DQI), an instrument to quantitatively measure the quality of deliberation. In my 
opinion, their emphasis on theoretical grounds, reliability (construct validity), 
observable phenomena and wide applicability makes the DQI undoubtedly the most 
sophisticated operationalization to indicate the quality of public deliberation. They 
analyze speeches, relevant parts of public discourse that “contains a demand, that 
is, a proposal on what decision should or should not be made” (Steenbergen et 
al. 2003: 27). These speeches are coded with a 0, 1, 2 or 3, indicating the relative 
weight attached to the degree in which the speech meets a criterion. Steenbergen 
distinguishes five different categories, derived from Jürgen Habermas’ discourse 
ethics (participation, level of justification, content of justification, respect and 
constructive politics). Each speech is coded according to these measurement criteria, 
added and divided by the total amount of speeches, which results in the DQI, a 
measure of deliberative quality.
Although I endorse the ambition of Steenbergen et al. to empirically investigate 
public discourse to develop an idea of deliberative quality, I think their measurement 
apparatus is problematic, precisely because of its “construct validity” – the extent to 
which the instrument really measures what it is purported to measure, in this case, 
quality of deliberation. As Steenbergen already notes, the instrument should be 
theoretically grounded, but it is very much dependent on which particular theoretical 
grounds you choose what it is that you measure. In their case, they use Jürgen 
Habermas’ discourse ethics as the theoretical foundation, which is not undisputed. 
But apart from that, they only scratch the surface of justification of reasons. They 
rightly contend that the deliberative quality increases when the justification of 
reasons increases. But what is a “sophisticated justification”, indicating the level 
of justification? Who determines that and how? Despite its thorough foundations 
and its quantifiable and objectifiable measures that the Discourse Quality Index 
renders, it provides no further insights into the quality of argumentation, just like the 
extended sets of evaluation criteria of the first strategy.
 The discussed methods provide useful tools for researchers to assess the quality 
of deliberation afterwards (De Vries et al. 2011; Steenbergen et al. 2003) or as a 
checklist for organizers to increase fairness and competence of the communicative 
discourse (Webler 1995), but they do not provide useful tools for a) researchers to 
analyze and evaluate the quality of reason-giving nor for b) facilitators to improve 
the quality of argumentation during public deliberation (see also the practical aim 
of this dissertation described in Chapter 1). In Chapter 3, I develop a conception of 
deliberative quality, based on argumentation theory, which enables both researchers 
and facilitators to assess the quality of reason-giving substantively.
First, however, I elaborate a second, performative perspective on deliberative quality. 
As reviews on empirical studies of deliberation demonstrate, its success relies much 
on the situated conditions in which it happens (Delli Carpini 2004; Mendelberg 2002; 
Ryfe 2005). “Deliberative theorists sometimes seem to adopt an ‘if we build it they 
will come’ mentality. If we infuse a context with the right procedures and [if we] 
organize an encounter to conform to the right norms then deliberation ought to take 
place” (Ryfe 2005: 63; italics KD). Although Gutmann and Thompson do acknowledge 
the practical problems of organizing public deliberation, they do not take the effect of 
organizational considerations and design on the process of deliberation into account. 
In the next section, I elaborate performative perspective.
2.5 Scientists on stage
2.5.1 Public dialogue as experiment
The theory of deliberative democracy is not uncontested, both theoretically as well as 
practically. Some critics believe public deliberation does not work in practice. Partly 
because of social psychological effects, such as groupthink which impedes genuine 
deliberation, partly because deliberation can lead to undesirable consequences 
such as the polarizing potential, which exacerbates differences and conflict rather 
than alleviate them (Tait 2009). Some other critics claim that concrete deliberative 
encounters are biased since not everyone has equal access to the deliberative forum. 
Because of the trade-off between group size and quality of deliberation, small-size 
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deliberations are exclusive. Some even claim that the very style of reasoning and 
providing arguments, favored by deliberative democrats, contains in itself a certain 
bias excluding different types of discourse such as storytelling and greeting (Young 
1996) and excluding people who have had less chance to develop the required 
competences.
 Felt et al. (2007) demonstrate in their report they are aware of the unruliness 
of deliberative practice. In fact, they are skeptical towards the seemingly limitless 
expansion of the “big industry” of public participation. Referring to concrete 
problematic examples of organized public deliberation exercises – such as GM 
Nation? in the UK – they even suggest that the “over-concentration on the ‘hardware’ 
of engagement”, the methodologies of consensus conferences and citizens’ juries 
has also added to the public unease with science and technology. The authors stress 
the need to reflect on how public participation is enacted. Important questions 
organizers of public engagement should address are: “what are the motivations to 
organize public deliberation (solutions for what problems, solution for whom), who 
are the actors who are supposed to be participating (construction of the different 
‘publics’), how these moments of participation and encounter are conceptualized 
(the very meaning of encounter and participation), when they are supposed to 
intervene (at what moment in the R&D process)?” (Felt et al. 2007: 56-7).
 Here, Felt et al. indicate the performative perspective on public deliberation and 
the issue of form reflecting the criticism of some science studies scholars that some 
of their colleagues seem to uncritically adopt modernist procedural conceptions 
of democracy (cf. Nahuis and Van Lente 2008). Drawing on Actor Network Theory 
(ANT) Gomart and Hajer (2003) for instance attempt to turn politics into an empirical 
question in a similar vein as ANT has used this research strategy to study the practices 
of science and technologies. With empirical philosophical work in medical and 
scientific practices, ANT has drawn attention to the ability of technological artifacts 
to mediate (e.g. Mol 2000). Technologies are not neutral means of representation but 
instead, they embody or perform particular capacities to act. Ethnographic research 
is needed to describe how these scientific or technological settings determine these 
capacities. Comparably, democratic settings and methodologies such as consensus 
conferences are not neutral means of representing public opinion. How these 
“technologies of community” (Irwin 2001) are performed affects the very capacities 
of its participants. Therefore, it is important to problematize the form of public 
dialogue settings.
 Instead of presupposing how democratic politics look like a priori, Gomart and 
Hajer suggest that politics “can also be seen as a constant experimentation on a range 
of forms” (Gomart and Hajer 2003: 34). Similarly, Bruun Jensen (2005) has argued 
that Danish consensus conferences can be viewed as “democratic experiments” 
(223), a risky and experimental practice rather than a method which automatically 
produces a democratically legitimate consensus, as the Danish board of Technology 
seems to suppose. Hamlett (2003) considers the organization of deliberative events 
as “intentional and planned interventions” to experimentally perturb the process 
which can be ethnographically studied as technoscientists in their research labs.
 The notion of experiment suggests a process of mutual learning, Gomart and 
Hajer emphasize. Whereas the scientific experimenter uses an experimental setting 
to learn something about the nature of things, organizers and facilitators of public 
deliberation can learn something from the political settings they create. Gomart and 
Hajer illustrate their argument using ANT’s philosophy of ‘good’ scientific experiments, 
applied to the performance of experimental settings in psychology research on 
rat sexuality. As the size of the habitat (cages) changed, female rats in particular 
demonstrated a dramatic shift in sexual behavior. Where they were rather passive in 
smaller cages, they showed significantly more initiative in the bigger ones. According 
to Glickman, one of the main laboratory researchers, the experimental settings 
embodied particular biases which deformed a truthful representation of the natural 
phenomenon of rat sexuality. For Glickman, therefore, “[t]he good experiment […] 
is a transparent looking glass.” (Gomart and Hajer 2003: 38-9). Similarly, Rowe and 
Frewer argue public participation exercises should be “independent and unbiased” 
(Rowe et al. 2004).
 Gomart and Hajer present an alternative interpretation of the good experiment. 
Recognizing the inherent performance of settings, they develop a more positive 
connotation of bias. The inscription of biases is not a problem per se. “The problem 
is not that certain elements of the experimental setting refused to be sufficiently 
silent, transparent, passive or absent. Impurity is not the problem. Rather, a good 
experiment is on the contrary the one where the setting is present, active enough” 
(ibid. 39). Variations of the material forms of experimental setting, therefore, allow 
for surprises, for subverting the expectations of the experimenter.
 Gomart and Hajer extrapolate this philosophy of scientific experiments to 
political settings, analyzing the events during a series of political moments in the 
regional planning in the Netherlands. Following formal political procedures, the 
plan for developing the Hoeckse Waard, (a rural area south of the city of Rotterdam) 
that expert planners and local administrators had prepared, was met with fierce 
opposition. An activist group mobilized the local inhabitants who have the legal right 
to comment on regional planning plans. After 6,000 preprinted letters of protest 
were handed in, the plan was withdrawn. This political impasse was only overcome 
when some local initiators organized a few public debates discussing an experimental 
cultural exhibition about the region. These discussions allowed for the local residents 
to articulate their own ideas about the planning of their environment which resulted 
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in a manifesto and ultimately, a vision shared by citizens and politicians that was 
presented to the Dutch minister of spatial planning.
 What Gomart and Hajer intended to illustrate is how experimentation with 
changing settings from formal political procedures (small rat cages) into an “apolitical” 
cultural manifestation (larger rat cages) have succeeded in transforming the behavior 
of both politicians and local citizens.
2.5.2 The performance of public engagement
It is this same case study that Hajer uses to develop a set of concepts (Hajer 2005) 
derived from dramaturgy to analyze the role of settings in public participation. “To 
understand the bias in participatory practices we should not merely focus on the 
type of arguments that are raised but include the conditions (physical, technical, 
theatrical) as well” (ibid. 625). The first concept is script or scripting. It comprises the 
selection of actors who are assigned a role in the play as well as the provision of “cues 
for appropriate behavior” (ibid. 631). Appropriate deliberative behavior is usually 
expressed in terms of civic virtues. Gutmann and Thompson for instance develop 
the virtues of civic integrity and magnanimity but some have added deliberative wit, 
humility and courage (Aikin and Clanton 2010).
 The second concept Hajer introduces is staging, “the deliberate organization 
of an interaction, drawing on existing symbols and the invention of new ones” 
(Hajer 2005: 631). Translated in terms of the recommendations of Felt et al., the 
staging in upstream public deliberation amounts to an assessment of the normative 
assumptions implied in technological innovation. Staging also encompasses the 
distinction between active players and passive audiences. The third concept is setting 
which refers to the physical situation and the artifacts used to support the staging 
and these together, form the stage set. Together, these three dramaturgic elements 
determine the performance, “the way in which the contextualized interaction itself 
produces social realities like understanding the problem at hand, knowledge, and 
new power relationships” (ibid.).
 These concepts allow an analysis of the dramaturgy of public deliberation on 
science and technology. Empirical STS research, for example, demonstrates how 
the public engagement event GM Nation? in the UK was scripted and staged. The 
organizers’ scripting revealed a particular construction of the public. Stakeholders 
(such as NGOs) were not invited to prevent them from hijacking the discussions 
(Irwin 2006). Instead, “ordinary citizens”, or “idiots” (Lezaun and Soneryd 2007) 
– disinterested normal people with no entrenched positions in the controversy 
– were selected to represent the British population on the issue of genetically 
modified crops. The consensus conference, at the top of every methodology toolkit, 
widely used and often praised, is another instance of public engagement hardware 
which takes the selection of ordinary citizens as its starting point. But, the selection 
of a group of demographically representative “blank slate participants” whose 
selection from a number of applicants, influenced the outcome of the final report 
(Kleinman et al. 2009).
 From a pragmatist political theoretical perspective, some scholars in STS have 
argued that the notion of the public as the people as a predefined and coherent 
(mostly national) political community is problematic in our technological culture 
(Marres 2005a; Dijstelbloem 2008). The selection of a random but (according to 
demographic criteria) representative sample of citizens taken from the British or 
Dutch population takes such an understanding for granted. Drawing on the work of 
John Dewey (1991 [1927]), these scholars depart from an issue or a problem that 
defines or implicates the public as “a grouping of actors who are affected by the 
actions or events but do not have direct influence on them” (Marres 2005a: 48). 
These groupings are not necessarily (and perhaps even almost never) social groups 
consisting of members who share a certain social identity. An important implication 
is that these publics have to be actively searched for. Another implication is that 
the “content [is] the only way that a public gets pulled into politics” (Marres 2005b: 
217). Therefore, it is a task for organizers of public dialogue to look for issues that 
mobilize publics.
 Hajer’s dramaturgic concepts also allow for a view on what is missing in the 
analyses of how participation experiments are enacted. STS literature is almost 
completely focused on the public. The EC report of Felt et al. is no exception. What 
is usually missing in these discussions, however, is the staging of scientists. Again, 
the consensus conference offers an illustrative example. After the recruitment 
and selection of citizens, panelists are provided with information and prepared to 
discuss the topic of discussion. During a first deliberative session they determine 
which (scientific) information is missing to questions that have arisen. In a second 
meeting, the participants present these questions to a panel of (scientific) experts 
who have been selected to provide the answers. Besides the practical problems of 
assembling such a panel of experts (language, budget etc.; see Kleinman et al. 2007), 
there is a division of (moral) labor (cf. Rip 2009) inscribed in consensus conferences. 
On the one hand there are experts providing factual information, on the other there 
are ordinary citizens discussing the moral and social issues. Qualitative research on 
the experiences of scientists who have participated in public engagement activities, 
demonstrates a sense of ambivalence towards this role of “neutral, distanced 
and responsive information provider” (Burchell et al. 2009), which was either pre-
assigned by organizers or actually performed. To use the typology of idealized 
roles of scientists that Pielke (2007) provides, scientists participating in consensus 
conferences enact a role of science arbiter, answering factual questions relevant to 
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the panel of citizens. From the perspective of co-production discussed in Section 
2.2, this division is problematic since scientific and technological developments 
also encompass normative commitments. Furthermore, some of the scientists that 
Burchell interviewed, stated they would have preferred to act as an issue advocate “to 
more deliberately direct the course of the dialogues” (Burchell 2009: 74). Therefore, 
life scientists in my study are staged as issue advocates on the assumption that they – 
wittingly or unwittingly – endorse the values implicated in their research projects.
Helpful as the concepts of script, staging and setting are, the empirical analysis 
of performative settings is somehow flawed because of the outsider perspective 
most social scientists take. Many organizational considerations remain unknown 
or speculative at best. Studying the role of settings from the vantage point of the 
facilitator of public engagement can improve the analysis of the scripting (the 
“politics” of what and why?) and the staging and setting (the “politics” of how?) of 
public deliberation This is demonstrated by Bruun Jensen’s “quasi-ethnography” in 
his role as an organizer of a consensus conference regarding electronic patient files 
in Denmark (Bruun Jensen 2005). Therefore, it is surprising that social scientists who 
have been in the position to study the performative role of settings from an insider 
perspective (Felt et al. 2009; Kerr et al. 2007; O’Doherty and Davidson 2010; Wieser 
and Karner 2010) did not include it in their analyses.8
 Social scientists “engaging in and contributing to policy debates in real time” 
(Macnaghten et al. 2005) as organizers of upstream public dialogue, have to take 
the performative perspective of settings into consideration as they become partially 
responsible for the outcomes of these science-society encounters. Therefore, it is 
also time to “dismantle the proscenium arch” to see how social scientists perform as 
practitioners backstage.
2.6 Conclusions
In this chapter I have explained the problem analysis of a group of STS scholars who 
were asked to investigate the growing uneasiness between science and society on 
authority of the European Commission. I use their problem analysis as a starting 
point for this dissertation to formulate the central research aims of this book.
8 Even more so, because Wieser and Karner (2010) adopt Hajer’s terminology, but only 
to describe the efforts of life scientists to re-stage discussions to their own benefit.
 The first identified problem is the European governance of science which reflects 
an economic or minimalist liberal conception of democracy that proponents of 
deliberative democracy, such as Gutmann and Thompson, criticize for its lack of 
political autonomy. In this economic conception of science governance, science-led 
technological innovation is stimulated for economic welfare as long as it does not 
entail harmful consequences (risks). In this “persistently technocratic […] governance 
culture” (Felt et al 2007: 41) harm is reduced to risks whose calculation is delegated 
to scientific advisory experts. Thus, a particular scientific framing of what the risks 
are is dominant in the governance of science, rendering articulated issues of the 
public as illegitimate or even irrational. “The problem is that expert counterparts’ 
positions on the same issues have been posed as if they were beyond reasonable 
and legitimate contestation, which stance inevitably and gratuitously depreciates 
their citizen interlocutors by refusing recognition to their very being as reasoning 
subjects” (ibid.60).
 Liberal principles of preclusion that stipulate the state’s neutrality and inactivity 
towards moral disagreement (such as on GMOs), remove public issues concerning the 
normative input that drives innovation research off the political agenda. In economic 
conceptions of democratic governance citizens are treated as mainly passive subjects 
to be ruled instead of autonomous agents who take part in the governance of their 
own society, as deliberative democrats advocate. Instead of giving European citizens 
a voice in the innovation process of new technologies (such as GMOs), the public is 
delimited as a collective of (health care) consumers who have a free choice to use 
these products of innovation or not (cf. Wynne 2001). Each free individual citizen 
should decide for him- or herself according to their own morality. As the European 
controversy on GMOs has demonstrated, this economic governance of science does 
not properly deal with the public’s problem.
 Even though the authors of the EC report do not explicitly refer to theories 
of deliberative democracy, their main recommendation concerns a “shift from 
expert-dominated to more open deliberative science-informed institutions” 
(Felt et al. 2007: 11) to publicly discuss the normative understandings about the 
desirable or expected social benefits and purposes of the research with which 
innovation-oriented research are imbued. Public deliberation on NEST has to 
move upstream so as to increase the influence of the public to direct innovation. 
Using a theatrical metaphor which advocates of upstream public engagement 
have stressed the importance of making the backstage process of techno-scientific 
research publicly visible.
 However, the authors of the EC report identify the unreflective practice of 
public engagement – “a big industry now” (ibid. 60) – as the second problem. In 
their opinion, this very practice intended to be a solution to public alienation, has 
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considerably contributed to the public unease with science and technology. Felt et 
al. are concerned with the quality of (upstream) public engagement. In this chapter I 
have developed two perspectives on deliberative quality.
 Drawing on Gutmann and Thompson’s theory of deliberative democracy, its 
central principle of reciprocity which amounts to a process of seeking mutually 
justifiable reasons, indicates a first direction for developing a conception of discursive 
quality: the quality of argumentation advanced to defend particular (science) policy. 
An important aspect of the work of facilitators of upstream public deliberation then 
is to critically investigate the quality of the reasons advanced to defend science 
policy, i.e. the input and direction of innovation trajectories.
 However, deliberative quality is lacking in dominant evaluative frameworks 
for public participation in STS literature (esp. in the influential work of Rowe and 
Frewer). On the other hand, attempts to operationalize the quality of reason-giving 
in deliberative democracy literature are problematic. Therefore, the first research 
focus of this thesis is to develop a theoretical concept of deliberative quality which 
a) enables a reconstruction, analysis and evaluation of argumentative discourse, 
particularly in the context of new and emerging science and technology and which 
b) allows facilitators to intervene in face-to-face public deliberation on NEST. In that 
sense, this dissertation aims to contribute to argumentative technology assessment 
(Brom and Van Est 2010) to enrich and deepen public discussion on NEST. For this aim, 
I discuss two concepts developed in the pragma-dialectical argumentation theory in 
the context of public debates on NEST: the concept of reasonable discussion (Chapter 
3) and the concept of strategic maneuvering (Chapter 4). In Chapter 5 and Chapter 7 
I use these theoretical concepts to analyze two upstream public deliberation events 
in a Dutch debating centre.
 The STS scholars of the EC report also refer to the performative dimension of how 
public deliberation is enacted to indicate the difficulties involved in organizing public 
dialogue. Deliberation does not automatically occur once the right procedural rules 
are followed, as empirical research demonstrates. Using the notion of dramaturgy, 
Hajer (2005) has called attention to the influence of settings on the performances of 
participants of public deliberation: “To understand the bias in participatory practices, 
we should not merely focus on the type of arguments that are raised but include the 
conditions (physical, technical, theatrical) as well” (625).
 Following Actor Network Theory, Hajer (and Gomart) turn(s) the form of politics 
into an empirical question. In addition to the politics of ‘who’, there is also a politics 
of ‘what’. One criticism articulated in the EC report was the over-concentration 
of organizers of public engagement on the hardware of mechanisms of public 
deliberation (such as consensus conferences). But “STS researchers observing and 
analyzing these [new experiments in public participation] have stressed the power 
of these concrete constellations over who is given voice or not, what forms of 
agency can be deployed, what issues or questions can or cannot be addressed, what 
knowledge counts as adequate, and what weight the outcomes might be given in the 
on-going institutional governance of science and innovation” (Felt et al 2007: 57).
 I have elaborated the dramaturgical concepts of script, staging and setting that 
Hajer has introduced to analyze the performance of settings. For instance, I have 
indicated the problematic selection of the characters in the play (as an aspect of 
scripting), i.e. “who is given voice or not” in consensus conferences. In addition to 
the questionable framing of the “ordinary citizen” (or idiot), scientists are staged as 
neutral, disinterested and responsive information providers, or science arbiter. Thus, 
a particular division of moral labor constitutes the practice of consensus conferences 
which is not in full agreement with scientists’ own role perception. Indeed, this 
hardly seems compatible with the idiom of co-production which also calls attention 
to the normative commitments that are diffused in science-led innovation processes.
 As Felt et al. argue these framings of participants are “rarely if ever explicit 
and probably not deliberate” (Felt et al. 2007: 57). The second research aim of this 
dissertation is to describe the dramaturgical work implied in public deliberation 
on NEST and to investigate its performative effects. Borrowing the same theatrical 
metaphor from proponents of upstream public engagement: in the theatre of 
public engagement the time has come to dismantle the proscenium arch and 
begin performing in the round. Descriptions and analyses of the dramaturgical 
work performed for the two upstream engagement events organized for this study 
follow in Chapters 5 and 6. The time has come to look behind scenes and to make 
visible the invisible dramaturgical work of facilitators of public deliberation. Social 
scientists who have been involved in the organization of public engagement as a 
social experiment to study the interactions between scientists and citizens have not 
taken the performative perspective into account. Therefore, the second research 
aim is linked to increasing the reflectivity of public engagement practitioners 
(cf. Schön 1983).
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REASONABLENESS IN PUBLIC DISCUSSIONS ON NEST
3.1 Introduction
In April 2009, two biotechnology plant researchers in the Netherlands engaged in 
a public debate on, at that time, new developments in the genetic modification of 
plants: cisgenesis.1 Cisgenesis is, contrary to its transgenic counterpart, a form of 
genetic modification of crops “with coding DNA-sequences originating from the 
species itself or from species that can be crossbred” (Cogem 2006: 5).2 The plant 
researchers claimed that their cisgenic crops would be beneficial to the environment 
because of their natural resistance to plant diseases that – without genetic 
modification – can only be treated with toxic pesticides. Furthermore, cisgenic 
crops (such as apples, potatoes and strawberries) were said to be more acceptable 
to the GMO-skeptical European public because they are “devoid of foreign gene 
sequences” (Schaart et al. 2011: 105). So, cisgenesis is a form of GMO that could 
meet the objections of those opposing the ‘original’ transgenic products (that GMOs 
are unnatural). At the same time, cisgenesis could accelerate the “classical” breeding 
process which is beneficial to the environment. “In conclusion, the cisgenic plant is, 
as far as the process is concerned, a GMO but it belongs to classic plant breeding as 
far as genetic origin is concerned” (Jacobsen and Schouten 2009: 28).
 Despite these expectations, a public debate ensued. Plant researchers who were 
at the heart of the development of the new genetic modification techniques wrote 
1 I define debate as an oppositional discussion where two or more parties attempt 
to prove each other wrong, whereas in a more neutral sense I use the concept of 
discussion to refer to different kinds of differences of opinion or to refer to the 
terminology used in pragma-dialectics. I consider the discussion on cisgenesis as a 
debate and I will refer to it that way.
2 Because its definition is contested, I borrow this description from the Cogem, which is 
an independent advisory committee of the Dutch government. 
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an opinion piece in a newspaper magazine. They complained about the quality of the 
public debate. In fact, the authors claimed that the debate had “derailed” (Jacobsen 
and Schouten 2009: 27). According to the plant geneticists, Greenpeace had 
turned into a “fundamentalist group” that fights against GMOs using “theoretical, 
unpredictable effects” as argument instead of being committed to improving the 
environment (ibid: 30). The attitude of Greenpeace (and perhaps subsequently of the 
public) would threaten to leave Europe’s strict regulations on genetically modified 
crops, enacted in the 1990s as a policy response to the public resistance towards 
transgenesis, unaltered. As a result, the valuable time gained in the breeding process 
would be undone again. Therefore, the authors made an appeal to policy makers as 
well as society at large to think about changing these regulations for GMOs.
In public controversy, complaints about the reasonableness of the debate and 
opponents are frequently heard – on both sides. If only “they” would listen to “our” 
good reasons. But what is a reasonable discussion? What did Greenpeace do that 
would qualify as unreasonable? And how reasonable were the two plant scientists 
themselves? In this chapter, I elaborate a notion of the argumentative quality of 
public discussions over new and emerging science and technology (NEST) on the 
basis of the so-called pragma-dialectical argumentation theory. According to this 
theory reasonableness refers to a formal procedure discussants agree to observe in 
order to resolve their difference of opinion by systematically testing standpoints (and 
their argumentative defense) for their acceptability.
 In Section 3.2, I introduce the philosophical foundations of the pragma-dialectical 
argumentation theory. At the heart of the pragma-dialectical theory is a normative 
framework for analyzing and assessing argumentative discourse in practice. Based on 
critical rationalism pragma-dialecticians assume that discussion involves subjecting 
views to a “maximum of doubt”. This framework – its different stages, its rules and 
its notion of fallacies – provides valuable instruments for both researchers and 
facilitators of upstream public dialogue.
 In Section 3.3, I particularly focus on the rules and procedures for analyzing 
and assessing the quality of argumentation as a product (how a conclusion can be 
inferred from its premises) in the argumentation stage because this stage “in fact 
largely determine[s] the outcome” (Van Eemeren et al. 2002: 28) of the discussion. 
When have standpoints been conclusively defended? This is the case, first, when the 
propositional content of every individual (“explicitized”) statement or premise of the 
argumentation is acceptable and second, when the argumentation’s justificationary 
force is accepted in the sense that all critical questions are answered satisfactorily.
 In Section 3.4, I apply the pragma-dialectical procedure to ethical argumentation 
patterns within the context of public discussions on NEST, as described by Swierstra 
and Rip (2007). As an illustration I use the public and political debate on cisgenesis in 
the Netherlands.3 I chose this debate about cisgenesis because a) several scientists and 
plant researchers (like the ones introduced at the beginning of this chapter) acted as 
issue advocates of this new technology4 and b) it was the explicit intent of politicians 
and policy makers to broaden the debate beyond the usual narrow framing of safety 
(discussed in Chapter 2) so as to include so-called “socioeconomic aspects of GMOs” 
(Cogem 2009) for the permission of imported and cultivated GMOs in Europe. Although 
this debate arose more downstream of the innovation trajectory, many ethical 
arguments described in Swierstra and Rip’s NEST-ethics were advanced. I reconstructed 
this public debate using opinion sections of both popular and scientific written media 
and journalistic articles reporting the different standpoints and arguments in the 
discussion. Most papers were found with an extensive search on the Internet (Google 
and Google Scholar) and Lexisnexis, a large database of (inter)national newspapers. I 
also used records of parliamentary proceedings and debates as well as the report of a 
seminar that the Dutch ministers of agriculture and environmental affairs organized in 
2009 and which I attended as a participant observer.
 In Section 3.5, I discuss some limitations of the pragma-dialectical approach to 
argumentation and the methodological additions needed to achieve the second 
research aim: the influence of the dramaturgy on the performance of participants. 
Finally, in Section 3.6, I draw some conclusions about the argumentative quality of 
the public debate on cisgenesis.
3.2 The Pragma-dialectical argumentation theory
3.2.1 Positioning pragma-dialectics: three concepts of reasonableness
Argumentation theorists are interested in the soundness of reasoning in practice. 
Frans van Eemeren argues in Systematic Theory of Argumentation (2004) that a 
3 The issue of cisgenesis was ideally suited for organizing public dialogue but one of 
the authors of the aforementioned opinion article I had approached to investigate 
his willingness to participate explained that he and the people he worked with in the 
development of the cisgenic apple had come to the conclusion that the debate had 
moved to the next stage: policy makers in Brussels. 
4 In a Dutch news paper article it was suggested that one of the scientific avocates of 
cisgenesis had indirectly drawn on an a report that was commisioned by multinational 
Monsanto (Van der Lugt, Sept 18 2009). In Parliament, politicians asked questions 
about the relationship between this expert and Monsanto (TK 27 428 nr. 160).
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comprehensive theory of argumentation has to establish “a well-considered link 
between, on the one hand, insights as they are expressed in normative models such 
as those of formal logic [for the soundness], and, on the other hand, insights derived 
from empirical descriptions as provided by discourse analysts that are primarily 
socially or linguistically oriented [for the language use in practice]” (Van Eemeren and 
Grootendorst 2004: 9).5 Van Eemeren regards discourse analysis – as the empirical 
study of language use – and formal logic as complementary.6 But viewed exclusively, 
both have their shortcomings since they are philosophically grounded in problematic 
concepts of reasonableness.7
 Formal logic is grounded in a geometrical notion of reasonableness. It is 
concerned with the validity of argumentation. It aims at demonstrating if and how 
a standpoint follows conclusively from its premises with indisputable certainty. 
The geometrical notion of reasonableness – or rationality – is dogmatic and anti-
argumentative since a geometrical philosopher does not attempt to convince a 
rational critic of the acceptability of his claim but to prove the absolute truth of it. 
Therefore, the geometrical notion of reasonableness is untenable for argumentation 
theorists.
 Empiricist discourse analysis, on the other hand, is founded on an anthropological 
notion of reasonableness. The acceptability of argumentation according to this 
philosophical perspective is a consequence of the extent to which the argumentation 
resonates with a particular historical contingent and cultural set of beliefs. 
Argumentation is acceptable when it succeeds in being persuasive to the audience for 
whom it is intended. Reasonableness, in this rhetorical sense, is dynamic and relative 
to the epistemic background of the members of this culture which can change over 
time. This is what Van Eemeren calls the anthropological-relativistic perspective.
 Van Eemeren himself adheres to what he calls the critical-rationalistic perspective 
of reasonableness, which is defended as a middle course. Drawing on the work of the 
5 In the following text, I only refer to Frans van Eemeren. Although Rob Grootendorst 
is a co-author of A systematic theory of argumentation, he had already passed away 
when the book appeared in 2004. Moreover, Frans van Eemeren developed his notion 
of strategic maneuvering (see Chapter 4) as a single author in Strategic Maneuvering in 
Argumentative Discourse (2010). 
6 See Chapter 4 for an elaboration on the relationship between pragma-dialectics and 
discourse analysis.
7 For these different notions of reasonableness Van Eemeren refers to Stephen Toulmin 
who elaborates on these notions extensively in Knowing and Acting (1976).
philosophers Karl Popper and Hans Albert, this conception of reasonableness has 
its roots in skepticism. There is nothing humans can be sure of and therefore the 
acceptability of every claim (whoever makes it) can be called into question. “This 
critical perspective focuses pre-eminently on discussion; it encourages the systematic 
submission of the one party’s standpoints to the other party’s critical doubts” (Van 
Eemeren 2004: 16). The critical-rationalistic ideal amounts to stimulating people to 
test claims methodically to a “maximum of doubt”. Practically, the corresponding aim 
is to engage participants into a dialogue and to further reflection.
 Reasonableness in this critical sense refers to a regulated exchange of views and 
their justifications – a formal procedure that discussants agree to observe in order 
to resolve their difference of opinion by systematically testing standpoints (and their 
argumentative defense) for its acceptability. Reasonableness in this critical sense is 
not absolute and definitive – as the geometrical philosopher suggests – but gradual.
 The pragma-dialectical argumentation theory provides a framework for analyzing 
argumentative discourse in everyday conversations (pragmatics) and for evaluating 
its acceptability on the basis of a normative model of critical discussion that aims 
at resolving a difference of opinion (dialectics).8 Although some argue that pragma-
dialectics is related to for example Habermas’s theory of communicative action 
(Knops 2006), Habermas does not provide sufficient tools to assess argumentative 
discourse practically (Webler 1995). Pragma-dialectics adds “a level of practical detail” 
(Knops 2006: 600). Therefore, it is suitable for the assessment of argumentative 
quality in public deliberation which is essential in deliberative democracy theory.
 Before explaining this formal procedure of critical discussion (as a set of rules) 
in more detail in the next subsection, it is important to note that its reasonableness 
8 Van Eemeren contrasts the theoretical, pragma-dialectical position with it 
critical-rationalist understanding of reasonableness with the epistemo-rhetorical 
approach towards argumentation based on the anthropological-relativistic notion 
of reasonableness. The latter is aimed at describing the persuasive success of 
argumentation by identifying different audiences and their beliefs. So, rhetorical 
analysts are concentrated on an empirical level on the process of persuasion, whereas 
dialecticians are focused on the process of convincing and the extent to which ordinary 
language users in everyday contexts are predisposed to resolve their difference of 
opinion following the procedure for critical discussion. Both theoretical positions 
(and their analytical, empirical and practical corollaries) are clearly demarcated in A 
Systematic Theory of Argumentation, but they are by no means mutually exclusive. In 
Chapter 4, I will demonstrate in more detail how discourse analytical studies of public 
debates and controversies over science and technology from this rhetorical perspective 
can contribute to a pragma-dialectical analysis of public deliberation. 
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depends, first, on its adequacy to contribute to the purpose it was created for, i.e. 
the resolution of a difference of opinion. This rather pragmatist criterion is what 
Van Eemeren defines as problem validity. This means that if the rules for a critical 
discussion contribute, as a necessary (but not sufficient) condition, to resolving 
disputes, every departure from these rules hampers the resolution process.9 
Put positively, reasonable discussants will abide by such a pragmatic resolution 
procedure. Second, its reasonableness depends on the extent to which discussants 
agree with this procedure, the inter-subjective or conventional validity.10
 From the critical-rationalistic perspective, nothing escapes systematic doubt. 
Therefore, the rules of the procedure themselves can be subjected to criticism as 
well. During the discussion – in a meta-discussion – the application of the rules can 
be discussed. Before and after the discussion, the rules themselves can be critically 
examined. As a result, they may be revised when it turns out that the rules are no 
longer successful in facilitating dialogue.
 In the next subsection, I focus on the different elements of the model of critical 
discussion. This model consists of four different discussion stages that discussants 
ideally complete; a set of rules that together form a procedure of critical norms that 
facilitates a reasonable discussion (culminating in a code of conduct for discussants); 
and the fallacies related to this model.
3.2.2 The pragma-dialectical model of critical discussion
Van Eemeren defines argumentation as a “communicative [verbal and non-verbal] 
and interactional [in dialogue with other people] (speech) act complex aimed 
at resolving a difference of opinion before a reasonable judge by advancing a 
constellation of reasons [..] justifying the acceptability of the standpoint(s) at issue” 
9 In Section 3.5 I return to other higher order conditions for resolving differences of 
opinion.
10 Van Eemeren has conducted empirical research to investigate the extent to which 
his own proposed procedure of critical discussion meets these two criteria (see 
e.g. Van Eemeren et al. 2009). The analyst of argumentative discourse who applies 
the rules for a critical discussion in practice needs to involve criticisms against the 
dialectical procedure during public deliberation in his analysis. This demands a certain 
amount of reflexitivity. In that sense, putting these rules into practice and performing 
interventions during critical discussions based on the situated utilization of them, is yet 
another opportunity to put them to the test. Consistently to the critical-rationalistic 
philosophy, even when there is not the slightest bit of opposition against them, one 
cannot be fully certain of their problem-validity.
(Van Eemeren 2010: 29). This definition applies to argumentation as product as well 
as to argumentation as process.
 Argumentation as a product concerns “the formal relations between the premises 
and the conclusions of the arguments” (Van Eemeren and Grootendorst 2004: 58). 
Here we are dealing only with the relations between propositions. For example, one of 
the scientific experts demonstrated his advocacy for genetic modification during the 
seminar the Dutch minister of agriculture organized. “A more sustainable solution for 
the control of the potato disease [Phytophtora] is the use of GMOs [such as cisgenic 
potatoes]. […] The use of cisgenesis is a fast, safe and effective method and crops do 
not need to be sprayed [with 1.4 million kilos of fungicides] anymore” (TK 27 428 
nr. 145: 21). Here, reduction of pesticides and crop losses are presented as a reason 
for thinking about permitting the cultivation of GMOs in agriculture. Moreover, it is 
tacitly assumed that reducing pesticide use in agriculture is sustainable. I return to 
the (quality of) argumentation as product in more detail in the next section.
 Pragma-dialectics is not solely confined to the evaluation of argumentation 
as product.11 Its model of critical discussion also comprises norms for speech acts 
advanced in the process of argumentation. Argumentation as a process concerns 
“every speech act in the discourse [...] that plays a role in investigating the acceptability 
of standpoints” (Van Eemeren and Grootendorst 2004: 58). For example, someone 
could challenge the standpoint of the proponent of biotechnology (“Are you sure 
that the production of cisgenic potatoes will lead to a reduction of pesticide use?”). 
Or someone could ask for clarification. A member of parliament stated in the first 
proceeding after the seminar: “So, there we have a fundamental question. […] What 
is it we mean when we talk about sustainable agriculture?” (TK 27 428 nr. 142: 3). 
Neither of these speech acts (expressing doubt, posing questions etc.) involves 
the advancement of reasons to support a standpoint. Yet, they are relevant in 
argumentative discourse and hence they are to be included in the pragma-dialectical 
model of critical discussion.
 This model is a normative standard that is a necessary condition for resolving a 
difference of opinion by means of “dialectically regulated critical exchanges in which 
the acceptability of the standpoints at issue is put to the test” (Van Eemeren 2010: 6). 
As Van Eemeren emphasizes, the model of critical discussion is an idealization, or 
even utopian as one might object, as in practice a discussion will hardly ever unfold 
11 Argumentation theories, such as Toulmin’s Uses of Argument and Perelman’s The New 
Rhetoric that are solely concerned with argumentation as product, suffer from what 
Van Eemeren calls “justificationism.”
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according to this model. Therefore, the model is not a means to describe what 
actually happens during discussions. Instead, the model is a theoretical standard 
that can be used to analyze and evaluate argumentative discourse. Nevertheless, a 
critical discussion should always be promoted to improve the quality of democracy. 
“In my opinion, the dialectical rules for argumentative discourse that make up a 
code of conduct for political discourse are therefore of crucial importance to giving 
substance to the ideal of participatory democracy” (ibid: 4).
The model contains three elements: four discussion stages; ten discussion rules that 
regulate the exchange of speech acts in these different stages;12 and fallacies (see 
Table 3.1 below). Before I briefly discuss these elements in more detail, it is important 
to note that fallacies are generally regarded as illegitimate conclusions inferred from 
premises or invalid arguments. Thus, they are confined to argumentation as product. 
In the pragma-dialectical argumentation, theory fallacies amount to “every violation 
of any of the rules of the discussion procedure for conducting a critical discussion” (by 
whichever party and at whatever stage in the discussion) (Van Eemeren 2004: 175). 
This means that fallacies also include the discussion rules pertinent to argumentation 
as process.
 The four discussion stages have to be completed successively in order to 
determine the acceptability of a standpoint. In the confrontation stage the difference 
of opinion between two or more interlocutors becomes apparent. A discussion is 
useless if there is nothing to argue over. A difference of opinion arises when not 
everybody agrees to a standpoint that has been advanced: someone calls a certain 
12 Actually the notion “rules” is ambiguous in the work of Van Eemeren. Van Eemeren 
and Grootendorst (2004) talk about fifteen discussions rules and ten commandments 
that are derived from these discussion rules, which are “too technical for immediate 
use by ordinary discussants” (Van Eemeren and Grootendorst 2004: 190). These 
commandments “list prohibitions of moves in an argumentative discourse or text that 
hinder or obstruct the resolution of a difference of opinion (ibid.).” The names of these 
commandments refer to rules again. Commandment 1 for instance is the “freedom 
rule”. When I refer to the discussion rules I mean these ten commandments. In the 
elaboration of the discussion rules (not being the commandments) in the next sections, 
I attempt to use the concept of rule as little as possible to avoid confusion. 
Discussion stage Discussion rule
Confrontati on stage
Diff erence of opinion becomes apparent: 
a standpoint is not accepted by all parti es
1. Freedom rule
Discussants may not prevent each other from 
advancing standpoints or from calling standpoints 
into questi on.
Opening stage
Shared premises and procedural commitments are 
determined: division of discussion roles (protagonist 
vs. antagonist)
2. Obligati on-to-defend
Discussants who advance a standpoint may not 
refuse to defend this standpoint when requested 
to do so.
3. Standpoint rule
Att acks on standpoints may not bear on a 
standpoint that has not actually been put forward 
by the other party.
Argumentati on stage
The advancement of the protagonist’s argumentati on 
to overcome the antagonist’s doubt
4. Relevance rule
Standpoints may not be defended by 
non-argumentati on or argumentati on that is not 
relevant to the standpoint.
5. Unexpressed-premise-rule
Discussants may not falsely att ribute unexpressed 
premises to the other party, nor disown 
responsibility for their own unexpressed premises.
6. Starti ng point rule
Discussants may not falsely present something 
as an accepted starti ng point or falsely deny that 
something is an accepted starti ng point.
7. Validity rule
Reasoning that in an argumentati on is presented as 
formally conclusive may not be invalid in a logical 
sense.
8. Argument scheme rule
Standpoints may not be regarded as conclusively 
defended by argumentati on that is not presented 
as based on formally conclusive reasoning if 
the defense does not take place by means of 
appropriate argument schemes that are applied 
correctly.
Concluding stage
Establishment of the result of the discussion
9. Concluding rule
Inconclusive defenses of standpoints may not 
lead to maintaining these standpoints, and 
conclusive defenses of standpoints may not lead to 
maintaining expressions of doubt concerning these 
standpoints.
All stages 10. Language use rule
Discussants may not use any formulati ons that are 
insuffi  ciently clear or confusingly ambiguous, and 
they may not deliberately misinterpret the other 
party’s formulati ons
Table 3.1 Pragma-dialecti c model of criti cal discussion
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claim into question (doubt) or someone contradicts this claim.13 A politician of the 
Party of the Animals for example stated in the first political discussion after the 
seminar: “She [the minister of agriculture] states that GMOs can contribute to crop 
security and productivity, to improved disease prevention and to a reduction of 
pesticide use. Apparently without any knowledge of facts she completely ignores 
that GM soy contributes to the deforestation of South America that it stimulates the 
use of toxic pesticides and that it most definitely does not lead to better yields. In 
fact, production can even decrease. That is hardly sustainable I would say” (TK 27 428 
nr. 142: 2).” Here, the claim of the minister of agriculture is clearly contradicted. 
Important in this stage is the freedom rule (rule 1) that stipulates the unconditional 
right for each participant to bring forward standpoints or to call them into question.14 
Some members of NGOs claimed that this rule was violated during the seminar on 
the future of GMOs since the minister of agriculture had said in her opening speech 
that “the question ‘Do we want GMOs in Europe?’ is therefore no longer relevant” 
(TK 27 428 nr. 145: 14). As one of NGO members asked in the closing plenary session: 
“I thought opponents would have a say as well. Why were we actually invited?” 
(Van der Lugt, June 10 2009).
 A violation of the freedom rule is the argumentum ad hominem: a personal 
attack that has no direct relation to the standpoint or argument being advanced (e.g. 
“The general public is too ignorant to understand science and technology” which 
is reflected in the deficit-model, see Section 2.2). The Dutch minister of agriculture 
stated that opponents of GMOs “acted out of emotion” (Dortmans and Van Dam Lev, 
May 2010: 16).
After the difference of opinion has become apparent, discussants enter the opening 
stage of the discussion. In this stage, the interlocutors decide if, and under what 
conditions they will enter into a discussion to resolve the difference of opinion. In 
this stage the common ground or “zone of agreement” is investigated, which “may 
include procedural commitments as well as substantive agreement” (Van Eemeren 
13 In the latter case, there is a mixed, in the former a non-mixed difference of opinion. 
This is important for the justificatory obligation to which antagonists are committed 
in the discussion. If someone advances a counterclaim, this person is supposed to 
adducing argumentation in defense of this counterclaim as well, just as the protagonist 
is.
14 In fact, the freedom rule applies to all the discussion stages, as Van Eemeren 
emphasizes. Most fallacies however, concern the violation of the freedom rule in the 
confrontation stage.
2004: 60). Procedural commitments, for example, are the distribution of discussion 
roles of protagonists (people who have made a certain claim) and antagonists 
(people who doubt or contradict this claim). Other procedural commitments concern 
the agreed upon methods to verify facts.
 Substantive agreement, on the other hand, refers to what discussants can 
explicitly indicate what it is they agree on despite their disagreements. The Dutch 
minister of agriculture stated: “Mrs. Wiegman and Mr. Van der Vlies and Polderman 
said that first the aim [of GMOs] must be defined before we can determine whether 
GMOs can be a solution. I agree with that (TK 27 428 nr. 142: 16).”15 Frequently, 
the opening stage remains largely implicit since discussants tacitly assume enough 
common ground to start a discussion.
 An important rule in the opening stage of the discussion is the obligation to defend 
(rule 2). This second rule states that the discussant who has advanced a standpoint, 
must defend this standpoint if it has been challenged. The discussant – or protagonist 
– is said to bear the onus probandi (the burden of proof). A well-known fallacy is 
evading the burden of proof, for instance when a protagonist pretends that his or her 
contentious standpoint does not need to be defended because it is supposed to be 
generally accepted. One of the NGO members presented some highly controversial 
claims in a regional newspaper as facts. “Over 60 studies demonstrate that GM crops 
are dangerous for people, animals and the environment. [O]ne of the participants [of 
the seminar] told that over 20 000 Indian farmers have committed suicide because 
they could not pay their debts after cultivating Bt (genetically modified) cotton. 
These are basic facts” (Bos June 20 2009).
 Another rule pertaining to the opening stage is the standpoint rule (rule 3): 
antagonists are not allowed to attribute a standpoint to the protagonist that has not 
been advanced. Discussants who violate this rule, commit the fallacy of the “straw 
man.”
The third stage is the argumentation stage. In this stage argumentation in defense of 
the standpoint is advanced and critically tested to establish its acceptability. Without 
the advancement and critical evaluation of argumentation there is no critical 
discussion in the dialectical sense. Since the main focus of this chapter is the quality 
of argumentation as product, I discuss the argumentation stage, the discussion rules 
that apply to this stage and some connected fallacies in more detail in the next 
15 This kind of statements has consequences in the argumentation stage (see 3.3 the 
Starting Point rule).
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section.16
 The final stage of the model for critical discussion is the concluding stage. In 
this stage (all) the discussants draw a conclusion from the discussion efforts aimed 
at resolving their difference of opinion. Discussants determine whether the initial 
standpoint was defended successfully (or not). If so, the antagonist must retract 
his doubts; if not, the protagonist must retract his standpoint (concluding rule). 
Refusing to do so is a fallacy, violating the closure rule. The question therefore is: 
when is a standpoint conclusively defended? In the next sections, I first elaborate 
on the procedures that Van Eemeren identifies to determine the soundness of 
argumentation as product (Section 3.3). Next, I apply these rules and procedures to 
recurring moral argumentation patterns in discussions over new technologies (NEST-
ethics) to derive a set of critical questions discussants in NEST-ethical discussions 
must answer once they have advanced one of these argumentation patterns.
3.3 Pragma-dialectics and argumentative quality
After discussants have established a difference of opinion in the confrontation stage 
and have agreed on how to conduct a critical discussion in the opening stage, they 
enter the argumentation stage. In this stage, the protagonist provides reasons 
that support his or her standpoint or claim over which a difference of opinion has 
arisen. Argumentation is, according to the definition in the previous subsection, a 
constellation of propositions that together count as a provisional defense of the 
advanced standpoint until the antagonist has fully accepted the argumentation. 
Proponents of cisgenesis for example argued that producing GMOs should be 
allowed because cisgenic crops are (potentially) beneficial to the environment 
because the use of pesticides can be reduced substantially. Having environmental 
benefits (pesticide reduction) is a reason for allowing GMOs.
16 It is notable to draw attention to the rules (not commandments) 10 – 13 that 
regulate the process of argumentation (as opposed to rules 6 – 9 that are about the 
argumentation as product). They specify the optimal use of the right to attack for 
antagonists (who can unlimitedly call standpoints and arguments into question); the 
optimal use of the right to defend for protagonists (who can unlimitedly advance 
arguments in defense of his standpoint); the right to retract argumentation and 
standpoints at any moment (for protagonists); the orderly conduct of discussion 
(discussants must in turn make a argumentative move and not more than one at the 
time). See Van Eemeren 2004:152-4).
 Such a defense is provisional because in a discussion the antagonist can first of all 
challenge any of the propositions that comprise the protagonist’s argumentation. As 
happened in the cisgenesis debate, the Party of the Animals Group contradicted the 
claim that GM crops are potentially sustainable. In this case, the propositional content 
of “GMOs are sustainable” is questioned. A sub-difference of opinion emerges, a 
sub-discussion ensues and argumentation needs to be advanced why GMOs are 
(not) sustainable.17 As the politician of the Animals Group argued GMOs are not 
sustainable because “GM soy contributes to the deforestation of South America in 
that it stimulates the use of toxic pesticides and that it most definitely does not lead 
to better yields. In fact, production can even decrease” (TK 27 428 nr. 142: 2).”
 Discussants have to abide by a set of five rules in the argumentation stage of 
(sub)discussion (see Table 3.1 above). The relevance rule holds that the arguments 
that support the standpoint must be relevant. For example, in a letter addressed to 
the minister of agriculture, people from a citizen’s initiative raised doubts against the 
controllability and the independence of scientific expert advice concerning the safety 
of GM crops: “We remain concerned about the uncontrollability of the [scientific] 
advice you [the minister] refer to. The minister of health once made an appeal to the 
transparency and independence of his advisors with regard to the authorization of 
17 The procedure that is aimed at determining the acceptance of the content of all the 
propositions in the argumentation is the inter-subjective identification procedure (IIP). 
Ideally and in accordance with the model for a critical discussion, both discussants have 
during the opening stage of the resolution process formulated their shared premises, 
“a complete list of propositions both [discussants] accept” and “which may concern 
facts, truths, norms, values, or value hierarchies” (Van Eemeren 2004: 145). In the 
ideal situation, both protagonist and antagonist pursue the IIP simply by checking if the 
proposition appears on the list of shared premises. If so, the antagonist has to accept 
the propositional content. If not, not.
 Unfortunately, drawing up such a list does not occur frequently. Therefore, the IIP 
prescribes that the discussants have decided – again in the opening stage of the 
discussion – a procedure to determine how the acceptability of the propositional 
content can be established. For instance, the participants can decide to adopt the 
view of an authoritative ethicist regarding the status of naturalness of GMOs. These 
first two options require a considerable amount of providence. Hence, the last option 
discussants have, beyond the scope of the IIP, is to conduct a sub-discussion to decide 
to the acceptability of the propositional content which in practice predominantly 
occurs. Rule 7 of the model of critical discussion stipulates that the protagonist has 
successfully defended the propositional content if the “IIP yields a positive result or if 
the propositional content is in the second instance accepted by both parties as a result 
of a sub-discussion (rule 7a).”
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drugs […]. In spite of signed declarations, it turns out that independence [of scientific 
advice] is out of the question ” (letter Citizens for GM-free food). The alleged lack 
of transparence in expert advice concerning human drugs seems hardly relevant in 
defense of the citizens’ standpoint that expert advice in the ministry of agriculture is 
uncontrollable.
 Other violations against this rule are the pathetic fallacy and the ethical fallacy 
(or abuse of authority). The numerous terrifying pictures in the GM debate illustrate 
nicely the pathetic fallacy. On the other hand, both opponents and proponents in the 
cisgenesis debate appeal to scientific authority to make contentious claims (more) 
acceptable. Appeals to authority are not necessarily fallacious of course. But for 
example on the website of gentechvrij.nl (translation: GMOfree.nl), one can seriously 
doubt that some claims are solely to be accepted because a long list of scientific 
experts say so. Under the heading “This is what scientists say about the dangers of 
genetic manipulation” Vananda Shiva from India is quoted: “Only a fascist society 
would deny consumers the right to know what they eat and farmers the right to 
replant what they have grown” (website www.gentechvrij.nl).
 Second, discussants always have to observe the starting point rule. Discussants 
are not allowed to present a claim as an accepted starting point both protagonists and 
antagonists agree on, when this is not the case. Conversely, they cannot falsely deny 
accepted starting points. A well-known fallacious application of this rule is begging 
the question (or: circular reasoning). The protagonist in this case simply repeats his 
or her claim as a premise (often veiled by implicit language use or verbiage) falsely 
assuming it to be a common starting point.
 Third, advanced arguments have to be logically valid as the validity rule 
prescribes. The intersubjective inference procedure is used to determine the logical 
validity of argumentation. For instance, scientific proponents of cisgenesis used 
the transitive law (A=B, B=C, therefore A=C) to argue that cisgenic crops must be 
put under the same regulatory regime as normally crossbred plants (Schouten et 
al. 2006). Their conclusion (“Cisgenic crops are safe”) necessarily follows from its 
premises (“Cisgenic crops are similar to traditionally bred plants” and “Traditionally 
bred plants are safe”), if these are true.  Even though some have denied the truth of 
its premises, this reasoning is logically valid and the validity rule is not violated (only 
the propositional content of the premises is challenged).18
18 De Cock Buning et al. 2006 contested the similarity between cisgenic crops and 
classically crossbred plants. Furthermore, in the scientific literature researchers 
have warned of “wide-ranging consequences” if cisgenic crops are released into the 
environment and the human food chain (Schubert and Williams 2006).
 These formal logical syllogisms are rare in everyday discussions, however. 
Argumentation is mostly put forward in rhetorical syllogisms (or enthymemes). In 
its Aristotelian meaning, an enthymeme is a rhetorical syllogism that is a) deductive 
in form (i.e. from the general to the particular), b) incomplete or “truncated” since 
(mostly general) premises are omitted for practical reasons in order to let the 
audience supply them. These omitted premises are c) statements of probable fact or 
d) reflections of values, beliefs and attitudes (Jasinski 2001: 205-207).19 These omitted 
premises are not explicitly mentioned (for example since they are deemed generally 
known) in accordance with the maxim of efficient communication: not to perform 
any speech act that is redundant. Even though these enthymemes are incomplete 
in nature, it does not mean they are necessarily invalid. On the contrary, they can 
easily be made valid after explicating unexpressed premises. “Invalid reasoning is 
certainly not the most important cause of failure to reach resolution of a difference 
of opinion” (Van Eemeren et al. 2002: 131-2).
 These unexpressed premises, however, can be contentious and must be 
defended as well if someone raises doubt against them. The unexpressed premise 
rule is the fourth rule prescribed to reasonable discussants. It stipulates that 
“[d]iscussants may not falsely attribute unexpressed premises to the other party, 
nor disown responsibility for their own unexpressed premises” (Van Eemeren and 
Grootendorst 2004: 192). To paraphrase the aforementioned statement of the 
scientific expert during his lecture at the seminar on socioeconomic aspects of 
GMOs: “Cisgenic potatoes are sustainable because toxic pesticides to control potato 
disease can be reduced” is an instance of an enthymeme. To support the standpoint 
(“Cisgenic potatoes are sustainable”), an argument – or a material premise – is 
provided (“pesticides can be reduced”). This enthymeme contains an unexpressed 
premise (or warrant in terms of Toulmin’s model or argumentation): “Pesticide 
reduction contributes prominently to sustainability.” This omitted premise is needed 
as a statement of probable fact to render the reasoning valid and to warrant the 
claim. This tacitly assumed general premise is controversial in our pluralistic society 
since the concept of sustainability includes much more than pesticide reduction 
alone. If the protagonist’s argumentation is to be evaluated for its soundness, the 
19 Jasinski emphasizes the notorious difficulty of defining enthymemes: “But what exactly 
is an enthymeme? This question continues to challenge scholars in a number of 
academic fields, especially rhetorical studies” (Jasinski 2001: 205). Since the definition 
of these technical concepts and their history is not part of this thesis, I rely on Jasinski’s 
Sourcebook on Rhetoric (2001) which provides in my view an eloquent collection of 
encyclopedic entries into the common concepts of rhetorical studies. 
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unexpressed premises need to be made explicit and tested as well. The scientific 
expert, therefore, will have to provide argumentation for this warrant once being 
challenged by one of his antagonists. Put differently, in order to test argumentation 
to a maximum of doubt, unexpressed premises in the argumentation must be made 
explicit. This procedure is called the inter-subjective explicitization procedure.20
 
Finally, the justificatory force of these enthymemes of the protagonist has to be 
established, following the inter-subjective testing procedure. The argument scheme 
rule states that every employed argument scheme must be tested for a) acceptability 
and b) correct application. Van Eemeren defines the notion of argument scheme as 
“a more or less conventionalized way of achieving a transfer of acceptability from the 
explicit premise to the standpoint” (Van Eemeren 2004: 4). He distinguishes between 
three main categories of argument schemes – causal argumentation, symptomatic 
or sign argumentation and argumentation based on a comparison or analogy – but 
he does not systematically develop a classification or typology of different sub-
categories of argument schemes (cf. Walton et al. 2008; Hitchcock and Wagemans 
2011).21
 Some argument schemes are considered as unacceptable. A well-known 
example is the populist fallacy of argumentum ad populum. In this case, a claim is 
deemed conclusively defended because it reflects general public opinion. GMOs are 
sustainable because a majority of the people thinks it is.
 Discussants can also incorrectly apply acceptable argument schemes. For instance, 
a protagonist can prematurely draw a general conclusion from an insufficient amount 
of particular cases. Such a hasty generalization (or secundum quit) can be recognized 
in the contribution of the politician of the Party of the Animals, who attempted to 
refute the general standpoint of the minister of agriculture (“GMOs are potentially 
sustainable”) by indicating that GM soy leads to deforestation and increasing use of 
toxic pesticides. It is questionable however that what applies to GM soy in particular 
20 Van Eemeren calls it “intersubjective” because both or all discussants have to agree on 
the elements of the argumentation that is made explicit.
21 Van Eemeren’s argumentation theory is not very articulate in its development of 
argument schemes. Douglas Walton, for example, has a far more elaborate list of 
argument schemes (Walton et al. 2008). Hitchcock and Wagemans (2011) have 
proposed to revise the typology of argument schemes based on five desiderata (among 
others, single order principle, exhaustiveness, mutual exclusiveness). Their typology 
consists of similarity argumentation (with four sub-types) and of sign argumentation 
(with eight sub-types).
applies to GMOs in general.
 Another way argument schemes are incorrectly applied is when not all the 
critical questions relevant for the employed scheme are answered satisfactorily.22 
Again, the argumentation of the politician of the Animals Group (Ouwehand) is 
illustrative. Suppose we accept the hasty generalization for the moment, then an 
analogy was implied between GM soy and cisgenic crops. Belonging to the same 
class (GMOs), soy and cisgenic apples or potatoes share certain characteristics. An 
important critical question Ouwehand should answer is this: are there any significant 
differences between GM soy and cisgenic apples? Proponents of cisgenics argue that 
Ouwehand cannot answer this in the negative since there are relevant differences 
between transgenic GM soy and cisgenic crops.
 These procedures for the determination of the conclusive defense of advanced 
argumentation are helpful to reflect on the ethical issues of new and emerging 
science and technology. In particular, the testing procedure of argumentation by 
means of critical questions is the operationalization of the concept of argumentative 
quality which is crucial for deliberative democrats (see Chapter 2). In the next 
section, I demonstrate how this testing procedure can be applied to recurring moral 
argumentation patterns in NEST-ethical discussions: pragmatic (i.e. consequentialist) 
argumentation (Section 3.4.1), and deontological and justice argumentation (Section 
3.4.2). I define a set of stock topics, a list of critical questions that need to be 
answered satisfactorily. Again, I use the public and political debate on cisgenesis in 
the Netherlands to illustrate my explanation.
3.4 Pragma-dialectics and the argumentative quality of NEST-ethical 
discussions
3.4.1 Pragmatic argumentation
Pragmatic argumentation is an argument scheme protagonists use to justify a 
particular action by indicating its desirable consequence(s). In political discourse, 
this argument scheme is frequently employed for the justification of public policy. 
Proponents of new science and technology often use this scheme as well: “In practice, 
22 As described in Section 3.2, Van Eemeren’s pragma-dialectical argumentation theory 
is philosophically grounded on critical rationalism. If critical-rationalists assume that 
“nothing is certain” then there is no reason to presume that the critical scrutiny 
will ever stop. This means that the satisfactory answering of critical questions can 
principally be infinitely exposed to a maximum of doubt. 
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NEST-ethics starts with a consequentialist pattern of ethical argumentation: the new 
and emerging technology is deemed desirable, or not, because its consequences are 
desirable, or not (Swierstra and Rip 2007: 11).” Ihnen-Jory represents the argument 
scheme of pragmatic argumentation as follows (Ihnen-Jory 2011: 146):
Argument scheme of pragmatic argumentation
Standpoint: Action X should (not) be carried out
Material premise: [because] action X leads to (un)desirable consequence Y
[Connection premise: [and] if action X leads to (un)desirable 
consequence Y, then it should (not) be carried out]
Plant researchers who developed cisgenesis argued in favor of an amendment of 
GMO legislation since legal restrictions “seriously hinder the use of cisgenesis” 
(Schouten et al. 2006: 750). A restricted use of cisgenesis is undesirable because 
“given the great potential that cisgenesis has to speed up the breeding process in 
plants, [...] such [a] decision would greatly enhance the economic and environmental 
prospects of agriculture” (ibid: 753). The environmental benefits, the researchers 
argue, are the reduction of the widespread use of pesticides in agriculture. Thus, 
cisgenesis contributes to (more) sustainable agriculture. If we restate their 
argumentation, the plant researchers argue as follows: Regulation for cisgenic crops 
should be amended because that leads to a widespread use of cisgenesis which will 
lead (subsequently) to (more) sustainable agriculture and economic growth. As this 
argumentation was (publicly) challenged, the plant researchers bear the burden of 
proof (see Section 3.2.2). They have to make a reasonable case for why regulations 
need to be adjusted.23 Pragmatic argumentation can be deemed acceptable from 
a dialectical point of view when all parties agree on the content of the separate 
propositions (propositional content) as well as the justificatory force (or refutation) 
of this argument scheme. In the next two sub-sections, both are elaborated upon 
separately.
— Discussing the propositional content of pragmatic argumentation
As Ihnen-Jory (2011) writes, the material premise of pragmatic argumentation is 
composed of a causal and an evaluative proposition. In our example: the development 
23 As some commentators argue, in a (neo-)liberal society the burden of proof is reversed: 
opponents of NEST have to have plausible grounds to stop the development of NEST 
(cf. Swierstra and Te Molder 2012). See Section 2.2.
of cisgenic crops leads to a sustainable agriculture and to economic growth; and: 
sustainable agriculture and economic growth are desirable. To solve their difference 
of opinion, the discussants have to agree on both the content of these propositions. 
I first elaborate the causal proposition.
 The causal connection between scientific research and its desirable outcomes is 
frequently projected into the future: the consequences are expected or promised. 
So, in the case of cisgenesis the proponents stress its “potential” and “prospects”. 
Literature belonging to the sociology of expectations has demonstrated that such 
expectations often serve as a public justification for the development of particular 
scientific and technological trajectories (see Section 4.4.3). As Swierstra and Rip 
have argued (2007), the plausibility of expected or promised future consequences 
is frequently challenged. In the case of cisgenesis, opponents indeed challenged 
the assertion that cisgenesis leads to (more) sustainable agriculture. The Party of 
the Animals argued that GM soy proved that pesticide use has increased. Others 
argued that cisgenesis, as an instance of genetic modification, is “incompatible with 
principles in organic agriculture of sustainability” (Struik et al. 2010: 18).
 In this case, a new sub-discussion about the propositional content arises. The 
premise – “Cisgenesis will lead to sustainable agriculture and economic growth” – of 
the initial pragmatic argumentation then turns into a standpoint which again needs 
to be defended by providing argumentation.24 The propositional content as well 
as the justificatory force of the argumentation in the sub-discussions needs to be 
agreed on et cetera.
 Agreeing on the causal proposition of the material premise, however, does not 
suffice to solve the difference of opinion. All participants have to accept the evaluative 
proposition that “Sustainable agriculture and economic growth are desirable” as 
well. Opponents of cisgenesis agreed on the desirability of sustainable agriculture but 
disagreed on the meaning of the concept. Economic growth hardly ever is generally 
accepted unconditionally as a reason even though it was not explicitly discussed. 
24 Protagonists may for instance, draw on the frequently used topos of scientific progress 
to defend it: “the new technology will bring us all kinds of good, because technologies 
have done so in the past” (Swierstra and Rip 2007: 8). According to the unexpressed 
premise rule (rule 5), the protagonist has to take responsibility for an unexpressed 
premise: “What technologies have done in the past, they will do in the future as well.” 
In the ensuing sub-discussion, the justificatory force of this argumentation must then 
be assessed i.e. can the protagonist answer all the critical questions satisfactorily? 
Possible critical questions might read: What specific good does this technology 
(cisgenesis) produce? What are possible negative side-effects of this technology? I 
return to the side-effect question below.
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Again, a sub-discussion is needed to actually define what sustainable agriculture 
means.
— Discussing the justificatory force of pragmatic argumentation
After the proponent of cisgenic crops has successfully defended the causal 
and evaluative propositional content of his material premise, s/he will have to 
satisfactorily reply to a set of critical questions that pertain to the argument scheme 
of pragmatic argumentation.
 The first critical question is about feasibility. As Ihnen-Jory writes: “the 
presupposition [of the standpoint that someone should do something] is expressed 
by the familiar principle ‘ought implies can’” (Ihnen-Jory 2011: 150). When new 
science and technologies are concerned, this critical question most obviously refers to 
technological feasibility (cf. Lucivero et al. 2011): will the technology be materialized 
in practice at some moment in time? What will its specific technical possibilities 
be? Are cisgenic crops feasible? These are relevant questions in the context of new 
technologies since innovation trajectories have proven to be obstinate. Therefore, 
questioning the plausibility of the expected future technologies is a first strategy 
to challenge consequentialist arguments in favor of a new or emerging science or 
technology.
 Because plant researchers have demonstrated in their laboratories that cisgenic 
apples and potatoes are indeed feasible, they must answer both the necessary-
means question and the best-means question. Are cisgenic crops a necessary means 
for reducing pesticide usage in agriculture or are there (better) alternative solutions 
to the problem? Adherents of organic farming who generally oppose cisgenesis, 
admit that phytophtora “cannot be controlled [organically] and must be avoided” 
(Struik et al. 2010: 19) because the damage of this oomycete responsible for late 
blight in potatoes is enormous. Biotechnologists then could argue that cisgenesis 
is a necessary means for a reduction of pesticide use in agriculture although some 
argue that alternative agronomic possibilities – “including biological pest control, 
co-cultivation of different crops, and use of symbiotic relationships between crops 
and soil organisms” (Jochemsen 2008: 71) and “targeted gene knock-in strategy and 
genomics assisted breeding” (Schubert and Williams 2006: 1328) – should not be 
precluded.
 Even if such alternatives to cisgenesis would exist, proponents may still 
successfully defend their claim by arguing that their technology is the best means 
to achieve a more sustainable agriculture. Whether a technology is the best of 
(technological and/or social) alternatives depends on the cost-benefit ratio of each 
alternative. For the new technology will probably not only produce benefits, but also 
costs or harms.
 The final set of critical questions plant researchers have to answer concern these 
possible costs or side-effects. “In the consequentialist pattern of moral argumentation, 
critics then have to identify undesirable consequences to get a hearing”, Swierstra 
and Rip write (2007: 11). Opponents of cisgenesis argue that genetic modification 
produces risks for human health, biodiversity and rain forests (Cogem 2006: 17). If 
the plant developers agree on (some of) those side-effects, they do have to answer 
the last critical question: do the benefits outweigh the costs?
Although consequentialism is dominant in NEST-ethical discussions, it is not the only 
argumentative pattern. The moral desirability of NEST can be disputed and defended 
on several alternative grounds. “[E]specially organic growers would benefit from 
new varieties, resistant to late blight [i.e. phytophtora] but not […] at the cost of 
disavowing the basic principles of organic agriculture” (Struik et al. 2010, 19). This last 
argument doesn’t mobilize future consequences as justification, but basic principles. 
This is therefore a different type of normative argument: not consequentialist, but 
deontological.
 Therefore, I propose to broaden Ihnen-Jory’s scheme of pragmatic argumentation 
so as to include non-consequentialist arguments. Drawing on various ethical theories 
Swierstra and Rip (2007) identify three other forms of moral argumentation: 
deontology25, theories of justice and “good life” ethics.26 In the next section, I extend 
and refine the set of critical questions that make up the critical testing procedure so 
as to include these alternative moral arguments.
25 Ihnen refers to deontological arguments in the margin of her discussion of the inter-
subjective testing procedure of pragmatic argumentation. The feasibility of action X, 
which is subject of the first critical question, is taken in two separate meanings. The 
second meaning - unfeasible as non-permissible – conceived as incompatible with 
(already) institutionalized forms of (ethical) governance (such as ethical guidelines, 
codes of conduct or legal/regulatory frameworks) is called deontological. 
26 Swierstra and Rip’s NEST-ethics also comprise meta-ethical arguments (e.g. 
technological determinism) and good-life ethical arguments. Since the latter are more 
narrative in character, they do not fit well in the propositional “grammar” of pragma-
dialectics, and therefore, we decided not to include them in this paper. Assessing good-
life ethics arguments is hard, since they draw on different philosophical understandings 
of the good life, which are mostly used as a warrant for other arguments in the 
dialogue. This does not mean that it is impossible to have a good dialogue in which 
these meanings are exchanged.
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3.4.2 NEST-ethics: critically questioning alternative moral argumentations
 — Deontology
Swierstra and Rip’s (2007) presentation of the dynamics of NEST-ethical discussions 
provides clues for finding other critical questions to be answered to improve the 
soundness of a public discussion on NEST. In deontological or duty-based ethical 
arguments Swierstra and Rip write, “deeply seated moral convictions about duties 
and rights” (2007: 14) are used to warrant a moral claim. In most cases, such moral 
principles prevail over desirable consequences as they project basic human interests. 
Ihnen-Jory’s scheme can be adapted in the following way:
Argument scheme of deontological argumentation
Standpoint: Action X should (not) be carried out
Material premise: [because] action X is (not) in accordance with moral principle Y
[Connection premise: [and] if action X is (not) in accordance 
with moral princple Y, then it should (not) be carried out]
For example, opponents of cisgenesis have argued, that “[a]lthough no natural 
barriers are crossed when inserting a gene from crossable species, isolating a gene 
from its natural genomic context and its random insertion can still be considered as a 
violation of the genotypic integrity” (Lammerts van Bueren et al. 2007: 408).
 Deontological arguments such as this can be challenged along three 
argumentative lines (Swierstra and Rip 2007) which can be re-formulated into critical 
questions. First, a different principle of higher order may be provoked. This leads to 
the following critical question: Is this the only relevant moral principle in this case, 
and if not, is it indeed the most relevant one? For example, a proponent of cisgenesis 
may invoke the moral right of an entrepreneur to maximize profits on the condition 
that others are not harmed. An opponent may accept that no harm may be done but 
prioritize the principle that the integrity of Creation should be respected.
 Second, one can argue that the principle does not apply in the particular 
situation. Question: Is the moral principle in this case adequately applicable? For 
example, proponents claim that the moral prohibition on genetic manipulation 
doesn’t apply in the case of cisgenesis since cisgenic crops “fundamentally differ 
from transgenesis” and are “similar to traditionally bred plants” (Schouten et al. 
2006: 753). Consequently, founding upon the deontological principle of equality 
they argue that these crops “should be excluded from GMO [regulatory] frameworks 
and [should be] regulated in the same way as traditional breeding” (ibid.). Critics, 
however, claim that this principle of equality is not adequately applicable because 
cisgenesis does not fundamentally differ from transgenesis or that it is not equivalent 
to traditional breeding (De Cock Buning et al. 2006).
 And third one could challenge specific interpretations of applications of 
general moral principles by providing alternative, contradictory interpretations or 
applications. The corresponding critical question would be: is the moral principle 
unequivocally applicable? For example, although an opponent of cisgenesis may 
argue that this technology is incompatible with our duty to respect nature’s integrity, 
a proponent may mobilize this same duty in support of cisgenesis, for example 
by arguing how this technology in fact does respect nature by doing justice to its 
essence as an ever evolving bricolage.
 This list of critical questions is not comprehensive. Other critical questions 
involving deontological-ethical reasoning are: is the principle widely or even generally 
accepted or is it itself contested? Are there commonly accepted exceptions? Which 
(un)desirable effects does the obligatory following of the rule have? These questions 
too, serve as instruments to critically test appeals to moral principles which are often 
used for “moral crusade[s]” (Nelkin 1992: xvii).
 — Theories of justice
Another important issue in NEST-ethical discussions are issues over distributive 
justice which are often overlooked (Jasanoff 2003). How will benefits or risks of NEST 
be distributed? Schematically the argumentation scheme could be:
Argument scheme of  argumentation of justice
Standpoint: Action X should (not) be carried out
Material premise: [because] action X is in itself or in its consequences (un)just
[Connection premise: [and] if action X is in itself or in its 
consequences (un)just, then it should (not) be carried out]
Distributive justice is a complex moral concept which revolves around the distribution 
of benefits or (social) goods (welfare, income, profits, health care, research funds 
etc.) and burdens (risks, taxes etc.) in situations of scarcity.27 Justice means giving 
each person his or her due. Most philosophical elaborations on justice start with a 
formal principle of justice all moral theories share. This minimal principle states that 
equal cases should be treated equally and unequal cases unequally. For example, 
proponents of cisgenesis have appealed to this principle to defend a less restrictive 
27 It is clear from this formulation that justice arguments are less basic than 
consequentialist and deontological arguments. Specific conceptions of justice can be 
more deontological, more consequentialist, or a hybrid combination of both.
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legislation for cisgenic products. Since cisgenic crops are equal to traditionally 
bred crops, their apples and potatoes should be treated accordingly. Therefore, 
biotechnologists could argue that it is unjust to treat cisgenic crops as cases of 
transgenetic modification. However, the problematic character of this minimal 
formal principle emerges from the debate on cisgenesis because opponents have 
applied the exact same principle to argue in favor of subsuming cisgenic crops under 
existing, more stringent regulation. How are we to determine that cisgenic crops 
really are an element of the subclass of normally bred plants? A first set of critical 
questions could therefore be: is the formal principle of justice rightly applied (are 
equal cases indeed equally treated; and unequal cases unequally)? And: does case C 
really belong to subclass of cases S?
 Because the minimal principle lacks discriminative power, material criteria are 
invoked to provide the substance for determining what relevant differences exist 
between equal and unequal cases in particular contexts. The most basic substantive 
criterion is equality or fairness: to each person an equal share. However, the question 
is whether equality should be the basis in all circumstances. Most people agree that 
in some cases differences between groups or classes of people are justified. One 
such relevant material principle is desert. Plant researchers and companies deserve 
the profits since they had the (lucky) talent of developing the technology and utilized 
their entrepreneurial spirit to make risky investments. Another justice criterion is 
need. Technological developments like cisgenesis are undesirable because stimulating 
agricultural product differentiation and consequently the Dutch economy, is an unfair 
investment of scarce resources because there are people who need these resources 
for other purposes more or these technologies more for their development.
 In the public debate on cisgenesis in the Netherlands, proponents mobilized 
justice arguments using this criterion of need. “[C]isgenesis will facilitate the second 
green revolution in India” (Jacobsen and Nataraja 2008: 1365), implying that people 
in developing countries benefit from this new technology. India needs a second 
green revolution (more than other countries) to guarantee a safe and secure food 
production, because of “global warming, population growth, environmental stresses 
and diminishing land resources” (ibid.). Therefore, it would be unjust not to allow and 
develop cisgenic crops. Producing them meets the second principle of justice that 
John Rawls (1971) stated in his theory of justice: “social and economic inequalities 
are to be arranged so that they are to the greatest benefit of the least advantaged” 
(the people in India).
 Depending on the particular context these discussions on distributive justice 
take place, the critical questions discussed in the previous subsection (deontological 
argumentation) can be formulated. Is the principle of justice discussants draw on the 
only relevant? In most situations the answer is no. Opponents for example claimed 
that “it is very unlikely that subsistence farmers in developing countries will be able 
to buy the expensive seed protected by numerous patents of the GMO varieties” 
(Struik et al. 2010: 18). These critics refer to the unjust distribution of benefits in 
India. Cisgenic crops are not to the greatest benefit of the very least advantaged: the 
Indian subsistence farmers. What is more, because of patents local Indian farmers do 
not have an equal opportunity to cultivate genetically modified crops to earn a living 
(which is contrary to another of Rawls’ principles of justice).
 If more than one material principle of justice is relevant, as was the case in the 
public debate on cisgenesis, discussants will have to answer two critical questions: is 
the material principle of justice the most relevant? Is it adequately and unequivocally 
applicable? These discussions on justice reflect some of the key questions Wilsdon 
and Willis have identified in their pamphlet about upstream engagement: who needs 
this technology? Who will benefit [and who does not]? What will it mean for the 
people in the developing world (Wilsdon and Willis 2004: 28)?
In the table below (Table 3.2) the critical questions pertaining to the various 
argumentation schemes in public discussions on NEST-ethical issues are summarized. 
Together these critical questions constitute the stock topics (a taxonomy or 
classification of critical questions that can be at issue in a NEST-ethcial controversy) 
to be satisfactorily addressed in order to conclusively defend a standpoint based on 
these schemes.
3.5 Some limitations of pragma-dialectics and
 methodological additions
The research object of the pragma-dialectical argumentation theory is well-defined. 
Argumentation theorists are concerned with what people directly or indirectly 
say or write. Their object of study is discourse as far as it is externalized or can be 
externalized (in case of unexpressed premises or conclusions). This limitation has 
methodological consequences for this study in two directions, one going inwards, 
the other outwards.
 The former means that argumentation theorists are not concerned with the 
psychological dispositions of language users and their motives for holding, rejecting, 
questioning or attacking standpoints. A proper critical discussion attitude requires a 
systematic doubt. Criticism is a means to resolving problems and argumentation a 
means to testing standpoints. “This requires a non-dogmatic and anti-authoritarian 
approach and a distrust of unshakeable principles and claims to infallibility (Van 
Eemeren 2004: 189).” Argumentation theorists do not deny the importance of 
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the psychology of language users. Their analysis, however, is confined to the 
commitments to which language users can be held based on their speech acts. 
The model of critical discussion constitutes a set of commitments reasonable 
arguers should observe in order to resolve their difference of opinion. This model 
constitutes first-order conditions for a reasonable discussion. These discussion rules 
are necessary but in themselves insufficient conditions for a reasonable discussion. 
Second-order conditions or the psychological “state of mind” of arguers are also 
prerequisites for a reasonable discussion. Nevertheless, these are excluded from the 
argumentative analysis.28
 This also holds for external conditions that (co-)determine what can be 
said and what cannot be said. These third-order conditions “relate to the social 
circumstances in which the discussion takes place and pertain, for instance, to the 
power or authority relationships between the participants and to special features of 
the situation in which the discussion takes place” (Van Eemeren 2004: 189). At the 
seminar on biotechnology for instance, opponents who raised issues of risk were 
silenced as the chairman simply interrupted them, telling that the risks of GMOs 
were not on the agenda. In Section 2.5, I elaborated Hajer’s notion of dramaturgy of 
public deliberation to call attention to these third-order conditions or performative 
dimension of settings. The “contextualized interaction itself produces social 
realities like understanding of the problem at hand, knowledge, and new power 
relationships” (Hajer 2005: 631). How do settings affect the deliberative performance 
of participants?
To include these internal and particularly external conditions (or performing settings) 
into the analysis of discourse in upstream public deliberation, the analyst has to 
change his epistemological position of the observer into a position of participant-
observer. Facilitators and (social) researchers concerned with the quality of 
public deliberation have to use additional ethnographic research methodologies 
(questionnaires, interviews) to take these higher-order conditions of a critical 
discussion into account. Furthermore, I think that the analysis of argumentative 
discourse gains power when discussed with participants afterwards off-stage. These 
empirical data also increase knowledge of the context which allows for a richer 
analysis of argumentative discourse (see empirical Chapters 5 and 7).
28 This seems to reflect a rather cognitivist approach to language use, “states of minds” 
and attitudes discursive psychologists have criticized (see e.g. Potter and Whetherell 
1987). As discursive psychologists argue, psychological phenomena are discursively 
constructed in social interaction (see Chapter 4, Section 4.3).
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The exclusive analytical focus on externalized discourse reveals another limitation of 
the pragma-dialectical framework as presented in this chapter. What does it mean 
when discussants are silent about some issues? Most of the contributions to the 
public debate on cisgenesis are written texts, but also for spoken argumentation 
– as for example in the parliamentary proceedings – holds that many if not most 
claims remain unchallenged. The plant geneticists for example express no opinion 
on principles of sustainable agriculture. Does it mean that these technologists agree 
with ecological farmers on these principles? Perhaps, but the contrary is more 
likely to be true. The same holds for opponents of cisgenesis. Suppose there is no 
ecological alternative to GM for the combat against phytophtora to be expected in 
the near future. Is it an option to revise the principles of sustainable agriculture so 
as to include GMOs? From the sources reporting on the public debate on cisgenesis 
I have found, I cannot infer the opponents’ view on the issue. Selecting topics for 
discussion (and hence, being silent about others) appears to be a powerful strategy 
in argumentative discourse. As Van Eemeren himself indicates in his later work 
(2010) strategic maneuvers (such as topical selection as he calls it) reveals a different 
perspective on a critical discussion attitude without being unreasonable. The average 
discussant is perhaps only in the second instance a critical-rationalist for whom 
“doubt is intrinsic to his attitude to life” (Van Eemeren 2004: 189). Discussants are 
primarily interested in having their critics or antagonists accept their standpoint. In 
the next chapter, I discuss this concept of strategic maneuvering in context of public 
discussions on NEST.
3.6 Conclusions: improving reasonable deliberation
According to the normative political theory of deliberative democracy elaborated in 
Chapter 2, the quality of argumentation and the reasonableness of the deliberation 
process are key elements for public deliberation. As I have argued in this chapter, 
the pragma-dialectical argumentation theory and NEST-ethics are both useful for the 
analysis of public discussions on NEST. Pragma-dialectics’ model for critical discussion 
offers a formal procedure to analyze and assess the quality of public deliberation 
on NEST in terms of reasonableness. This discussion model (with its stages, rules 
and fallacies) provides useful instruments not only for researchers who empirically 
analyze argumentative discourse but also for facilitators and organizers whose task it 
is a) to stimulate reasonable discussion conduct for the resolution of differences of 
opinion (argumentation as process) and b) to improve the quality of reason-giving in 
public deliberation (argumentation as product).
 NEST-ethics, on the other hand, offers a contextualization of argumentative 
discourse utilized in everyday discussions on new and emerging science and 
technology: a description of recurring moral argumentation patterns in NEST-ethical 
discussions that researchers and facilitators of public discussions on NEST can expect. 
To illustrate the utility of both I have analyzed the Dutch public debate on cisgenesis. 
This contentious technology defying existing categories, turned out to be a “matter 
of concern” (Latour 2005), an issue that has called a public into being because of 
its normative ambitions concerning sustainable agriculture. Although its developers 
had called this technology prematurely “acceptable to consumers” (Schaart et al. 
2011) it sparked considerable debate perhaps because of the relative late stage in 
the innovation trajectory (Dortmans December 9 2009). Nevertheless, the political 
debate in the Netherlands is decided in favor of proponents of cisgenesis (TK 27 
248, nr. 233) even though the Dutch state secretary has not convinced her European 
colleagues yet (Anon. January 8, 2014).
 Using the model of critical discussion I have attempted to assess the quality 
of this debate. I identified some major differences of opinion on whether cisgenic 
crops are safe for environment and consumption, are sustainable and beneficial 
for the least advantaged. Particularly, the discussion over risks and facts resulted in 
violations of discussion rules. The Dutch minister had prohibited the discussion on 
risks during a seminar she had organized to discuss the socio-economic aspects of 
GMOs. The interventions of the chairperson prevented opponents from advancing 
their objections freely. Furthermore, it can be argued that the plant geneticists 
who had called Greenpeace an irrational and fundamentalist group committed an 
argumentum ad hominem (again a violation of the freedom rule). Greenpeace’s 
“theoretical problems” were supported by scientists (Schubert and Williams 
2006). On the other hand, some opponents presented contentious claims (farmers 
committing suicide) as facts to evade the burden of proof. Some have argued in 
favor of experiments in order to settle issues of facts (De Vriend and Schenkelaars 
November 25 2009). Ultimately, the European Food Safety Authority (EFSA) stated 
that cisgenic products are as safe as traditionally bred plants (EFSA 2012) but 
opponents challenge the transparency and controllability of EFSA’s expert advice.
In this chapter, I have particularly focused on argumentation as product. Pragma-
dialecticians define three procedures important to facilitators for stimulating critical 
reflection and confronting argumentation systematically with a “maximum of 
doubt.” Firstly, it is important to explicate unexpressed premises that remain implicit 
largely for communicative efficiency reasons. Secondly, the explicated propositional 
content of every individual statement must be acceptable. If not, the protagonist 
needs to advance argumentation in a sub-discussion to defend this claim. Third, the 
108 109
Behind the scenes of… life scientists on stage
3
REASONABLENESS IN PUBLIC DISCUSSIONS ON NEST
justificatory force of every argumentation needs to be critically tested. The facilitator 
leads the critical testing procedure that is successfully completed when protagonists 
who defend a claim by advancing argumentation, have answered all critical questions 
satisfactorily.
 I have developed a comprehensive set of critical questions that together form 
the stock issues to be addressed in NEST-ethical discussions. Is cisgenesis the only 
or best solution to plant diseases? What moral principles are violated? Are these 
commonly agreed upon? Who needs cisgenesis and are benefits and risks distributed 
justly?
 These critical questions are first and foremost a measure for deliberative quality, 
but these stock topics constitute a heuristic in order to fulfill another quality aspect 
of deliberation: inclusiveness. What are possible issues to be addressed? Issues 
of justice were only marginally discussed and were absent in the parliamentary 
debates. Finally, these questions are an indication of possible knowledge deficits. 
What (scientific) evidence corroborates certain claims, what is still unknown? What 
do we know about suicide rates among farmers in developing countries and is the 
widespread use of GMOs indeed the major cause?
 In the public debate on cisgenesis, I hardly found any overt violations of 
the discussion rules pertinent to the argumentation stage. As far as issues were 
discussed, the debate was reasonable in the sense that a) relevant argumentation 
was advanced and b) the discourse was deprived of major fallacies. On the other 
hand, much argumentation was not subjected to a maximum of doubt either and 
therefore not conclusively defended. Most participants expressed their views in 
written (popular or scientific) media. This allows both proponents and opponents 
to strategically select issues at will. This topical selection is a powerful strategy to 
be effective in discussion without violating the argument scheme rule. Apparently, 
discussants do not automatically adopt a critical discussion attitude integrating 
systematic doubt in resolving differences of opinion. In the next chapter I elaborate 
the concept of strategic maneuvering which pragma-dialecticians have developed to 
incorporate a rhetorical dimension in argumentation theory.
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4.1 Introduction
“I witnessed the seminar [on the socioeconomic aspects of GMOs]. First of all, it 
was very much [sic] disappointing. […] [T]he minister [of agriculture] states [in her 
speech]: no discussion on biotech [is needed] any longer, we will just have to live with 
them. She claims GMOs can contribute to crop security, productivity, improvement of 
disease prevention and to a decrease of use of pesticides. Apparently without being 
bothered by any knowledge of facts, she completely ignores that GM soy contributes 
to the deforestations of South America, stimulates the use of pesticides and [it] 
definitely does not lead to higher yields. Indeed, production can even drop. That is 
not sustainable really, I would say. Among the key note speakers there was Dr. Bino 
of Wageningen University, the publicity agent of cisgenesis, apparently. Using slogans 
such as ‘GMO, the choice for sustainability,’ he wanted to convince us that GMOs do 
not involve any risk and that biotech can solve all sustainability tasks in agriculture. 
That promise is not new. In fact, it has been the mantra of [biotech] industry right 
from the start of the discussion on genetic manipulation. In practice, not a single 
word has come true. That an independent scientist [such as Dr. Bino] lends himself 
for such bold statements, is characteristic of the position of Wageningen University 
in the debate.” (TK 27 248 nr. 142: 2)
In the previous chapter, I discussed the pragma-dialectical model of critical 
discussion to analyze and evaluate argumentative discourse such as the contribution 
to a parliamentary proceeding on biotechnology quoted above. The member of 
parliament (Ouwehand) presents a clear difference of opinion: both the Dutch 
minister of agriculture and Dr. Bino assert that GMOs are possibly sustainable, 
Ouwehand claims the opposite. To defend her standpoint she uses a combination of 
an argumentation from example (GM soy) and pragmatic argumentation (see 3.4.1) 
to defend her standpoint that GMOs in general (including cisgenic crops) are not 
sustainable. To evaluate this argumentation, one must examine whether the rules 
for a critical discussion are observed (for an overview see Table 3.1, Section 3.2.2). 
chapter 4
Strategic maneuvering in public discourse 
on new science and technology
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Are the standpoints of opponents accurately represented (standpoint rule): did Dr. 
Bino indeed use slogans such as “GMOs, the choice for sustainability” or is this a 
straw man? Does the argumentation conclusively substantiate these standpoints 
(argument scheme rule)? Is there agreement on the propositional content: does the 
use of GMOs indeed stimulate pesticide use as Ouwehand asserts? Is the argument 
scheme (argumentation from example) correctly applied? Are the critical questions 
pertaining to this argument scheme satisfactorily answered: does what applies to 
GM soy apply to all GMOs? Are there GMOs that help decrease the use of pesticides? 
Do GMOs indeed lead to the undesirable consequences of deforestation or an 
increase of the use of pesticides? Do the alleged benefits (crop security, productivity, 
improvement of disease prevention) outweigh the costs (deforestation, increasing 
use of pesticides)?
 Still, it seems that Ouwehand is doing more than just arguing, i.e. “advancing 
a constellation of reasons the arguer can be held accountable for as justifying the 
acceptability of the standpoint(s) at issue” (Van Eemeren 2010: 29). She depicts the 
Dutch minister of agriculture as ignorant (“Apparently without being bothered by 
any knowledge of facts…”). And what is she doing with Dr. Bino? The contrast of 
representing him as “publicity agent” and an “independent scientist,” is interesting. 
Both categorizations are paradoxical when combined: how can Dr. Bino be a publicity 
agent (having an interest in selling products) and an independent scientist (meeting 
Merton’s ethical norm of disinterestedness) at the same time?1 Using the predicate 
of “independent scientist,” Ouwehand evokes certain associations of proper behavior 
for scientists (what Dr. Bino should be doing) that contrast with his actual behavior 
of selling products as represented by Ouwehand (what Dr. Bino is in fact doing). This 
reinforces the implication of a  lack of credibility; since Dr. Bino is said to be talking 
like a salesman, people do not have to believe what he says as a scientist. I return to 
this instance in Section 4.4.2 on subject positioning.
 This example nicely illustrates that people who are involved in (political) 
argumentative discourse can draw on other discursive resources than just advancing 
reasons to convince reasonable critics. People can do things with words. Ouwehand’s 
construction of Dr. Bino’s identity illustrates how discussants use language not 
merely to convey their message (for communicative purposes) but also to elicit 
certain responses from their rivals or the public (for interactional purposes).
1 The American sociologist Robert Merton (1973) formulated a set of norms (mostly 
abbreviated in the acronym of CUDOS) scientists have to observe: Communalism, 
Universalism, Disinterestedness, Organized Skepticism. 
 Although deliberative democrats are well aware of this performative dimension 
of speech acts (cf. Fischer and Forrester 1993) in everyday political deliberations, 
they seek “practices in which only better arguments carry weight and in which 
manipulation or strategic maneuvers are minimized” (Hamlett 2003: 129). How can 
these strategic maneuvers be understood? As a manipulation of language that needs 
to be minimized?
 In this chapter, I elaborate on the concept of strategic maneuvering introduced 
to refine the “standard” pragma-dialectical argumentation theory (as discussed in 
Chapter 3) so as to include the rhetorical dimension of argumentative discourse.2 
Discussants do not only aim at resolving their difference of opinion. They also want 
their reasonable critics to accept their claims and argumentation. Selecting an 
appropriate argument scheme is but one strategy to be persuasive. In Section 4.2, I 
present a definition of the concept of strategic maneuvering and I describe its three 
analytical aspects indicating different strategies for persuading audiences. Again I use 
the debate on biotechnology in agriculture (cisgenesis) as an illustration.
 According to Van Eemeren the combination of these three aspects amounts to 
the framing of argumentative moves. Framing can be defined as the selection of 
“some aspects of a perceived reality and make them more salient […] to promote 
a particular problem definition, causal interpretation, moral evaluation, and/or 
treatment recommendation” (Entman 1993: 52; more on framing in Section 4.2.2). 
As I argue, drawing on framing as a central concept within the field of discourse 
analysis (DA) indicates a step of including insights from sociological studies of situated 
language use to enrich the study of the rhetorical dimension of (argumentative) 
discourse. In Section 4.3, I explore the common ground further between pragma-
dialectics and branches of DA that adopt a sociological perspective on language 
use as social practice. DA studies are useful for the study of strategic maneuvering 
because a) one of their shared premises is that different constructed versions of 
the (social) world serve rhetorical functions and b) their focus is on other discursive 
strategies than argumentation (in the pragma-dialectical sense) alone.
 In Section 4.4, I present three forms of discursive work – identified in DA studies 
in Science and Technology Studies (STS) literature – which can be considered 
2 Van Eemeren does not provide a detailed definition of rhetoric. Following Jasinski 
(2001) there are innumerable meanings of rhetoric as practice (or “rhetorica utens”). 
I subscribe to what Jasinski calls the constructivist or constitutive perspective 
on rhetoric, which means that rhetoric does not refer to some sort of discourse, 
but instead, rhetoric is a particular quality or function of any text (the persuasive 
dimension of discourse).
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as strategic maneuvers utilized in argumentative discourse on new science and 
technology: boundary work, subject positioning (or identity work) and expectations 
(future work). The aim of this chapter is to continue the exploration of strategic 
maneuvers in public discussions on new and emerging science and technology 
(NEST) beyond recurring argumentative patterns presented in Chapter 3 using STS 
literature on public controversies on NEST. In Section 4.5 address the question when 
these three discursive practices conflict with the rules of a reasonable discussion as 
elaborated in Chapter 3.
4.2 Strategic maneuvering in argumentative discourse
4.2.1 Strategic maneuvering: a definition
In A Systematic Theory of Argumentation Van Eemeren (and Grootendorst) (2004) 
had already alluded to the benefits of a fruitful cooperation between dialectical and 
rhetorical research programs of argumentation. Parallel to his own pragma-dialectical 
program he had developed a rhetorical version as an alternative, but equally 
comprehensive study of argumentation. This epistemo-rhetorical argumentation 
theory, grounded on an anthropological-relativistic notion of reasonableness, aims 
at studying the process of persuasion (as opposed to convincing) by means of an 
audience-oriented reconstruction (the rhetorical analysis): “what kinds of audiences 
have to be distinguished and which rhetorical devices work persuasively on the 
different audiences?” (39). The discourse or text is reconstructed as an attempt to 
expose rhetorical patterns.
 Both theoretical positions (and their analytical, empirical and practical “estates”) 
are clearly demarcated in A Systematic Theory of Argumentation but they are by 
no means mutually exclusive. Indeed, the two versions are part of a comprehensive 
research program: “To make our point, we present [...] the dialectical version of a 
research program sharply contrasted with a rhetorical version, but in practice certain 
elements of both programs may be combined” (ibid: 37 footnote 36).3 At the time 
of writing his systematic theory of argumentation Van Eemeren had already started 
a research project to incorporate the rhetorical dimension of argumentation (see 
Van Eemeren and Houtlosser 1999). Only in Strategic Maneuvering in Argumentative 
3 Such as predominant argumentation theories that are mainly rhetorical (e.g. 
Perelman’s New Rhetoric and Toulmin’s The Uses of Argument) who “start from the 
idea that argumentation is always addressed to an audience and that the quality of 
argumentation depends on its acceptability to the audience” (Van Eemeren 2010: 114)
Discourse (2010) Van Eemeren explores the benefits of including the rhetorical 
dimension more systematically. Discussants do not only pursue the dialectical aim 
of reasonableness (following the procedure which is instrumental to the resolution 
of differences of opinion), but also the rhetorical aim of effectiveness:4 to have their 
standpoint, supported with argumentation, accepted.5 People are “also, and perhaps 
even primarily, interested in resolving the difference of opinion effectively in favor of 
their case, i.e. in agreement with their own standpoint or the position of those they 
represent” (Van Eemeren 2010: 39). The “argumentative predicament” discussants 
find themselves in comprises having to be effective while being reasonable at 
the same time. In their pursuit of effectiveness, not every argumentative move is 
allowed. Discussants have to strategically maneuver.
 Van Eemeren defines maneuvering as moving about in argumentative discourse 
to end up in the most advantageous position in view of the particular argumentative 
context, using the metaphor of the maneuvering of wind-catching boats in a 
competition. The adjective strategic is added to denote the planned and aimed 
efforts to maintain the equilibrium between effectiveness and reasonableness. Thus, 
strategic maneuvers are contributions to the discussion which are aimed at resolving 
a difference of opinion while at the same time attempting to “shape one’s case to 
one’s own advantage” (Van Eemeren and Houtlosser 1999: 483).
 What is more, strategic maneuvering is part and parcel of every discussion which 
means that is not a priori detrimental to a reasonable discussion. Therefore, strategic 
maneuvering does not necessarily need to be minimized as deliberative democrats 
suggest. Indeed, most of the time, arguers succeed in maintaining the delicate 
balance between the rhetorical and dialectical aims of argumentative discourse. Yet, 
4 Van Eemeren gives preference to the notion of “effectiveness” instead of the notion 
of “persuasiveness”, which traditionally is used to denote the rhetorical dimension of 
discourse. The main difference between the two, according to Van Eemeren, is that 
persuasiveness is limited to “those parts of the argumentative discourse (arguments) 
that can be reconstructed as belonging to the argumentation stage” (Van Eemeren 
2010: 39), whereas effectiveness is more comprehensive in the sense that it also 
encompasses the other three stages of the critical discussion (see Section 4.2.2). 
5 To illustrate his point, Van Eemeren analyzes an advertisement of tobacco company 
Reynolds that is no longer allowed to promote smoking among non-adults in the 
United States. In the advertisement the tobacco company explicitly argues why young 
people should not smoke, using paternalising arguments with the effect to achieve 
the opposite: encouraging young people to start or continue smoking (Van Eemeren 
2010: 20-22).
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sometimes effectiveness prevails at the expense of reasonableness. In these cases, 
strategic maneuvering is said to derail. Derailments of strategic maneuvering occur 
when the rules for a critical discussion (Chapter 3) are violated.
Van Eemeren distinguishes between three “inseparable aspects” of strategic 
maneuvering: the choice from topical potential (or topical selection for short), the 
appeal to (an) audience(s) or audience demand and presentational devices. “No 
strategic maneuvering can occur without making simultaneous choices regarding 
how to use the topical potential, how to meet audience demand and how to employ 
presentational devices” (Van Eemeren 2010: 94).
 In the next subsection I examine how discussants can strategically maneuver 
in all four different discussion stages (Section 3.2.2). So, there are confrontational 
maneuvering, opening, argumentational and concluding maneuvering. For example, 
in addition to the dialectical aim in the confrontation stage (to achieve clarity 
concerning the differences of opinion and the different positions parties hold in 
these issues) participants will strive for an optimal definition of the difference of 
opinion. In each of the other discussion stages discussants will try to find a balance 
between reasonableness and effectiveness. I illustrate the three aspects of strategic 
maneuvering using the Dutch debate on cisgenesis and Swierstra and Rip’s NEST-
ethics (2007).
4.2.2 Three aspects of strategic maneuvering
The first aspect of strategic maneuvering is topical selection which is defined as 
“the repertoire of options for making an argumentative move that are at the 
arguer’s proposal in a certain case and at a particular point in the discourse” (Van 
Eemeren 2010: 93-93). Topical selection refers to the concept of topos (or the plural 
topoi) which is an ambiguous concept.6 It ranges from recognizable “recurrent or 
commonplace themes and images” (such as Brave New World or Frankenstein Food 
in discussions on GMOs) to “common lines of argument” or “abstract patterns of 
inference” (such as causality, analogy etc.) in the work of Aristotle (Jasinski 2001: 
578-581). Because of its predominantly Aristotelian interpretation, topical selection 
is primarily associated with argumentational maneuvering: the protagonist’s 
choice from available argument schemes that provide an optimal defense for his 
standpoint. The member of parliament for example selected a complex combination 
6 Topoi (singular topos; locus in Latin) is an ambiguous notion, which literally means 
“place” or “location”. I define topoi here narrowly as abstract patterns of inference or 
simply argument scheme which relies on the Aristotelian notion of topos. 
See Jasinski 2001: 578-581.
of similarity (GMOs are not sustainable because GM soy is not sustainable) and 
pragmatic argumentation (GMOs will lead to the undesirable consequences of 
increase of pesticide use, deforestation etc.) to defend her standpoint that cisgenic 
products (which are genetically modified) are not sustainable (see 3.4.1 on pragmatic 
argumentation). From a rhetorical perspective, Ouwehand could have selected 
a different defense for her standpoint. For instance, cisgenesis is not sustainable 
because it defies the sustainability principles of organic agriculture (implying that 
only products that meet these principles can truly be called sustainable).
 Topical selection is not confined to the argumentative stage, however. For 
instance, in the confrontation stage, a discussant can select effectively from the 
available issues at hand (or “topics” discussants disagree on). There are a number 
of controversial issues concerning cisgenesis (see Chapter 3). Are cisgenic crops 
sustainable? Is cisgenesis safe? Does it respect the natural order of God’s creation? Do 
cisgenic products offer sufficient business opportunities for Dutch small and medium 
enterprises (SMEs)? Ouwehand selects sustainability as the issue to disagree on in 
the confrontation stage whereas politicians of the liberal party select the economic 
benefits to argue in favor of this new technology.7
 Discussants can also direct the course of the opening stage of the discussion 
using topical selection. In the opening stage the common ground is explored both 
procedurally and materially so as to find out whether a discussion can resolve their 
difference of opinion. Protagonists of new technologies (such as cisgenesis) can select 
two arguments which render a reasonable discussion futile. First, protagonists can 
use technological determinism as a rhetorical device. According to this philosophical 
vision on technological innovation, the possibility of social influence on scientific and 
technological development is denied a priori (Swierstra and Rip 2007: 7-8). Science 
and technology will evolve according to their own internal logic independently from 
human opinions, decisions, actions and deliberations.8 The premise of technological 
7 It is worth mentioning that the Dutch minister of agriculture and proponents of 
cisgenesis chose sustainability as an important topic to defend this new genetic plant 
technology. Because of the controversial status of GMOs and the sceptic general public, 
it seems strategic to stress the environmental benefits of cisgenesis; see also audience 
demand in the next subsection.
8 Swierstra and Rip also discern an immanent form of technological determinism, 
which refers to the international (economical) competition scientists see themselves 
entangled in. Stopping scientific or technological activities within national borders 
is useless, because the technology will be developed anyway, when not in the 
Netherlands so it will be elsewhere.
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determinism is rhetorically effective or at least persistent even if it is descriptively 
insufficient (Wyatt 2007)9: the European GMO resistance towards cultivation 
and import of GMOs has proven de facto the social influence on technological 
development. Nevertheless, “some actors some of the time present projects as simple 
and straightforward. It is necessary for them to do so in order to make things happen 
and to justify their actions” (172). Only its simplism can explain the persistence and 
the rhetorical success of this justificatory technological determinism, Wyatt argues. 
Also because opponents of technology frequently share this premise with their 
proponents, as Swierstra and Rip note, the idea of technological determinism can 
persist.10 In his plenary speech at the seminar on biotechnology, a director of an 
NGO used the metaphor of a rumbling train indicating the autonomy of technology 
development: “An ideological or ethical rejection will not help us very much. If only 
because the train is hurtling and we are at the sideline if we do not contribute to the 
discussion” (TK 27 428, nr. 145: 20).11
 The metaphor of the train is also invoked in a second so-called meta-ethical 
argument (Swierstra and Rip 2007) that can be used in the opening stage of the 
discussion: the habituation argument. This argument also stresses the inevitability 
of technological development indicating that people will get accustomed to new 
technologies in the future even though people hold objections against them at 
present times. Once, people regarded the train as a threatening new technology that 
would kill you. Now everyone is used to the presence of trains all these objections 
have disappeared.
9 In a similar vein, Swierstra and Rip argue that technological determinism can (and 
perhaps must) be considered to be a rhetorical device. Whereas in a front stage 
performance technology enactors employ technological determinism to make public 
discussion unnecessary, backstage they express their hope to influence the course 
of things. For example, their efforts in communicating nanotechnology are aimed at 
preventing nanotechnology from becoming the next GM disaster.
10 Wyatt distinguishes between four meanings of technological determinism. The version 
opponents of technology adhere to, is the normative variant. This refers to the extent 
to which people experience a lack of agency “when confronted with new machines and 
new ways of doing things” (Wyatt 2007: 167).
11 Metaphors are a presentational device. See below.
The second aspect of strategic maneuvering is audience demand.12 In addition to 
its rational and its verbal character, argumentation is also a social activity, “aimed 
at achieving certain communicative and interactional effects on other people” 
(Van Eemeren 2010: 108). In order to be effective participants have to adjust to the 
frame of reference and the preferences of their audience at which the argumentative 
move is directed. This means, first, that audiences need to be identified and second 
that their views and preferences with which strategic maneuvers have to accord 
are known. Taking the frames of reference of audiences into account is complicated 
because of the heterogeneity of the audience: there is a multiplicity of audiences. 
Furthermore, sometimes argumentation is not solely aimed at convincing a direct 
antagonist (the primary audience) – the person or persons who have challenged 
a claim – but sometimes also at indirect antagonists (or secondary audiences) 
who witness the discussion at a larger distance (e.g. voters watching a TV debate 
in election times, members of political parties etc.). The claim of the politician of 
the Party of the Animals that GMOs lead to deforestation (bringing to mind the 
mediagenic images of bulldozers ruining precious rain forests) will effectively appeal 
to her environmentalist constituency. Peter van Dalen as member of the European 
Parliament for the Christian Union (CU) on the other hand, stresses CU’s advocacy 
in favor of cisgenesis “because it respects God’s Creation” which is important for his 
Christian voters (Versluis 2012: 20).
The final aspect of strategic maneuvering is the choice from available presentational 
devices. These are the linguistic – both semantic and syntactic – options arguers can 
select from to construct their speech acts and arguments effectively. An obvious 
example of a semantic presentational device frequently employed for argumentative 
purposes is the metaphor, a figure of speech based on an analogy or comparison. The 
public debate on cisgenesis is full of metaphors. The rumbling train is one example. 
Comparing plants with a box of Lego is another: “A plant is not a box of Lego, where you 
can take out bricks at will to build whatever you like” (Versluis 2012: 20). Sometimes, 
metaphors can become culturally recognizable symbols such as Frankenstein Food, 
a label widely circulated in the European GM controversy in the 1990s. The former 
Dutch minister of agriculture herself, for instance, explicitly referred to this metaphor 
12 The notion of audience implies a certain degree of passivity. Although Van Eemeren 
recognizes the partly active role the recipients of speech acts play, I prefer, in the 
context of face–to–face public deliberation the notion of public (or the plural publics 
to indicate its heterogeneity). In my exposition of Van Eemeren’s concept of strategic 
maneuvering, I conform to his terminology, to avoid confusion.
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in her opening speech at the seminar on socioeconomic aspects of GM crops. Not 
to depict GM crops as a deterrent or monstrous product because of its defiance to 
natural order (see Section 4.4.1 on “boundary work”), as opponents of GM crops did 
in the 1990s but to remind her listeners that this metaphor is a relic from past times. 
“Meanwhile more than a decade has passed and much has changed,” implying that 
GM crops are simply all around us, so the opportunity to ask ourselves whether we 
want this technology has passed too (TK 27 428 nr. 145: 11).
 Another well known presentational device is the rhetorical question. This 
syntactical form of a question allows a discussant to weaken a claim or to advance a 
premise indirectly. Tofik Dibi, a member of the Dutch Green Party (GroenLinks) used 
a rhetorical question in the parliamentary proceedings: “Why another investigation 
on the alleged safety of cisgenesis if the eventual qualities and hence the risks are the 
same as in the case of transgenic crops?” (TK 27 428 nr. 142: 6). Since it is not fully 
externalized, this politician cannot be committed to defending his claim (“Another 
safety inquiry is useless”) and thus he can evade the burden of proof.
In combination these three analytical aspects of strategic maneuvering entail the 
selection and choices made to serve the purpose of constructing argumentative 
moves that bring the arguer to an advantageous position in a discussion. Van 
Eemeren refers to the concept of framing to indicate that strategic maneuvers 
make some things more salient than other things.13 “Exploiting the possibilities of 
presentational variation in strategic maneuvering in agreement with one’s topical 
choices and adjustments to audience demand boils down, in my view, to ‘framing’ 
one’s argumentative moves in a communicatively and interactionally functional way” 
(Van Eemeren 2010: 119).
 His relating the concept of strategic maneuvering to the concept of framing, 
a “modern concept widely used in the social sciences and in discourse analysis” 
13 It is hard to find a widely accepted definition of framing (Scheufele 2008). Entman’s 
attempt to define framing to bring some clarification in a “fractured paradigm” is 
often quoted (and resonates with Van Eemeren’s description): “Framing essentially 
involves selection and salience. To frame is to select some aspects of a perceived 
reality and make them more salient in a communicating text in such a way as to 
promote a particular problem definition, causal interpretation, moral evaluation, and/
or treatment recommendation” (ibid: 52). As Ensink and Sauer (2003) argue, however, 
(knowledge and interactive) frames should be distinguished from perspective, which 
seems to be the way in which Van Eemeren seems to understand it. “Perspective,” they 
write, “refers to the fact that the content of a discourse necessarily is ‘displayed’ from 
some point of view” (2).
(Van Eemeren 2010: 126), demonstrates Van Eemeren’s orientation towards discourse 
analysis (DA) as a useful source to study strategic maneuvering in context.14 However, 
in his exposé on strategic maneuvering in general and presentational devices in 
particular, he mainly draws on the (classical and modern) rhetorical tradition.15 In my 
view, Van Eemeren’s brief theoretical elaboration on framing is a promising but only 
a first step to establish a more fruitful cooperation between his concept of strategic 
maneuvering and the empirical study of language use in DA. His reference to Erving 
Goffman’s Frame Analysis (1974) as his “source of inspiration” is telling because 
Goffman’s concept of framing in discourse analysis is but one “frame” on framing.16 
Moreover, framing is only one central concept in DA (Van den Berg 2004).
 In the next two sections I attempt to establish a more detailed link between 
14 In A Systematic Theory of Argumentation, Van Eemeren had already emphasized the 
importance of interdisciplinary collaboration in the study of argumentation to include 
“the expertise of empirically minded linguists and social scientists, especially those 
engaged in discourse analysis and communication studies” (Van Eemeren 2004: 40-41).
15 The field of rhetoric which draws on the rich classic tradition of persuasion is useful 
for studying discussant’s strategic maneuvers, too. Constructions of definitions (or: 
definitio) which discourse analysts consider to be an important discursive resource 
were dealt with in classic rhetorical treatises as well (Fahnestock 2009). 
“[S]ubdisciplines of pragmatics, discourse analysis, and sociolinguistics are all ultimately 
concerned with language in use” that “overlaps with the functional approach to style 
found in rhetoric. […] [D]espite [the] dissimilarities [of different linguistic schools] 
in origin and purpose these disciplines offer insights that can add substantially to 
rhetorical stylistics” (Fahnestock 2011: 10).
16 It is beyond the scope of this dissertation to discuss different notions of frames and 
framing extensively. DeWulff et al. (2009), who use the concept of framing in conflict 
and negotiation studies, assert that the research of framing “represents a smorgasbord 
of approaches that differ conceptually, ontologically and methodologically from each 
other (DeWulff et al., 2009: 156).” They pose two questions to elucidate the ambiguous 
concept of framing. First, they identify three different categories providing answers 
to the question what it is that gets framed: a) issues (see Brian Wynne’s use of the 
concept of framing; Chapter 2), b) identities and relationships (see Section 4.4.2) and 
c) interaction processes. Second, it is also important to answer the question about 
the nature of frames. They discern between two different paradigms: an interactional 
paradigm (with Goffman’s symbolic interactionalism as one of its roots) and a cognitive 
paradigm. Whereas the cognitive paradigm “focuses on surface evidence that reveals 
underlying structures of the participants’ cognitions”, the interactional paradigm “looks 
for co-constructions of issues, identities and interactions that are negotiated in the 
talk.”
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strategic maneuvering and DA in the context of public discussions on NEST. An 
important reason to explore what DA has to offer the study of strategic maneuvering 
is that most empirical research in the field of Science and Technology Studies draws 
on DA. In the next section I elaborate some foundations of DA and illustrate the 
added value of DA for pragma-dialecticians. Drawing on a branch of critical discourse 
analysis, I illustrate four other discursive strategies other than advancing reasons 
that arguers can utilize to present their strategic maneuvers in order to be effective 
in public discussions. Derived from these four strategies, I discuss in Section 4.4 three 
discursive practices (boundary work, subject positioning and future construction) that 
frequently recur in public discussions on new science and technologies, described in 
empirical studies in STS reflecting these four discursive strategies.
4.3 Discourse analysis
Despite clear differences the pragma-dialectical approach to argumentation is 
considered “part of the study of verbal communication also known as discourse 
analysis” (Van Eemeren 2004: 52). The prefix “pragma-” indicates the relationship with 
pragmatics as an empirical field of studying language use. Nevertheless, to consider 
the study of argumentation as a part of DA is not obvious. For DA is a label for many 
different theoretical assumptions, methodological approaches and empirical foci 
(Te Molder 2009; Van den Berg 2004; Whetherell 2001) and Van Eemeren does not 
specify what kind of DA pragma-dialectics is. Furthermore, argumentation – however 
defined – does not seem to be a major focus of DA studies. Several handbooks and 
introductions indicate that argumentation is not considered a part of DA (Schiffrin 
et al. 2001; Gee et al. 2012; Whetherell 2001; Jørgensen and Philips 2002) or only 
marginally (Van Dijk et al. 1985, 1997 and 2003; Renkema 2004).
 The only explicit link I am aware of is between argumentation and critical 
discourse analysis (CDA). For instance, Norman Fairclough recently integrated the 
analysis of arguments into critical discourse analysis and political discourse analysis 
(Fairclough and Fairclough 2012). Furthermore, one of the very few comparisons 
between CDA and argumentation theory is a comparison between pragma-dialectics 
and Wodak’s Discourse Historical Approach (DHA) (Ihnen and Richardson 2011) that 
considers argumentation as one of five discursive strategies. I discuss DHA below 
to demonstrate what DA has to add to the empirical investigation of strategic 
maneuvering in interactional context. But first, I examine some foundations of 
sociological perspectives on DA.
— Three central themes of Discourse Analysis
DA is a complex field of empirical inquiry. As a guide into the foundations of DA 
I use Margaret Whetherell’s Discourse Theory and Practice (2001). She focuses on 
approaches to DA that accentuate the interactional or social aspect of language-
in-use such as conversation analysis, critical discourse analysis and discursive 
psychology.17 It is easy enough to list the differences between these several subfields 
of DA. First of all, discourse analysts do not agree on the concept of discourse itself. 
What is discourse? Whereas some discourse researchers only focus on everyday 
written and spoken talk, others are concerned with discourses circulating in society 
on a more abstract level. Others are again somewhere in between.
 In an attempt to identify overarching themes and issues within discourse 
research as the study of language-in-use within the social sciences, Whetherell 
considers discourse to be a form of social action. She identifies three common 
themes. Firstly, discourse is constructed and constructive. Language is not a neutral 
and transparent communicative medium of information transfer, merely serving to 
reflect people’s ideas or other mental representations of aspects of reality (objects, 
worlds, identities, social relations). Instead, language is constitutive. “Words are 
about the world but they also form the world as they represent it” (Whetherell 2001: 
16). Discourses are constructions of the (social) world, determining how people can 
make sense of the world in terms of the available discourses, using frames or, within 
discursive psychology, interpretative repertoires.18
 Secondly, the meaning of words and language is a co-production of culture – 
in which certain discourses circulate that people can draw on as they speak – and 
of people who create meaning in particular social interactions. Discourses are, as 
constructions, to a degree fluid but demonstrate a certain “viscosity”: discourses 
arise and disappear; they can conflict and dominate, even if they demonstrate a 
particular stability. The degree to which meaning is a co-production is contested 
17 Whetherell (2001) discerns between six “more or less distinct discourse traditions: 
conversation analysis and ethnomethodology, interactional sociolinguistics and the 
ethnography of communication; discursive psychology; critical discourse analysis and 
critical linguistics; Bakhtinian research; Foucauldian research (6).
18 “culturally familiar and habitual line of argument comprised from recognizable themes, 
common places and tropes (doxa)” (Wetherell 1998: 400). 
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within different theories in discourse analysis.19
 Third, discourses are functional. As people can do things with words, words can 
serve certain purposes. As designed constructions, language use can be varied in 
different contexts. The variability of versions of constructed reality allows language 
users to achieve particular effects. The production of discourse involves work. 
Because language allows for multiple versions, it “creates an argumentative and 
rhetorical context (Billig 1991). The notion of rhetoric comes from ancient studies of 
political oratory but is has an important modern resonance. It suggests that discourse 
is often functional (Potter and Whetherell 1987). It is designed to be persuasive, to 
win hearts and minds. The study of rhetoric is, in part, the study of persuasive work 
and the organization of discourse to that end” (Whetherell 2001: 17). The rhetorical 
function of what people do with words makes DA interesting for the study of strategic 
maneuvering.
 The variability of accounts (even within the same conversation, interview 
or discussion) has led discourse analysts to stress that utterances depend on the 
context; they are indexical. So, important questions for discourse analysts are: what 
is the specific function of a constructed version in a certain context? Why this version 
here and now?
19 In their introduction into a selection of currents within the field of discourse analysis 
– discourse theory (of Chantal Mouffe and Ernest Laclau), critical discourse analysis 
(of Norman Fairclough) and discursive psychology (Margaret Whetherell and Jonathan 
Potter) – Jørgensen and Philips (2002) characterize the differences between these 
currents as gradual. In a continuum, they try to indicate the degree to which discourse 
is constitutive for the social world. “The different approaches have developed 
different concepts of the subject […]. But gradually speaking, it can be said that all 
the approaches see the subject as created in discourses – and therefore as decentred 
– the constitution of subjects being the key focus of empirical analysis. However, 
the approaches differ as to the degree of emphasis given to the subject’s ‘freedom 
of action’ within the discourse – that is, they differ as to their position in the debate 
about the relationship between structure and agent. Laclau and Mouffe’s discourse 
theory largely follows Foucault, viewing the individual as determined by structures, 
whereas critical discourse analysis and discursive psychology to a greater extent are in 
line with Roland Barthes’ slogan that people are both ‘masters and slaves of language’” 
(Jørgensen and Philips 2002: 17). As Van den Berg states (2004), discursive psychology 
(and critical discourse analysis) depart from an actor perspective (as opposed to a 
structure perspective), indicating that, although existing discourse constitute social 
worlds, actors can construct their versions of the world using available discursive 
repertoires.
 — The discursive strategies of Discourse Historical Approach
To illustrate what DA can offer pragma-dialectics, I now more closely examine the 
Discourse Historical Approach (DHA) which adheres to the socio-philosophical 
orientation of critical discourse analysis (CDA) (Reisigl and Wodak 2001; Wodak 
2001; Wodak 2009).20 Of course, this selection is somewhat arbitrary, but as far as 
I am aware, DHA is the only approach within DA that explicitly draws on pragma-
dialectics (Ihnen and Richardson 2011) because DHA considers argumentation 
as one of five discursive strategies. Ihnen and Richardson argue that the alleged 
incommensurability between DHA and pragma-dialectics which they observe in 
academic disputes is mistaken and undesirable, despite the evident differences 
between them. They discuss how the pragma-dialectical concept of critical discussion 
can contribute to DHA’s analysis of argumentation. Here, I make a reverse move to 
demonstrate how DHA’s attention towards four other strategies is useful for studying 
strategic maneuvering.
 DHA and pragma-dialectics share a strategic perspective on discourse. A strategy 
is a “more or less accurate and more or less intentional plan of practices (including 
discursive practices) adopted to achieve a particular social, political, psychological 
or linguistic aim” (Reisigl and Wodak 2001: 44). In DHA five different discursive 
strategies are identified. DHA is interested in argumentation as discursive strategy 
but not exclusively or even primarily. Argumentation (as the use of topoi or argument 
schemes) is only one of five strategies. I discuss the other four in more detail.
 The first set of strategies contains referential strategies or nomination strategies 
“by which social actors are constructed and represented for example, through the 
creation of in-groups and out-groups. This is done through a number of categorization 
devices, including metaphors and metonymies, and synecdoches” (Wodak 2009: 40). 
The last three categorization devices pertain to stylistic tropes in the long and rich 
20 It is important to note that CDA can be defined as “fundamentally concerned with 
analyzing opaque as well as transparent structural relationships of dominance, 
discrimination, power and control as manifested in language” (Wodak 2001: 2). 
Therefore, the meaning of being critical differs from a pragma-dialectic understanding 
of critique. Rooted in critical theory, CDA presumes an active political engagement 
as a researcher of discourse (whereas pragma-dialecticians are more concerned with 
procedures of reasonable discussion). Wodak for instance, has concentrated on racism 
and discrimination. Even though public controversies on biotechnology – the GMO 
public debate – do not revolve around social exclusion directly, “strategies of positive 
self-presentation and the negative presentation of others” (Wodak 2009: 40) were 
frequently utilized as I demonstrate below (esp. Section 4.4.2).
128 129
Behind the scenes of… life scientists on stage
4
STRATEGIC MANEUVERING IN PUBLIC DISCOURSE ON NEST
rhetorical tradition.21 But any categorization can be considered as a strategic device. 
In the context of public controversies on science and technology one stumbles upon 
“activists”, “scientists”, “policy makers”, “experts”, “lay persons”, “media” etc. Any 
categorization does rhetorical work. Calling opponents activists evokes associations 
of a non-deliberative or unreasonable attitude, of people who are not willing to 
listen. People represented as lay persons, do not have the expertise required to 
establish factual knowledge. Furthermore, the more or less stable cultural meanings 
of (social) categories also determine its demarcations: people who belong to one 
social group are excluded from another (see boundary work in Section 4.4.1).
 Predicational strategies constitute the second cluster of strategies. “[S]ocial 
actors as individuals, group members or groups as a whole, are linguistically 
characterized through predications. Predicational strategies may, for example, be 
realized as evaluative attributions of negative and positive traits in the linguistic 
form of implicit or explicit predicates. These strategies aim at labeling social actors 
in a more or less positive or negative manner” (Wodak 2009: 42). Returning to 
the parliamentary proceeding on biotechnology at the beginning of this chapter, 
scientists are expected to be “independent.” Another example: two biotechnologists 
and proponents of cisgenesis wrote that “Greenpeace however has become a 
fundamentalist organization that does not dedicate itself to a better environment, 
but fights against genetically modified crops” (Jacobsen and Schouten 2009: 30). 
Fundamentalism evokes negative associations immediately of a dogmatic and 
perhaps even violent group.
 Thirdly, one can concentrate on the perspectivation, framing or discourse 
representation “by means of which speakers express their involvement in discourse, 
and position their point of view in the reporting, description, narration or quotation 
of relevant events or utterances” (Wodak 2009: 42). It is not my aim here to discuss 
these three concepts at length because the differences in understanding these 
concepts within DA would require an inquiry of its own. I limit myself to a short 
exposeéon the concept of “participation framework” or “footing” which Goffman 
21 An example of a synecdoche is the totum pro parte, where something is named after 
something else of which it is only a part: “A world wide potato genome sequence 
consortium is running which is partly directed by the Netherlands” (Jacobsen and 
Schouten 2009: 30).
developed in order to elaborate the concept of perspective and framing.22
 Goffman discerns between different forms of relationships that relate individuals 
to the discourse and which allows for a more differentiated perspective on the various 
participation roles a speaker (or writer) can have in a conversation (or text) etc.: 
animator, principal and author.23 The author is the originator or creator of the words. 
The animator is the person who produces the utterance. The principal is “someone 
whose position is established by the words that are spoken, someone whose beliefs 
have been told, someone who is committed to what the words say” (Goffman 1981: 
144-145). Often, these different roles coincide, but in some occasions this is not the 
case. For instance, as the minister of agriculture was delivering “her” speech at the 
seminar on biotechnology she was the animator and the principal, but probably 
one of her communication officers was the author of the text. Someone quoting 
or paraphrasing someone else’s words is another example. As a politician of the 
Christian Union said in the parliamentary proceedings: “Speaking with Louise Fresco: 
which GMO, where [and] with what accompanying policy?” (TK 27 428 nr. 142: 3). 
In this case the CU politician is the animator and the “co-author” of the words since 
he is paraphrasing an expert – Louise Fresco – who was a key note speaker at the 
seminar. Who is the principal here? Who is responsible for these words? Whose 
beliefs are presented?
 Footing can be used as a strategy to express degrees of involvement or 
detachment (Wodak 2009), but also as a device of “stake inoculation” (Potter 1996). 
For social scientists should interpret people’s discourse as attempts to discount 
reports and descriptions of others as a “product of stake or interest” (p. 110). Shifting 
in participation role from author to animator (using quotations or paraphrases), as 
the CU politician is doing, can be seen as a defensive rhetoric to resist the possible 
undermining of his statements by his political rivals or as a means to reduce 
accountability for utterances. Conversely, it can be regarded as an offensive rhetoric 
22 Goffman’s concepts of framing, participation work and footing is complex if not 
confusing. Whereas Reisigl and Wodak (2001) refer to the different relationships 
people can have to discourse as “participation work,” Whetherell (2001) and Potter 
(1996) refer to as footing (e.g. Whetherell 2001; Potter 1996).
23 In the representation of Goffman’s work, Whetherell (2001) and Potter (1996) identify 
only three possible roles: principal, animator and author. In addition, Reisigl and Wodak 
(2001) add the figure as a fourth participation role, whom Goffman defines as “the 
agent, a protagonist in a described scene, a ‘character’ in an anecdote, someone, after 
all, who belongs to the world that is spoken about, not the world in which the speaking 
occurs” (Goffman 1981 in Whetherell 2001: 105).
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to render the statement authoritative because it is not the politician’s own words but 
those of an expert.
 The fourth and last type of strategies, are “intensifying strategies on the one 
hand and mitigation strategies on the other. […] These strategies can be an important 
aspect of the presentation inasmuch as they operate upon it by either sharpening it 
or toning it down” (Wodak 2009: 42). Intensification and mitigation can be used to 
qualify the epistemological status of utterances and to express different degrees of 
certainty (or modality; see Section 4.4.4). A discourse analysis typically concentrates 
on modalizing terms such as always, completely, never, somewhat, perhaps etc.24 
Saying that the Dutch minister of agriculture is not “bothered by any knowledge of 
facts” for example nicely illustrates the intensifying strategy. As Potter (1996) notes, 
statistics and numbers can be used as well to make a strong case. In his plenary 
speech, professor Bino for instance put the environmental impact of using pesticides 
in large numbers: “1 424 000 kilos of fungicide every year” (TK 27 428 nr. 145: 21). 
Minister Verburg on the other hand utilized a mitigation strategy so as to prevent 
opponents of genetic modification to think that she is an explicit and uncritical 
advocate: “According to its producer [cisgenic potatoes] can generate environmental 
gains” (ibid: 13). The modal verb “can” expresses a certain reservation. This example 
also shows how Verburg chooses a footing to take more distance to the discussion 
on cisgenesis. She reveals the source (author) of the belief: the producer of the GM 
crop.
Of course, the discursive strategies of DHA are not exhaustive. First of all, DHA’s 
analysis of categorizations and predicates is confined to humans and social relations. 
The five strategies “are all involved in positive self- and negative other-presentation” 
(Reisigl and Wodak 2001: 44). But as the public debate on cisgenesis demonstrates, 
referential and predicational strategies can be extended to objects and situations 
as well. How should we categorize cisgenic apples and potatoes? What kind of 
genetically modified crops are they: are they similar to traditionally bred crops or, 
instead, similar to transgenically modified crops? Are they sustainable, profitable or 
natural or not?
 Moreover, Potter (1996) for example presents a large collection of constructions 
of facticity which can hardly be subsumed under these five categories (e.g. creating 
out-there-ness using the empiricist repertoire, Potter 1996: 151; see also Section 
24 For a detailed categorization of linguistic mitigation strategies see Reisigl and Wodak 
2001: 84. 
4.4.1). My aim however was to demonstrate how a broader perspective on discourse 
and its rhetorical function opens up new entries for studying strategic maneuvering 
in context.
 In the next section, I discuss three recurring discursive practices in public 
controversies over new science and technology which are described in STS literature: 
boundary work, subject positioning and the construction of futures. All three are 
related but cannot be completely reduced to the discursive strategies of DHA. 
For example, boundary work in the original meaning of Thomas Gieryn, as the 
attribution of selected qualities to scientific experts, can be considered as a specific 
nomination or predicational strategy (Section 4.4.1). But boundary work can refer 
to any demarcation between categories, be they social or not. Nomination and 
predicational strategies are important for the representation of identity i.e. for 
subject positioning (Section 4.4.2), but they also apply to futures which can be good 
or bad, certain or uncertain, distant or proximate etc. (Section 4.4.3).
 For each strategy, I first present a short theoretical elaboration, then some 
empirical studies in which these concepts were used and finally some examples from 
the cisgenesis debate (when available). All these studies are concerned with how 
language is used in social interaction, even though many authors do not commit 
themselves explicitly to DA or do not clarify what kind of DA it is that they have done. 
Some of the studies are critical (comparable to CDA), others are more descriptive.
4.4 Discursive devices
4.4.1 Boundary work
As discussed in the previous section, discourse as a situated social practice, in which 
identities and (social) worlds are (to a certain extent) actively constructed, involves 
work. So, the concept of boundary work refers to the work involved in constructing 
boundaries. Thomas Gieryn (1983) originally coined the concept of boundary work 
to indicate scientists’ social practice of rhetorically demarcating science from other 
social domains, but the concept has evolved significantly since its introduction 
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(Yamaguchi 2007; Bijker et al. 2009; Metze 2010)25. Since there are an innumerable 
number of demarcations that can be drawn, boundary work is a multivocal concept. If 
one uses the distinction – itself a boundary – between symbolic and social boundaries 
(Lamont and Molnar 2002), the concept of boundary work can easily be extended 
to all categorizations. Symbolic boundaries are “conceptual distinctions made by 
social actors to categorize objects, people, practices, and even time and space. They 
are tools by which individuals and groups struggle over and come to agree upon 
definitions of reality” (Lamont and Molnar 2002: 168). These categorizations are 
constructed and contested as well as solidified and naturalized (some more than 
others), which means that people can use them as strategic maneuvers in discussions.
 In this subsection, I elaborate first on Gieryn’s original conception of boundary 
work since it is relevant in the context of public disputes over science. Subsequently I 
discuss instances of how boundary work is being done as described in STS literature. 
As this literature shows, scientists do discursive work on both sides of the boundary 
between science and society.
Thomas Gieryn (1983) introduced the concept of boundary work as a sociological 
understanding of what has come to be known as the demarcation problem 
within the philosophy of science. Against the essentialist tenor of carving the 
demarcations between science and non-science in stone analytically (Merton’s 
CUDOS and Popper’s falsifiability), Gieryn interprets these boundaries as constructed 
discursively. Using the metaphor of the map, Gieryn (1999) changes scientists into 
geographical cartographers, who actively draw and re-draw the boundaries between 
25 Yamaguchi (2007), in her study on the controversy on genetically modified crops in 
India, proposes to also examine the boundary work of other elite actors (policy makers, 
industrialists, civil society etc.) within a more generalized theoretical framework 
of social categorization, and hence utilizing symmetry as a methodological tool. 
Boundary work is not something that only scientists do; it is a rhetorical strategy 
of other stakeholders as well. They all claimed to be the exclusive, self-appointed 
representatives of (the socially constructed category of) farmers, whose concerns 
had to be taken care for. Metze (2010) studies changes of boundary work in terms 
of the transcending of demarcations in dominant discourse or between (rival) 
discourses. Bijker et al. (2009), argue that because of his primary focus on the “contest 
for cognitive authority”, Gieryn “tends to emphasize processes of monopolization, 
expansion, exclusion and protection” (ibid: 146). In their study of the Dutch Health 
Council as boundary organization between science and policy, Bijker et al. observed the 
transgression of these boundaries in the backstage process of scientific advisory work, 
as to include more coordinative aspects of the interaction between science and policy 
institutions across these boundaries as well (see also Halffman 2003).
science and non-science, i.e. who do boundary work in cases of situated disputes 
and controversies in which science is publicly challenged and its credibility is openly 
questioned. Gieryn defines boundary work as: “the discursive attribution of selected 
qualities to scientists, scientific methods, and scientific claims for the purpose of 
drawing a rhetorical boundary between science and some less authoritative residual 
non-science” (Gieryn 1999: 4-5; emphasis KD). Boundary work is strategic practical 
action, Gieryn writes, “an effective ideological style” at times, “scientists fail to 
provide the technological fix that the public desires, or they produce technological 
capabilities that the public fears or loathes” (Gieryn 1983: 789).
 Thus, boundary work can be regarded as a nomination strategy to rhetorically 
demarcate between the social categorization of science (or scientists) and non-
science (other social actors). It is a presentational device to produce certain effects. 
Indeed, Gieryn’s focus on the empirical studies of boundary drawing turns scientists 
into interests-driven utilizing boundaries to mobilize public support. What is at stake 
for scientists? What effect is it that scientists want to achieve? Gieryn’s general answer 
is cognitive authority, but he discerns three different “genres” of boundary-work, 
all reflecting different goals.26 Boundary work serves, firstly, expulsion: to deny rival 
authorities access to “the” scientific community (e.g. maverick researchers, working 
on reproductive human cloning). Secondly, expansion: to extend the jurisdiction over 
new and/or contested ontological domains (e.g. a genetic approach to psychiatric 
disorders). Thirdly, to protect professional autonomy: to avoid inhibitions of scientific 
research or to prevent exploitation of science’s authority by people with all-too 
obvious political intentions.
This poses the question of how is boundary-work being done? What is the function 
of drawing these boundaries? As STS literature demonstrates, the science-society-
boundary is flexibly constructed as separated in one context and conjoined in 
another. So, besides Gieryn’s divisive understanding, transgressive boundary work 
is also performed.
 Kerr et al. (1997) for instance have analyzed divisive boundary work of 
interviewed geneticists in their accounts of both the promises and the ethical and 
social implications of the Human Genome Project. They report the boundary drawing 
between the micro-world of scientific practice and the macro-world of society at 
large (and its publics). Although the interviewed life scientists acknowledged society’s 
26 In his 1983 and 1995 texts, Gieryn distinghuises a fourth goal of monopolization, which 
has been left out in his 1999 book.
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influence on research agendas and the use of scientific insights, they stressed that 
their own work in the laboratory is confined to obtaining objective facts about nature 
that is in no way obscured or determined by social values. Genes, they claim, are 
not man-made, but “are [simply] there” (286). Drawing on the notion of empiricist 
repertoire (Gilbert and Mulkay 1984), Kerr et al. argue that this micro-laboratory 
world is constructed as empiricist: “following unproblematically and inescapably from 
the empirical characteristics of an impersonal natural world” (Gilbert and Mulkay, 
1984).27 In the interview setting, the new geneticists adopted this formal discourse, 
while attributing the contingent repertoire to wider society or other scientists – like 
eugenicists – as an explanation for their un-scientific work.
 In Kerr’s critical interpretation, the “micro/macro-split” allows the geneticists 
to, first, discern between their own good scientific practice and an associated form 
of science from the past (social Darwinism, eugenics) that culturally prevails as bad 
science. Unlike the less ethical (or perhaps un-ethical) eugenicists (cf. Wainwright et 
al. 2006), the new geneticists claim not to be influenced by social preferences and 
political ideas of the macro-world. Second, the boundary allows them to “deflect 
responsibility” for the unintended consequences as a result of an unwise application 
of their products, Kerr et al. claim. It is part of a “rhetoric of non-responsibility.” 
27 Mulkay and Gilbert (1984) introduced a distinction between a formal empiricist 
repertoire and an informal contingent repertoire to understand the variability of 
conflicting accounts of biochemists involved in a scientific controversy over oxidative 
phosphorylation. Scientists use the former to depict their actions and beliefs “following 
unproblematically and inescapably from the empirical characteristics of an impersonal 
natural world.” Backstage, however, in informal discourse among fellow researchers on 
the work floor, these biochemists adopted a contingent repertoire, which, by contrast, 
characterizes scientists actions as “activities and judgments of specific individuals 
acting on the basis of their personal inclinations and particular social positions” 
(Gilbert and Mulkay, 1984: 56-57). So, in their front stage presentation (e.g. through 
the use of language in their articles published in peer-review journals) scientists adopt 
an impersonal, neutral style to present the facts of nature as they have revealed 
themselves. Within the context of laboratory life, however, they showed contingency. 
These repertoires were also used to explain why, during the scientific controversy, 
opponents of their own scientific position are wrong. Whereas scientists use the 
empiricist repertoire to account for their own behavior, scientists belonging to the 
other paradigm are described in contingent terms. The question Gilbert and Mulkay 
raise is: why, if in the empiricist repertoire, nature speaks for itself, is this not the case 
for scientists making opposite scientific claims? It is important to emphasize Kerr et al.’s 
shifting of meaning when translating Gilbert and Mulkay’s notion of these repertoires 
from good and bad science to science and society. The same goes for Kevin Burchell 
(2007b). See par. 4.2.2.
Without adopting this normative interpretation, this boundary work can be seen as a 
nomination strategy to allow the geneticists to enact a role as pure and disinterested 
scientist (cf. Pielke 2007 and Merton 1942) and to maintain public credibility.28
 Similarly, Felt et al. (2009) identified a “repertoire of closure mechanisms” (359), 
i.e. discursive practices of divisive boundary-drawing, although they do not explicitly 
refer to the concept of boundary work in their analysis. In their understanding, the 
effect was that public deliberation on the social and ethical aspects of genomics 
research on lipid disorders was closed down. They discern two groups of mechanisms, 
the first of which closely relates to the construction of boundaries between facts and 
values. This distinction rendered issues as non-ethical: providing the right, factual 
information dissolved the articulated ethical issues. Furthermore, Felt et al. argue 
that the life scientists expanded their field of expertise, and performed as “lay 
sociologists” (ibid: 368) to construct “societal facts” about the cause of obesity from 
personal experiences, to present genome research to be the natural and inarguable 
solution to lipid disorders.29
 The second repertoire of mechanisms they identified, consisted of “displacement 
strategies,” by drawing boundaries between delegated responsibilities (division of 
moral labor), stages of the innovation process (upstream versus downstream), and 
between different kinds of research (applied versus basic). In Felt et al.’s normative 
28 Their interpretation seems to presuppose a clear set of responsibilities for genomics 
researchers with respect to the social implications of their scientific work, which life 
scientists are supposed to take. These responsibilities are far from obvious and indeed 
part of the (public) debate. An alternative interpretation is that life scientists construct 
boundaries between settled and controversial ethical issues, i.e. between issues where 
consensus has already been reached and issues that are still open for discussion (Firth 
et al. 2011) which reflect scientists’ perceptions of what issues they think they have 
control over. So, I would argue, boundary work is rather a reflection (instead of a 
deflection) of life scientists’ perception of responsibilities at best, an explanandum. Kerr 
et al. take the demarcation as explanans. 
29 The analysts suggest this is an illegitimate expansion of expertise which reflects an 
imbalanced power relation between scientists and lay persons, subscribed to by both 
parties. Here, the authors seem to step out of their own empiricist repertoire and 
neutral, distanced analytic style, to do some boundary work themselves. Apparently, 
there exist “sociological facts” about obesity, the genomics scientists as lay sociologists 
do not have access to but are predetermined to being grasped only by expert 
sociologists (like Felt et al.). I do not claim the argumentation of the life scientists 
cannot be critically questioned according to pragma-dialectical norms. But, in my view, 
to dismiss fact claiming as “an instrument of power” employed by scientists and as an 
illegitimate expansion of expertise, is a normative conclusion that I cannot subscribe to.
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interpretation, these displacements of ethical issues allowed the scientists to 
acknowledge ethical issues but to present themselves as “simply not the right 
addressees for ethical questions.” Delegating ethical issues to ethicists, ethics 
committees or regulatory frameworks (see also Kerr et. al. 1997 and Firth et. al. 
2011); demarcating basic and upstream science from downstream application, in 
order to present research activities are “purely scientific” as a result of scientific 
excellence and remote from any application (cf. Calvert, 2006); claiming that their 
research activities are conducted within the shielded space of the laboratory, safely 
separated from society (see Kerr’s “micro-world”). All these demarcations serve, Felt 
et al. claim, to position scientists “on the safe side” (364).
 Whereas Kerr et al. and Felt et al. analyzed boundary work in terms of the 
separation of science from non-science, Brown and Michael (2001) found, in their 
study of the controversy over xenotransplantation (XTP) using transgenic pigs, a more 
complex discursive pattern, indicating both the demarcation and the transgression of 
the science-society boundary. Studying popular press articles on xenotransplantation 
(XTP), they found that promoters of this novel technology switched from a “privileged 
non-public-expert” discourse in the one context to a “non-expert-popular” discourse 
in the other. Scientists (and promoters of XTP) switched between these two 
repertoires, emphasizing that on scientific grounds, they are different from their (lay) 
audience as the only legitimate experts to assess the suitability of porcine donor 
hearts (demarcation). On moral grounds, however, they stress the similarity of their 
audience in holding the same moral views which reveals a discourse of alignment 
“away from antagonism toward the recruitment or enrollment of the public” (Brown 
and Michael 2001: 19).
 Similarly, Bloomfield and Vurdubakis (1994) argue that proponents of new 
genetic reproductive technologies (NRTs) seek to align with society. In order to 
restore the discursive demarcations (or boundary talk) of their opponents, these 
advocates perform “boundary repair work” (538). Drawing on the notions of rhetoric 
of fear and hope in the Great Embryo Debate in British parliament (Mulkay 1993), 
Bloomfield and Vurdubakis suggest that “Both Hope and Fear […] tend to derive 
their evocative powers from the notion of boundaries as the means through which 
cultural categories and moral values are upheld. Boundary talk can in this sense be 
understood as providing a key discursive register for formulating issues pertaining 
to new technologies in ways that imply either threat or reassurance” (Bloomfield 
and Vurdubakis 1994: 535). Opponents on the one hand attempt to represent new 
technologies as monstrous, defying existing moral and cultural classifications in 
order to invoke feelings of abhorrence. The metaphor of Frankenstein food is a well-
known example. Advocates of new technologies on the other attempt to recover 
normality and, in doing so, these technologies must be perceived as continuous with 
other, already existing therapeutic technologies or “business as usual” (Swierstra and 
Rip 2007).  To add to the complexity, agricultural biotechnologists have proven to 
switch between discourses of similarity and difference in different contexts (Burchell 
2007a). Within the context of risks and dangers, the interviewees pointed out the 
similarity of GM crops and conventional breeding techniques (business as usual), 
whereas in the context of productivity and efficacy, GM’s superiority was emphasized 
(the new technology’s revolutionary aspects).
During the controversy over cisgenesis, similar boundaries were drawn and 
contested. Plant geneticists claimed the “fundamental” (Schouten et al. 2006: 
750) and scientifically established boundary between transgenic and cisgenic crops 
(and hence a more relaxed regulatory regime for the latter). At the same time, the 
boundary between cisgenesis and traditionally bred plants was flexibly constructed. 
Whereas cisgenesis was represented as morally similar to traditional breeding 
processes, it was represented as technologically different (higher efficiency). 
These boundaries were heavily disputed. In Parliament the distinction between 
transgenesis and cisgenesis was represented as a “purely political and not a scientific 
distinction” (TK 27 428 nr. 142: 2). Others evoked a natural-unnatural distinction to 
accentuate the difference between cisgenic and normally crossbred crops (Lammerts 
van Bueren et al. 2003).
To conclude, boundary work can be seen as a generalization of nominations and 
predications so as to include humans, objects, situations, practices etc. Many 
boundaries can be constructed: between science and non-science (Gieryn 1983, 
1995, 1999), science and society (Kerr et al. 1997; Brown and Michael 2001), basic 
and applied science (Calvert 2006; Felt et al. 2009), facts and values (Felt et al. 2009), 
ethical and unethical science (Wainwright et al. 2006), settled and unsettled ethical 
issues (Firth et al. 2011), public and private (Gutmann and Thompson 2004), “purity 
and pollution, sanctity and profanation, normalcy and abnormality (Bloomfield and 
Vurdubakis 1994: 543), natural and unnatural etc. As these studies demonstrate, 
for both advocates and critics boundaries are an important rhetorical resource in 
controversies over new science and technology. In addition, these studies show how 
scientists in public controversy flexibly construct the boundary between science and 
society in different contexts.
4.4.2 Subject positioning
The second concept which is frequently employed in discourse analytical studies of 
science society interactions is subject positioning. Contrary to modern understandings 
of individuals as autonomous and unitary selves, subject positioning is based on the 
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social constructionist premise that the identity of individuals is dynamically formed 
and constantly reformed in social interaction, particularly in discursive practices. 
Subject positions are also a more dynamic alternative to the more fixed concept of 
(social) roles. Identities of people are fluid. There is a multiplicity of self, a variety 
of different and sometimes even conflicting social categories within discourses that 
people can use to make sense of themselves and others. Thus, people’s identities are 
products of prevailing discourses and subjectivity is constituted in these discourses. 
At the same time, people are also producers of talk. In specific contexts, people can 
functionally choose from this available multiplicity of subject positions to construct a 
particular self. In short, people can do identity work. Here, I confine myself to social 
identities and social selves, since I am particularly interested in how life scientists 
position themselves and others in public discourse (or accounts thereof).30 First, I 
elaborate and illustrate some important distinctions developed in positioning theory. 
Then, I discuss some examples of subject positioning in discussions over new science 
and technology I found in STS literature.
 Harré and Van Langenhove (1999) define the concept of position as 
“a metaphorical concept through reference to which a person’s ‘moral’ and personal 
attributes as a speaker are compendiously collected” (17). During the course of 
a discussion or conversation, one can variably position oneself or one can be 
positioned as for example rational or irrational, activist or diplomatic, lay person 
or expert. In their positioning theory, Harré and Van Langenhove present different 
modes of positioning. Let me return to the excerpt of the parliamentary debate at 
the beginning of this chapter to illustrate the most important modes.
 The first relevant distinction is between tacit (or unconscious) and intentional 
(or conscious) positioning. The latter is a form of “strategic interaction” with people 
having a particular aim in mind. The politician is intentionally positioning Dr. Bino 
in the parliamentary proceeding on biotechnology. Comparing Dr. Bino pejoratively 
with a “publicity agent” can be understood as a form of offensive rhetoric (Potter 
1996: 107) with the aim of undermining the facticity of Dr. Bino’s representation 
of GMOs as a choice for sustainability and thus of discounting the benefits of 
30 As Harré and Van Langenhove (1999) note, there are two kinds of identity that can 
be attributed to people, the self of personal identity and the self as social identity, 
a compendium of more or less coherent qualities or personae that are “publicly 
presented in the episodes of interpersonal interaction in the everyday world.” These 
two selves cannot be separated: “Human beings must display both a personal identity 
(appear as singularities) and a social identity (appear as instances of types) in order to 
appear fully as persons” (24).
biotechnology as a personal stake.
 Secondly, people can be morally positioned. A moral position refers to someone’s 
more or less institutional or formal role and his or her expected moral behavior. Dr 
Bino is morally positioned as “independent scientist.” This social category fits within 
Robert Merton’s ethos of science within which disinterestedness is an important 
norm (besides communalism, universalism and organized skepticism). The contrast 
between the moral position of disinterested scientist and the metaphor of publicity 
agent reinforces the stake Dr. Bino is attributed.
 Thirdly, there are positioning of self and other which are mutually constitutive. 
Positioning is relational: the position of self implies the positioning of the other and 
vice versa. The additional effect of positioning Dr. Bino as an unreliable scientist 
positions the Member of Parliament as the one who debunks alleged benefits and 
protects citizens from an unsafe technology and rain forests from being cut.
 
Subject positioning has served as a discourse analytic tool in STS literature on 
social interactions in public deliberation settings in which social issues concerning 
biomedical and genomics research were discussed. Unfortunately, these studies 
do not provide much information about identity work of (life) scientists in public 
deliberation because the participants were citizens (O’Doherty and Davidson 2010)31 
or “interactional experts” (Kerr et al. 2007).32
 Although Motion and Doolin (2007) focus on the autobiographical and reflexive 
self-positioning, their critical discourse analysis of narrated accounts of life scientists 
who were confronted with activists provides a better illustration of scientists’ subject 
positioning (and the shifting between them). Motion and Doolin found how scientists 
performed identity work in their rhetorical reconstructions by demonstrating a 
variety of expert as well as social or public subject positions. Scientists presented 
31 O’Doherty and Davidson found that different subject positions influenced the course 
of deliberation on the social issues of human tissue biobanks in Canada. Participants’ 
expert positions (expressing their claims as universally valid) were hardly challenged, 
as compared to the “hedged, non-universal” claims from patient or cultural/religious 
subject positions (in their case indigenous Canadians). 
32 Kerr et al. found that participants of three public dialogue events (a citizen’s jury, a 
Café Scientifique and a public meeting), shifted subject positions but their analysis 
is confined to the subject positions of “expert” and “lay person.” Moreover, their 
analysis is to a campaigner of an NGO and representatives of patient organizations. Life 
scientists – or “contributory experts” in terms of Collins and Evans’ (2002) typology – 
only played a bit part in these deliberative settings.
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themselves as the only or the “real” expert who are in the position to exclusively 
provide “accurate and factual” knowledge to inform the general public, whereas 
“so-called” experts of NGOs and activist social movements only have “outdated and 
discredited” knowledge. Moreover, in the situation of public controversy, scientists 
tend to ascribe themselves attributes typical for scientists such as “rationality” and 
“control” when confronted with “emotive” and “unreasonable” activists.
 The public part of scientists’ identity is meant to legitimize and to promote 
the social value of their science and to present themselves as the only legitimate 
spokesperson on behalf of the general public. Scientists construct activists’ naivety by 
depicting them as too “young [..] to have experienced their friends dying of cancer” 
or depicting their subscribers as “well-off and middle class” (ibid: 75) who are in the 
luxurious position to spend their time on supporting activist protest against science 
and technology. In Motion and Doolin’s interpretation, (animal) activists become 
marginalized as radical protest groups with extreme claims and ideas that find hardly 
any resonance within society at large. Vice versa, scientists position themselves as 
the ones talking in the interest of the general public. Scientists find themselves in a 
“discursive struggle to establish who has the legitimate right to speak for the public, 
and define and determine what is in the public interest. In essence, both activists and 
scientists are competing for the same discursive space (ibid: 76)”.
 Kevin Burchell’s discourse study (2007b) of interviews with crop geneticists 
supplements Motion and Doolin’s conclusions. Drawing on Gilbert and Mulkay 
(1984), Burchell reports on the reciprocal process of positioning empiricist selves 
conveying the legitimacy of claims of scientists and contingent others questioning 
the legitimacy of claims of other social actors.33 Scientists tend to portray their own 
intentions as honorable (e.g. “I got involved in biotechnology for solving the world’s 
hunger”) and the objectives of others as unethical (e.g. “The Zambian dictator 
is prepared to let its people starve because an NGO is meddling in the politics of 
another country and trying to peddle their own ideology”).34 The discursive dualism 
between empiricist self and contingent other “can be related to the performative 
function or social intent of defending or justifying one’s own legitimate beliefs and 
actions, while at the same time attacking those of others with whom one disagrees” 
(Burchell 2007b: 160). Four categories of contingent others are derived from the 
interviews with GM geneticists: in addition to critical “fellow-scientists” who hold an 
33 For a short discussion of empiricist and contingent repertoire,  
see footnote 19 of this chapter.
34 These are paraphrazed quotations from Burchell 2007b.
opposite view on the risks and benefits of GM crops, there are also “the media,” “the 
public” and “NGOs.” The media only have an interest in “selling juicy stories”, NGOs 
are inclined to increasing membership and donations and the public is ignorant 
enough to believe their stories (cf. Cook et al. 2004).
 Finally, Kitzinger and Williams (2005) analyzed national newspapers and main 
TV news bulletins in the UK, reporting on the stem cell debate in the UK. Opponents 
and proponents attempted to claim moral and expert authority on the plausibility 
of diverse visions of the future (see Section 4.4.3). Proponents of new reproductive 
technologies framed their (expert) identities as rational and realistic, while 
positioning opponents variably as old-fashioned or oppositely as science fictionists 
who overrate the possible dangers of technological innovations.
 As described above, in the public debate on cisgenesis participants drew on 
various nomination and predicational strategies to position their antagonists and 
themselves for rhetorical aims. What the empirical studies on subject positioning 
also demonstrate, is how life scientists’ identity work indicates their operating on 
both sides of the science-society-boundary, as described in the previous section on 
boundary work. This also holds for rhetorical constructions of the future, as I discuss 
in the next subsection.
4.4.3 Expectations
Expectations are inextricably part of contemporary Western knowledge societies in 
which scientific research is stimulated for its return on investment, be it economically 
or socially. Moreover, the recent trend to move public engagement upstream 
stimulating “an accountable process of debate over […] expectations […] shaping 
the innovation trajectory” (Wynne 2006: 216) draws attention to the future (see 
Chapters 1 and 2). Researchers in the sociology of expectations have shifted the 
“analytical angle from looking into the future to looking at the future” (Brown et al. 
2000: 4). Their main research object, therefore, is not how to predict the future as 
accurately as possible, but the performative force of representations of the future.35 
35 Research in the dynamics of expectations indicates the variability of constructions 
of the future. Expectations vary over time (temporal variability). They are variably 
distributed over different social groups with varying distance to scientific research 
(socio-spatial variability). Expectations vary depending on the degree of novelty of 
the scientific and technological innovation (“prospecting retrospects”) and memories 
of past expectations are modified and rationalized in order to forget complexity and 
contingency (“revisionist histories and retrospecting prospects”, Brown and Michael 
2003). Douglas (2005) has demonstrated how setbacks are justified rhetorically.
142 143
Behind the scenes of… life scientists on stage
4
STRATEGIC MANEUVERING IN PUBLIC DISCOURSE ON NEST
Expectations are projections of the future to mobilize the present. Or, as Francis 
Collins (one of the pioneers of the Human Genome Project) quotes from Saint-
Exupéry’s The Little Prince: “As for the future, your task is not to foresee it, but to 
enable it” (Collins 2010: 278).
 Expectations, promises and visions are constructed to be persuasive for a 
specific audience (Lucivero et al. 2011). To put it in terms of strategic maneuvering, 
representations of the future constitute the supply for an audience demand.36 This 
audience consists of various non-scientific actors (patient organizations, regulators, 
funding agencies, consumers, investors etc.) in innovation networks necessary 
to marshal (financial) resources that enable the fabrication of the future (Borup 
et al. 2006). Expectations are the flexibly interpretable binding agent of heterogeneous 
groups to align research agendas and collective action. Particularly scientists 
“wearing the entrepreneurial hat” can make strong claims about the promise of their 
innovation (Brown and Michael 2003: 13). The function of expectations for a broader 
audience (the general public) is to “legitimize, justify, back [its users’] arguments, 
give reasons in general” (Van Lente 1993: 187). Indeed, as the case of cisgenesis in 
the Netherlands demonstrates, plant scientists project several expected benefits into 
the future: increased crop yield, decrease of herbicide use for example.
 Brown (2003) describes two key features of the dynamics of expectations. Firstly, 
a straightforward story line is enunciated, a normative vision of the future, in which 
a route is mapped out how to get there. This means that futures are imagined 
and that imagination is a social practice that is part and parcel in the production 
of science and technology (Fujimura 2003). Thus, such sociotechnical imaginaries 
(Kim and Jasanoff 2009) or technoscientific imaginaries (Kearnes and MacNaghten 
2006) are the (provisional) results of a process of co-production defined in Chapter 
2 since these imaginaries are “socially and culturally embedded assumptions that 
unwittingly shape future worlds and possibilities through technoscientific practice 
and innovation” (293).”
 Secondly, promises are almost always exaggerated at the risk of generating a 
highly polarized and unproductive public debate on ethics. Therefore, futures are 
often contested. Before discussing a few empirical studies, I first elaborate Mike 
36 Referring to Perelman and Olbrecht-Tetyca’s The New Rhetoric, Lucivero et al. (2011) 
identify three different, but closely interrelated types of claims which determine the 
(rhetorical) acceptability of expectations for specific audiences: technological feasibility, 
societal usability and moral desirability. For the assessment of expectations “the aims 
of the actor who states expectations and the audience that she has to reach are two 
important factors to take into account when analyzing expectations’ plausibility” (133).
Michael’s (2000) rhetorical parameters of future construction, illustrated with 
expectations from the cisgenesis debate.
Michael (2000) explores the rhetorical function of future visions. Drawing on Billig’s 
rhetorical psychology (1996), Michael asserts that attitudes of people in general 
and attitudes towards the future in particular are to be understood as arguments 
against counter-claims and -positions. “[W]hen someone argues that a future is 
‘distant’, there is a tacit argument against it being nearby. What is such an argument 
performing rhetorically?” (Michael 2000: 24). Michael identifies a (non-exhaustive) 
list of five dichotomous parameters by which futures are discursively constructed 
and provides an interpretation of their function. These parameters can be considered 
predicational strategies to characterize futures for rhetorical aims.
 Firstly, constructions of the future will represent a certain distance: how distant 
is the future from the present? Futures can be depicted as distal or proximal. 
Rhetorically, it serves several functions, Michael argues. “It can urge immediate action 
or measured consideration, it can be used to accuse actors of tactical procrastination 
or opportunistic band-wagoning, and it can serve in the judgment of relative 
efficiency or risk” (ibid: 25). In the debate on cisgenesis, proponents were implicitly 
accused of not taking the distant future into account: “As minister [of agriculture] 
but certainly as an ethical and honest person, one has the duty and the responsibility 
[…] to take decisions which respect and guarantee future generations, the health 
of citizens and the protection and [bio]diversity of the environment not only in the 
short term, but also in the long term” (Letter Citizens Initiative, June 8 2009).
 As this example shows, there always is a particular subject presupposed in future 
situations, be it an individual or a group of people who experience the future.37 
Subject is the second parameter that Michael discerns. The critical citizens made an 
appeal to “future generations,” whereas advocates of cisgenesis constructed futures 
in which collective subjects as beneficiaries are premised: in some cases a country 
(to master “global warming, population growth, environmental stresses, diminishing 
land resources associated with increased demand for quality food […] a second green 
revolution is needed in India” [Jacobsen and Nataraja 2008: 1365]), and sometimes 
even the entire future world population (“9 billion people will have the right to 
balanced food. […] New technologies can make an important contribution” [director 
of NGO Solidaridad, TK 27 428 nr. 145: 20]). These individual and collective subject 
37 To justify xenotransplantation, for example, appeals to the benefits for individual 
patients suffering from cardiovascular disease are made.
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positions have primarily the rhetorical effect of identification but they also evoke a 
sense of responsibility towards these subjects.
 Thirdly, Michael discerns between substantive and instrumental rationality. 
The latter form of rationality refers to orientations towards means in which present 
ends are projected onto the future. In that sense, the future is a continuation of the 
present. By contrast, substantive representations of the future are ends-oriented. 
“These accounts can be more or less utopian explorations of possible futures in 
which [...] ‘the good life’ is examined (Michael 2000: 28).” Whereas instrumentalists 
can rhetorically claim “realism” (as opposed to “dreaming”), “utopians” in their 
turn can impute “poverty of imagination” to those oriented towards the means. 
The debate on cisgenesis illustrates both kinds of rationalities. Opponents of GMOs, 
who embrace organic farming, for example, stress that cisgenesis is merely an 
instrument for “symptom treatment,” whilst the real problem is lost out of sight: 
the “big monocultures” in intensive agricultural crop breeding (Versluis 2012: 20). 
Their critics on the other hand, claim that biological farming is not realistic. “The only 
alternative is more hunger” (De Vré, Sep 3 2012).
 A fourth parameter is valency. Futures are represented as good or bad, desirable or 
undesirable. Thus, valency often plays an important role in pragmatic argumentation 
(see 3.4.1) where an action is justified (or refuted) by indicating its projected positive 
(or negative) future consequences. Rhetorically, advocates of certain policies or 
technologies tend to stress the good (higher yield, less environmental damage) and to 
downplay or even keep silent about the bad (deforestation, health risks) thus selecting 
the topics for discussion. Opponents on the other hand strategically maneuver in the 
opposite direction. Closely related to the parameter of valency, therefore, is modality 
(or degree of certainty) with which the positive or negative future is constructed. 
Intensifying and mitigating strategies are utilized here to exaggerate or understate 
future effects. The member of marliament depicts deforestation as an almost certain 
negative consequence of GMOs, a fact the minister of agrilculture is ignorant of. 
Although certainty can exude confidence and might earn trust, it can also spark 
controversy. Therefore, as Michael notes, modesty can be a powerful “rhetorical 
tool” too (see Chapter 5).
 The last dimension of representations of the future is speed: how fast is a beneficial 
future to come or how far ahead is an inescapable whim of fate? Representing the 
future as accelerating or as inching can be both rhetorically functional and harmful, 
Michael argues: “[L]ow speed can be negative (mindless inertia) or positive (reflexive 
obstruction). Similarly, high speed can be negative (headlong, irresponsible rushing) 
or positive (entrepreneurial grasping of the future moment)” (Michael 2000: 32-3). 
Comparing the development of cisgenic products with a rumbling train nicely 
illustrates this parameter of speed.
Michael thus provides a useful inventory of parameters, which amount to a set of 
devices used to construct futures for rhetorical purposes. Only a few empirical studies 
demonstrate how constructions of the future are utilized as a rhetorical resource in 
public debate (be it without any reference to Michael’s parameters). Parry (2009) for 
instance shows how scientists utilized expectations as a means to reframe the ethical 
debate over stem cells in the UK. The British anti-stem cell lobby almost succeeded 
in mobilizing public opinion to ban embryonic stem cell research (Parry 2003; in the 
US this anti-lobby was successful). This religiously motivated lobby reframed the 
“scienticized” framing of human embryos as “just a bunch of cells,” stressing the 
ethical status of embryos as unborn life worthy of protection. To settle the issue, 
some politicians suggested that scientists should confine their research to adult stem 
cell and cut off the path of research on embryonic stem cells. In their defense, stem 
cell researchers reframed the discussion “in terms of scientific progress” (100; cf. 
Mulkay 1993) to keep options for embryonic stem cell research open.38 Rather than 
blocking embryonic stem cell research because of ethical considerations, scientists 
argued in favor of developing both research trajectories. In the long run medical 
therapy will more likely and solely benefit from research on embryonic human 
cell tissue. Here the parameters of distance and modality do rhetorical work to 
indicate the usefulness of embryonic stem cells. As in the case of boundary work 
and subject positioning, stem cell researchers transgress the discursive boundary 
between science (scientific facts as settled knowledge within the stem cell research 
community) and society (expected production of scientific knowledge reflecting 
social benefits and values).
 Similarly, in their analysis of the public controversy over transgenic cows 
in New Zealand, Bloomfield and Doolin (2010) argue that in the “struggle to 
represent the imagined consequences [and benefits] of technoscientific 
innovation” the expert versus non-expert boundary turns out to be efficacious. 
The imaginaries of biotechnology researchers (controlling lactose allergy, 
finding new therapies for multiple sclerosis, creating new businesses) were 
deemed more credible, plausible and legitimate than those of non-expert NGO 
opponents (e.g. the social movement of Mothers Against Genetic Engineering 
in Food and the Environment). Despite the inherent uncertainty and skepticism 
among fellow-scientists, the imaginaries of opponents had little influence on 
38 Mulkay writes: “[b]y their very nature, future-claims about the course of scientific 
research are extrapolations that go beyond the existing evidence. They have to operate 
by means of some kind of analogue with other areas of science and/or by reference to 
some implicit model of scientific progress (Mulkay, 1993: 724-725).”
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the regulatory process of the research project on transgenic cows.39
Boundary work, subject positioning and representations of the future are important 
analytical concepts from discourse analysis for studying strategic maneuvering in 
the context of public disputes over science and technology. Nevertheless, I want to 
address a few methodological issues. Firstly, it is important to note that almost all 
these studies have been conducted within the context of public controversy on NEST 
where emotions and entrenched are dominant. Because the material was drawn 
from diverse empirical sources (interviews, press releases, news paper articles), from 
different countries, and from different controversies on NEST, translations of these 
findings into face-to-face upstream public deliberation deserve attention.
 Secondly, many of these (critical discourse analytical) studies reflect an 
asymmetrical focus on discursive patterns of scientists without taking the strategic 
maneuvering of other social actors into account. This may produce the effect of 
reifying the social category of “the” scientist as “socially unreflexive” (Cook et al. 
2004). This effect is increased when authors (e.g. Kerr et al. 1997; Felt et al. 2009) 
draw normative conclusions in their studies about science’s hegemonic exercise of 
power, researchers’ deflecting of (social) responsibilities and the wrongly expansion 
of their expertise. In my view, such a moralistic approach is empirically problematic 
and it needs to be justified. It is tacitly assumed that the effect of these strategic 
maneuvers can be objectified implying that it is the same for the multiplicity of 
audiences (including the analyst). It is important, however, that the concept of 
effect is not identified with the concept of aim (or the social analyst’s construction 
thereof): the rhetorical strategy may not be effective. I think additional ethnographic 
material is needed to investigate effects and aims. How do participants perceive the 
effectiveness of discussants? What is it that scientists aim for?
4.5 Conclusions
The standard pragma-dialectical argumentation theory, discussed in Chapter 3 
does not take the rhetorical dimension of argumentation into account. People who 
are involved in a discussion are also – and perhaps first and foremost – aiming at 
39 In his typical critical way, Wynne writes: “Indeed, these claimed benefits are often 
asserted by scientists to be as much a part of the factual domain over which science 
claims sovereignty as are questions of risk” (Wynne 2003: 222).
effectiveness, at having their standpoint accepted. In this chapter, I have discussed 
the concept of strategic maneuvering that was introduced to include the rhetorical 
dimension of effectiveness into the analysis of discussions. Strategic maneuvers in the 
pragma-dialectical meaning are an inherent feature of every discussion. Therefore, 
strategic maneuvering is not detrimental to discussions and deliberations per se so 
it does not necessarily need to be minimized. However, it can derail when the rules 
for a critical discussion are violated. I will return to the problem of how to establish 
derailments of strategic maneuvering below.
 The concept of strategic maneuvering draws attention, first, to how discussants 
make a selection from the topoi (available issues or argument schemes) to defend 
their claims (topical selection). Proponents of cisgenesis for example choose the 
argument scheme of pragmatic argumentation to stress the desirable (expected) 
consequences of cisgenic crops without explicitly referring to possible side-effects. 
Furthermore, these crops’ contribution to sustainable agriculture is selected as the 
main benefits of this new technology. Thus, proponents construct a normative vision 
of a good future which certain publics in particular (or audiences) or the public in 
general perceive as plausible (audience demand). Thirdly, discussants choose a 
suitable presentation for their standpoints and arguments (presentational devices) 
to have their standpoint accepted.
 Although the notion of strategic maneuvering allows for a more refined 
(rhetorical) analysis of argumentative discourse, it could benefit from a discourse 
analytic perspective on presentational devices. Particularly the main idea of 
discourse analysis (DA) of language users constructing different versions of reality 
in different contexts for rhetorical purposes makes DA an interesting empirical field 
for the study of strategic maneuvering. The Discourse Historical Approach (DHA) to 
critical discourse analysis nicely illustrates how various discursive strategies serve 
rhetorical functions in social interaction.
 The aim of this chapter was to empirically explore strategic maneuvering in 
the context of public discussions on new and emerging science and technology 
beyond the discursive strategy of argumentation as discussed in Chapter 3. Using 
DHA’s theoretical elaboration of various discursive strategies – nomination strategies 
(categorizing objects and people), predicational strategies (characterizing them 
through predicates), footing (acting as author, animator or principal) and intensifying 
and mitigation strategies – I have investigated discursive practices as described 
in STS literature that can be expected in public controversies on NEST. In order to 
end up in an advantageous position in the discussion, i.e. to be effective in public 
deliberations in the discursive struggle over controversial science and technology, 
proponents and opponents draw on a repertoire of strategic maneuvers: boundary 
work or the conceptual demarcations made to categorize people (e.g. as publicity 
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agent, scientist, lay person or activist), objects (e.g. crops as transgenic, cisgenic or 
traditionally bred), practices (e.g. as basic or applied scientific research) and even 
social realms (e.g. as science or society); subject positioning or the nomination and 
predicational strategies to construct public identities of selves and others (e.g. as 
fundamentalist, unrealistic or myopic); and expectations or predicational strategies 
to represent futures (e.g. as distant, good, uncertain and rumbling).
The question, however, is when do these strategic maneuvers derail? When does the 
eagerness to be effective gain the upper hand at the expense of being reasonable? 
When do the strategic maneuvers that I have identified as frequently reoccuring in 
NEST-ethical discussions conflict with the norms of the model of critical discussion? 
As Van Eemeren stresses, fallacies, as derailments of strategic maneuvers often, pass 
unnoticed since these maneuvers “manifest themselves as strategic maneuvers that 
seem to comply with the critical discussion rules but in fact do not” (Van Eemeren 
2010: 199). Moreover the boundaries between sound and fallacious strategic 
maneuvering are hard to detect since judgments on the soundness of argumentative 
discourse are mostly contextual judgments. The general, context-independent rules 
of critical discussion alone are a necessary but in many cases not sufficient conditions 
for determining fallacies. More specific, context-dependent criteria are needed in 
those cases that Van Eemeren derives from a typology of different communicative 
activity types (adjudication, mediation, deliberation and negotiation) each of 
which provide a macro-context with a particular set of more or less institutional 
preconditions in which the argumentation takes place. Unfortunately, Van Eemeren’s 
definition of the institutionalized conventions of deliberation remain rudimentary, so 
that these are not very helpful in identifying the maneuvers, that are not clear-cut 
fallacies when applying the norms of critical discussion. Unsatisfactory as it is, many 
shades of grey exist and it chiefly depends on the context whether speech acts are 
fallacious or not and many evaluations are open for discussion.
 For instance, the claim of plant researchers that the boundary between trans- 
and cisgenic crops is “fundamental” and scientifically established can be considered 
as a perfectly legitimate appeal to authority: their proposition is acceptable because 
they are considered to be experts in the field of plant genetics. Nevertheless, since 
there is considerable controversy within academia as well, the certainty with which 
they make their claim can also be considered as an argument ad verecundiam, a 
fallacious appeal to scientific authority wrongfully referring to scientific facts. The 
same goes for claiming desirable consequences of a new technological innovation 
which can only be concluded at hindsight.
 Boundary work is another example. As I have argued, any definition of reality 
contains demarcations and categorizations and any of these do rhetorical work. 
Positioning opponents of GMOs as “activists” perhaps is acceptable, but calling 
them members of a “fundamentalist organization” tends to be an argumentum ad 
hominem, a violation of the freedom rule. Equally difficult is the more subtle moral 
subject positioning of Dr. Bino as a scientist allegedly disguised as publicity agent 
who does not quite bother with the norm of disinterestedness.
 Generally, these strategic maneuvers as various descriptions of reality (be it 
demarcations, subject positions or futures) may be constructed on the one hand 
to resist undermining by others (defensive rhetoric: e.g. the fundamental boundary 
between transgenic and cisgenic plants) or on the other to undermine alternative 
descriptions (offensive rhetoric: e.g. discrediting Dr. Bino’s claims on the desirable 
benefits of GMOs by positioning him as an interested party; Potter 1996).  These 
discursive strategies need attention in the analysis of argumentative discourse as 
well as in the work of facilitators of public deliberation, firstly, because they might 
serve the purpose of closing down a critical discussion in the confrontation stage: 
claims of scientists who have a (financial) stake or people who belong to an NGOs 
that legitimizes violence need not be discussed at all. Secondly, because they “enter 
as premises into reasoning about what we should do” (Fairclough and Fairclough 
2012: 86-87). As argued in Chapter 3, an important task of facilitators is to open 
up the propositional content of these premises for discussion. As I will demonstrate 
in the next chapter, representations of the future (particularly the feasibility of 
new technologies) turned out to be effective strategic maneuvers. Unfortunately, 
these maneuvers closed down the discussion at such an early stage that the moral 
desirability of certain futures was not critically examined.
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5.1 Introduction
In the late 1970s and early 1980s a fierce (academic) controversy illustrated the taboo 
of predisposition to criminal behavior in the Netherlands. The controversy arose 
when Wouter Buikhuisen was appointed professor of criminology at the University of 
Leiden.1 Buikhuisen had suggested that his new research agenda was aimed at studying 
delinquency “in biosocial perspective,” to also include biological factors of criminal 
behavior. His research program was heavily criticized, within the academic community 
as well as in popular press. In terms of reasonableness, the discussion reached rock 
bottom in the leftist weekly Vrij Nederland, when columnist Piet Grijs strung argumenta 
ad hominem together (violating the freedom rule; see Section 3.3.2 and Table 3.1). 
Buikhuisen was called “a bald, impotent career scientist,” “stupid charlatan” and “the 
assembly point of Dutch fascism” (Cohen 2005). Worse still, others did not flinch from 
using argumenta ad baculum (argument to the cudgel): Buikhuisen’s inaugural lecture 
was violently disturbed and he and his family were threatened. In the end, his institute 
was shut down and in 1989 Buikhuisen retired, frustrated.
 This controversy has become part of Dutch collective memory and it has deeply 
influenced the research field of criminology in the Netherlands.2 “[I]t is still impossible 
1 There is to my knowledge, no systematic historical study of this controversy. In an 
interview in 2009 Buikhuisen looked back at the affair. “I was terribly treated. It is 
almost indescribable. I was threatened with death.” (Bongers 2009). Others, who 
condemn these threats, argue however that Buikhuisen himself “had given cause for 
protest” and “current researchers on biological factors of criminal behavior seem to 
have, more than Buikhuisen, an eye for the contribution of other scientific disciplines” 
(Anon. 2000: 5). Meanwhile, Buikhuisen has been rehabilitated but not without public 
and political debate.
2 The media contribute to the “re-enactment” of the Buikhuisen affair 
(see De Haan 2009).
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to bring up the relation between criminology and biology without referring to the 
[Buikhuisen] issue that had upset his plan for biosocial research […] and that had 
lead to the early end of his career” (Anon. 2006: 6). Nevertheless, internationally 
“knowledge about genetics and gene environment interactions” and criminality is 
increasing and the “expectation is that we are only at the beginning” (ibid: 5).
 As a result of these high expectations and the historical context of the Buikhuisen 
affair, I organized a series of three public dialogues on behavioral genomics, in 
close collaboration with the CSG Centre for Society and the Life Sciences (CSG) in 
2008. Behavioral genomics is a field of research that tries to locate and identify 
specific genes or groups of genes, associated with behavioral traits (e.g. anti-social 
behavior, aggression, intelligence and sexual orientation) in order to understand the 
contribution of these genes to human behavior and to understand the interaction 
between genes and environment (prenatal conditions, upbringing, nutrition etc.; cf. 
Plomin et al. 2003). The unraveling of the Human Genome has given a new impetus 
to the scientific research on the biology of human behavior.
 Ethicists had stressed the importance to anticipate the ethical, legal and social 
implications of this “complicated area of research in genetics, often controversial, 
occasionally explosive and with the capacity to ignite dangerous passions” (Nuffield 
Council on Bioethics 2002: 5) and the need for a public conversation to discuss these 
issues (Parens 2004; Parens et al. 2006). As a result, leading life scientists in the Dutch 
field of behavioral genomics were invited to the LUX Theater to engage into a dialogue 
with other (scientific) experts and various (invited) members of the public, “groupings 
of actors who are affected by the actions or events but do not have direct influence on 
them” (Marres 2005: 48; see Section 2.5.2).3 In a series of public deliberations, entitled 
The Preprogrammed Human, “life scientists and publics will collectively explore 
questions such as: what does behavioral genomics research yield, and for whom? 
What social issues does this science raise?” as the promotional text read.
 These questions were to be discussed in three separate public dialogues, 
each of which revolved around one particular human behavioral trait or 
psychopathology: Attention Deficit Hyperactivity Disorder (ADHD), delinquency (in 
fact: psychopathologies related to delinquency, e.g. anti-social behavior), and Autism 
Spectrum Disorder (ASD).
3 We defined the public as people who might (in the future) be affected by these 
developments: patients diagnosed with behavioral disorders and their family; ex-
convicts; (health care) professionals, such as general practitioners, psychotherapists, 
institution directors, psychiatrists; and people working in special education. In order to 
interest the public, a promotional text was distributed on digital and social media. 
 Differently than expected, controversy on these issues hardly arose. Only the 
value of genetic tests for people with ASD was fiercely contested at the LUX. As I 
will demonstrate in this chapter, these discussions were hardly critical discussions 
on the moral desirability of the developments within behavioral genomics. Using 
the pragma-dialectical argumentation theory (Chapters 3 and 4), argumentative 
discourse is reconstructed, analyzed and evaluated in terms of strategic maneuvering. 
The first set of questions I address in this Chapter is: How did participants – both life 
scientists and publics – strategically maneuver in upstream public deliberation on 
behavioral genomics? What effect did these maneuvers have on the quality of these 
deliberations? And how could this quality be improved?
 To address these questions, I present a reconstruction of the argumentative 
discourse of these public deliberations based on the texts of the discussions that 
were audio-visually recorded and transcribed ad verbatim. Since an analysis of 
argumentative discourse “is pragmatic in the sense that the discourse is viewed as 
essentially a contextualized exchange of speech acts” (Van Eemeren 2010: 17), the 
context is a valuable source for understanding and interpreting strategic maneuvers 
in discussions.4
 Pragma-dialectics, however, only applies to first order conditions, i.e. the 
procedural rules to be followed to have a reasonable discussion (see Section 3.2.2). 
As I have argued in Chapters 2 and 3, the setting also determines the quality of the 
deliberation. I have elaborated Maarten Hajer’s dramaturgy of public deliberation 
as an instrument to analyze (Section 2.5 and 3.5) the performative effects of the 
4 Several levels of context can be discerned. Here, I particularly mention the micro-
context and the intertextual context. The former refers to those parts of the same 
discussion that support the analyst’s interpretation of the primary argumentative text. 
The transcript of the deliberations is the main empirical source, but interviews with 
participating life scientists after the events at the LUX were additionally used to clarify 
the context during the discussions. Occasionally, the video recordings turned out to be 
helpful in case of doubt.
 The intertextual context refers to “other texts or speech events with which the 
discourse passage or the text of speech event as a whole is somehow connected” 
(Van Eemeren 2010: 18). So, texts about the public deliberation on ADHD, delinquency 
and ASD in general or on behavioral genomics in particular as well as texts directly or 
indirectly referred to during the discussions were also used for the reconstruction. For 
example, during the deliberation on ADHD, a psychotherapist alluded to a book that 
had just been published. This book, and the media attention it received, was included 
in the analysis (see Section 5.2).
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setting of the discussions at the LUX.5 “We should not merely focus on the type of 
arguments that are raised but include the conditions (physical, technical, theatrical) 
as well” (Hajer 2005: 625). Hajer introduced the concepts of scripting, staging and 
setting as a framework to analyze “how the design affects what is said, what can 
be said, and what can be said with influence” (ibid: 624). The second question of 
this chapter therefore reads: How does the dramaturgy of these upstream public 
dialogues scripted as public inquiries into the ethical and social issues concerning 
behavioral genomics, influence the performance of participants?
For the reconstruction of the dramaturgy of the public deliberations at the LUX, I 
utilize the transcripts of preparatory interviews with participating life scientists; 
draft documents for internal use containing concept versions of script, staging and 
setting; the briefings to prepare all the active (i.e. invited) participants;6 promotional 
texts; e-mail correspondence; journalistic accounts of the event published on the 
website; and questionnaires. Also interviews with participating life scientists to 
reflect on the dialogue events afterwards were used as an empirical source. Each 
source that supports observations is mentioned between parentheses. For example, 
the excerpt “the path of bio-criminology is disastrous” (Discussion) comes from the 
transcript of the deliberation. The interview with life scientists before and after the 
public dialogue will be referred to as (Interview 1) and (Interview 2) respectively. For 
reasons of anonymity, the names of the main characters in this analysis are fictitious.
In the next three sections, I present detailed reconstructions of both the organizational 
processes (the dramaturgical work behind the scenes of) and of the deliberations 
in terms of strategic maneuvering of each episode of The Preprogrammed Human 
(the discursive performance on stage). The deliberation on behavioral genomics 
and ADHD is analyzed in Section 5.2, the public dialogue on delinquency and ASD 
are presented in Section 5.3 and Section 5.4 respectively. For each case study, I first 
provide the reconstruction of the dramaturgical process and then I reconstruct the 
discursive events on stage. The analyses of the three deliberations will be presented 
5 Van Eemeren defines these external factors as third order conditions for a critical 
discussion that “relate to the social circumstances in which the discussion takes 
place and pertain, for instance, to the power or authority relationships between the 
participants and to special features of the situation in which the discussion takes place 
(Van Eemeren and Grootendorst 2004: 189).”
6 In the week preceding the event, participants received a document which contained 
the purpose, the main characters in the play and the main questions.
chronologically to demonstrate how the events in one deliberation determined 
organizational considerations and decisions in the next.
 In Section 5.5 I draw some conclusions about how appeals to scientific authority 
particularly with regard to the technological feasibility of future visions proved 
effective strategic maneuvers in the public deliberations at the LUX. Furthermore I 
present two strategies of critically assessing future expectations.
5.2 Discussing the effect of biological research on the
 medicalization of ADHD
On a cool Monday evening in June, the debating centre at the LUX in Nijmegen was 
crowded. The first episode of The Preprogrammed Human was sold out within days. 
The genetics of ADHD had mobilized a public of eighty patients, parents, general 
practitioners, psychologists and other professionals working in the field of Attention 
Deficit Hyperactivity Disorder (ADHD) as well as members of a more general public 
(Questionnaires and Discussion).
 Perhaps the considerable media attention that a book called “The depression-
epidemic” received in the week prior to the public deliberation at the LUX 
contributed to this high turn-out. The book was brought up during the public 
discussion at the LUX (see below). In some interviews in Dutch popular and medical 
press, the author of the book (Trudy Dehue) had drawn a parallel between ADHD 
and the increasing number of people actively working on their depression – using 
medication or doing self-help therapies (Maassen 2008; Slob 2008; Vanheste 2008).7 
In her constructivist criticism (cf. Press 2006)8, Dehue argues that human behavior 
is increasingly put under the medical purview which turns more human behavior 
into disorders (denoted with labels such as ADHD as a set of symptoms): individual 
medical problems with material causes (genes, the brain) and solutions (mainly 
7 In “The Depression-Epidemic”, Dehue attempts to provide a sociological explanation for 
why so many people in the Netherlands (and elsewhere in the Western societies) are 
actively working on what they call “depression,” by taking medication or doing all kinds 
of therapies and (alternative) treatments. 
8 As Nancy Press (2006) argues, psychiatric disorders, such as ADHD, as classifications in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM) are social facts, names 
denoting a set of criteria to determine when behavioral traits are deemed deviant. 
However, these disorders are wrongfully represented as labels indicating medical 
conditions that really exist and that are the cause of the disorder.
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medication). “This biological perspective distracts the attention from circumstances 
[people do not necessarily have control over] as the cause [for their emotions] and 
[this perspective] makes us not only think of recovery in terms of own responsibility 
but also in terms of self-improvement” (Maassen 2008: 895).9 Dehue’s conclusion 
is that no biological or genetic underpinnings for these behavioral traits have been 
found yet and even when so, “this does not automatically mean that we are dealing 
with a disorder” (ibid: 894). The book sparked a controversy within the biological 
psychiatry community.10
 John Lush, a professor of child psychiatry at a Dutch academic hospital, who 
had accepted our invitation to engage in dialogue with the public, had also referred 
to Dehue’s much discussed book during the preparatory interview. Lush, a well-
known ADHD expert in the Netherlands who had just received a large research 
fund to investigate ADHD children, using both DNA-analysis combined with neuro-
imaging techniques, expected “much discussion about ADHD as a medical condition” 
(Interview 1) because of a few recent articles “I assume you have read in the weekend 
news papers about a woman who has written a book about depression [i.c. Dehue]” 
(ibid) in which the biological explanation of behavioral traits was criticized.
In the first of three acts of the script of this public deliberation, the public would be 
offered the opportunity to articulate their “views, expectations, hopes, concerns, 
fears” (Discussion). Thus, an active participation of the present public was scripted. 
To support the staging without any distinction between active players and a passive 
audience, the physical setting of the LUX resembled an XLfocus group arrangement, 
with the invited scientist among the public.
 In the second act, Lush would first respond to the contributions of the public 
and next, be interviewed to provide his views on the scientific state-of-the-art of 
behavioral genomics research on ADHD. The interview would be concluded with Lush’ 
9 In later work Dehue (2009) claims, that medical science is mainly responsible for 
putting human behavior under the medical purview and for the “skyrocketing” 
diagnose of ADHD and intake of drugs, even with children younger than ten years of 
age. She identifies two disadvantages of this medicalization of ADHD. First, people 
might suffer because “they are not allowed to be like they are” and second, the focus 
of care and treatment might wrongfully on the individual patient instead of social 
conditions, such as “deprived neighborhoods, poor working conditions, overfull 
schools” (95).
10 See for example Van der Does (2009) and Dehue (2010) for her response to the 
contributions to the public debate.
addressing the main question: what does his research on the biology of ADHD yield 
for society? This question was intended to leave enough room for both life scientists 
to explain the public value of their work as well as to invite the participants to 
articulate and critically investigate ethical and social issues that behavioral genomics 
research can raise. In the third act, the floor would be opened for discussion to 
deliberate the issues articulated in the first round. I, as the facilitator, would utilize 
an interrogative question technique aimed at understanding; summarize statements; 
look for differences of opinions to resolve; watch the agenda and keep time.
Although I had scripted the event as public deliberation and even though I had 
expected controversy because of the attention of Dehue’s book, the issue of 
behavioral genomics was not heatedly discussed at the LUX, an observation that 
was subscribed to in the questionnaires. “I can still recall that Dr. Buikhuisen was 
victimized because he dared to suggest a link between genetic disposition and 
criminal behavior. Apparently, the social climate has changed so that now it is not an 
issue anymore,” a male psychiatry nurse described his experiences after participating 
in the public discussion on ADHD (Questionnaires).
 A relatively large portion of the public had no intention to critically engage 
with science, which other people (mostly professionals in health care) regretted. 
Instead, these people restaged the event into an information session – or “refresher 
course” as someone wrote in the questionnaires – to amass knowledge from the 
ADHD expert Lush (Questionnaires public).11 Apparently, most parents and patients 
had come to the LUX for information, either for a better (self-)understanding or 
for empowerment – “Knowledge is power” (Discussion) – to receive the necessary 
(health) care for their children that was claimed to be withheld from them. Others, 
working professionally with ADHD, expressed their expectations (or rather hopes) 
about the desired outcomes of behavioral genetics research, reflecting their needs: 
a solution for controversial drugs (esp. Ritalin) as medical treatment of ADHD or the 
hope for early diagnostics since “children [with ADHD] become older and older as 
they come to our school, when problems have already mounted up” (Discussion) as 
11 As one of the questionnaires read: “In the audience, there were some people who 
are diagnosed with or have to deal with ADHD. I understand that they want to know 
all there is to know about ADHD and [that they] want to be informed about most 
recent developments, but the consequence was that the discussion looked like an 
open information evening of the prevention department of a mental health care 
organization” (Questionnaires ADHD).
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a health care professional in special education said.
 People who actually were interested in a discussion, however, came to the LUX 
for consumption rather than participation (“I am more of a person who sits back 
instead of joining the debate,” commented a male professional in youth care in his 
fifties; questionnaire) or did not feel comfortable being involved in a discussion as an 
active participant (“A considerable amount of people will experience the idea to be 
addressed any time as unpleasant,” male psychologist in his thirties; questionnaire).
 As a facilitator I attempted to restage the discussion into a public discussion 
again: “These are all positive expectations. Are there any people who think that 
genetics research could contribute to the other [negative] side as well?” (Discussion). 
It was only after this intervention, that some criticisms were expressed but no 
serious discussion ensued. In this analysis of argumentative discourse, I focus on 
the resolution of differences of opinion on the issue of medicalization that some 
professionals raised.
GENERAL PRACTITIONER: “I can see the advantages of this [research], [...][b]ut 
there is a side effect*, too. [...] I am curious about [...] what consequences we, as 
physicians, parents, social workers ourselves will attach to this [development].”
FACILITATOR: “Do you think that the expectations are too high?”
GENERAL PRACTITIONER: “Yes. That is part of my concern. To look at 
the whole social system has, I think, more added value than such a 
gene determination [alone] [...]. I would not want our broad systems 
approach to be substituted with this [gene determination].”
[...]
PSYCHOTHERAPIST: “I think it is great that science provides us with many new 
insights. At the same time, there lies the big danger, too. We live in a medical 
age in which a lot of importance is attached to scientific understanding. [...] If 
we adopt a medical gaze, it does not mean that it is the truth. A critical attitude 
towards this [is needed]. What does this genetic knowledge mean exactly? 
[...] There is this book that has just been published with the same purport [...]. 
That woman [Trudy Dehue] talks about a ‘ban on cautiousness.’ It would be 
a pity really if this scientific development would decrease our cautiousness 
[...]. If we stop looking critically at who a person is in his context and system, 
just as that man [the general practitioner] said. [...] As a psychotherapist I 
sometimes end up in a row when I refuse to put a label on [a patient]. [...] 
This label determines his whole identity and that is the big problem.”
[ excerpt 5.1 ]
 
Here, the general practitioner and the psychotherapist use pragmatic argumentation 
to express their concern about “the medical gaze” as a negative consequence (“side-
effect”) of behavioral genomics research. In his (cautiously) constructed future, 
the general practitioner is “curious” how advancing science could contribute to the 
medical purview and its accompanying reductionist perspective on people’s behavior. 
The remarks of the psychotherapist add to the issue of medicalization. As his short 
anecdote from his professional work demonstrates (explicating his subject position), 
the psychotherapist does not always agree with the people in his consulting room 
who frame their own behavior or that of their children as a medical condition. The 
label ADHD can have stigmatizing consequences, too, he suggests. Referring to the 
prominent motto of the “ban on cautiousness” in Dehue’s The depression-epidemic, 
he hints at a particular deprivation (“it would be a pity really”) due to this reductionist 
medical framing on human behavior. As Dehue writes, cautious people are “deprived 
of” their worrying (Dehue 2008: 254) since antidepressants are marketed as a 
remedy against worrying. From this intertextual context the psychotherapist can 
be said to suggest that remedying ADHD with medication such as Ritalin, deprives 
people of something valuable, too. As another professional expressed it at the LUX: 
“Let us consider ADHD as a chance. Someone with ADHD has by definition a lot of 
talents” (transcript).
 How did Lush respond to these expectations? He did not directly respond to the 
negative side-effect of medicalization:
FACILITATOR: “You have heard many voices, views and 
opinions. What are your thoughts?”
LUSH: “I think that if one is not involved in the research, 
it is hard to estimate the value of genetics.”
[...]
FACILITATOR: “To what extent do the questions and remarks 
of the public [...] ensue from a lack of knowledge?”
 LUSH: “That is absolutely so.”
[ excerpt 5.2 ]
Here, Lush performs boundary work (see Section 4.4.1). He demarcates between 
insiders – researchers in the field of behavioral genomics – and outsiders not involved 
in the research – the public. Lush does not explicitly claim expertise about the future. 
But he infers to a public ignorance even though the minor premise and the conclusion 
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of his modus ponens argument remain unexpressed.12 Outsiders, the public at the 
LUX, according to this argument, do not have knowledge or expertise of the (future) 
social benefits or the “value of behavioral genetics” (Discussion). That Lush’s remark 
also refers to the criticisms of the two health care professionals, was confirmed in the 
interview after the dialogue event: “[I]f you do not know how it works in genetics, if 
you are not well-informed, you can of course invent all kinds of scenarios yourself. 
[...]. [T]here are of course people who think that it [behavioral genomics research] 
has many consequences […] that you stigmatize people with it” (Interview 2). The 
expectation that more genomics research will also lead to more medicalization and 
stigmatization is pictured as originating from public ignorance and imagination which 
can be considered as an argumentum ad hominem and hence a violation of the 
freedom rule (see Section 3.2.2). So Lush’ strategic maneuvering derails.
 Lush does not address the suggested relationship between medical science, 
psychiatry and medicalization. This explains why the general practitioner returned 
to the issue again in the discussion round, rephrasing the same concerns how the 
advancing knowledge in behavioral genetics might “affect the society at large, 
medical practice and schools” (transcript). I asked Lush to respond:
FACILITATOR: Mr. Lush, how would you respond to that? The idea that genetics 
contributes to the possibility of labeling too much. 
[…]
LUSH: Of course, I am sensitive to the fact that scientists can collect 
information and that this knowledge can be used by others differently.
FACILITATOR: Who are these other people?
LUSH: That could be politicians. [...] I can imagine [...] that malicious insurance 
companies could say: ‘Look, if you have ADHD and you have a gene that proves 
you have a bad prognosis [...] then we are going to look differently at [medical] 
treatment. Perhaps we have to invest more.’ But it could also lead to nihilism 
[...]. I do not say this is [a] legitimate [response].  Statistically, I think it is 
nonsense but I think that we as a society – and for a moment I do not speak as a 
physician – have to face the possible risks that are attached to this knowledge.”
[ excerpt 5.3 ]
12 The modus ponens argument follows the following pattern: if p, then q; p therefore 
q. If I explicate the unexpressed argument, it reads: if you are not closely involved 
in behavioral genomics research (p) then, it is hard for you to estimate the value of 
behavioral genomics (q). Because you (the public) are not closely involved, it is hard to 
estimate the value of behavioral genomics. 
In his response, Lush makes – again – a distinction. Here between the production 
of scientific knowledge on the one hand, and the use (or misuse) of this knowledge 
by other social actors (such as malicious insurance companies) on the other. First, 
this boundary allows Lush to acknowledge behavioral genomics information as risky 
(as the general practitioner indicated) while preserving the integrity of scientific 
researchers. Second, the subject positioning (see Section 4.4.2) of Lush – switching 
from physician to fellow citizen? – stresses what he and the general practitioner 
– “we as a society” – have in common: the risks of genetic information that both 
citizens are exposed to. Thus, Lush transgresses the boundary between the public 
and scientists (we are on the same side) that he had drawn earlier in the discussion 
(see Excerpt 5.2).
 As argued in Chapter 2, this boundary between production and use of knowledge 
is problematic (Section 2.2). Nowadays, scientific knowledge is almost completely 
produced for its societal use. What is more, Lush justified the spending of scarce 
funding resources emphasizing the utility for society, such as personalized treatment 
and hence using pragmatic argumentation: “I think that genetics will play a role to 
better understand why one child can better be treated using method A and the other 
using method B” so as to “offer eventually, I think, more targeted treatment” and 
develop “new medication” (Discussion).
 Futhermore, Lush adduces irrelevant argumentation here I argue (violating the 
relevance rule, Section 3.2.2). The fact that “malicious insurers” and “politicians” 
could misuse genetic information, does not address the suggested direct causal 
relation between the production of genetic knowledge of human behavior and the 
risk of medicalization.
 The discussion on the issue of medicalization ended here. I directed the discussion 
to the issue of protection of genomic information against insurers. The general 
practitioner did not insist anymore and by the time I returned to the psychotherapist 
for his reply, it turned out that he had already left LUX, for reasons unknown.
From this reconstruction and analysis of the first episode of The Preprogrammed 
Human, it is fair to conclude that behavioral genomics research on ADHD was not 
fiercely discussed, contrary to our and John Lush’s own expectations. What effect did 
the strategic maneuvering of participants and the dramaturgy have on this outcome?
 Firstly, most members of the public did not adopt the role of citizen critically 
engaging with the social and ethical implications of behavioral genomcs research 
that was scripted in The Preprogrammed Human. A majority of the public restaged 
the public deliberation into a refresher course in ADHD. Apparently, they had come 
to the LUX to gain the latest scientific insights from a well-known expert. People who 
were interested in a discussion, however, refrained from an active participation. A 
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bias that was included in the script can explain this hesitance. To ensure their role 
in framing and agenda-setting, the public was invited to start the discussion. My 
intervention as facilitator implied that the burden of proof rests on the public in 
the first instance (according to the burden of proof rule; see Section 3.2.2). When 
asked, the public would have to advance argumentation to defend its claims about a 
complex sociotechnical issue in the presence of a well-known expert, Dr. Lush.
 Secondly, Lush did not really engage with the concerns of the general practitioner 
and the psychotherapist. Instead, he strategically maneuvered towards his goal 
of “highlighting the positive aspects of my research” (Interview 2). Particularly his 
boundary work (insiders vs. outsiders; production vs. use of scientific knowledge) was 
aimed at circumventing a response to the claim that biological research on human 
behavior might lead to medicalization and stigmatization. His strategic maneuvers 
even derailed, I argue since explaining public concerns as “mainly a result of a lag 
of information” (Interview 2) as Lush repeated in the interview afterwards, can be 
considered as an argumentum ad hominem. Moreover, claiming a clear boundary 
between knowledge use and knowledge production is logically inconsistent with his 
expectations in which the utility of his research is presumed.
 Thirdly, the cast lacked a critic of medical science and medicalization of ADHD 
such as Dehue to counterbalance the expertise of Lush. Now, his sociotechnical 
imaginaries (see Section 4.4.3) were not investigated. Nor was the knowledge about 
the value of behavioral genomics. In short, there was hardly any critical discussion. 
As argued in Chapter 3, in a critical discussion argumentation that is advanced to 
provisionally defend standpoints must be confronted to a maximum of doubt. I could 
have helped the participants to critically discuss Lush’s pragmatic argumentation that 
he had used to explain the public value of behavioral genomics research on ADHD: 
according to Lush, his research would lead to the development of personalized 
treatments or new medication (desirable consequences). As the public concerns 
articulated in the LUX demonstrate, there was no agreement on the propositional 
content i.e. that medical treatment is desirable or that ADHD is a medical condition 
that (always) needs to be medically treated in the first place (ADHD as a normal 
variation in human behavior). Furthermore, the justificatory force was not examined 
since critical questions pertaining to pragmatic argumentation (see Section 3.4.1) 
were not addressed. Are new medication and more personalized treatment feasible? 
Are there better alternatives? According to the medicalization critique, interventions 
in the social conditions are as effective (and necessary) as medication. What are the 
negative side-effects (e.g. medicalization, harm due to long term medication use) 
and do they outweigh the benefits?
5.3 Assessing constructed futures of neurobiology on
 delinquency
Because biocriminality had proven to be a very controversial issue in the Netherlands, 
I expected a more lively discussion in the second edition of The Preprogrammed 
Human. However, my experiences during the ADHD deliberation resulted in some 
dramaturgical changes in order to stage the deliberative event as a critical public 
assessment of ethical issues of this field of research. First, as part of the new script, 
the cast was extended (cf. Hajer 2005). Similar to the public dialogue on ADHD, a 
representative of the life sciences was asked to engage in public dialogue: Roger 
Lamb. Lamb is the medical director of a Dutch academic centre for child and youth 
psychiatry and professor in forensic youth psychiatry, with research interests in 
delinquency at risk groups and neurobiological aspects of criminal behavior. This time, 
however, new actors would be introduced on stage. Two correctional psychologists 
(one working with adolescents in a juvenile detention centre, one with adults in 
penitentiary), a psychiatrist working in a detention hospital (a so-called TBS-clinic), 
an ex-convict now working as a youth worker, and a member of Parliament were 
invited as members of the affected public and instructed and prepared as “catalyst” 
(briefing) to increase active public participation.
 Furthermore, two critics of (neuro)biological research on delinquency were 
added to the list of characters, to stimulate deliberation. The first critic was an 
expert in behavioral science, Dr. Martin Lobb, who had expressed his concerns in 
his inaugural speech about the current domination of biologically oriented research 
and its possible bias at the expense of his own behavioral sciences field. The second 
critic was Harry Tubb, a science writer and journalist of a Dutch national newspaper 
who had written on the Buikhuisen controversy. He had argued that the objections 
against Buikhuisen are, while neurobiology and psychiatry are making progress, 
perhaps a more topical issue than ever.
 The second dramaturgical change was the re-scripting of the deliberation as a 
critical public investigation of the sociotechnical imaginaries of Lamb’s scientific field. 
Behind the scenes of and prior to the deliberative event on stage, Lamb’s future 
visions were investigated. Even though participants in the LUX would still be invited 
to articulate their own issues, the organizers intended to anticipate ethical issues and 
to set the agenda.
 As Lamb explained in the preparatory interview, brain imaging and genomics 
techniques promise to contribute to actuarial criminology, a recent trend in the 
research on criminal behavior which focuses on the statistical risk factors and the 
assessment of criminal behavior instead of its cause(s) (Harcourt 2007). Lamb 
underlined the novelty of neurobiological risk assessment tools that promise to more 
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accurately detect people at risk of behavior or psychopathology related to criminality 
(anti-social behavior, impulsiveness etc.) than current “classical,” “limited” and 
“subjective” (Interview 1) risk assessment instruments – questionnaires and lists to 
be scored by a medical expert or physician.13, 14 “We want, of course, an assessment 
of ‘is that person a risk for the future?’ That knowledge is of course of social 
importance” (Interview 1). “Can we find a gene combination which indicates that 
someone belongs to that group [of people] with higher impulsiveness, [to such an 
extent that] we have to take care of?15 The same applies to neuroimaging (ibid.).” 
Thus, Lamb claims the potential future utility of neurobiological research, using 
pragmatic argumentation (see Section 3.4.1) indicating the benefits for society: a 
more accurate risk assessment of criminal behavior (desirable consequence).
 Because of our experiences with Lush who had not engaged in the ADHD 
deliberation with the possible negative consequences of the use of the knowledge 
he is helping to produce (esp. medicalization), I subsequently probed Lamb’s position 
on the moral desirability of improved risk assessment tools. First, Lamb was asked 
what he thinks it will mean for the treatment of and detention regimes for convicted 
criminals, if these improved (neuro)biological risk assessment tools are used in the 
future? Will people at risk receive (obligatory) medical treatment? Will they be held 
into custody preventively etc.? Second, the issue of preventive criminology was 
discussed: would it be possible to assess the risk of criminal behavior even before 
people have committed a crime?
 Lamb acknowledged the first issue, but as a scientist he did not want to take 
an explicit stance on these issues. “I hold a personal view. […] But […] then I do 
not speak as a scientist. […] I do not want to use my research to spread a political 
message [about how to implement this knowledge]” (Interview 1). About the second 
issue – preventive criminology – he was explicit: this is scientifically not feasible and 
13 Despite these possible improvements, neurobiological factors will be limited, Lamb 
emphasized. Predictions will always be statistical and therefore “an error rate will 
always remain” (Interview1).
14 Indeed, actuarial criminology is controversial. The risk assessment instruments lack 
validity, critics claim, whereas “there is an aura of scientific and evidence-based 
operation attached to these instruments” (De Ruiter 2010; cf. Harcourt 2007; Blok et al. 
2010).
15 Even though Lamb holds that “delinquency is not a psychiatric problem” (Interview 
1), he observes a trend of perceiving criminal behavior as a health care problem that 
needs to be medically treated.
morally undesirable. “That is not the research we want to do” (Interview 1).
 Even though he abstained from making his position public, the investigation 
of both issues was scripted in a new attempt to elicit Lamb’s personal opinion on 
stage. “The idea is to discuss two fictitious cases. An offender who […] has already 
committed a brutal lust murder. During his/her imprisonment, the science of 
biological factors of criminal behavior advances. What does this knowledge mean for 
the treatment of this person? The second case is a preventive case […] Is it desirable 
to screen DNA of ‘petty thiefs’ who are obligated to give a sample of their DNA for 
more serious offences?” (briefing for participants).
 In the first act, the invited members of the public, the two critics and the 
politician would be asked to give their opinion on the scientific developments in the 
field of the biology of criminality by means of a short, closed question: “Do you see 
the advantage of behavioral genetics research on delinquency for society?” (hand-
outs). In the second act, Lamb would be interviewed, to provide information on the 
scientific state-of-the-art about neurobiological and particularly genetic research. At 
the end of the interview, he would be asked to take his position on the first issue 
of risky detainees, to allocate the burden of proof to him. Then, the floor would 
be opened for discussion in the third act. Compared to the ADHD deliberation, the 
physical setting of the second edition of The Preprogrammed Human underwent no 
significant modifications.
In the first act, quite some skepticism was articulated. A correctional psychologist 
said that if the discussion would evolve towards a “mono-causal explanation for 
criminal behavior”, “they will find me on their way” (Discussion). The TBS-psychiatrist 
was skeptical about when his practice would benefit from genetic research: “it is 
all about redeeming a promise (ibid).” The professor in behavioral sciences, Martin 
Lobb, said that “molecular genetics will [...] teach us particularly how important the 
environment is in influencing [human] behavior.” The science writer Harry Tubb was 
most skeptical. He stated that the “path of bio-criminology is disastrous” (ibid.). But 
after the second act (the interview) and some skirmishes early in the third act (the 
discussion), the controversy faded.
 In the reconstruction of this second deliberation I describe how issues of moral 
desirability of more accurate (neurobiological) risk assessment tools were taken 
offthe agenda as a result of Lamb’s strategic maneuvers in the interview (second act) 
and in a fierce but short debate between him and the science writer (third act). First, 
I analyze the interview and then the deliberation in more detail.
In his first response to (and perhaps because of) these criticisms, Lamb warned 
against high expectations. At the LUX, Lamb said that “(…) [n]eurobiology will never 
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tell us who someone is and what someone is going to do; it depends on other factors 
as well, such as social environment, but perhaps it can help us to make some better 
predictions. Better than [the predictions] we do now” (Discussion). However: “In this 
respect [risk assessment], we are actually not so far. […] Not as far as is written in 
newspapers” (ibid.).
 He acknowledged that some of his respected fellow researchers are co-
responsible for raising expectations in the media. As an example, he referred to 
a newspaper interview in the week prior to the public deliberation at the LUX. 
There, the well-known criminologist Adrian Raine had claimed that “In practice, 
this means that we can say to parents: ‘We have administered social, biological 
and genetic tests to your child and we can say with ninety percent certainty that if 
no action is taken, he will grow up to be a violent criminal (Van Hintum November 
8 2008).” In Lamb’s scientific opinion, these claims are “nonsense” and “talking 
rubbish” (Discussion). In fact, he explained that the predictive power of risk 
assessment instruments at this moment is still very low and that “modesty” (ibid.) 
is appropriate.
 Here, Lamb enacts his part as a scientist on stage, positioning himself (Section 
4.4.2) as an expert capable of assessing the quality and feasibility of scientific results. 
Furthermore, he indirectly constructs an identity of a responsible and modest 
scientist vis-à-vis his colleague Adrian Raine, mitigating (or even contradicting) 
Raine’s expectations who wrongfully suggests the prediction of criminal behavior 
using several predictive tools. As a response, I attempted to probe Lamb on his own 
position on the feasibility of neurobiological assessment instruments (instead of 
merely refuting Raine’s) and to imagine possible effects in order to address the issue 
of their moral desirability.
FACILITATOR: “But that means I might possibly lose the right to…that I will be  
forced to be administered a genetic test, or [then] a susceptibility will be 
established and then I will be released and then it will be determined for 
instance where I will live, or not?”
LAMB: “That is not something to ask me. I think that society has to say what  
they want to do with such things. The same as with these risk assessment  
tools [in the current public debate].”
FACILITATOR: “But it cannot be ruled out that your research will in the  
end lead to this?”
LAMB: “That interpretation is possible, and as I have already said, I can see 
the danger of that. [...] You will always talk about chances, chances are 
big or small. What the interpretation will be, is in other people’s hands. 
I am willing to discuss that of course, [...] but I think it concerns society 
as a whole. [...] What are we going to do with risk assessment tools?”
FACILITATOR: “But you say that there has to be a concrete result of that [kind 
of] research. [...] What are the typically possible increased risk factors, 
impulsivity, you name them. You say that there is a genetic factor, isn’t it?”
LAMB: “A genetic correlation has been established, yes.”
FACILITATOR: “How high are these risks then? What are the rates?”
LAMB: “[...] The problem is, we are not that far at the moment. [...] And  
the question is whether it is going to happen ever at all, because our  
genome is immense and immensely diverse.”
[ excerpt 5.4 ]
As John Lush did in the ADHD deliberation (previous section), Lamb is performing 
boundary work here as well, demarcating between science as knowledge producer 
and society as knowledge user. As a scientist, he is able to communicate the 
scientific facts about genomic risk factors but he is not in the position to address 
the issue of how the scientific knowledge is used. Society is to decide. Although 
he says he holds a personal view he is willing to discuss, close examination of 
the transcript demonstrates that Lamb never expressed it at all.16 I consider this 
boundary work as a form of confrontational strategic maneuvering (see Section 
4.2) that allows him to abstain from publicly taking a position on this controversial 
issue and to remove the burden of proof when challenged. However, as argued 
in the previous section, presuming a sharp distinction between fact and value is 
problematic, if not untenable.
 Furthermore, using Michael’s rhetorical parameters (Section 4.4.3), Lamb 
can be said to have constructed a distal or even implausible future. Practical 
neurobiological applications – valid risk assessment tools – are remote, perhaps 
even unfeasible (“whether it is going to happen ever at all”) because of the human 
genome’s complexity. The effect was that I stopped interrogating Lamb: what is 
the urgency or use of deliberating ethical issues publicly of technologies that are 
probably unfeasible? To mark the passage to the discussion round (act three) I 
returned to the science writer who in the confrontation stage had claimed that 
Lamb’s research “follows a disastrous path.” I discuss the strategic maneuvers in 
the discussion that ensued.
16 During the interview afterwards, I confronted Lamb with it, using the transcript to 
substantiate my observation. Lamb’s response was: “Well, you should have fished it [his 
position] out of me, then” (Interview 2).
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TUBB (science writer): [A]ll [neurobiological] research hitherto [shows] [...], 
just as Lamb holds, that the variance [...] is so small that you might as well 
look at sociological things or at social things or to ask about psychological 
things. Why would you, for Gsake, be interested in the biological factors if 
that [...] would account for 2 percent? [...] I think that you [as a researcher] 
have to take responsibility and that you just cannot investigate anything 
you want, I think that you have to consider well how this kind of research 
can be used or misused. If I predict…let us say, [...] you have certain genes 
that clearly make you aggressive, if you can predict that with eighty percent 
certainty, what kind of society will you create then, that all those people 
will be locked up in advance, before they have actually done anything?”
[ excerpt 5.5 ]
Tubb challenges the feasibility of neurobiological research in general, using the 
rhetorical trope of conciliatio. Conciliatio is a strategic maneuver in which an arguer 
“uses a proposition the opponent is explicitly committed to in order to support his 
or her own position (Van Eemeren 2010: 207).” Tubb explicitly uses Lamb’s assertion 
(“just as Lamb holds”) about the small contribution of neurobiological factors 
resulted from research until now to draw the conclusion that interest in this field of 
research is incomprehensible. Using the trope of rhetorical question, Tubb implies 
biological research on criminal behavior will never be useful.
 He also challenges the moral desirability of preventive applications of this 
scientific knowledge. The science writer constructs a negative (parameter of valency) 
and most certain (parameter of modality) future consequence of neurobiological 
knowledge production (see Michael 2000 and Section 4.4.3), again using a rhetorical 
question: it can and will be misused to hold people preventively into custody when a 
genetic profile indicates a high risk. Tubb had warranted this claim earlier by arguing 
that preventive confinement contradicts an important fundamental principle of 
criminal law: one can only be guilty of a crime one has committed.
 Here, Tubb constructs a logically inconsistent future (and hence, his argumentation 
derails) since his moral concern is based on rather optimistic estimates of future 
risk rates, whereas a minute earlier he had denied the feasibility of neurobiological 
research altogether. Still, it is important to analyze Tubb’s argument to understand 
Lamb’s response.
FACILITATOR: Does Mr. Tubb make a logical error and when so, what is it?
LAMB: Yes, that logical error is, first, that he assumes that we will screen 
people in advance and put them in prison before they have done anything, 
and that is absolutely not the direction we should take. We [researchers] 
look at is there a chance of recidivism and can we help, and is there a 
contribution of neurobiology possible [...]? The other thing is scientific, to 
make assumptions about variance in advance. How can he say something 
about variance before we have even conducted the research?”
[ excerpt 5.6 ]
Even though Lamb had repeatedly stressed not to overestimate the significance of 
scientific results or to overstate the expectations of neurobiological research, here he 
defends the feasibility of his research adducing the inherent uncertainty of scientific 
research itself as an argument. Making an appeal to the fundamental academic value 
of autonomy, Lamb had already concluded that his “research cannot be banned” 
(Discussion) arguing that “scientific research cannot be conducted because people 
know in advance that it will not produce any results” (ibid.). “History will decide 
whether we have made a contribution” (ibid.).
 Lamb performs a delicate balancing act at the LUX: using mitigation strategies to 
tone down high expectations that raise complicated ethical issues while at the same 
time using science’s unpredictability to foil arguments about the a priori uselessness 
of scientific research. However, his defense derails. Lamb violates the standpoint rule 
(Section 3.2.2) since the claim that is his research should be banned is wrongfully 
attributed to the science writer who had asserted that “scientists should take 
responsibility” (Excerpt 5.5).
 Moreover, Lamb subscribes to the undesirability of preventive custody by simply 
making a moral appeal (“we should not go in that direction”) and explaining what 
contrary direction researchers are in fact going. Taking this explanation for granted, 
I asked Tubb to explain the origin of his future scenario: “Mr. Lamb also said [that] it 
can be ruled out that we are going to use the research for that purpose [preventively, 
before someone has committed a crime]. Where did you get this idea?”
TUBB: [H]e [Lamb] himself refers to Adrian Raine [and his statements in the 
newspaper interview] and Raine said something similar in De Volkskrant [Dutch 
national newspaper] ten years ago, that now we are not [yet] able to do it, but if 
you pick six-year-olds then you are actually already too late, you will have to do 
it [screening for risks for criminal behavior] on two-year-olds. […] [W]hat I said 
[earlier during the deliberation], it is a false presumption, it is pretended that 
much is possible and I would not want to have a society in which children at the 
age of two are screened for possible delinquency. I fully disagree with that! [...]
FACILITATOR: And you say that scientists in the field suggest that?
TUBB: Who make these kind of statements, yes. […]
FACILITATOR: Short response, Mr. Lamb.
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LAMB: […] I agree with that, that I am equally concerned about this 
interpretation as well. I oppose to that just as much, but still think 
it would be a shame when, because of that, the value, or the 
potential value, […] of this kind of research will be undone.
[ excerpt 5.7 ]
My intervention reveals a change in perspective or footing (Section 4.3). Whereas 
earlier Tubb seemed the author of the future of preventive screening (Excerpt 
5.5), convinced as he perhaps was that such sociotechnical imaginaries were 
representative for the field of criminology, now it turns out he is the animator of 
Adrian Raine’s imaginaries. Now, Tubb is calling them into question (“it is pretended 
that much is possible”). It is reasonable to presume that Lamb has succeeded in 
persuading (or reassuring) Tubb of the implausibility of Adrian Raine’s expectations. 
Although no conclusion was drawn explicitly, a critical discussion between the child 
psychiatrist and the science writer is not useful because there is no difference of 
opinion anymore. Both men agree on the unfeasibility and the undesirability of 
preventive screening of people (particularly young children) at risk for criminal 
behavior (as Raine suggests).
 Behavioral sciences Dr. Martin Lobb subscribed to this conclusion. “Currently, it 
is sexier to provide a biological explanation for criminal behavior than a sociological 
one. […] That’s why these kinds of statements, that are completely wrongf, like Rain, 
those are picked up by journalists, because that is interesting and that is what people 
want to hear. Then, you can organize a debate” (Discussion). No one else challenged 
the opinion of these three men and other issues were discussed, such as storage and 
misuse of DNA in forensic biobanks.
From the reconstruction of the argumentative discourse of the second episode 
of The Preprogrammed Human, it can be concluded that there was indeed some 
controversy, but it was limited to issues of scientific and technological feasibility 
of expectations. However, there was hardly a critical discussion about the moral 
desirability of risk assessment tools for people at risk for criminal behavior despite 
the dramaturgical work behind the scenes (extending the cast, priming the invited 
public, investigating Lamb’s sociotechnical imaginaries). How can this be explained? 
Mainly, because of Lamb’s effective strategic maneuvering, I argue.
 Reflecting on the events at the LUX afterwards, Lamb said he had been 
aiming at increasing public understanding so that people would think “‘Now 
I understand what the value [of this research] is’ […] and ‘why we should not 
oppose it by definition’” (Interview2). This aim, anticipating public opposition, 
must be understood in the historical context of the Buikhuisen controversy. In 
the preparatory interview he had already alluded to the role of scientists such as 
himself to participate in public dialogue, to communicate the significance of their 
research findings without exaggeration. “Otherwise, other people with simplistic 
ideas will start the discussion. […] They will only harm our research discipline” 
(Interview 1). On stage at the LUX, Lamb indeed embodied the role as scientist. 
Firstly, Lamb simply did not take a position on the matter (just as in the preparatory 
interview). He argued that he is not in the position to address the issue. He was 
performing ethical boundary work, demarcating his responsibilities as a scientist: 
producing facts, in this case risk numbers.
 Secondly, Lamb succeeded in acting as a more credible scientific expert of 
technological feasibility than Raine and Tubb. What makes Lamb’s (modest) 
assessment of the future more plausible than Raine’s, who can be considered 
a respected expert as well? “[M]odesty (as an admission of contingency and 
uncertainty) has become a major rhetorical tool” (Michael 2000: 31). Using the 
rhetorical parameters of valency and distance (Section 4.4.3), Lamb toned down 
Raine’s high expectations, constructing them as morally problematic and therefore 
distal (“we are not that far”) if not implausible. “Great distance of a future bad 
facilitates a ‘relaxed’ set of responses” (Michael 2000: 24). This was the case in the 
second edition of The Preprogrammed Human. Why discuss the moral desirability 
of scientific developments in behavioral genomics or preventive neurobiological 
screening tools in particular that are technologically unfeasible? The urgency of the 
issue decreased, which explains that the criticisms fell silent after the first round.
 Thus, Lamb morally positioned himself as sound scientist indirectly by 
constructing Raine’s identity as a fellow researcher exaggerating the social meaning 
of his findings. Indeed, Lamb was perceived at the LUX as a sound scientist, indicating 
the shortcomings of neurobiological research. As a philosophy student observed 
during the discussion: “I think that his gentleman [Lamb] does fantastic work and I 
think it is unpleasant that he is critically treated, while this man considers research 
ethics of paramount importance. This man is far too intelligent to stigmatize people” 
(Discussion). The questionnaires, distributed afterwards, confirm this perception. 
Tubb himself declared afterwards, that he thinks Lamb is an “interesting and balanced 
man” (Questionnaires participants).
 At the same time, Lamb had to defend neurobiological research against Tubb’s 
claim that it is useless, because it is unproductive. Here, he argued that only 
“autonomy has resulted in scientific progress” (Discussion) and that furthermore, 
scientific endeavor is fundamentally uncertain. So, no one can a priori ban scientific 
research. However, there is a logical inconsistency in Lamb’s argumentation and 
hence, his argumentation derails (violating the validity rule; see 3.2.2). He switches 
modality: if the future is inherently uncertain, as Lamb argued, how can he be so sure 
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about the unfeasibility of Raine’s future scenario?
 Because Lamb was considered as a more authoritative expert on technological 
feasibility, the deliberation was suboptimal. The moral desirability of (Lamb’s own) 
sociotechnical imaginaries was not critically assessed because scientific developments 
were treated as unfeasible. But, as Lamb himself argued, the future is uncertain. Even 
though the experts at the LUX, who happened to be cast for this deliberation, agree 
on the unfeasibility, the literature demonstrates that others anticipate technological 
applications. Professionals in the legal system – probation officers, social workers and 
solicitors – suggested that “calculations of genetic susceptibility to aggressiveness 
could be integrated with other indicators used to identify risky individuals and to 
plan and manage interventions” (Pieri and Levitt 2008). Others expect a shift towards 
“more predictive and preventive criminology” (Schermer 2006) or “identification 
of, and preventive intervention upon, aggressive, risky or monstrous anti-citizens” 
(Rose 2000). Lamb himself had said in the preparatory interview that “it is already 
the case that in the United States neuro-imaging is admitted as evidence in lawsuits” 
(Interview 1).
 Expectations do something (Section 4.4.3): attract attention from the media, 
but also from policy makers and funders. Therefore, Raine’s sociotechnical 
imaginaries need critical reflection, I argue. Here, the critical questions of pragmatic 
argumentation can be applied again. Is risk assessment necessary? What are 
unintended consequences of preventive criminology? Stigmatization, increasing 
health care costs because of false-positives (Brom and Van Keulen 2009; Schermer 
2006)? Do these impacts outweigh the benefits? These issues remained unaddressed 
since Raine’s future scenario was considered as unfeasible. And what about 
Lamb’s own future expections? Due to Lamb’s (derailing) strategic maneuvers, his 
imaginaries were not discussed. But how (un)feasible are his own expectations? On 
what grounds did he claim that neurobiological research will contribute to a more 
accurate risk assessments in the preparatory interview? If Raine’s prediction rates 
are too optimistic, what are more realistic ones? Aren’t lower rates ethically even 
more problematic? These issues were not discussed.
5.4 Challenging the moral desirability of genetic tests for ASD
 using technological feasibility
FACILITATOR: “Mr Gibbs, when I was at your office a while ago, […] 
we thought: ‘Magnificent debate.’ And now it is slipping away […]. 
What is it we need to discuss in terms of what is technically feasible 
and what not? […] We were discussing genetic tests [for Autism 
Spectrum Disorders] weren’t we? Or did I misunderstand then?”
[ excerpt 5.8 ]
Indeed a few weeks earlier, William Gibbs, the life scientist participating in the third 
edition of the Preprogrammed Human, had elaborated his sociotechnical imaginaries 
in his office. Dr. Gibbs, directing the genetics research of the child and adolescent 
psychiatry department at a Dutch academic hospital, told me that genetic tests are 
feasible in the near future, enabling early diagnostics – at least for some variants of 
autism with a large genetic risk.17 Gibbs’ belief was based on new scientific findings of 
the Autism Genome Project (AGP) Consortium, in which his group was participating. 
The AGP had recently published in Nature Genetics in which new genetic biomarkers 
– so-called Copy Number Variants or CNVs – for autism were described (Szatmari 
et al. 2007).
 Based on Gibbs’ articulate imaginaries we expected a “magnificent debate.” 
In the Netherlands, genetic testing had been controversial in the 1980s (Van El et 
al. 2007). Particularly, prenatal genetic testing and screening had sparked a lot of 
public debate. Genetic testing for incurable behavioral disorders such as ASD would 
raise ethical issues, as was demonstrated during an online discussion organized by 
the Center for Society and the Life Sciences on a parenting web forum (Jeucken and 
Radstake 2008; Radstake et al. 2009).
 Gibbs, who had also participated in the online dialogue, anticipated controversy 
at the LUX about his claims, too. “In general, people have doubts about genetics 
research. I think because they do not know the ins and outs. That raises suspicion. 
So I think people will probably pay more attention to the risks of genetics research 
17 Gibbs indicated that, besides genetic testing for drugs metabolism and disorders 
associated with autism (fragile X syndrome, tuberous sclerosis), “what will come in the 
near future is an extension of diagnostics. So you will say we know that an amount of 
smaller abnormalities indicate an increased risk. You can produce a test kit out of that. 
[…] Then you say: ‘If you hand in your blood, then we can produce a percentage’. That 
is, what I think is coming, in the next two or three years” (Interview 1).
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and less to the potential benefits” (Interview 1). Therefore, Gibbs perceived his 
role as an expert responsible for informing the public about developments that are 
“inescapable” (ibid). Providing information will increase public acceptance for this 
new technology that people will eventually get used to.18
 Gibbs’ prediction proved to be correct. A reconstruction of the complete 
argumentation structure of the deliberation indicates that genetic testing of 
autism was contested from various ethical perspectives. However, a scientific 
controversy about the technological feasibility of genetic tests for ASD arose on 
stage and dominated the discussion. Particularly, the expert dispute on the technical 
specifications of genetic tests (esp. their predictive value) framed the discussion 
on moral desirability. The controversy was confusing (see Excerpt 5.8); it sidelined 
non-expert participants and it closed down the discussion, as I demonstrate. More 
importantly, my interventions as facilitator contributed considerably to this particular 
framing. Before I analyze the strategic maneuvers in this expert dispute in detail, 
however, I first elaborate on the modifications of the dramaturgical setting.
First, a new character in the play was introduced. A social scientist of the Centre for 
Society and the Life Sciences (CSG), involved in a project aimed at increasing the 
participation of psychiatric patients in the scientific research on their behavioral 
disorders, would enact the role of commentator. She would observe the deliberation 
from the sideline and could be asked to stimulate discussion when needed. For the 
rest, the scheme of the cast of the second edition of The Preprogrammed Human 
was copied. Besides geneticist Gibbs and representatives of the affected public 
(parents and professionals), two experts of ASD outside the field of (behavioral) 
18 “When people look suspiciously at a topic, it is mostly because they do not know the 
ins and outs. There are so many examples that demonstrate this. The train…the first 
train in the Netherlands, that story you must be familiar with. The cows are dying, 
perilous, that train drove 40 km/hr, aren’t you going to die? That sort of considerations 
are caused by a lack of knowledge and understanding. And now, everybody thinks it is 
normal because it is widely accepted, you just know how it works. Therefore, you have 
to inform people” (Interview 1). Here, we recognize a mixture of recurring arguments, 
described in the previous chapter (see Section 4.2.2). Gibbs associates a habituation 
argument (Swierstra and Rip 2007) with an information-deficit thinking: if I provide the 
proper information, people will get used to genetic tests.
genomics completed the cast, both well-known in their field.19 One expert was Roger 
Roote, professor in child psychiatry, chair of a Dutch association for psychiatry and 
director of the local centre of expertise that operates at the interface of care practice 
and scientific research. The other expert was Dr. Matilda Cutts, scientific researcher, 
therapist, instructor and author of many publications about ASD.
 Their presence affected the dramaturgical setting: the physical setting was 
reconsidered as a result of the huge public interest in attending the deliberative 
event. As questionnaires demonstrated, the presence of Roote and Cutts as national 
stars in the field of ASD had drawn a large audience. To provide seats for almost 
250 people, a stand was used which differed from our initial staging. Now, a stage 
separated active players (the panel) from the audience. Still, an active public 
involvement was intended. However, the setting affected the public recognition of 
the contribution from the audience.20 Moreover, a large majority of the audience was 
out of reach for the microphone.
 Third, the deliberative event was re-scripted, too. We had experienced in the 
previous episode that Roger Lamb’s representation of sociotechnical imaginaries on 
stage differed from those constructed offstage: in public he had mitigated the high 
expectations of fellow researchers. Therefore, the interview on stage was substituted 
for vignettes: short sketches that give a trenchant impression about the future vision 
of our participating life scientist. Designed as a qualitative research technique we 
used vignettes because its context “provides respondents with an opportunity 
to discuss issues arising from the story from a non-personal and therefore less-
threatening perspective” (Hughes 1998: 383). In vignettes, perceptions, beliefs, 
attitudes and opinions are separated from the people who have them. Gibbs would 
not be recognized as the author of the imaginaries. The first of two vignettes to be 
discussed, read:
“Mrs. Jansen recently gave birth to a bouncing boy. The midwife performed 
a heel prick on the eighth day of the young boy’s life. The blood of the 
19 We invited three parents of children diagnosed with ASD, a member of the board of 
directors of a large health care institution for ASD patients, a professional working in 
a child health care center (CHCC) specialized in early diagnostics of ASD and a project 
leader of the National Network Autism (LNA), an organization devoted to education 
and ASD. 
20 As some one wrote on the LUX blog afterwards: “All in all a disappointing debate.  
Too much attention for the audience, too little for the expert panel” 
(LUX forum, 17 December 2008, 11:26 am).
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new born collected with the heel prick was screened for autism. The 
test result shows that the son of Mrs. Jansen has indeed a susceptibility 
to autism. What is the consequence of this test result?” (briefing).21
This was a concise reproduction of Gibbs’ sociotechnical imaginaries. Besides the 
technological feasibility of genetic tests, we also used the preparatory interview 
to investigate his ideas about the societal usability – how tests for ASD would 
be integrated in current medical practice – and the moral desirability of such a 
practice (Lucivero et al. 2011). Gibbs endorsed our suggestion of integrating these 
genetic tests in the Dutch neonatal screening program.22 Thus, children and parents 
would optimally benefit from genetic tests. As the other two genetic researchers 
did, Gibbs substantiated his claims on the moral desirability of genetic testing 
using pragmatic argumentation (Section 3.4.1): developing tests and using them 
in the neonatal screening program will enable early diagnosis of autism (desirable 
effect X
1
), which will prevent frustrations among parents as well as harm for 
their children (desirable consequence X
2 
and X
3
), since at present autism is often 
21 The second vignette described the prenatal situation of clinical genetics practice for 
genetic counseling on carrier status and reproduction. The last situation was not a topic 
of the preparatory interview, but we estimated that prenatal use of genetic tests would 
spark debate, too. In this chapter, I only focus on the first vignette, since this case 
stimulated enough discussion for almost the entire evening (although the discussion 
about prenatal use lurked).
22 Gibbs did not seem determined about this idea of social usability. Our impression 
was that Gibbs did not have very articulate ideas about how to integrate genetic tests 
for autism in medical practice. We had to make some suggestions, one of which was 
integration of the tests into the heel prick screening.
 FACILITATOR: “[H]ow would the practice of testing look like, [the practice of] this  
 early diagnosis? Does it mean, that everyone at the child health care…”
 GIBBS: “That is a good question…that is a good question…”
 FACILITATOR: […] Next [we] will sequence one’s DNA for a thousand dollars  
 and then we know.”
 GIBBS: “Yeah. […] then it is like the heel prick…”
 FACILITATOR: “Would you want that? Because you say…”
 GIBBS: “Yes. Because I think that is beneficial. I think that…it will limit harm.”  
(Interview 1).
 From an ethical point of view, genetic testing in neonatal screening is not a very 
realistic option, since autism is a condition that cannot be prevented or cured. It makes 
more sense to use genetic testing in prenatal diagnostics or screening, which was the 
topic of our second vignette.
diagnosed at a relatively late age (social need).
 The vignettes would be discussed in act 2 and act 3. In the first of four acts, 
however, opinions would be polled about the main proposition of Gibbs’ moral 
argument: “The early as possible diagnosis of autism is necessary to prevent harm. 
Only genetic tests enable this early diagnosis” (Discussion). The analysis of the 
online dialogue on the parenting website proved this claim was controversial.23 The 
proposition would first be presented to the public and only later, the panel would 
be asked to respond, because invited participants had dominated the previous 
deliberation on delinquency. The organizers intended to increase public participation. 
In the final act, participants would reflect on how “these social issues affect the 
organization of genetics research on autism” (briefing).
Indeed, in the first act the propositional content, particularly its evaluative element, 
i.e. the desirability of an early diagnosis of ASD implicated in Gibbs’ argument, 
proved controversial among the public. A young man, diagnosed with ASD at eight 
years of age, for instance endorsed Gibbs’ reasoning: “My parents have trained my 
social skills since I was young. My guess is that if my parents had started earlier, this 
[training] would have been even better” (Discussion). However, a mother questioned 
the desirability of a very early diagnosis. She said an ASD diagnosis is “rather 
crude” (ibid.). Autism is a spectrum disorder, she argued. Even if your condition is 
manageable, you receive the label ASD. The sooner the diagnoses, the sooner people 
will experience its harms. The justificatory force of Gibbs’ pragmatic argumentation 
was challenged as well. A professional was concerned that more testing would lead 
23 Here are some contributions to the online dialogue indicating a difference of opinion 
about early diagnosis of autism:
 Monday 2 June 2008, 9:36 pm
 My little son has been diagnosed with autism at 2.5 years of age, so a lot earlier than 
most children I read about. And I am very happy with that. Exactly because you know 
it at such an early stage, you can also start treating him properly at an early stage. It 
prevents a whole lot of frustration within the family I think.
 Wednesday 4 June, 9:57 am
 The child with Autism [sic] constantly gets the message that he/she is doing WRONG.
 That does not have a positive effect on the self confidence.
 Diagnosing, especially early, does not work in favor of the child with Autism  
(and I am mostly talking about children with Asperger).
 Sunday 8 June 12:03 pm
 For me, it must be established that early care actually helps.
 Why would you diagnose early when it remains absolutely unclear what you need  
to do next and what it exactly adds.
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to an undesirable side-effect: “even more over-diagnosis” (ibid).
 Moreover, this health care professional was the first one to raise the issue of 
(technological) feasibility of genetic tests for autism. Particularly, he questioned 
their predictive value. It was I who selected the feasibility issue for discussion in 
the panel soon after the professional’s response. After asking the parents as the 
potential end users of neonatal genetic testing whether they had preferred an early 
as possible diagnose, I investigated the differences of opinion about the feasibility 
issue within the panel: “Who of the people who sit here [in the panel] has doubts 
about such a genetic test: ‘Well, it does not mean quite so much’?” (Discussion). 
Roote immediately seized the opportunity to enact his role as scientific expert.
ROOTE: The tricky thing with genetics is, I think, that no single genetic marker 
can be [uniquely] identified in all people with autism. It means that you will 
probably find all kinds of susceptibilities. But if you and I subject ourselves to 
a genetic test, we can be utterly miserable because you and I have all kinds 
of flaws in our DNA we do not have the slightest idea of. [...] The ethical 
question is: Do you want to know? [...] Children of people with Huntington’s 
disease can do a genetic test to find out if they have it [the mutation] or not. 
Generally, they do not want to know. Because, what is the use of knowing 
that? You know that one of your parents has suffered from a terrible dementia, 
you have a chance of one out of two that you will develop it, too. Do you 
have to think at fifteen: Oh my God, I have only fifteen years left?” […]
FACILITATOR: Do you believe that this will eventually be possible?”
ROOTE: Well, I don’t think I will witness it, but look, it is of course a kind of 
brave new world, that at a certain time all genetic risks can be determined. 
[But] it is not like blue and brown eyes. I mean, that is not how the 
heredity of autism works. You do not know what will happen in life.”
[ excerpt 5.9 ]
Using the parameters of valency and distance (see Section 4.4.3), Roote constructs 
a distant future for genetic tests for autism (“I don’t think I will witness it”) that 
he evaluates as bad. He draws on the familiar dystopian cultural symbol of Aldous 
Huxley’s A Brave New World as a rhetorical device to show that he is not supportive 
of the new developments in genetics research. Indeed, he claims that genetic tests 
are unethical, using an argument from consequence challenging the justificatory 
force of Gibbs’ pragmatic argumentation: information about genetic risks will cause 
unnecessary worry (an undesirable consequence) for conditions and diseases 
that perhaps will not ever develop. “You do not want to know” is the answer to 
his rhetorical question, indicating that the possible benefits of an early diagnose 
can never outweigh the negative side-effect of worrying. Roote substantiates 
his claim using an argument by analogy, for the case of Huntington’s disease had 
demonstrated that people do not need or want genetic testing. Roote’s comparison 
falls short and hence his argument by analogy is derailing because Huntington’s 
disease is a hereditary disease that is almost fully penetrant whereas Roote’s claim 
was that people can only have a genetic risk for ASD.24 Nevertheless, the professor 
is taking the technological specifications of genetic tests (low predictive value) as a 
premise in his argumentation that genetic tests for ASD are morally undesirable. It 
demonstrates how the issue of moral desirability is inextricably related to the issue 
of technological feasibility.
 Taking the scientific authority of Roote seriously, I attempted to elucidate the 
feasibility issue:
FACILITATOR: “Mr Gibbs, [...]What is it we need to discuss in terms 
of what is technically feasible and what not? […] We were 
discussing genetic tests [for Autism Spectrum Disorders] weren’t 
we? Or did I misunderstand then?” [see Excerpt 5.8]
GIBBS: “About these genetic tests, I am convinced [...] that there are a few genetic 
variants that are strongly predictive for an ASD diagnose and these are not only 
the [...] gentle but functional forms of autism, but these are the people…whose 
children will probably be severely disabled early on, who will be institutionalized 
for the largest part, and from a young age, you must have the courage to think 
about that. I will be honest about it, [...] I have not made up my mind about the 
ethical issue, that is a very complex matter, certainly in the prenatal case, but 
those [tests] are simply on their way. 
[T]en years ago [...] we thought there in terms of risk genes. And we actually 
overlooked the small chromosomal variants that give a high risk. Well, that 
has only been acknowledged since 2007. That has been replicated three 
times now, in Nature Genetics, Science. Anyway, I realize that [information] 
is so new, that the discussion here, that people here in fact, still use the 
old model of polygenetic abnormalities. But that just is not the case.”
[ excerpt 5.10 ]
24 Gibbs criticized this analogy with Huntington’s disease. Contrary to the inescapable, 
incurable and lethal symptoms of this monogenetic disease, Gibbs believes, 
interventions in the daily environment could alleviate the symptoms of autism.
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Here, Gibbs uses two different strategies to decide the issue about technological 
feasibility in his favor. He employs technological determinism as a rhetorical device 
(Section 4.2.2) to stress that “a few genetic variants are strongly predictive”: “Those 
tests are simply on their way.” This sounds like a prophecy: the deliberation at 
the LUX will not stop these highly predictive tests from being developed, so their 
consequences have to be dealt with. So, society has to dare to think about these 
consequences, Gibbs argues.
 Furthermore, Gibbs is performing boundary work. Without publicly offending his 
scientific colleague (using the impersonal “people here”), he demarcates those who 
use “the old model of polygenetic abnormalities” (Roote and others) and geneticists 
(like Gibbs himself) who perfectly keep up the leading scientific literature (Nature 
Genetics, Science) on the subject. Thus, he is attempting to establish exclusive 
expertise. Yet, these argumentative moves did not help Gibbs to position himself as 
the only credible expert, as I argue below.
 Realizing that this scientific controversy on stage was hard to conclude, I proposed 
to pass over the dispute and to invite Gibbs, the professor and the other participants, 
who were sidelined in this technical issue, to imagine a world in which Gibbs’ scientific 
claims are facts to discuss its moral desirability. “Wait a second. I really want the case 
[described in the vignette] to be discussed. […] Let us assume that we live in a world 
in which uncommon and serious kinds of autism are screened” (Discussion). Still, the 
controversy persisted. It shifted somewhat. According to Roote, having a high risk for 
some variants of ASD does not necessarily mean that you will develop the disorder. 
Furthermore, he indicated high uncertainties regarding the gravity and manifestation 
of symptoms.
ROOTE: “[...] I think [Gibbs] will agree, that it is very well possible that you can 
become a gifted engineer at Philips with the same genes [...] [or] you can be 
a severely mentally disabled person with a grave form of autism. [...] In my 
opinion, at this moment it is not possible to see that in your gene combination.”
GIBBS: “It is also possible that you pick out the group you know they will not 
become a gifted engineer, they become chronically severely handicapped.”
[ excerpt 5.11 ]
As argued in Chapter 3, it is hard to determine the effect of strategic maneuvers in 
public deliberations. However, some observations indicate that  Roote was regarded 
as the more persuasive expert on stage at the LUX. An opinion poll by hand raising 
during the discussion for instance indicated that a large majority of the people at 
the LUX believed that neonatal genetic testing for autism is undesirable (Video-
recordings).
 Moreover, the argumentative context of the discussion shows that the perceived 
low-predictive value was an important reason. As a health-care professional phrased 
it: “As I understand [Roote], even if you talk about severe variants of ASD, it does 
not mean it will develop. […] What information is it you provide for parents, then? A 
severe variant, but you know nothing. That seems terrible to me” (Discussion).
 The questionnaires distributed afterwards confirm this observation. Almost 
half of the respondents’ perceptions on technological feasibility contrast sharply 
with Gibbs’ expectations. “If there is any discovery at all, it is too complex to do 
something with it” (Questionnaires), a health care professional replied. For some 
participants, the controversy on stage had particularly a confusing effect. A 29 year 
old psychologist wrote: “To me it is not clear what we know and what we do not 
know about the genetics of autism” (ibid.).  Or the discussion affected their sense of 
urgency. A young psychiatrist stated that scientific research is still in its early stages 
and therefore that “there hardly needs to be discussion about it” (ibid.).
 Gibbs himself who had stated before that he had “not made up his mind about 
the ethical issue (Discussion 0h43m; see Excerpt 5.10)” yet, later seemed to have 
made a decision about this “dilemma” all of a sudden: “I do not think that I am a 
proponent for [genetic testing] in the neonatal screening” (Discussion 1h08m). Of 
course, it is unlikely that the low predictive value was convincing for him, so there 
must have been other reasons.
 A consensus about the undesirability of integrating genetic testing in the 
neonatal screening program became apparent. I decided to conclude the discussion 
with vignette #1: “Then I can just ask who does not [agree], but that is a bit hard 
I think” (Discussion(Discussion). This conclusion was premature, however. First 
of all, two parents in the panel still were in favor of this scenario, as our analysis 
of the argumentative text indicates. Furthermore, as he reported in the interview 
afterwards, Gibbs was unhappy about this apparent consensus that was “produced” 
(Interview 2). At the LUX, the predictive value of chromosomal abnormalities (CNVs) 
and “general risk factors” were wrongfully “mixed up” (ibid.).
It can be concluded that the controversy about the technological feasibility or 
specifications directed the discussion on the moral desirability of genetic tests for 
ASD. If the predictive value of these tests is indeed low, as Roote asserted contrary 
to Gibbs’ expectations, then the conclusion that these tests are undesirable is 
understandable. As normative screening criteria stipulate, the moral desirability of 
screening technologies depends on their validity (Gezondheidsraad 2008: 58).
 What made Roote the more credible expert at the LUX despite Gibbs’ strategic 
maneuvers to claim expertise (technological determinism and his subtle boundary 
work)? Roote is an authoritative and well-known expert in the field of ASD, an 
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influential administrator in several professional bodies. As the director of the local 
centre of expertise on ASD, Roote was the star in a home match, addressing people 
by name (“But Kees Kamp in the room here knows that we sometimes diagnose 
people of my age with autism” (Discussion(Discussion). The very reason many people 
had come to LUX was because Roote was one of the speakers. The cast therefore has 
affected “what can be said with influence” (Hajer 2005: 624).
 Furthermore, the professor was probably more successful in adjusting to 
the audience’s frame of reference of ASD (audience demand; see Section 4.2.2): 
“Children who are at high risk of developing ASD, still do have a reasonable chance 
of becoming a “gifted engineer at Philips” (see Excerpt 5.11).25 When Roote had 
declared his sympathy with young people with an ASD diagnosis, he earned much 
applause: “Our society is not worth a straw when we say: ‘We only want perfect 
people who do not need extra support’” (Discussion). Gibbs criticized the professor’s 
framing of autistic patients as people who still have a reasonable chance to succeed 
in the interview afterwards. “[T]here is brutal genetics, too. If you have this [gene] 
defect, you just have bad luck. In that situation, you have an IQ of 50 or less. […] 
These are all children who are just chronically hospitalized. […] I think that if you as a 
parent have a severely mentally handicapped and withdrawn child, you would have 
entered that discussion of ‘Is this what I really wanted?’” (Interview2)
 Therefore, Gibbs preferred “a continuation of the discussion,” because “[t]he 
question should actually be, if I have a [genetic] test now which produces a very 
reliable result, which let me say differentiates with a 99 percent certainty between 
having an autism spectrum disorder or not, what would you do then?” (ibid.)
 Indeed, this question was not critically discussed at the LUX. Because most people 
relied on Roote’s expertise, the critical discussion of Gibbs’ pragmatic argumentation 
stopped after Roote successfully challenged the feasibility of genetic tests. Most 
people believed Gibbs could not answer the feasibility question satisfactorily. So, 
challenging the feasibility of new technologies is an effective strategic maneuver 
because moral desirability cannot be separated from technological feasibility. 
However, there is no reason to think that Gibbs’ expectations are implausible, even 
though he failed to provide sufficient warrant for his claim (as the burden of proof 
25 In the preparatory interview, Gibbs had already alluded to what he perceived as a 
widespread misconception of autism. “There has of course been this film Rain Man, 
that is what autism is for the average Dutch citizen. […] That does not reflect reality” 
(Interview1).
rule prescribes). It is not unimaginable that Roote’s claim will turn out to be wrong.26
 Now, the investigation of Gibb’s pragmatic argumentation was not confronted to 
a maximum of doubt. First, the propositional content implicated in Gibbs’ argument 
(the desirability of an early diagnosis of ASD) was not properly discussed, whereas 
the analysis of the complete argumentative text indicates that people disagreed over 
this content. Whereas two fathers supported the benefits of early diagnostics, a 
mother had doubts about the quality of bonding between parent and autistic child: 
“When your child is labeled as autistic so soon after birth, I wonder if parents can 
look at their child in an unprejudiced manner. You will always be interpreting its 
behavior in terms of autism” (Discussion). The other expert, Matilda Cutts, opposed 
the framing of autism as a “disorder,” caused by “static genetic defects” (Discussion). 
She criticized the need to diagnose autism as a “medical condition” (ibid).
 In addition, other critical questions to determine the justificatory force of Gibbs’ 
argumentation – necessary-means question, best-means question and side effect 
questions (see Section 3.4.1) – were not critically discussed. These issues were only 
touched upon, partly due to my interventions as a facilitator.27
26 Since Dr. Roote and Gibbs are entangled in a mixed difference of opinion, Roote also 
has an obligation to defend his claim (see Section 3.2.2). According to Gibbs, Dr. Roote 
has “a bit of a knowledge problem” (Interview 2).
27 The issue of feasibility of tests as being “non-permissible” (see Ihnen-Jory 2011: 152) 
was also raised: integrating autism as a medical condition to be detected in the 
neonatal screening program would not meet the normative screening criterion of 
benefit. As the Dutch Health Council writes this criterion for (genetic) screening reads: 
“It must be clearly established that early detection of the illness(es) or condition(s) [...] 
in question can lead to a significant reduction in the burden of disease in the target 
group in question” (Gezondheidsraad 2008: 58).
 Both experts had doubts about the necessity of genetic tests and asserted that the 
available and widely used questionnaires (such as the Early Screening of Autistic Traits, 
or ESAT) are better alternatives because genetic tests only establish a genetic cause but 
provide no clues for treatment.
 Other participants indicated some negative side-effects of genetic testing: an early 
genetic diagnose would raise false hope about the treatability of autism; genetic 
testing would increase the risk of over-diagnosis.
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5.5 Conclusions
In this chapter, I have investigated a) strategic maneuvering and b) dramaturgical 
effects in three public deliberations on the ethical and social implications of 
behavioral genomics, using argumentative texts and additional empirical sources 
(different contexts and addition ethnographic data).28 Firstly, I elaborate on how 
participants have strategically maneuvered and the effect thereof on the quality of 
the deliberation. In this conclusion section I discuss how the quality of these upstream 
public dialogues could be improved. Secondly, I discuss how the dramaturgical 
setting affected “what could be said, what could not be said and what could be said 
with influence” (Hajer 2005).
 As the analysis of argumentative discourse demonstrates, futures were contested 
at the LUX. Participants of these public deliberations were involved in a “struggle to 
represent the imagined consequences of technoscientific innovation and to render 
dominant their particular view of the future” (Bloomfield and Doolin 2010: 59). Life 
scientists mainly select pragmatic argumentation as a topos of consequentialist 
reasoning (see Section 3.4.1 and 4.2.2 on topical selection) to be effective in this 
struggle about the moral desirability of behavioral genomics research. Pragmatic 
argumentation reflects a public reason because it is used to indicate the beneficial 
social consequences of their scientific activities: personalized treatment, better risk 
assessments or early diagnosis of ASD. However, these argumentations were not 
confronted with a maximum of doubt. Neither the propositional content or the 
justificatory force were systematically examined. This means that mostly the public 
28 Even though the concept of strategic maneuvering emerged to be a powerful 
analytical concept to reconstruct, analyze and evaluate argumentative discourse, 
this case study also shows that additional (ethnographic) data are essential for a 
maximally argumentative interpretation (see Section 3.5). Firstly, including texts 
which are (explicitly) referred to in the discourse – the inter-textual context – enrich 
interpretation and analysis. In the delinquency deliberation for instance, Adrian Raine 
turned out to be an “inter-textual discussion partner.” Secondly, ethnographic data 
on stage as well as back stage from video-recordings, interviews and questionnaires 
complement the analysis. These data provide a) context of how to interpret statements 
(John Lush’ boundary between insiders and outsiders); b) knowledge about what 
participants were aiming for; how participating life scientists managed their impression 
(Lamb’s toning down of expectations; see Chapter 1); how to determine the effect of 
particular strategic maneuvers (Dr. Roote’s claim on technological feasibility) or how 
participants experienced the outcome of the deliberation (Gibbs’ discontent with the 
produced consensus).
deliberations at the LUX were not critical discussions. Critical questions belonging 
to pragmatic argumentation were only partly discussed at best, mostly (but not 
exclusively) due to (sometimes derailing) strategic maneuvering of participating life 
scientists identified in Chapter 4. Some of these strategic maneuvers closed down 
discussions on the moral (un)desirability of behavioral genomics research.
 First, boundary work was performed. The demarcation between insiders (scientists 
contributing to behavioral genomics research) and outsiders (the public) allowed 
John Lush to depict the future unintended consequences health care professionals 
articulated as “invented” and hence, unrealistic. Similarly, the boundary between 
the production of factual scientific knowledge and its socially determined use proved 
an effective strategic maneuver in the confrontation stage to abstain from taking a 
position in ethical issues.
 Secondly, participating scientists carefully constructed their public identities 
(subject positioning) in different contexts as insider or fellow citizen (ADHD), modest 
and sound scientist (delinquency), scientific expert involved in the state-of-art 
research on genetic markers on autism (Gibbs) or as the socially committed child 
psychiatrist who is advocating the social support of young people with ASD (Roote).
 Thirdly, representations of the future determined the course of the deliberations. 
Futures were constructed as distal, bad, desirable, uncertain, or impossible. However, 
appeals to scientific authority about the technological feasibility proved to be an 
effective strategic maneuver. Because the feasibility question is the first in the logical 
order of critical questions, questioning technological feasibility successfully means 
that other critical questions (necessary-means, best-means and side-effect questions) 
do not have to be discussed. John Lush’s future visions were not critically questioned. 
Adrian Raine’s sociotechnical imaginaries about predictive criminology for instance 
are “not as far as written in newspapers” so that difficult ethical questions remained 
unaddressed. Similarly, claims were made about the low predictive value of future 
genetic tests for autism so that other issues were not discussed. But assessing the 
truth of expectations is impossible, since “whether or not they [expectations] are true 
can only be assessed in hindsight – if ever (Lucivero et al 2011: 132).” In such cases, 
appeals to authority derail (argumentum ad verecundiam) violating the argument 
scheme rule. Instead of performing a “reality check” (Nordmann and Rip 2009), it is 
only possible to publicly check the plausibility of expectations.
 However, one must not overstate the seriousness of the violations of the 
discussion rules. As the empirical material presented in this chapter demonstrates 
(e.g. comparing testing for Huntington’s disease with testing for autism), such 
a violation is easily made, mostly unwittingly for sure or as a result of “indolence 
or sloppiness”(Van Eemeren 2010: 197). The aim of this chapter is not to point an 
accusing finger at life scientists (or other participants) as soon as the quality of their 
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argumentation is questionable. Claims about quality are in fact debatable themselves. 
Nor do I want to suggest that argumentative moves were meant to obstruct a 
reasonable discussion intentionally. So what I do not claim is that every participating 
scientist committed an argumentum ad verecundiam. As I have indicated in this 
chapter, expertise about the future was mainly attributed to scientists as their visions 
remained unchallenged. My point rather is that, particularly when these visions are 
contested, a critical investigation increases the dialectical quality of the discussion.
 One strategy of checking the plausibility of expectations can be derived from 
the pragma-dialectical evaluation of argumentations from expert opinion using a set 
of critical questions experts must answer satisfactorily (Wagemans 2011). Perhaps 
the “field question” (Is the expert an expert in the field of expertise, in this case 
genetics?) and the “expertise question” (How credible is the expert as a source?) 
are not very useful. As social studies of sciences have demonstrated, the boundaries 
of fields of expertise are socially constructed (Gieryn 1995, 1999) and credibility is 
gained in social interaction as the public dialogues at the LUX demonstrated. The 
“back-up evidence question” and the “consistency question,” however can be used 
to interrogate expertise both off-stage and on-stage: Is the expert able to provide 
evidence for his claim? Is the expert’s claim consistent with other experts assertions? 
And perhaps a “certainty question” can be added (cf. Webler 1995): what is the 
amount of uncertainty attached to this claim?29 These critical questions can work as 
a tool for facilitators to increase reflectivity about the difficulty of rendering a certain 
future implausible and to create discursive space to explore possible futures.
 A second strategy to broaden public deliberation is to conduct a vision 
assessment (cf. Grin and Grunwald 2000). Lucivero et al. (2011) suggest some 
tools to critically assess expectations. With respect to technological feasibility, the 
consultation of a number of different experts, an analysis of the context in which 
claims are made and a lab study are helpful. An analysis of fictive scripts casts light 
on how technologies are envisioned to function in social practices (social usability). 
And finally “[b]y making explicit which values and moral justifications are embedded 
in expectations” (Lucivero et al. 2011: 140) and using NEST-ethics, differences of 
opinion about the moral desirability can be anticipated. As argued in Chapter 3, 
NEST-ethics and the set of critical questions (stock topics) both provide a heuristic to 
anticipate moral argumentation (not only consequentialist, but also deontological, 
29 Among Webler’s “rules for redeeming truth validity claims”, rule E3 reads: “The model 
should make certain that the uncertainty of factual information is considered along 
with content (Webler 1995: 82).”
good life ethics etc.). In the next chapter I describe how these two strategies were 
used as dramaturgical work behind the scenes. I present a critical vision assessment 
of omics profiling for common diseases (Chapter 6), particularly an assessment of 
the moral argumentation. The critical questions constitute a heuristic to find relevant 
information and expertise for a well-informed discussion.
The second question I have addressed in this chapter read: How does the dramaturgy 
of these upstream public dialogues, influence the performance of participants? The 
reconstruction provides some clues that scripting, staging and setting affected the 
deliberations at the LUX. Firstly, the script – the selection of “characters in the play” 
and “cues for appropriate behavior” (Hajer 2005: 631) – affected the performances 
of participants. The public in the ADHD deliberation who were staged as active 
participants did not automatically adopt the role of critical citizen. The script of 
the ADHD deliberation for instance allowed a majority of the public to re-stage the 
interaction and turn the public investigation of sociotechnical imaginaries into a 
“refresher course.” Most other people were hesitant to participate in a discussion in 
the public sphere not least because of a bias that lurked in the script. In an attempt 
to involve the public in the setting of the agenda of issues, the burden of proof was 
allocated to the public who were asked to provide reasons for the undesirability 
of behavioral genomics research. In the ASD deliberation on the other hand, the 
presence of two national scientific celebrities induced a change in physical setting 
which prevented a large part of the public from participating. Furthermore, Dr. Roote 
was “the star” whose authority and fame influenced the course of the discussion.
 Secondly, the staging – “the deliberate organization of an interaction” (ibid.) – in 
the delinquency deliberation failed. Because of Roger Lamb’s modest representations 
of the future, hardly any interaction between him as protagonist and the two 
critics as antagonists occurred. The public setting presumably has affected Lamb’s 
public presentation of expectations. The interview scripted as the very beginning 
of the interaction, proved to be a problematic staging technique to elicit advocacy, 
particularly within the historical context of the Buikhuisen affair. This means the 
considerable influence organizers and facilitators of upstream public deliberation 
have on the performance of participants as they define the “cues for appropriate 
behavior” (Hajer 2005: 631).
 However, for a more profound analysis of the dramaturgical effects the empirical 
data of this case study, particularly the questionnaires, provided insufficient 
information for investigating specifically how participants experienced the 
dramaturgical interventions. In Chapter 6, I provide in more detailed description of a 
more empirically informed analysis of the effect on the dramaturgical considerations 
of a public dialogue event on omics profiling for common diseases.
6
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6.1 Introduction
“Revolution in personalized medicine: First-ever integrative ‘omics’ profile lets 
scientist discover, track his diabetes onset.”1 Thus read the headline of a press release 
from Stanford University on March 15, 2012. The report announces a publication 
in scientific magazine Cell (Chen et al. 2012). In that article, the Stanford Genetics 
researchers present the so-called “integrative Personalized Omics Profile,” or iPOP. 
The iPOP is a genetic risk profile derived from the personal genome, supplemented 
with recurring measurements of RNA, metabolites and proteins from the blood of a 
healthy test subject: the head of the Stanford Genetics Department himself, Michael 
Snyder. Snyder having his DNA completely sequenced multiple times and letting it 
be searched for genetic susceptibility for various diseases and disorders without a 
medical cause was not new (cf. Ashley et al. 2010).2 What was new was that he had 
his blood tested twenty times over a 14-month period for the presence of all sorts 
of other biomolecules. In the article, the researchers claim that an iPOP, if measured 
over a longer period of time for one test subject (n=1, longitudinal research) can give 
relevant information about the state of health of an individual.
 The test subject proved, for example, to have a genetic predisposition for 
cardiovascular diseases and type 2 diabetes. A risk of cardiovascular diseases was 
to be expected on the basis of his family’s medical history, but a predisposition to 
diabetes was not. Other risk factors (obesity, too little exercise etc.) were not present 
either. During the longitudinal tests, the researchers measured the blood glucose 
levels in the healthy state, but also when the test subject was ill. His glucose levels 
rose significantly after he contracted a viral infection. However, these levels remained 
1 http://med.stanford.edu/ism/2012/march/snyder.html, accessed November 25, 2013
2 To get an insight into margins of errors, three sequencing machines that are by now 
commonly used in genome sequencing were employed.
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much higher than is normal after the subject’s body had successfully eliminated  the 
virus. This leads the researchers to conclude that they witnessed the onset of type 2 
diabetes in real-time. The glucose levels only decreased as a result of an intervention: 
the test subject adapted his diet and started exercising more.
 As such, the creation of iPOPs would enable finding diseases like diabetes at such 
an early stage (predict) that symptoms of the disease could be reversed long before 
complications occur (prevent). “The researchers say that Snyder’s diabetes is but 
one of myriad problems the iPOP can identify and predict, and that such dynamic 
monitoring will soon become commonplace” (Conger March 15 2012).
 It is hard not to be enthusiastic after reading the press release. The public is, after 
all, made witness to nothing less than a scientific breakthrough, a historic moment, 
“an important milestone in the realization of the promise of truly personalized 
medicine” (ibid.). The reader sees, furthermore, that money invested in medical 
research was usefully spent: on prevention of an extensive health problem “that 
affects millions of Americans.” The press release contains countless maneuvers to 
persuade the reader of the prospect of personalized medicine or P4 medicine (for a 
more extensive explanation of this concept, see Section 6.2).
 This incident and the study as they were described in the press release formed 
the immediate cause for an upstream public deliberation event in at the LUX that was 
titled An iPOP for everyone? Is preventing diabetes better than curing it? In a publicly 
accessible setting, a panel of members of the public, life scientists and experts on 
public health and diabetes were to deliberate on the desirability issues concerning 
the expected future application of systems biological technologies (such as iPOPs) in 
the (preventive) care for diabetes.3
 This deliberative event formed the case study that I describe as a diptych in 
this chapter and the next. In Chapter 7 I analyze the strategic maneuvers of the 
participants on stage during the public deliberation, whether or not as a response to 
my interventions as the facilitator. This chapter, on the other hand, is also a detailed 
description of the preparatory work for the public deliberation that was done behind 
the scenes, in terms of Hajer’s dramaturgy of public deliberation (see Chapter 2). 
How did the framing of the issue, the scripting, staging and setting come about? I 
will describe these dramaturgic interventions that I deemed necessary for a staged 
3 In chapters 6 and 7 and will simply speak of ‘diabetes’ rather than ‘type 2 diabetes’ 
from this moment onwards. The distinction, however, is crucial, given the differences in 
genetics between type 2 diabetes, type 1 diabetes and, for example, MODY (Maturity-
Onset Diabetes of the Young). Type 2 diabetes is by far the most common, but it is far 
less heavily genetically predetermined than type 1 and MODY are.
performance of a panel of laypersons, life scientists and experts. In each case I 
refer to how these dramaturgical interventions relate to the events that occurred 
in the series of public engagement sessions on behavioral genetics as discussed in 
Chapter 5.
 I will also describe, wherever possible, the effects of the dramaturgical work 
on the participants, drawing on a) the observations of two observers during the 
dialogue event, b) my own observations during the preparation and performance 
of the deliberation, and c) the responses of both panelists and people from the 
audience to questionnaires distributed after the event at the LUX.
Section 6.2 is a short introduction into the concept of P4 medicine and health. 
Section 6.3 contains the reconstruction of the dramaturgical process of the upstream 
public deliberation event on P4 medicine and diabetes. First, I describe the work of 
framing the public issue (Section 6.3.1). Second, I discuss the selection of relevant 
participants and the contingent process of forum formation (Section 6.3.2). In the 
next section, I particularly focus on the investigation of expectations (Section 6.3.3) 
as was reported to all participants prior to the public deliberation. Since expectations 
are part and parcel of the discourse in NEST-ethical discussions, exploring the socio-
technical imaginaries of P4 medicine and health was considered to be a prerequisite 
for discussants to perform as deliberating citizens. Finally, I discuss issues of scripting, 
staging and setting of the public deliberation event (Section 6.3.4). In Section 6.4 
I conclude that a) the dramaturgical work mainly consists of making trade-offs 
between deliberative and participative quality criteria and b) that public deliberation 
events are experimental in nature with unforeseen effects.
6.2 What is P4 medicine and health?
The authors of the article in Cell see in the iPOP, and in the “high-throughput 
technologies and computational frameworks [that] enable the examination of 
biological systems in unprecedented detail,” a new and important instrument that 
contributes to “significant advances in personalized and precision medicine” (Chen 
and Snyder 2012: 73). In this section I want to consider the definition of the concept 
of personalized medicine since this term has various meanings. I am using the term 
as it was defined in the 2012 report by the European Science Foundation (ESF) 
that was published as Personalized Medicine for the European Citizen (ESF 2012), 
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even if its authors admit that there is no general consensus about its definition.4 
Personalized medicine “can be broadly described as a customization of healthcare 
that accommodates individual differences as far as possible at all stages in the 
process, from prevention, through diagnosis and treatment, to post-treatment 
follow-up” (ESF 2012: 13). Defined as such, personalized medicine is broader than 
terms like genomic medicine or precision medicine (also used by Chen and Snyder), 
which both do contain a significant portion, but fail to really articulate the broader 
vision. Genomic medicine, for example, wrongfully suggests that information about 
the genome alone is sufficient for the customization of healthcare. Moreover, 
genomic medicine could be wrongfully associated with the image of personalized 
medicine, now that the notion that genomics has failed to deliver on its promises is 
spreading (ESF 2012: 14; in Section 6.3.1 I offer a more expansive discussion of the 
technological feasibility of applications of whole genome sequencing in health care).
 According to the ESF report, “the future of medicine might best be considered 
[...] as proactive P4 medicine” (ibid: 14).5  The concept of P4 medicine is attributed to 
Leroy Hood (see e.g. Hood et al. 2012; Hood and Flores 2012), an American biologist 
who tries to apply insights from systems biology to medicine. Systems biology is the 
coordinating (holistic) view on the biology of humans and their health. It integrates 
the knowledge of multiple different “omics” disciplines within the life sciences 
that each have a specific level in biology as their object of study: the complete 
individual DNA and the genes of humans (genomics), RNA-molecules that come 
into being as a result of the process of transcription (transcriptomics), produced 
proteins (proteomics) or products of the metabolism and metabolites like glucose 
(metabolomics). The presence of, the quantity (or concentration) of, or a change in 
the chemical composition of all these molecular biomarkers may be timely indicators 
of an aberrant process that denotes the development of a disease.
 The term P4 medicine refers to four Ps: Predictive, Preventive, Personalized 
and Participatory. This form of health management is about a) the identification 
of actionable genetic variants (with the aid of whole genome sequencing) and the 
divergent or changing values of measured biomolecules (in comparison to previous 
measurements conducted on the same individual) that, respectively, predict a risk of, 
or indicate the early onset of certain diseases (predictive); b) the early detection of 
pathological processes so that they can be reversed or even prevented before severe 
4 For reasons of consistency of the American spelling used in this dissertation, I have 
adapted the title of the ESF report.
5 It is unclear to me why they themselves hold on to the term personalized medicine. 
complications arise, as with diabetes, with the aid of measures such as medication 
and lifestyle interventions (preventive); c) the customization of prevention, diagnosis 
and treatment to the specific biology of the individual (personalized) and d) the active 
contribution of proactive patients and health care consumers to their own health 
management and to scientific research by making their data available (participatory).
 In Section 6.3.3 I will further explicate the promises that surround P4 medicine 
and health. In the next paragraph, I will describe how the iPOP as future technology 
was made the subject of a public dialogue.
6.3 The dramaturgical work behind the scenes at the LUX
6.3.1 Identification of an issue: why P4 medicine here and now?
A public deliberation is useful only when a) an actual difference of opinions exists, b) 
when the right people engage in debating each another, and c) when the plausibility 
of expectations concerning the feasibility of the new technology is recognized. Before 
P4 medicine was chosen as a suitable issue, I conducted an extensive preliminary 
investigation, which I will describe in this paragraph.
The germ for beginning the preparations of the public deliberation about iPOPs and 
P4 medicine and health was the publication of the report Het ‘duizend dollar genoom,’ 
een ethische verkenning (The ‘thousand dollar genome,’ an ethical exploration) by 
the Dutch Health Council (Gezondheidsraad or GR) (Dondorp and De Wert 2010). 
The report is an exploration of the ethical, legal and social issues (ELSI) incited by the 
development of whole genome sequencing, the technical possibility to sequence the 
complete hereditary material of an individual “to deliver prevention, diagnostic testing 
and treatment to individual patients (personalized medicine)” for an affordable fee, 
i.e. thousand dollars or less (Dondorp and De Wert 2010: 13). In the preface to the 
report, the urgency of a broad social discussion is stressed, because “we are at the 
threshold of a development that is in many ways uncertain, but that has potentially 
major consequences for healthcare as well as society as a whole” (ibid: 4). As an 
organizer of public deliberation, I seized this call for further investigation. After all, I had 
observed in the report a difference of opinion: as opposed to the advocates of these 
technoscientific developments (as represented in the report, at least), the ethicists feel 
that a “positive balance of advantages and disadvantages” is out of the question for the 
time being, so that “a reliable offering within public health care is out of the question 
anyhow” (ibid: 31). At the same time, the report gave me two tasks to face. First, how 
do I delimit the issue, and second, how to determine the plausibility of these future 
expectations? I discuss the demarcation of the problem first.
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The plethora of questions articulated in the report prompted me to make choices 
for a suitable delineation. In this case, the technology of whole genome sequencing 
determines the scale and scope of the issue. The screening of the complete personal 
genome of individuals complicates a clear focus more than, say, the issue of specific 
genetic testing for autism (as was discussed in the previous chapter) or other diseases, 
disorders or defects. The authors of the report do, after all, discern several divergent 
ethical fields that each evoke their own questions. I decided to further investigate 
the genome-wide screening of healthy people with no medical reason in order to 
predict as many common diseases as possible.6,7,8 The screening of healthy people 
and the impact of genomics on health care is, after all, a pre-eminently public matter 
since it potentially affects (and mobilizes) a wide public (cf. Pröpper and Witteveen 
1995). Moreover, some of the other issues were already extensively looked after 
(for example: informed consent and reporting unsolicited findings in whole genome 
diagnostics of people with rare (mono-)genetic disorders, cf. Rigter et al. 2013).
6 This choice was at the expense of matters like genome-wide diagnostics, genome-wide 
prenatal screening or pre-implantation genetic screening, which all have bearing on 
diseases and disorders with a much stronger genetic factor than common diseases. 
Genome-wide diagnostics – and exome sequencing – is already a standing practice in 
the Netherlands. It is about the merging of a diagnostic and a scientific practice, aimed, 
in first instance, at identifying a (mono)genetic cause for a disease or a congenital 
defect (e.g. mental retardation), but in second instance – if none of the established 
genetic causes were found – aimed at finding new genetic causes by systematically 
scanning the whole genome (or exome). In this case, it often concerns monogenetic 
diseases and disorders that are largely incurable. It is also expected that prenatal 
screenings (during the pregnancy) and pre-implantation genetic screenings of embryos 
after IVF treatments will be limited to severe, heavily genetically determined and 
untreatable disorders. As yet, there is little reason to assume that prospective parents 
would opt for abortion if a heightened risk for diabetes is detected in the unborn 
child. Incidentally, another matter the authors observe is genetic carrier screening for 
diseases such as sickle-cell disease, so that couples of which both partners have taken a 
carrier screening before their intended pregnancy know in advance what their odds are 
for having a child with a hereditary disease.
7 Initially, the choice of focusing the debate exclusively on the screening of adults or on 
the screening of newborn children as well (for example during the neonatal heel prick 
screening) remained open. See 6.3.2 under “social usability” for an elucidation of the 
choice for the screening of adults only.
8 See Becker et al. 2011 for a description “Common disorders have a multifactorial 
etiology: they are caused by several genes and environmental factors, involving gene-
gene and/or gene-environment interactions” (S6).
 I copied the behavioral genetics deliberations’ manner of framing the dialogue 
by focusing on a single common disease – type 2 diabetes – in order to prevent 
the discussion from becoming too extensive, even though the ambition of genomics 
(and life sciences) is much wider than the detection of the genetic risks of one 
multifactorial disorder alone. 9,10
Next, I examined the technological feasibility. In Chapter 5 I have demonstrated the 
effect when there is no (one presenting himself as an) advocate publicly defending 
the new technology. All observed ethical issues in the report are, after all, founded 
on highly uncertain expectations of what is technologically possible. So obscure 
are these expectations, that Nordmann and Rip call the attention for personalized 
medicine a form of “speculative ethics” (2009: 273-274). This might give too much 
attention too early to a matter that, in the end, may never become reality at the 
expense of present matters and of the scarce resources available to ethics research. 
Nordmann and Rip plead for a “reality check,” but when is a scientific development 
“too futuristic?” Which criterion applies here (cf. Grunwald, 2010)?
 My first step was an assessment of the feasibility of the expectations that 
were described in the report itself. The articles referenced in the report, however, 
mainly serve as a prelude to the impossibility of predicting common diseases on 
the basis of genetic information only (Janssens and Van Duijn 2008). They warn 
against deceptive information and unrealistic expectations (Janssens et al. 2006, 
Bunnik et al. 2009). Other studies that were consulted primarily express moderate 
expectations (Khoury et al. 2008; Wijmenga et al. 2009) or even skepticism (Becker et 
9 In the aspiration of a wide social debate as advocated by Dondorp and De Wert, a 
public deliberation cannot be restricted to a single common disease. However, a broad 
approach was not performable within this research project. All the same, if it had been, 
I would still have chosen to have multiple deliberations, with each focusing on a single 
common disease, i.e. beside type 2 diabetes, on cardiovascular disorders, cancer etc.
 The choice for diabetes was more or less made by chance: the Dutch Diabetes Fund 
had recently started a poster campaign with the ambitious slogan “A future without 
diabetes. Let’s do this. Support research.” Nevertheless, the observed drastic increase 
in the number of diabetics and the scope of this disease do meet the first of Wilson 
and Jungner’s screening criteria: it concerns an important health problem that every 
Western citizen has a chance of getting.  Moreover, it is a recognizable disease to many 
people. 
10 Because of this framing, issues as a result of cumulative effects stay out of the picture, 
even though those could play a significant part in the future  
(Horstman and De Vries 2007). 
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al. 2011). Why organize a dialogue about predictive technologies while the scientific 
community itself has severe doubts about their feasibility?
 This changed when I was made aware of the article in Cell. The study in Cell 
indicated that in principle, omics profiling provides valuable new information about 
the health situation of individuals. Second, the authors of this study acknowledged 
the limited value of genetic information for the prediction of common complex 
diseases.11 But most importantly, TNO, an independent Dutch research organization 
that works for the Dutch government, the SME sector, large companies and NGOs 
in order to develop “knowledge for practical application,” had started to participate 
in social experiments or field labs (“proeftuinen”) aimed at the early diagnosis and 
prevention of diabetes and the provision of personalized lifestyle advices.12 What is 
more, TNO had prominently adopted Hood’s P4 medicine as a paradigm for future 
health care in general and of diabetes in particular. In a report, TNO anticipates new 
medical technologies for the prevention of diabetes (Wevers and Gijsbers 2013). So, 
new networks built around the promises of personalized medicine were emerging 
and considerable amounts of research funds had already been invested to stimulate 
these scientific developments. This indicates that within these networks, these 
sociotechnical imaginaries revolving around predictive and preventive health care 
are not considered to be “too futuristic.”
 In short, the transition to P4 medicine and health with the aid of iPOPs proved 
a suitable issue: a current but still young development in the life sciences that is 
receiving financial investments and that evokes ethical questions. The selected 
framing – genome-wide screening of healthy people for type 2 diabetes as part of an 
iPOP – made the organization of the dialogue more manageable, because it defines 
the public explicitly. Who should actually participate in such a dialogue?
6.3.2 Casting the characters in the play
As described in Chapter 2, an important element in scripting a public deliberation 
setting is to determine the characters in the play (Hajer 2005: 631). Which people 
are suitable for the cast? Which life scientists who work as authorities on the systems 
biology of health? Who belongs to the public? And who has relevant expertise? In 
11 “However, genomic information alone usually is not adequate to predict disease 
onset, and other factors such as environment are expected to play a critical role in this 
process” (Chen and Snyder 2012: 76).
12 https://www.tno.nl/content.cfm?context=overtno&content=overtno&item_id=30, 16 
dec. 2013 12:05.
this section I will discuss the formation of the panel, a mini-public (Fung 2003) which 
was to publicly deliberate the issues (see Section 6.3.4 on staging). I elaborate on 
the selection of life scientists, next the identification of members of the public, as 
“implicated in” the issue of P4 medicine (Marres 2005: 48) and finally various experts 
from outside the community of life scientists. I looked for a professional organization 
that was active in the field of diabetes care as a partner, in order to be able to make 
use of their networks and communication channels (also for subsequent publicity 
campaigns).13 My assumption was that the public would sooner recognize the 
relevance of a dialogue if it was co-organized by an organization with which they 
were familiar.
In Chapter 5, I demonstrated the significance of the participation of delegates of the 
scientific community who consider the feasibility of future technologies as plausible 
and who are willing to publicly perform as advocates of these new technological 
innovations. Dr. Lamb, for instance, employed several strategic maneuvers in order 
to refrain from advancing a standpoint on the moral desirability of improved risk 
assessment tools for criminals and citizens based on biological indicators. He drew 
an ethical boundary between his responsibilities as a scientific researcher and the 
responsibilities of society that has to make a final decision about the usefulness 
of such risk assessment tools. Thus, the aim of upstream public deliberation – to 
ask scientists to publicly justify their decisions on the course of scientific research 
programs – was hard to accomplish.
 I wanted to have four participating life scientists, in order to not just give a 
broader representation to science, but also to publicly expose possible differences of 
opinions within the scientific community. The report of the Health Council provided 
little indication to find proponents of this new technology. The only explicit source 
that the ethical exploration itself offers is Francis Collins (2010a), the author of a 
13 Eventually, the Dutch Diabetes Federation (Nederlandse Diabetesfederatie, NDF), 
with whom the Center for Society and the Life Sciences had previous contacts, was 
approached. The NDF is a coordinating organization which “unites people with diabetes 
with health care providers and researchers. [...] The NDF works for a better quality of 
health care and life for people with (pre-)diabetes and acts as a representative and 
spokesperson for the diabetes field with the government, the media and many other 
parties inside and outside of the social service sector” (http://www.diabetesfederatie.
nl/nederlandse-diabetes-federatie, accessed, 16 dec. 2013). Furthermore, the NDF, like 
TNO, is actively involved in regional “experimental gardens,” public-private partnerships 
between NDF, commercial parties and scientists in which the consequences of medical 
interventions and social innovations are tested in society itself.
202 203
Behind the scenes of… life scientists on stage
6
BACKSTAGE OF… THE DRAMATURGY OF DELIBERATING FUTURE HEALTH CARE
popular science book about “DNA and the Revolution in Personalized Medicine,” as 
its subtitle reads. The only explicit mention of Collins was in the inaugural lecture of a 
professor in clinical genetics who was also a board member of the Dutch Association 
of Clinical Genetics (Vereniging Klinische Genetica Nederland) whom I sent an 
invitation.14 Other invitations I sent out to researchers who a) were mentioned by 
people in my own network who overlook the field of (genetics) research into common 
diseases, b) who came up in an extensive search on the Internet, or c) who were in 
the network of the Dutch Diabetes Federation (NDF), that agreed to collaborate in 
this deliberative project.
 Some life scientists who were invited really wanted to come, but had to give 
priority to other planned activities on the proposed dates. Others did not deem 
themselves suitable discussion partners and had to be persuaded. With varying 
success. I did, for example, send an invitation to a principal investigator of a public-
private partnership project that is aimed at finding new biomarkers of type 2 diabetes. 
His expertise made him a very relevant speaker.15 In his own opinion, being an “expert 
in the field of the molecular mechanism of the development of diabetes” was exactly 
what made him unsuitable, given his “limited understanding of the discussion at 
issue.” He did express his willingness to give me the names of “researchers who are 
far better than I to participate in the discussion” as a “project leader of a big project 
concerning the prevention of diabetes” (e-mail correspondence). A second attempt 
in which I emphasized his expertise and his function as a project leader (which he 
himself acknowledged) once more came to nothing.
 In the end, three life scientists committed: 1) the previously mentioned 
clinical geneticist and board member of the Dutch Association Clinical Genetics; 
2) an innovation director of life sciences at TNO; and 3) the program manager of a 
consortium that experiments with whole genome sequencing in diagnostics. The last 
mentioned also blogs about new technological developments; his blogs (sometimes) 
appear in Dutch newspapers and newsmagazines.
For the invitation of members of the public, “called into being” (Marres 2005: 55) by 
the issue, public groups were identified from an analysis of the promises surrounding 
P4 medicine, which I will describe in greater detail later on (Section 6.3.3). These 
promises do, after all, imply an audience. As Michael (2000) states, a subject who 
will experience this (favorable) future is often presupposed in these expectations 
14 For anonymity reasons I do not make explicit reference to this publication.
15 http://www.ctmm.nl/nl/projecten/hartvaat/predicct, accessed, 30 dec 2013.
for the future (26-7). In the case of P4 medicine, this does not simply concern an 
individual subject: the health care consumer who can live healthier. Hood and Flores 
(2012) assert that the transition to P4 medicine stems from the needs (“push”) 
of a collective of articulate and “newly activated and networked patients and 
consumers,” who “are beginning to push for a health care that is adapted to their 
own particular circumstances” (619). In addition to this, other collective subjects are 
constructed: risk groups that can be reached sooner and better, citizens who need 
to pay less for health insurance so that health care will remain affordable for future 
generations as well, and people in Developing Countries who share in the benefits. 
On the other hand, individual health care consumers are expected, as citizens, to 
take responsibility of their own health and to place their biological information at 
the disposal of science through a large infrastructure for the exchange and storage 
of big data. Apart from individualizing – in the sense that each individual gets 
customized medical treatments and advice – the technology of the iPOP, then, is 
also collectivizing (cf. Dijstelbloem and Klaassen 2008). This makes P4 medicine a 
public issue. Who wants this change in health care? Who will have to deal with its 
consequences?
 It is typical for P4 technologies such as iPOPs that, besides diabetes patients and 
risk groups (such as obese individuals), they open up new public groups: still-healthy 
(and young) citizens, articulate health care consumers or pre-patients who want to 
actively monitor their health for risks without displaying symptoms. I chose not to 
have a random sample of Dutch citizens (as is customary in, for example, consensus 
conferences). Instead I approached not just patients and people at risk, but four 
active members of local political youth organizations who each represented a major 
Dutch political party, thus covering a significant share of the political spectrum: 
the socialist party (Socialistische Partij, SP), the labor party (Partij van de Arbeid, 
PvdA), the progressive party (D66) and the conservative party (VVD). These people 
are all young and as such have little to do with diseases; they are articulate, as is 
evident from their political interests; they belong to the future generation that would 
benefit from these developments; and they represent different political movements. 
Another important public group that might have to face the consequences is the 
group of health care professionals (nurses, general practitioners and internists). A 
new way of working will, after all, be expected of them, a way that is aimed more at 
health monitoring.
The third group of panelists – beside life scientists and members of the public – 
were people with relevant expertise other than the expertise of life scientists and 
the expertise through personal experience that I assumed the public groups to 
have. What kind of expertise is relevant? Who knows the practice, the prevention 
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of, and the research of diabetes well? Who will be using the technology? I further 
invited: a) a manager working at a local public health institute (GGD) whose primary 
public assignment is organizing disease prevention, b) the head of research of the 
Diabetes Fund, the largest private fund that finances the research of diabetes, c) 
the director of the NDF, d) an ethicist specialized in the medical-ethical questions 
around prevention, e) a philosopher specialized in issues around public health, f) a 
professor in diabetology (who is also an internist), and g) a sales manager of medical 
equipment for diabetes patients (glucose meters, etcetera).
 The amount of control the dialogue organizer has on the eventual composition 
of the panel turned out to be limited. Many invitees gave precedence to other (daily) 
activities. Negotiations with the collaborating partner also partially determined 
who did and who did not receive an invitation to the panel. The NDF insisted, for 
example, that “official representation of the [diabetes] patient is a must,” while I 
considered their suggested candidates (an ex-parliamentarian, for example) to be 
too administrative. To me, direct personal experience as a diabetes patient or risk 
group was important. In addition, not everyone identified with the role that was 
allotted to them in the cover letter that was sent along with their invitation. In the 
invitation, they were initially addressed “as opinion leaders.” After a considerable 
number of negative responses, many people indicated, upon further inquiry, 
that they considered themselves to be too ill-informed of the technoscientific 
developments. The place of action – a city in the east of the Netherlands – proved 
to be of importance for many participants (this was a reason to invite local political 
youths): after a series of cancellations from people all over the country, the NDF 
and I successfully aimed at people from the Nijmegen area. The panel members also 
proved to be, without exception, well-educated.
After all panel members had confirmed their attendance, the phase of substantive 
preparations began. To that end, I carried out an assessment of the expectations for 
the future regarding P4 medicine, which I will discuss in the next paragraph.
6.3.3 Assessing future visions of P4 Medicine
As was discussed in Chapter 4 (Section 4.4.3), the sociology of expectations focuses 
on the performative function of expectations. Expectations are strategic maneuvers, 
often projections of a morally desirable future that are discursively presented with 
the rhetorical goal of persuading a (possibly critical) audience (audience demand). 
Advocates of new science and technology use expectations as a rhetorical device for 
arousing interest sponsors and for anticipating public discomfort. Expectations do, in 
short, belong to the standard repertoire of public performances of scientists. As the 
dramaturgist of this public deliberation, I considered a critical analysis and assessment 
of the sociotechnical imaginaries around P4 medicine and health necessary for two 
reasons. Firstly, a vision assessment is a helpful tool to broaden public deliberation 
as I indicated in the conclusion section of Chapter 5 (see Section 5.5). Consulting 
literature in which these imaginaries are elaborated helps anticipating the public 
issues at stake instead of merely responding to the issues that are articulated ad hoc. 
As the analysis of the public deliberations on behavioral genomics showed, there was 
plenty of reason to suggest that the imaginaries of participating life scientists could be 
more critically discussed. Secondly, the events described in Chapter 5 demonstrated 
that members of the public do not automatically adopt the role of deliberative 
citizen. Instead, they refrained from participating in the public sphere or they 
adopted a more passive role of recipient of state-of-the art information. To prepare 
all panelists for their deliberative performance the results of my vision assessment 
were reported to all participants in the week before the deliberative event at the LUX 
(see Figure 6.1). The report (see Appendix E) was meant to be an understandable, 
accurate and an as complete as possible introduction to P4 medicine and the main 
ethical issues concerning the moral desirability of systems biology approaches to 
health care to warrant an equal point of departure for all panelists.
 For the analysis I made use of the patterns of moral argumentation (NEST-
ethics, Swierstra and Rip 2007), various parameters (Michael 2000), and the three 
types of closely related rhetorical claims made in expectations for the future: 
technological feasibility, social usability, and moral desirability (Lucivero et al. 2011; 
see Section 4.3.3).
 Apart from official publications (popular science books, academic orations, 
reports, trend analyses, but also scientific publications), I also conducted a number 
of backstage interviews about constructed futures with various experts, including 
some who were not directly involved with the life sciences. These interviews were 
compared to the publications (cf. Lucivero et al. 2011).
 For the interviews, five life scientists were interviewed. Some of the interviewed 
experts were to participate in the discussion, others were not. Three of them were 
participating panelists, one was a principal author of the paper on iPOP in Cell and 
one was a principal investigator of a research project aimed at developing molecular 
technologies for the early identification of people at risk and a personalized 
prevention and therapy program for diabetes in a Dutch public-private research 
consortium for translational medicine. Furthermore, the ethicist (see panel) and a 
philosopher of public health with a background in science and technology studies, 
the professor of diabetology (see panel) and two other panelists were interviewed: 
the director of NDF and a diabetes patient who had been active as a representative 
in a diabetes patient organization, the Dutch Diabetes Association (DVN).
 Important questions were: how do the interviewees look upon the future 
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of P4 medicine? Which issues are identified? More specifically, I examined how 
representations of futures are articulated frontstage, and how those representations 
differ from the constructions that were made by the (participating) life scientists in 
the backstage interviews. Which issues do they expect the public will articulate? 
Which moral issues do they identify themselves (see Appendix D)?16  Emphasis was 
laid on moral argumentation and a critical analysis thereof (see moral desirability).
16 To contrast the findings of these preparatory interviews with participating life scientists 
with their actual performance on stage, I present the results of these interviews 
backstage in Chapter 7.
Figure 6.1 Timeline organizati on upstream public deliberati on on iPop technology.
 Between parentheses the capitals refer to the appendices.
Investi gati on sociosocial imaginairies
Development scenario
Development scriptInterviewsInvitati ons
May 2013 June 2013 July 2013 Aug 2013 Sep 2013 Oct 2013
September 20
Preparatory report (B) 
sent to panelists
September 30
Scenario (C) and script 
(D) sent to panelists
October 4
Public dialogue iPOP
I sent the report to the panel members two weeks ahead of the public deliberation 
(see Figure 6.1). Participants were invited to ask questions, make remarks or 
corrections, but no one did. To maintain neutrality, I chose a footing as animator 
(see Section 4.3.2) to demonstrate that I am not the author of P4 sociotechnical 
imaginaries: I made explicit reference to the literature and I provided all the 
sources that were used. With the exception of the GGD manager (see social 
usability below), the participants (13 respondents) found the information helpful 
or neutral (questionnaire panel members). For some, the information served as 
a first introduction to the iPOP, others used it as “background information.”17,18 A 
board member of a patients’ association thought the information was too heavy 
and too complex. Five people indicated afterwards that they specifically used the 
report in forming their opinions. One of them – a representative of diabetes patients 
– answered the question “How did you use the information that was distributed 
beforehand?” as follows: “[B]y writing a position report beforehand and answering 
the preparatory questions. This helped me put into focus the subconscious thoughts 
that went into choosing my position, thus allowing me to put these thoughts forward 
in the deliberation” (questionnaire panel members).
 Except the report, I also developed a scenario using the input from the literature 
and the interviews to draw attention to the envisioned social practices in which 
iPOP technologies are supposed to work (see social usability below). I discuss 
the technological feasibility, social usability and moral desirability of the future 
expectations separately.
— Technological feasibility
An important lesson from the public deliberations on behavioral genomics, described in 
Chapter 5, is to anticipate differences of opinion on technological feasibility. On the one 
hand, indiscriminate trust in experts’ claims on technological feasibility is unfounded. 
Technological developments are contingent. Some of them will materialize, some (or 
perhaps even most) will not. Above, I already described how P4 medicine and health 
17 The two life scientists who participated in the end were questioned more extensively 
in an interview that took place after the deliberation. Of the other 15 panel members, 
13 filled in the questionnaire. One panel member refused to fill in the questionnaire 
because it was not anonymous. The fifteenth panel member did not fill in the 
questionnaire.
18 The manager of the local public health institute (GGD) described the report as 
“absolutely not neutral” in the questionnaire. See also footnote no. 23 in this chapter 
for his response to the information and scenario on stage.
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will be difficult to dismiss as too futuristic, since various networks are already forming 
around these promises. On the other hand, challenging technological feasibility can be 
a very effective strategic maneuver on stage without risking derailment because of the 
elusive character of future expectations, as demonstrated in the autism deliberation 
(Section 5.4). Challenging technological feasibility renders the other critical questions 
and hence, a critical discussion on moral desirability redundant. Why discuss moral 
issues of technologies that will not materialize in the first place? How plausible did 
participants believe P4 medicine to be?
 According to the literature, the expectations with respect to technological 
feasibility of personalized medicine or P4 medicine are high. The question is not if 
iPOPs will materialize, but when. Their advocates construct an optimistic future. 
The future of P4 medicine is certain, near (“In 10 years we see every consumer of 
healthcare surrounded by a virtual cloud of billions of data points,” Hood and Flores 
2012: 614), it is rapidly developing (“The way we understand and treat disease is 
changing rapidly,” ESF 2012) and revolutionary (“Advances in the ability to perform 
large-scale genetic and molecular profiling are expected to overcome the limitations 
[of current medicine] by addressing individualized differences in diagnosis and 
treatment in unprecedented detail,” Chen and Snyder 2012: 73). Some figures in 
these documents are used strategically to demonstrate the gradual progress “from 
bench to bedside” (see ESF 2012: 24; see Figure 6.2).
 Nevertheless, the literature also explicitly mentions concerns, limitations and 
challenges (Chen and Snyder 2012; ESF 2012; Hood and Flores 2012; NHGRI 2011). 
Those challenges are often of a social and organizational nature (e.g. whether or not 
health care professionals and consumers have sufficient knowledge), but there are 
still uncertainties on a technical level as well, especially concerning the processing 
power, suitable bioinformatic calculation models for analysis, and the integration 
of different types of data. But the purport in the literature is that these technical 
challenges can be overcome. In the end: “the era of personalized precision medicine 
is about to emerge” (Chen and Snyder 2012: 79).
 The interviews demonstrated a more nuanced vision of the future. The 
diabetologist was skeptical: “Valeriya Lyssenko [a Russian researcher] has managed 
to put all those genetic traits, those risks that are determined, into a model and she 
has checked whether or not those can predict a risk of diabetes.  And that turns out 
to be really disappointing” (Preparatory interviews). He questioned the usefulness of 
Figure 6.2 This is how the authors in the ESF report picture “Projecti ons for medicine”. 
 It demonstrates the higly complex and mutually dependent technological, 
 organizati onal and social aspects of personalized or P4 medicine, 
 including ict’s, nanotechnology, telecare soluti ons etc.
Five years Ten years Twenty years
Proof of principle
 - Target available 
technology on one 
disease area
 - Identi fy available 
resources (electronic 
health records, 
cohorts, etc.)
 - Enhance biobanks and 
clinical sampling
 - Expand measures for 
healthy individuals
Introducti on
 - Cumulati ve data to 
follow the person
 - Dynamic qualitati ve/
quanti tavie measures
 - Synergic outputs from 
multi ple markers
 - ICT infrastructure to 
support real-toime 
heathcare delivery 
across regions
 - Non-invasive informati on 
collecti on and sharing
 - Increased precision of 
imaging technologies 
and therapy
Implementati on and 
refi nement
 - Integrati on of imaging 
technology 
in physiological 
monitoring
 - In silico model for 
individual pati ents
 - Real-ti me monitoring 
(nanomaterials)
 - Remote monitoring / 
personalized 
telemedicine
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having a public deliberation in this early a stage.19
 One out of the three participating life scientists emphasized, conversely, that the 
scientific developments should be a reason to organize a dialogue at this early stage. 
“I feel that we [as scientists, as doctors] are indeed working on a development which 
people should already be thinking about. Not because we have direct applications 
for it or because we can directly... Well, work on the improvement of health care. But 
because we are presently working on technologies which will enable decisions about 
that within, well, five or ten years” (Preparatory interviews)
 Nevertheless, the life scientists had divergent opinions about the technological 
feasibility of iPOPs. Two of them were cautious. The PI: “I think that there is too 
much emphasis on the biological risk factors at the moment. Because, if you’re 
being honest, the research into genetic variations in relation to the development of 
diabetes that has been done so far has yielded awfully few results. Looking at our 
own research one actually sees that the biological risk factors that emerge are really 
not all that surprising at all” (Preparatory interviews). Even so, he stressed, “This 
technology should absolutely be developed.”
 The clinical geneticist indicated that she had readjusted her views of the future 
as she had articulated them in her oration a year earlier. Then, she told her audience 
that “by sequencing hundreds of thousands, maybe even millions of genomes, we 
are going to find genetic variations which individually, or in combination with a small 
number of other variations, are strongly decisive in the development of common 
diseases such as diabetes, rheumatism, and asthma.”20 Now she sees “the period in 
which that [the charting of genetic variations] will happen, [...] as much, much longer, 
and I even think ‘if it will happen at all’” (Preparatory interviews).
19 In the interview with the diabetologist I asked: “How useful, in your opinion, would 
it be to organize such a dialogue?” Diabetologist: “Well, I strongly doubt it [will 
be useful]. Yes, I strongly doubt it.” Me: “And do we set too much store by such a 
publication, for example? Or do we risk...?” Diabetologist: “Yes, I think so.”
 I also asked the diabetologist what, then, were his reasons for participating in the 
dialogue. To that he answered: “There needs to be someone there who has the proper 
expertise. Otherwise it will become a dialogue about an abstract subject, with no people 
present who have the relevant know-how. If it takes place in the Nijmegen area, I feel like 
I should be that person. Or at least, I am one of the people in the area who could be that 
person. So that’s it.” Me: “And then you will say: ‘Well, people, I am skeptical about all 
these possibilities,’ and then we can all go for a cup of coffee?” Diabetologist: “Yes... Well, 
if you put it like that.... If you would have asked me: ‘Is this a good idea? Would you want 
to organize an afternoon like that?’ I would not have done it.”
20 For anonymity reasons I do not make explicit reference to this publication.
In short: opinions about the feasibility of P4, medicine differed (in particular with 
regard to the P’s of prediction and prevention), as is the case in all scientific and 
technological development. Nevertheless, this information from the interviews was 
helpful. First of all, the expectations of P4 medicine and health are plausible to a 
considerable part of the life scientific community, although concerns exist. Second, 
it was possible to prepare a possible intervention in case someone would close the 
discussion claiming that iPOPs for preventive use are not technologically feasible. 
I would be able to appeal to the asking of critical questions: what is your opinion 
based on? And: does a consensus exist about this in the scientific community? The 
preliminary investigation provided me with a negative answer to the last question, 
which would make it easier for me as the facilitator not to get stuck in issues about 
feasibility. To further decrease that risk, I invited the panel members to consider the 
technological feasibility of iPOPs a given, with the aid of a scenario. For that matter, 
the technological feasibility proved not to be an issue during the deliberation. The 
preparation might have had a significant role in that, although this cannot be proved 
with empirical material.
— Social usability
Sociotechnical imaginaries were also examined for social usability. What social 
practices are envisioned in which iPOPs are supposed to be functioning? As was 
argued in Chapter 2 (Section 2.2), technologies are inextricably linked to social 
practices. How technologies are used in practice partially determines the ethical 
questions they can evoke (see Horstman and De Vries 2007).
 To get a sense of what experiencing the repeated testing of molecular biomarkers 
might be like for research subjects, and how the device might possibly be used in the 
future, I interviewed a principal author of the Cell article. Although he indicated that 
“a lot of devotion is needed” of the research subject for him/her to give even more 
blood during viral infections, he did indicate that the lab setting that was used cannot 
be compared to the way in which the measurements will eventually be conducted 
in the future. “But as it [the iPOP technology] gets further, it will become more 
streamlined, take shorter time, and a lot less [bodily] material. Less stressful, and 
in the end it might be just a tabletop thing. Or just a wristband that the patient is 
wearing. That’s how I view it.” (Preparatory interviews) He could not be much clearer 
in his description of the practice around these technologies.
 This kind of detailed information about the practices in which P4 technologies 
are to be used was also lacking in the literature. There is quite a lot of attention for 
the (rational) social organization that is required for a successful implementation of 
P4 technologies: health literacy, stimulating interdisciplinary work, harmonization 
of protocols for data collection and handling (ESF report), new interpretation of 
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tasks (from clinical geneticist to wellness coach; Hood and Flores 2012). Hood and 
Flores (2012) are an exception, even though the practices they envision remain very 
sketchy and contradictory. On the one hand, they envision “clinical institutions” 
where consumers can monitor and improve their health with the aid of “wellness 
coaches and genetic counselors,” who provide actionable information “largely 
through digitally linked social networks, the most important of which will be family 
networks.” This information comes from personal genome sequencing which has to 
be iterated regularly and preferably compared with the genome sequence of family 
members (family sequencing). On the other hand “P4 medicine will not be confined 
to clinics and hospitals. It will be practiced in the home” (Hood and Flores: 614).
 Important questions about the context of application are not addressed, however. 
Will people be able to order their iPOP profiles from commercial providers off the 
Internet, in the same way we are now able to order direct-to-consumer genetic tests? 
Or will the risk profiles only be used in certified public health facilities because they 
are viewed as medical proceedings? Will there be portable devices that can be taken 
everywhere, such as a glucose meter for diabetes patients that implies a certain 
home use? At what age is a personal genome sequence made? How will the family 
be involved when “family sequencing” (Hood and Flores 2012) is recommended for 
optimal measurement results? Will common disease risk identification become a 
part of neonatal screening (Idenburg et al. 2012; Collins 2010)? However, this type of 
expectation is poorly articulated, both in the literature and during the interviews.
In order to provide more detailed information about a possible future, a more 
elaborate sociotechnical imaginary or scenario of a preventive outpatient clinic (in 
Dutch, the “preventiepoli”) was developed (Appendix C), drawn from several scenario 
studies (esp. Van Rijswoud et al. 2008). The scenario sketches a possible future in 
with civil society (patient organizations and insurance companies) take initiative 
in founding preventive polyclinics which are accessible to anyone who wants to 
preventively manage their health, and which are a facility for general practitioners to 
intervene more pointedly in the lifestyles of risk groups. The government stimulates 
this technologically supported practice because it considers it an ally in its goal of 
health care improvement.
 The scenario served multiple purposes. First, this image of the future presumed 
that a number of decisions were already made, in order to be able to give focus and 
direction to the deliberation. The technological feasibility of iPOPs, for example, was 
taken as a given. The scenario also explained why, in an earlier stage, the political 
decision was made to waive doing the screening for genetic risks as early as the 
neonatal heel prick. In this manner, as I had learned from previous experience, I 
could prevent the discussion from switching too quickly to the more loaded ethical 
theme of the screening of children (about which the report by the liberal VVD was 
positive; see De Haan et al. 2010).21
 Secondly, the goal was to anticipate the future sociotechnical developments, 
the accompanying ethical dilemmas (see “moral desirability” below), the political 
decisions to be taken about it, and the arguments that might play a role in the 
deliberation. How will (health care) insurance companies handle their knowledge of 
the health conditions of individual citizens? In the scenario it is suggested that health 
insurance companies will offer basic policies at attractive prices to people who have 
low risk profiles. Will such a premium differentiation undermine the solidarity in the 
health care system? This was one of the issues that was articulated in the discussion 
with the panel (see Chapter 7). Another issue was the accessibility of this technology 
(together with the related justice arguments): the iPOP will not completely be made 
a part of the free market, but will instead function as an integral element of public 
health care. “In this way, it is also easier to guarantee equal access to these facilities” 
(Appendix C).
 The panel members received the scenario a few days ahead of the deliberation. 
The attached script (see 6.3.4) read that “the short sketch of the future [is] the 
starting point of the conversation: what does this vision of the future of preventive 
or P4 Health and Care evoke in you?” (Script panel members; see Appendix F). 
Gauging the effect of the scenario is not easy. The questionnaires do show that panel 
members were ambivalent about the scenario. First of all, I noticed that five of the 
participants had no comments (the only question that had this low a response). Out 
of the panel members who did fill something in (8 in total) about half considered 
the scenario “too abstract,” unhelpful (“I was not really aided by it”), ineffective 
(“the contents produced little result”) or incomprehensible (“Many [of us] did not 
21 One of the participants a sales manager of medical equipment, for example, referred to 
a possible future practice of screening young children during the debate:
 SALES MANAGER: “When it concerns the premature revelation of [health] information, 
 I think that it is at least also very important to guide the people, in how to deal with  
 that. And for an adult, you could do that, but when a child gets all kinds of  
 information after a heel prick, the parents have all that information, and should  
 that be passed on to the child later on, or shouldn’t it?”
 ME: “[...] But that is based on the assumption that [a] heel prick screening would  
 be conducted. I understand you would find that objectionable?”
 SALES MANAGER: “Yes.”
 ME: “Yes. Okay. I am just going to put that between brackets, because with the  
 scenario we are trying to see what happens when you have got this from a  
 mature age onwards” (Discussion).
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understand it”). The ethicist indicated after the deliberation that the scenario had a 
“social” framing and that it was based on an “abstract individual,” as a result of which 
it lacked the imagination to see how the technological developments “might changes 
the lives” of “actual persons” (Discussion).
 Others, on the other hand, thought the scenario was “fine,” “a convenient, 
pleasant way to think about the future.” The GGD manager indeed thought that the 
scenario was a “story that was lousy with presuppositions” (Discussion), but also that 
it was helpful in “seeing a wider perspective” (questionnaire panel members). This 
man, by the way, kept seeing me as the author of the scenario, in spite of my chosen 
footing.22 The audience largely shared the panel members’ views on the scenario.
 Nevertheless, four panel members explicitly based their first contributions to 
the dialogue on the scenario, which indicates that they used the scenario in their 
preparations. Some participants also pointed out to their opponents that they were 
to stick to the scenario.23 One of the observers, conversely, doubted the impact of 
the scenario. In his opinion, the impact could have been magnified had there been 
not just one, but multiple scenarios, so that contrasts become larger and “choices 
become clearer” (observations Observer A). “Now you [as the organizer of the 
dialogue], had already made a number of choices, more or less implicitly” (ibid.) I 
made this choice to make sure that within a limited time frame at least one scenario 
could be profoundly discussed.
22 The manager of the public health institute (GGD) persistently referred to me as the 
author of the scenario. During the debate, I made an attempt to negotiate the footing:
 MANAGER: “When I look at your story, at what you put there, I notice you are really  
 mostly talking about health care. While, when you are talking about diabetes and  
 about obesity, you will also have to be like ‘How will we do this, as a society?’”  
ME: “I have to say something about... I have heard you say ‘your story’ a couple  
 of times now. I have tried, of course...”  
MANAGER: “No, I understand. No, but still...”
 ME: “Before I become the only one here to defend what will happen” (Discussion).
23 Chair of the local youth liberal party: “But I think we now have to look: how will this 
scenario work in society as we now know it? And in society as we now know it, the 
scenario will not work, because way more people than we would want will get access 
to that information” (Discussion).
— Moral desirability
As was argued in Chapter 4, in their expectations of the future, the advocates of 
new technologies appeal to the moral desirability to thus construe a good future 
(Michael’s parameter of valency). They paint a normative vision on a future reality, 
or even use a “rhetoric of hope” that, according to Mulkay (1993), is an “idealized 
vision of the relationship between science and society which enables its users to 
project an indefinite range of science-based technologies into a radically simplified 
future” (728). As preparation for the public deliberation, I have analyzed the moral 
argumentation used in the future imaginaries of P4 medicine advocates, and 
reported the results of this analysis to the participants. I have, furthermore, made a 
number of unexpressed premises explicit. Using the NEST-ethics (see Chapter 3) in 
the future imaginaries themselves, I also used bio-ethical literature and interviews to 
find answers to a series of critical questions.24
Analysis shows that the sociotechnical imaginaries and moral justifications for P4 
Medicine are strongly liberally inspired. Firstly, the advocates of using the iPOP as 
P4 technology stress the fourth P of participatory, which means that health care 
consumers will be (even more) in charge of their own health. Using the argumentation 
outline of deontological argumentation (see Section 3.4.2), the advocates thus find 
the iPOP worth the effort of developing, because it does justice to the autonomy 
principle, an important moral principle in medical ethics which expresses that 
individuals should be as capable as possible to shape and direct their own lives 
according to their own moral standards.
 Although Leroy Hood never uses the concept of autonomy, his vision of the future 
implies it. He describes the rousing self-awareness of ever more articulate “activated 
and networked consumers [who] are beginning to push for a healthcare that is adapted 
to their own particular circumstances, including their individual genome [...] and 
dynamic measurements such as from blood” (the iPOP) and who “are beginning to 
demand that science-based healthcare address their need for assistance in managing 
24 In the report I omitted the word “critical” to prevent advocates of P4 Medicine to 
perceive me as biased.
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their own health” (Hood and Flores 2012: 619).25 The current, reactive health care 
system is more of a “disease management industry,” while the needs of health care 
consumers are specifically made up of managing their own health.
 The concept of autonomy is a complex philosophical concept with a rich history 
and many different meanings, as also became apparent during the dialogue at the 
LUX (see Chapter 7).26 The implicated autonomy principle strongly resembles that of 
J.S. Mill, which strongly influenced the liberal body of thought: autonomy as freedom 
of choice. Here, autonomy is, in first instance, a negative ideal of freedom; a “free 
of.” The iPOP firstly supplies the knowledge the individual needs to no longer let the 
diseases that hinder him determine his fate. But more than that, the iPOP enables the 
individual to proactively make his own choices about his health, and to no longer be 
dependent on what he is told by doctors, the experts who populate the reactive health 
care system, as a “passive recipient of expert advice” (Hood and Flores 2012: 619).
Secondly, the sociotechnical imaginaries of P4 medicine and the iPOP commonly 
bear witness to a technologically instrumental rationality (Michael 200: 27-9) which 
is often interpreted as a liberal vision of technology (Zwart 2011; Feenberg 1999): 
a technology like omics profiling is seen as a neutral instrument in reaching 
positive goals: prevention or early diagnosis of lifestyle disorders (like diabetes), 
the prevention of the burden of diseases, shortly, an “improvement of the health 
care quality as it is experienced by the patient” (Wevers and Gijsbers 2013: 17). 
Advocates of P4 medicine therefore also use a consequentialist argumentation, in 
the form of pragmatic argumentation (Section 3.4.1). In their papers, they point out 
the desirable consequences, the benefits of the developments in systems biology 
and the life sciences.
 As such, P4 health and care is also an instrument for pushing back the cost of 
25 At the same time, an inconsistency lurks in Hood and Flores’ plea. On one hand, they 
create a need: “Activated and networked consumers are beginning to push […] for 
new ways in which to engage with our science-based healthcare system to maintain 
wellness and achieve life goals as well as treating disease” (Hood and Flores 2012: 
619). On the other hand, they see education for “consumers, patients, physicians 
and members of the broader medical community” as an enormous and necessary 
challenge, because “[m]any individuals will initially want to remain ‘old-fashioned 
patients’ letting the doctor tell them what is best” (ibid: 620-1). As it turns out, the 
autonomous and articulate health care consumer belongs to a vanguard of sorts, but 
does not speak on behalf of everyone.
26 See Section 7.3 for a more elaborate discussion of the concept of autonomy.
health care, which is tightly connected to another value that is typical of liberalism: 
one’s own responsibility.27 “We wanted to show that technological breakthroughs 
leave a large and increasingly large mark on health care. [...] But above all, with 
that we also want to stress the normative aspect which such a health care of the 
future contributes to a participation society, which enables individuals to take 
responsibility of their own health and of social participation” (Wevers and Gijsbers 
2013: 87).28 Citizens are expected to take responsibility in staying healthy and the 
iPOP technology will help them with that. Because, although freedom of choice is 
a fundamentally liberal principle, this freedom applies only as long as it does not 
impair the freedom of others (impairment principle). This would, for example, be the 
case if collective health care costs were to needlessly rise because someone did not 
grasp the possibility to gather information about his health in an early stage, thus 
later having higher costs for his disease or disorder. “If someone did not want certain 
predispositions to be examined, and this leads to higher costs for society as a whole 
[...], he should in all reasonableness be confronted with his choice. This can be done 
by partially or entirely recouping the costs from him, or by raising his health care 
insurance premium” (De Haan et al. 2010: 45).
 Hood en Flores furthermore stress the positive effects of this revamped health 
care on economic development and industriousness. Thanks to digitalization and the 
decrease of health care costs, even the developing nations can profit from these 
scientific and technological developments (Hood and Flores 2012: 621).
27 The publications diverge between themselves. While Hood and Flores see reducing the 
costs of health care as an important promise, the ESF report is more cautious about 
this. “A realistic expectation could thus be cost containment rather than reduction” 
(ESF 2012: 18-19). 
28 Incidentally, I would like to immediately remove the notion that the TNO report only 
represents a liberal discourse. It is a nuanced piece and not, like the report of De 
Haan et al. 2010 a document intended to think through the ethical issues that stem 
from new scientific developments from a liberal perspective. This shows, for example, 
in the following extract: “Restructuring unhealthy behavior to healthy behavior is, 
however, difficult, and it requires skillful handling and support. [...] When candy bars 
are attractively displayed near every cash register and when each train station and 
gas station has a wide variety of (unhealthy) foods on offer, the will power of the 
individual is taxed to the extreme. [...] [H]ow much paternalism [...] of the government 
is justified in the aim of the desired behavior of citizens, in this case the prevention of 
public enemy number 1, obesity [which is a well-known and important risk factor for 
type 2 diabetes]. At first instance, technological solutions appear to be of secondary 
importance here. Rather, it is about social innovation” (Wevers and Gijsbers 2013: 28).
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Then, I studied which other NEST-ethical issues could be anticipated. Which rights 
would possibly be at issue? What are the unintended consequences? Will everyone 
profit from this technology in equal measure? And if not, how will the difference be 
justified? I used the stock topics derived in Chapter 3 to systematically investigate 
potential NEST-ethical issues (see Table 3.2). The amount of attention for these 
issues highly varies. Francis Collins uses a “rhetoric of hope” in his book and seems 
to pay little thought to the ethical, legal and social issues to which he was initially 
so dedicated (cf. Zwart 2011b).29 The liberal biomedical ethics from the report by 
the Teldersstichting and “the hyperliberal utopia” from Hood’s publications about P4 
show a great “convergence” (Zwart 2011a).
 De Haan et al. (2010) do, after all, mainly (or even only) stress the protection 
of the rights of the individual in their liberal vision, as do Hood and Flores (2012): 
the privacy of and command of personal details (this is, by the way, an issue that 
is widely recognized). Although sharing “anonymized patient data” is essential, this 
information cannot get in the hands of insurance companies or employers: “Laws 
must be enacted to protect the individual against the exploitation of their medical 
data by other elements of society such as employers or Insurance companies” (Hood 
and Flores 2012: 618-9).
 To Dondorp and De Wert’s concerns about the right of not-knowing (2010), De 
Haan et al. (2010) answer that the right of not-knowing is not important to liberals in 
the end: “If treatment in a late stage is significantly more expensive, the person does 
not have the right of not-knowing. In many cases, liberals do not acknowledge the 
29 Zwart writes in his critique of Collins’ book: “I take it as rather symptomatic for the 
approach adopted by the author that, instead of using the June 2000 press conference 
as his point of departure, as is done in previous publications, Collins now prefers the 
‘science-only’ celebration that took place one month earlier. This is symptomatic of 
the fact that the book conveys a ‘science-only’, technology-driven vision of future 
developments. The various pitfalls and concerns involved in personalised medicine 
and human genome sequencing are more or less delisted from the agenda, in order 
to clear the way, as it were, for the potential benefits as envisioned from the point of 
view of pure science. From a bioethical and societal perspective, the book represents a 
remarkable relapse into a science-only, pre-HGP approach to science” (Zwart 2011: 90).
right of not-knowing (De Haan et al. 2010: 41-4). 30,31
Unintended consequences do not appear in the liberal and scientific visions. The 
authors of the ESF report, which was realized in close collaboration with ELSA-
researchers, and the authors of the TNO report do observe these consequences, even 
if they are not systematically studied like in other consulted bio-ethical literature 
and in the interviews. The reports do, for example, envision a continuing trend of 
medicalization, just like a panel of citizens (Stol and Nelis 2009) and the interviewed 
ethicist did. First of all, a systems biological view puts the cause of the disease in the 
individual biological condition of the (pre)patient. Other, often social factors, which 
are specifically important in causing disorders like diabetes, may be neglected. In 
his interview, the ethicist mentioned yet another side of medicalization: the ever 
expanding medical view on aspects of daily life and the increasing knowledge of our 
own health – aided by technologies like the iPOP – leads to a situation in which 
people begin to consider their health “a shaky balance that is always in danger” 
(Preparatory interviews).
 Others mentioned added unjust reassurance and unnecessary concern as 
unintended consequences (Dondorp and De Wert 2010), also for family members 
who share the hereditary material at least in part (cf. Haga 2009). A culture of victim 
blaming and the decrease of solidarity as a result of an increasing emphasis on the 
individual responsibility for health might also come into being (ESF report). Yet others 
articulate an issue of justice: do iPOPs not lead to (larger) socioeconomic health 
differences as a result of differences in education (and health illiteracy) and access to 
and use of ICT-applications like smartphones (ESF 2012; Wevers and Gijsbers 2013; 
Van Rijswoud et al. 2008)?
30 The fourth condition is that participation in screening must be based on an informed, 
well considered choice (informed consent). Even if taking the time for routine, 
extensive multidisciplinary counseling is a realistic option, obtaining anything beyond a 
form of generic consent appears unfeasible. […] The question is whether this is enough 
to allow a considered choice to be made about the offer to analyze the personal 
genome. The ‘right to not know’ in particular will be difficult to shape in this context” 
(Dondorp and De Wert 2010: 51).
31 During the debate itself, two liberals - the chairperson of the young liberals and the co-
author of the report - came to be diametrically opposed to each other about this issue, 
which shows that the liberal body of thought is open to multiple interpretations. See 
Section 7.3 for a more elaborate discussion of this difference of opinion.
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In the report I sent to the panel members, I listed the expected advantages and 
disadvantages in order to facilitate critical questions during the deliberation. I 
also pointed them to questioning the propositional content of the expectations: 
do the technological developments in fact lead to the expected advantages and 
disadvantages? “Does P4 Health and Care really deliver a reduction of health care 
costs? Are people not psychologically able enough to handle new information about 
their health?” (report panel; see Appendix E).
 Apart from an overview of desirability issues, I made explicit a number of 
unexpressed premises that are incorporated in these representations of the future. 
The visions of the future around P4 medicine imply, after all, a liberal image of man as 
an autonomous health care consumer who can decide in freedom how he/she wants 
to manage his/her health, using the increasing medical knowledge that originates 
from an enormous data explosion.32 “One big revolution in medicine is that we will 
create massive amounts of digital data for the ‘quantified self’ of each individual 
that will transform our ability to monitor and optimize our own wellness” (Hood and 
Flores 2012: 616).
 These unexpressed premises were made explicit and questioned in the 
information for the panel members. Do people even want to take responsibility of 
their health in the way that Michael Snyder did? Are they able to do so? Do they 
accept the responsibility of making their biological information available? Do suitable 
lifestyle interventions which deliver health improvement even exist (report panel)?
A few days ahead of the public deliberation (see Figure 6.1) the panel members 
received a script (Appendix F), a document with instructions and a timeline of events 
they could expect to happen during the deliberation. The instructions contained 
“cues for appropriate behavior” for the characters in the play (Hajer 2005: 631). The 
dialogue is a “critical exploration of the issues surrounding the potential future broad 
application of systems biological technologies (like iPOPs) in the (preventive) health 
care of diabetes. The aim of the informative text is to enlighten you all as well as 
possible about the issue. The short sketch of the future [...] is the starting point of 
the conversation: what does this vision of the future of preventive or P4 Health and 
Care evoke in you?” (script panel members).
 My preparation as the facilitator followed a more detailed script. Since the panel 
32 “The ‘data explosion’ requires that new analytic tools be created for capturing, 
validating, storing, mining, integrating and finally modeling all of these biological data 
sets – thus helping to convert them into knowledge,” (Hood and Flores 2012: 616).
members’ positions with regard to the desirability issues were not fully known, the 
dialogue would start off with making an inventory. Participants would be asked to 
articulate one, and no more than one, issue. With this choice I wanted to move the 
participants to really consider which issues they thought were worth discussing. 
Discussions about the statements or the articulated issues would not be allowed in 
this stage, to prevent the deliberation from starting off too arbitrarily. The inventory 
round also had to promote equal participation: everyone should get an equal chance 
to have their say. Thus, I wanted to prevent the bias that the public deliberation on 
ADHD had characterized (see Section 5.2).
 The two life scientists were to begin the inventory. The goal was to position 
them as advocates of P4 medicine and to allocate the burden of proof to them 
in accordance with the basic assumptions of upstream public engagement. The 
deliberative interaction was scripted since the behavioral genetics case demonstrated 
that the visions of the life scientists were not critically discussed. In the preparatory 
conversations they had, after all, presented themselves as clear advocates of these 
technological developments (see Section 7.2).
 I also had the statements that were made in the inventory round projected on a 
screen. This served multiple purposes. It was to slow down the discussion, so people 
could really let the statements of the others get through to them. It would also offer 
an overview for the panel and for the audience.
 After the inventory, a prioritization was to follow. I wanted to give the panel 
members themselves control over and responsibility for the agenda. I suggested we 
would discuss the most controversial issue first. To that end, I would ask people to 
raise their hand if they agreed with the proposition or statement, for example “iPOP 
technology leads to more autonomy among health care consumers.” The issue that 
raised the most divergent opinions, would be the first to come up for discussion in 
the deliberation. A supporter of the statement would be asked to give arguments to 
support his or her point of view. Then, I would ask an opponent to substantiate why 
he or she disagreed with the statement. Then the floor would be open to all. The 
deliberation session would have an intermission as well. Not just for the participants, 
but also to give me, as the facilitator, the opportunity to analyze the discussion 
together with a colleague and, if necessary, give it a new direction.
 Apart from the script, the staging and setting also play an important role in the 
dramaturgy of public deliberation. I will discuss these in the final subsection.
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6.3.4 Staging and setting
The public deliberation would take place at a day and time that deviated from other 
public discussions organized at the LUX: a Friday afternoon, from 1 until 5 pm. This 
would give us more time for a profound deliberation than the usual Monday or 
Tuesday night. The past had shown that the audience certainly considered these 
nights, long working days notwithstanding, suitable for participation in or attendance 
of a public deliberation. The choice for the Friday afternoon broke this expectation, 
but was in a sense also obvious: for part-time workers, it is the most-used day off. A 
dialogue in the free weekend would, furthermore, ask for too much commitment.
 From the earliest moments in the preparations of the public deliberation onwards 
I chose for a clear staging: the life scientists, audience and experts in the panel would 
“chiefly be active participants” in the dialogue (set-up dialogue 5 April 2013). To 
nevertheless answer the principle of publicity, an important normative principle in 
the theory of deliberative democracy (Section 2.3.2.) the deliberation would take 
place in a public setting to be “freely accessible to anyone” (ibid.). For that reason 
LUX, a recognizable public theater, was chosen. As such, the panel discussion got a 
public gallery. An extensive publicity campaign was to fill this gallery. This staging 
with a clear “distinction between active players and (presumably passive) audiences” 
(Hajer 2005: 631) thus created a clear division of labor, which I considered necessary 
due to the extensive preparations and the size of the panel.
 The only room that was available on the day of the deliberation – a theater 
with a level floor – allowed me to accentuate this division of functions between 
the observing audience and the actors. The lighting plan would also support the 
staging, by putting the stage and the panelists in the spotlight, and by obscuring 
the audience. Even the presence of a camera was an influence on the staging. On 
one hand, the extra light that was needed to guarantee video recordings for the 
study partially negated the lighting plan. On the other hand, the camera increased 
the distance between spectators in the auditorium and panel members on stage, 
because, as the observer noticed, the audience took their seats behind the camera 
(observations Observer B).
 Everyone on stage got their own headset microphones. Not just for their audibility 
for the audience and for the recordings, but also to give each panel member an 
equal chance of participation, and to allow the discussion to run a “natural” course 
(interruptions included). The volume of my own microphone had to allow me, 
as the facilitator, to be heard louder than everyone else, in case multiple people 
would start to talk at the same time. This technology did cause a trade-off between 
the participants’ freedom of movement on stage and their audibility. To adapt a 
speaker’s volume on the spot, if necessary, the technician had to know directly, at all 
times, who was speaking and which slide to move on the mixing panel. To that end, 
everyone got a fixed position on the stage. Having the participants demonstrate their 
differences in opinion by moving around the stage (something I considered during 
the preparation) no longer was a possibility.
 Thus, the panel members would sit on chairs in a semicircle on the stage. This 
was to allow them to make eye contact with whomever they ended up debating, 
without having to turn their backs on the audience. The benefit of fixed seats was 
that everyone could be given a name tag, so that the audience could immediately tell 
who was talking.
In the run-up to the deliberation date, this staging came to be called into question. 
The overview of the sold tickets and the reservations (and the names of the visitors), 
generated by the automatic ticket module on the LUX website to monitor the 
expected audience attendance, revealed names of people who might just as well 
have been panel members themselves. The division of panel members on the stage 
and an onlooking audience proved artificial. For that reason, I decided to allow for 
contributions from the audience at fixed moments during the deliberation.
 Furthermore, the audience had to be provided with information, because it 
could not be ruled out beforehand that they would be too little in the know about 
the theme. The audience had to catch up on iPOP, P4 medicine and health, and the 
problems it was to solve, in a relatively short amount of time (ten minutes). To ensure 
neutrality here as well, I made a presentation in the form of a video with a voice-
over, in order to prevent the audience and panel members from considering me 
the author of the presented sociotechnical imaginaries. The video ended with the 
scenario, the starting point of the discussion.
 Eight out of thirteen panel members supported the choice for this staging. “Why 
invite a panel if you are not distinguishing between panel and audience?” One of 
the diabetes patients did remark that such a division is only possible as long as 
“the audience is not more knowledgeable than the panel.”  Others thought it was 
“a pity” that the audience had little opportunity to participate, or saw the staging 
as “artificial,” “considering the disappointing number of visitors. Especially in this 
setting it would be interesting to offer the stage up as a platform for the audience, 
and approach the panel members as experts on the matter,” wrote one of the young 
politicians.
 The audience had varying opinions as well. Some had expected more room to 
contribute because that had been “announced,” or thought the scant contributions 
of the audience “unpleasant.” Others were used to “little interaction between panel 
and audience.” A 60 year-old woman who described herself as a “citizen who is 
generally interested in technological developments” felt that “the debates [at the 
LUX] are too tightly organized at present.” Yet another group of audience members 
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(about half), on the contrary, were positive about the staging because the discussion 
otherwise “might [have become] chaotic” or “too wide.”  A 27 year-old man who 
studies the social aspects of new technologies cast doubts about the contributions 
that were made by the audience: “It felt more like a workshop that had an audience. 
Which I, by the way, did not find annoying. Personally, I’m not a fan of audience input, 
since [...] people from the audience usually start talking about themselves and/or 
formulate their questions badly” (questionnaires). As was described in Chapter 5, 
some members of the public tend to depreciate the contributions of non-experts.
6.4 Conclusions
Maarten Hajer (2005) asked for people to take notice of the performative character 
of public deliberation. By viewing deliberation as staged performances, a new 
perspective is given on the quality of deliberative processes. It is not only about 
the argumentation that is used, but also about the conditions within which these 
discursive actions take place. How does the design of the setting affect “what is said, 
what can be said, and what can be said with influence?” (p. 624). In short, Hajer asks 
for attention for the dramaturgy of public deliberation. In this chapter, I have put the 
dramaturgical work done back stage to design an upstream public deliberation event 
on NEST centre stage.
 The first part of the work behind the scenes consisted of a critical assessment 
of the sociotechnical imaginaries of P4 medicine and iPOP technology. As argued 
in Chapter 5, such an assessment is an important tool for facilitators of upstream 
public deliberation on NEST to anticipate claims about technological feasibility, social 
usability and moral desirability of new technologies. From the discursive analysis 
it can be concluded that the moral argumentation of advocates of P4 medicine 
coincides with a minimally liberal bio-ethics (with its emphasis on the autonomy 
principle and its instrumentalist tendency). In Chapter 7 I will demonstrate how this 
liberal idea of future health care was contested from a more social perspective.
 The focus of this chapter, however, was the ethnographical reconstruction of the 
practice of organizing public deliberation about new science and technology. This 
ethnography reveals the dramaturgical dimension of the work behind the scenes: 
the scripting, staging and setting of a deliberative drama. I consider it as a study in 
empirical philosophy (cf. Mol 2000) that has an “ethnographic interest in practice” to 
uncover “the practical entanglement of abstract concepts” which “shows how such 
entanglement produces specific effects” (Bruun Jensen 2005: 222).
 In the above-mentioned description it becomes clear that the dramaturgical 
work for upstream public deliberation is a practical entanglement in the execution 
of different norms and criteria for input (inclusiveness, independence and early 
involvement) and throughput legitimacy (dialectical quality of the deliberation), 
as discussed in Chapter 2 (esp. Section 2.4.1). The dramaturgical work consists of 
making trade-offs between these criteria repeatedly, which affects what can and 
cannot be said as well as how participants evaluate the quality of deliberation.
 The first preparatory phase concerns finding a relevant and urgent issue that has 
the power to mobilize an audience. A current technoscientific development that is 
sufficiently plausible. One that will potentially have huge consequences is morally 
uncertain and potentially controversial, but that is in an early enough stage to still 
be influenced. Although I considered the iPOP and P4 medicine and health such a 
development, others considered them too premature. Despite the eventual rather 
low public attendance, the issue mobilized a broad and diverse panel.
 The delineation of the issue was also deemed important for the engagement of 
the implicated public. At the same time, the framing determines what will not be 
discussed. Yes to moral desirability, no to implementation. Yes to personal genome 
screening of common diseases, no to pre-implantation genetic screening. Yes to 
adults, no to children (as in the scenario). Yes to diabetes, no to cardiovascular 
diseases and, therefore, no to the cumulative effects of P4 medicine. Nevertheless, 
the focus made the issue maneuverable enough to start a targeted search for a 
collaboration partner and a public.
 The composition of the cast displays internal tensions. Firstly, the organizer has 
only a limited measure of control on who does and does not participate. The panel 
is the result of a contingent process that depends on negotiations with the speakers 
and the collaboration partner, the geographical location, and unexpected events 
(e.g. illness). Secondly, the choice for an orderly mini-public for active participation 
and high deliberative quality is at odds with inclusiveness and participation. 
The inclusiveness proved to be at issue, since the panel members (as well as the 
audience) were primarily well-educated; a lesser educated public was excluded. The 
participation decreased because it was decided that there would be a clear staging 
of the panel as active players on the stage on one hand and a passive public in the 
auditorium on the other hand. The opinions of the public about this staging reflect 
this trade-off. Some mourned the lack of interaction, while others appreciated the 
orderly course and the profound conversation.
 The preparation of the contents strengthened this chosen strategy. Extensively 
informing the mini-public beforehand gave them an intrinsic head start, which did 
not stimulate the participation of the audience. Even so, the passive audience was 
a necessary prerequisite for realizing a public setting and answering the principle of 
publicity. The preparation of the contents did, however, induce further compromises. 
I carried out a discourse analysis of the expectations for the future and the (moral) 
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lines of reasoning, not just to provide the panel members in advance with a shared 
starting point, but also to increase the dialect quality of the deliberation: to make tacit 
premises explicit, to ask critical questions, and to explore all NEST-ethical issues. At 
the same time, every intrinsic intervention increases the risk of losing independence. 
The authorship of the scenario that “was lousy with presuppositions,” for example, 
was attributed to me, despite the carefully chosen footing of the written information 
and availability of all read sources (transparency and resource accessibility). The 
disputable presuppositions were specifically needed for the discussion.
 Even the technology that was used mediated the performance of the participants. 
The research setting interfered with the discussion setting because the camera 
increased the audience’s distance from the panel. The microphones that were 
needed to get audio recordings made it impossible to move freely around on stage.
 In Chapter 2 I wrote that public deliberation sessions are experiments with 
unexpected effects (see Section 2.5.1). An ethnography of the dramaturgical work 
underlines the experimental character and displays the divided views on quality. 
It furthermore casts a light on the countless choices, compromises and tensions in 
the practice of the organization of a dialogue, which remain mostly invisible in the 
theoretical and conceptual work of deliberative democracy. An understanding of the 
“normative surfeit” (Zuiderent 2007) of this practice is essential for the sensitization 
of dialogue organizers and participants to improve, respectively, their dramaturgy 
and performance.
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7.1 Introduction
A Friday afternoon in October, a few minutes before 1 p.m., debating center LUX:
Room 6 most closely resembles a television studio, right before a broadcast. 
On the non-elevated floor there are a mixing console and a jumble of cables. 
A sound technician turns switches while his colleague sticks a theater 
microphone to the cheek of a man who is wearing a suit and striking green 
pointed shoes. “Can you say something, so we can get the right volume?” 
On the big screen on the rear wall, a wandering camera image appears. 
One by one, the people on stage who have already been outfitted with 
microphones appear, magnified on the enormous screen, chatting easily.
 Then, people start shuffling into the room, a bit ill at ease. They pause for 
a moment and ponder the situation. Then, they pick a seat behind the 
camera that is positioned prominently in the middle of the stands. Their 
chairs offer a view on the big screen that shows the words: “An iPOP for 
everyone? Is preventing diabetes better than curing it?” They see how the 
people on the floor are slowly starting to occupy the seats on the first few 
rows. Seventeen chairs remain unoccupied on stage,  set up in the shape 
of a crescent. The white color of chair backs lights up bright orange  in the 
shine of the theater lights. Only when a man walks onto the stage and his 
amplified voice fills the room, the conversations in the room fall silent.
 “Ladies and gentleman,  I bid you a warm welcome at the LUX. [...] My 
name is KD. I am the facilitator of – I can call it that – an experiment. At 
least, this is the first time I am putting this many people on a stage. [...] If 
you were to summarize the theme in one question, or in a number of short, 
concise questions, then today’s discussion is about: Will new technologies 
change the looming trend of ever more diabetics in the Netherlands? And 
what is responsible application of those technologies? [...] Today we try 
to critically explore  the promise that lies in the term “P4 medicine,” or 
P4 medicine. [...] To see what those promises entail, and to [...] explore 
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those critically. How advisable are these developments in health care?”
[ transcript iPOP ]
The scene that was described above marks the transition from the last preparations 
backstage – such as sticking on theater microphones – to the public performance front 
stage, which starts with the announcement of the facilitator of the public discussion 
that is about to start. In the previous chapter, I have discussed the dramaturgical work 
that was carried out behind the scenes for setting up a critical public deliberation 
about the desirability of the Integrative Personalized Omics Profile (iPOP). In this 
chapter, I will analyze the discursive effects on the deliberation as a result of the 
interventions that were, a) part of the preparatory dramaturgical work off-stage and, 
and b)  part of the work as facilitator during the public deliberation on stage.
 As was discussed in Chapter 6, the first backstage intervention was an extensive 
vision assessment to investigate the plausibility of three interrelated types of claims 
about the future. I deemed such a vision assessment an important strategy to a) 
investigate the plausibility of claims about the technological feasibility (specifically 
the unfeasibility) of new technologies that could make a critical discussion about 
moral desirability issues impossible from the very start (as turned out to be the case 
with the public discussions about behavioral genetics; see Chapter 5); b)  identify 
possible contexts of use or implementation (social usability) which partially define 
which desirability issues are relevant; c) systematically map the moral justifications 
(moral desirability) in the sociotechnical imaginaries surrounding P4 medicine (Type 
2 Diabetes in particular), using the stock topics (NEST-ethics and critical questions) 
that were discussed in Chapter 3, in order to be able to subject these visions to a 
critical public investigation: making the unexpressed premises explicit, identifying 
the propositional content of claims, and formulating critical questions in anticipation 
of possible public issues (see Section 6.3.3).
 This vision assessment demonstrated that the moral argumentations of advocates 
of this new technology are grafted onto a liberal bio-ethic. On one hand, advocates 
of P4 medicine strongly emphasize autonomy as a central medical-ethical value. On 
the other hand, they apply an instrumental rationality in which technologies like the 
iPOP are envisioned as neutral instruments to realize desirale goals (consequences) 
– (altering the course of increasing collective health care expenses, increasing 
individual health, etc.). In preparation for the public deliberation, all members of 
the mini-public were sent the results of the vision assessment beforehand, together 
with all sources used, to give them the opportunity to make their own analysis 
(transparency criterion).
 The second important backstage intervention concerned a modification of 
the script. Specific attention was paid, for example, to  casting, to the selection 
of characters in the play. Chapter 5 demonstrated the importance of the cast life 
scientists’ willingness to adopt their roles as advocates publicly. In extensive 
preliminary interviews with the invited life scientists, I investigated how their personal 
views on the future related to the sociotechnical imaginaries that surround P4 
medicine. In addition to that, it was made explicit in the script that the participating 
scientists would clearly be staged as advocates during the first round of deliberation 
– the inventory of issues. By inviting them to articulate their views on the moral 
desirability of P4, I tried to allocate the burden of proof to the scientists. The goal of 
the dialogue was, after all, to critically question their visions and the accompanying 
argumentations.
In this chapter, I present a discursive analysis of the strategic maneuvers of the 
participants in this upstream public deliberation session about the moral desirability 
of P4 technologies that I staged as a dramaturgist and guided as a facilitator. 
As in Chapter 5, I will focus on interactions in which the participating scientists 
were involved. I do, however, approach the analysis of the selected fragments 
symmetrically.
 When necessary for an optimal reconstruction of the argumentative discourse, 
I have also put the (philosophical) content of the discussion within a broader 
philosophical or social context. A discursive reconstruction of the deliberation shows 
that the liberally oriented sociotechnical imaginaries were criticized from a social 
perspective, just like in the philosophical and ethical literature. My analysis does 
indeed show that critics put the liberal perspective – with its emphasis on autonomy 
for the individual and instrumental rationality – up for discussion by drawing attention 
to solidarity and justice.
 Finally, I use ethnographic methods (participant observation and interviews) to 
write a “thick description” of the deliberative events at the LUX. In conversations 
after the discussion, I examined a selection of video fragments with the participating 
scientists. This gave me additional information about the goals they pursued, the 
roles they played, etc.1 All names of the participants are invented. Their  background 
is stated between parentheses each time, so the reader is clear on which social role 
the speaker personifies.
1 In order to maintain readability, I have often omitted quotation marks – even when 
what I write is often based on statements made in the conversations beforehand and 
afterwards.
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In Section 7.2, I analyze how the participating life scientists, cast because of their 
advocacy, maneuvered strategically to position themselves differently when 
they were staged as advocates. The discursive analysis shows how the scientists 
constructed a certain identity (subject positioning; see Secion 4.4.2) that differed 
from the intentions that were expressed backstage.
 In Sections 7.3 and 7.4 I analyze the strategic maneuvers in the discussions 
about the liberal moral reasoning that underlies the sociotechnical imaginaries of 
P4 medicine. In Section 7.3 I discuss the argumentative discourse in the discussion 
about the autonomy principle, while I analyze the argumentation about unintended 
consequences or side effects in Section 7.4. Here, too, the interviews with life 
scientist offer insights into the disparities between their front stage performance 
and their off stage behavior.
 In the conclusion (Section 7.5), I argue that the life scientists used impression 
management as a theatrical technique to be effective in the deliberation (Hilgartner 
2000; see Chapter 1). They tried to regulate the others’ perceptions of themselves 
and of P4 medicine without derailing (i.e. violating the dialectical rules of a critical 
discussion; see Section 3.2.2). The analysis also shows that the constructed public 
identity of the scientists is not static, but that it changes during the discussion under 
the influence of the situated interaction. Finally, I draw conclusions about what the 
strategic communication of the scientists does to the quality of public deliberation.
7.2 Staging the advocate
The starting point for the public deliberation about the iPOP was to let advocates of 
these new developments in science and technology explain the benefits in a public 
setting. The underlying thought was to allocate the burden of proof of explaining 
the desirability of a transition to P4 medicine to life scientists who are involved in 
realizing these sociotechnical imaginaries, or who at least implicitly endorse them. 
In Chapter 5, I already observed a bias in the public discussion about ADHD: the 
public was asked what they considered undesirable about the developments in 
behavioral genetics, which was a possible reason for a reserved attitude of the 
public (see Section 5.2). This bias fits what some commentators have called the 
dominant liberal discourse of science and technology developments (Swierstra and 
Te Molder 2012). At the center of this liberal discourse is the no-harm principle: as 
long as a new technology is not expected to do any obvious damage (hard impacts), 
technology developers do not have to publicly give a full explanation on the soft 
impacts (see Section 2.2).
 In accordance with the ideas of upstream public engagement (see Chapters 1 
and 2), the script of the public deliberation at the LUX tried to break  away from this 
discourse. According to the script, life scientists who work on these new technological 
developments would be staged as advocates who would explain which benefits they 
expected from P4 medicine. They would also be the first to speak in the inventory 
round. As was described in the previous chapter, all panel members were instructed 
to articulate no more than one issue that relates to something they find desirable 
or undesirable about this new technological development (see Section 6.3.3). In 
contrast to the other participants, the life scientists were not given the choice to 
explain what they found desirable or undesirable about this transition. They were 
only asked to name a benefit.
 In this section I contrast the presentations of the two life scientists in the private 
sphere of the preparatory interviews I had with them, with their public performances 
at the LUX in reaction to this staging as advocates, and my interventions as a facilitator. 
First, I will present the empirical material from the preliminary interviews. Then I 
will analyze their public performances in terms of strategic maneuvering, using the 
additional ethnographic material from the interviews afterwards to identify their 
rhetorical goals. I will do so for both life scientists individually.
Innovation director Davies had positioned himself as a socially responsible advocate 
of P4 medicine in the preliminary interview. He spoke about “we at TNO,” people who 
see it as their responsibility to contribute to solutions for social problems. Not standing 
in an ivory tower, but being led by society, tuning in to the government, to companies, 
but to the public as well. For, as a scientist, it is very easy to find solutions no one 
wants.2 Take the surgery robot. Costs three million euros. Every hospital wants one, 
but it hardly offers any improvements. The risk of a “technology push” is present for P4 
medicine and for the iPOP as well. “Look, we’ve got a nice new gadget that can measure 
yet another thing.” “Technicians expect a lot from P4 and the iPOP,” but do the people 
want this technological transition? Scientist should be open to that question. So Davies 
had seized the invitation to the dialogue as a means to show his responsiveness to the 
public’s needs. He feels, after all, that society makes these choices.
 Davies does, for that matter, anticipate that many people will be open to this 
technology and that they will embrace this transition. Personally, he is convinced that 
2 See here Davies performs boundary. He creates a distinction between techies in their 
ivory tower, indifferent to the wishes of the public, and  ““we at TNO”,” people who 
want to listen to the public’s ideas and needs. Once again, the relational aspect of 
subject positioning shows: Davies positions himself as a responsible innovation director 
by creating a contrast with the technician (see Sections 4.4.1 and 4.4.2).
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P4 medicine will benefit. His advocacy was most strongly expressed in a technological 
imperative: “I think we are morally obliged [to use it] it, as a society” (Interview 
1 Davies)...3 To diminish the burden of illness, to restructure health care costs, to 
increase citizen participation in society and in the process of labor. These are the 
benefits described in the TNO report Davies wants to propagate at the LUX (Wevers 
and Gijsbers 2012). “[In LUX] I would like to contribute to creating a picture of the 
areas in which it can be beneficial.” However, this is how Davies responded during 
the inventory round at the LUX:
ME: “I would like to start with Mr. Davies. [...] TNO has embraced this concept,  
so I thought: ‘It should not be hard for you to mention the most important 
desirable thing that makes this a good development.’”
DAVIES: “Yes, I see. Still, I wanted to mention an undesirable side.”
ME: “Gosh, instant rebellion.”
DAVIES: “Because the fact that we have embraced it of course does not mean that 
we see very many possibilities here, as TNO. We did not invent the concept, of 
course, but we have only adopted it from the United States and [we] advocate it 
in the Netherlands. But what we do fear is that there is going to be an enormous 
technology push. When you see all [the tests] that Mr. Snyder has performed 
on himself, [...] what he learns from that is enormous. But he could have simply 
[...] just measured his blood glucose and then he could have reached the 
same effects. So the question is whether you actively need the whole array of 
possibilities. So [...] we feel that implementing [current possibilities] is at least 
as important, so that the patient and the human really benefit. And what is also 
important: all knowledge that is gathered should be useable. Knowing without 
being able to take action... The technology push, then, should not just be us 
throwing ever more knowledge into the ether. People should be able to use it.”
ME: “So, no technology push? That is an undesirable thing?”
DAVIES: “Yes.”
ME: “But I’m sure you could mention something which makes you say: ‘Well, 
this is a good development after all.’ TNO did not endorse it for no reason.”
DAVIES: “The fact that we diagnose many diseases on the basis of symptoms 
right now and not [...] on basis of the underlying biology offers many 
3 In a certain sense, this technological imperative is the positively phrased version of 
a claim that is often heard in NEST-ethical discussions: “It would be unethical to not 
develop this technology.”
opportunities to offer people more focused prevention, but also to 
take therapeutic action. So more knowledge can lead to better results 
and hopefully to lower costs, provided you know what to do.”
ME: “Health gains.”
DAVIES: “Yes.”
ME: “And I  heard you mention a [second benefit], too: lower costs.”
DAVIES: “Ideally, yes.”
ME: “Ideally, but do you believe in it? Is it really that, ‘Yes, I do believe 
that it will eventually enable lower costs in health care?’”‘“
DAVIES: “Yes, I do believe in that, but not if you set 
unleash everything on everything.”
[ excerpt 7.1 ]
As facilitator, I try to stage Davies as an advocate (“it should not be difficult for you 
to mention something desirable”). But he does not take up his role as an advocate. 
He is the first speaker and he does not yet know the positions of the others. 
Furthermore, he wants to prevent being seen as a “geek” (Interview 2). The night 
before the deliberation, Davies had once more read all articles in the information 
package that was sent to all panel members in preparation. Mike Snyder’s article 
(Chen and Snyder 2012) had made him think: “It is very overblown” (Interview 2). 
An exaggeration of the expectations will only hurt the matter. People give up when 
there’s overpromising. So he tempers the expectations (mitigation strategies; see 
Section 4.3).
 First of all, he “rebels” against the ’facilitator’s instructions. Davies first wants 
to mention something undesirable, to “indicate that you’ve considered both sides” 
(Interview 2). Furthermore, he changes the footing to somewhat dissociate himself 
from the future visions of P4 (see Section 4.3). Davies makes it clear that TNO is 
not the author of these imaginaries, but at most the animator (“We did not invent 
the term, of course”). He also puts his own role (“only adopted it from the US”) 
and agency (“what we do fear is that there is going to be a technology push”) in 
perspective. Davies further distances himself from technician Snyder by doubting 
the need for the iPOP. Snyder could have just used a glucose meter, couldn’t he? And 
what is the use of measuring just to measure (“throwing ever more knowledge into 
the ether”), without the ability to use that knowledge?
 In the end, an intervention by the facilitator is necessary to make Davies designate 
two desirable consequences of P4 using pragmatic argumentation: P4 technologies 
such as the iPOP will lead to a more focused prevention and treatment, and to lower 
health care costs.
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Stokes also presented himself as a different character on stage than he did in the 
preliminary interview. During the interview, Stokes had unequivocally positioned 
himself as an advocate of new technologies in the life sciences. “I am very much 
in favor of actually using this kind of [technology]” (Interview 1). He endorses the 
subject category of missionary that I used to summarize his position. Stokes wants 
to persuade people to use new technologies  – such as personal genome sequencing 
and the iPOP. He considers the deliberation successful “if there is even one person 
who asks about getting themselves screened [after the discussion at the LUX]. At 
the DNA, RNA, whatever level, I mean. And it would really be great if that person, 
or someone else, would actually do it. So they’d send their saliva or blood in for an 
analysis, simply because they want to know more [about their health]” (Interview 1).
 At the same time, Stokes portrays himself as a member of the scientific community 
who are constructing a very probable, nearby and beneficial future (see Section 
4.4.3). “We scientists, we doctors” are working “on technologies that will enable 
a decision about [health improvement] within five or ten years.” The function he 
envisions for the discussion at the LUX is to prepare the public for these technological 
developments. Hence his message: “And what’s specifically going to happen, and 
that is probably going to be my standpoint in the discussion, is that we have to be 
able to deal with more uncertainty instead of less uncertainty” (Interview 1). As 
opposed to clinical genetics, new tests – such as the iPOP – won’t give any “black 
or white answers,” no clear results. This drawback does not, however, outweigh the 
great advantage of having more autonomy than before in making decisions about 
your own health. “Where we’re heading [...] is a place where  everyone [...] has the 
autonomy or the right to [...] check and govern their own health [...]. That is where 
these instruments help, and not to give more black or white answers” (ibid.).
ME: “Mr. Stokes. [You are] employed at Centre X. With you, I also thought: 
‘You are probably able to mention a desirable thing.’ […]”
STOKES: “Yes, we do a lot of work with reading DNA. Specifically the DNA of 
patients who come to us [...] on a clinical indication. And that is still the line 
of action in the current health care system. I agree with the desirability of 
adding some more molecular measurements to that. I think I see this as a 
desirable development. One thing that is very important to me, I think, or for 
us, is that an awareness will develop that the iPOPs, the sequencers and the 
other variations you mentioned, will not necessarily lead to a clear-cut answer. 
They will not necessarily lead to more certainty, but they will lead to a kind of 
autonomy in decisions you might take on the basis of certain insecurities.”
ME: “Okay, so I’m hearing two things. On the one hand, 
there’s more insecurity. Is that something...”
STOKES: “At least, there’s more information that is not necessarily more certain.”
ME: “Not necessarily more certain. And that is something 
that makes you say: ‘Yes, this is a good thing?’”
STOKES: “I think so. Because you make decisions...”
RILEY (philosopher): “And yet there’ll be more autonomy?”
ME: “Okay. Let’s first try to gather [...]. So there will be more uncertainty, 
but this enables people, at the same time, to take more autonomy 
about their health. I do understand that correctly, right? Okay.”
[ excerpt 7.2 ]
Although I try to stage Stokes as an advocate as well, he mainly positions himself 
“as a technician,” a role he says he had already chosen for himself ahead of the 
discussion at the LUX (Interview 2). The divide between active members of the 
mini-public and the audience as part of the dialogue’s staging had further amplified 
that perception of his role: “The panel members sit there [on stage] as experts. [...] 
[T]he public, the audience, would like to hear from the experts how it works or what 
is going on.” (ibid.).
 As an expert, Stokes immediately wants to adjust a public perception of the new 
biomedical technologies in the public discussion: “One thing that is very important 
to me, I think, or for us, is that an awareness will develop that the iPOPs [...] will not 
necessarily lead to a clear-cut answer.” Who are the “us” he is referring to? And why 
is it so important to speak for this “us” instead of for “me” (he does, after all, correct 
himself)? Stokes considers it important to emphasize that this statement is not his 
personal opinion, “not something I’ve thought up on the spot” (Interview 2). No, 
Stokes speaks for a collective of eight Dutch clinical-genetic centers with scientists, 
clinical geneticists, lab specialists, and bio information scientists. In this manner, he 
tries to give his statement the status of an expert opinion that represents a wide 
scientific consensus in this field. This makes it difficult for others (outsiders) to deny 
it. The use of “us” suggests a group of experts that is marked off from other groups 
(boundary work; see Section 4.4.1).
 Why is it so important that people come to realize this? Stokes immediately tries 
to refute an important premise that is presupposed by critics in discussion about new 
P4 technologies. “The ‘measuring means knowing’ adage is rather dominant. [...] The 
assumption in all discussions about this [ethical issues], whether it concerns health 
insurance companies or the government or politics or whoever will use it [biomedical 
information], is that it is indeed a sort of, well, absolute certainty. And that is “where 
[the debate] fails “ (interview 2). When privacy was mentioned as an issue later on in 
the discussion, Stokes posited that statement (see Section 7.4).
  Despite the emphasis Stokes puts on this message, he also appeals to 
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the autonomy principle as an argument to indicate that these technological 
developments are desirable. This directly incites a discussion. Before Stokes even 
gets to finish his sentence, Riley (philosopher) reacts. He mutters, “And yet there’ll 
be more autonomy?” frowns his brow to express his incomprehension, and shakes 
his head (video). I nip that discussion in the bud.4 I want to follow the script and 
take inventory first, and I summarize Stokes’ position once more. His most important 
argument was given.
This analysis shows that both scientists constructed a different identity in public than 
in the preliminary interviews, even though (or perhaps because?) they were staged 
as advocates. They used different strategic maneuvers to reach that goal. Davies 
positioned himself intentionally (see Section 4.4.2) as a nuanced scientist who is able 
to indicate the undesirable sides of this technological development, in order to distance 
himself from “geeks” (boundary work). In this way, Davies attempted to prevent a 
public resistance against the overblown sociotechnical imaginaries of P4 as envisioned 
by Snyder et al. Only after an intervention of the facilitator was Davies willing to 
substantiate what he thinks is desirable about the transition towards P4 medicine.
 Davies’ performance had several effects. McCann (health care professional) 
thought he was “far more nuanced than the panel chairman tried to depict him” 
(survey panel). Someone in the audience wrote that “he didn’t let himself be tricked 
into making statements” (survey audience). On others, Davies made a different 
impression. “Surprisingly enough, he was not able to substantiate TNO’s choice to 
invest in this” (survey audience). The philosopher in the panel called him “rather 
ambiguous”, and felt that he “sometimes almost sounded like he was against 
it” (survey panel). In hindsight, Davies himself feels that he “tried to be a bit too 
nuanced” in his attempt to cast off his role as an advocate (Interview 2).
Stokes had considered his role in advance and decided to take the role of expert. 
This subject position was decidedly different from the missionary [he was] backstage. 
By appealing to a collective “us,” he constructs his identity as an expert in a field 
that is marked off from outsiders who hold a dubious premise in discussions about 
social issues concerning NEST in the life sciences. Both the public and the other panel 
members recognized Stokes’ positioning as an expert, although that was appreciated 
in various ways. A panel member: “He took the right position as a scientist” (survey 
4 Later on, when philosopher Riley makes his own contribution to the inventory round, 
he directly responds to Stokes’ words. In Section 7.3 I will discuss this more extensively.
panel). Someone in the audience considered his contribution “useful background 
information” (survey audience). Others considered his contribution as a “real techie”, 
on the other hand, “mediocre” and “a bit (exaggerated?) in the ‘I am a neutral 
scientist’-role and ‘it is up to politics/society to decide’” (Survey audience).
 Some even thought that “industry and bioscience lacked” from the panel (ibid.). 
These reactions show that the clear staging as an advocate did not work out for 
everyone. The reserved attitudes of Davies and Stokes furthermore incited the 
advocacy of fellow scientist Nick Havers, who responded to criticism about these 
technological developments from the audience (see Section 7.4).
 Nevertheless, my interventions led to the achievement of the inventory round’s 
primary goal: the gathering of the arguments the life scientists use defend the moral 
desirability of these new technological developments. These arguments were to be 
critically examined in the deliberation phase.
7.3 Discussing autonomy
During his contribution to the inventory round, Stokes appealed to the autonomy 
principle to defend the desirability of the developments in P4 medicine . His reasoning 
resonates with the sociotechnical imaginaries of P4 medicine that emphasize that 
the iPOP is an instrument that enables individual health care consumers to be in 
charge of their own health (more) (see Section 6.3.3: moral desirability). Stokes 
selected the deontological topos of the autonomy principle to argue for the 
desirability of the developments in P4 medicine (Excerpt 7.2). As was described in 
Section 4.2.2, the topical selection in the argumentation phase includes the choice 
for the argumentation scheme or topos that discussants consider most effective in 
supporting their point of view. Since autonomy is a central value in medical ethics, 
the choice for this topos is obvious: more personal direction would obviously be 
appealing to people (audience demand). Stoke’s topical selection did indeed quickly 
strike a sympathetic note with other members of the panel. Boles (diabetes patient) 
echoed for example “that it means you can take the reins, that you can manage your 
own health”, and “that you can take responsibility for your own health” (Discussion). 
Briggs (science communicator and co-author of a liberalist ethical exploration) said 
“it was enormously welcome” that the “autonomy and own responsibility of citizens” 
would be increased if the iPOP “would deliver practical medical information to which 
you can adapt your health and your lifestyle” (Discussion).
 Yet, from the first discussion round onwards, opinions about Stokes’ standpoint 
and argumentation differed. As was mentioned before, Riley (philosopher) 
immediately responded to his statements with a rhetorical question (“And yet there’ll 
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be more autonomy?” Excerpt 7.2). When the issues from the first discussion round 
were prioritized (see Section 6.3.4 about script), the autonomy issue proved most 
debatable. While both life scientists (Davies and Stokes), both diabetes patients, the 
general practitioner, and two out of three liberals had raised their hands to indicate 
that they agreed with the statement that the iPOP technologies would increase 
autonomy, the others were less certain (video).
 In this section, I zoom in on the discussion about autonomy. Not so much 
because this issue proved most controversial, but to demonstrate how life scientist 
Stokes reacted when his own chosen topos was brought up for discussion. I will first 
briefly elaborate the concept of autonomy with the aid of philosophical literature. 
The context of philosophical literature and the analysis of the autonomy principle 
allow me to make explicit the unexpressed premises (indicated with Roman numerals 
i, ii, iii, etc.) that are necessary for making a reconstruction of the argumentative 
discourse that is as complete as possible. First, it will become clear how the different 
speech acts of the panel members can be interpreted as contributions to the 
discussion about autonomy, and how the opinions about autonomy differed. Second, 
I can demonstrate that my interventions as facilitator offered Stokes enough space to 
develop an evasive discussion strategy without derailing.
Autonomy is a complex philosophical concept with many different meanings 
(Arpaly 2003), as became apparent during the public deliberation at the LUX (see 
below). According to a well-known definition, people are autonomous “when their 
decisions and actions are their own; when they are self-determining” (Dworkin 1988: 
13). Autonomy as self-determination can be characterized as the capacity to act or to 
live according to one’s own values, principles and rules.
 According to Barnhill and King (2013), this notion of autonomy requires, first of all, 
a form of liberty: it requires that you have (treatment) options to choose freely from 
(i) and that nothing or no one external forces or limits you to choose between these 
options (ii). Secondly, it is presumed that you are able to get access to information 
that provides you with insights in your (health) condition (iii), and that you want to 
have access to this information (iv). Indeed, within the context of predictive genetic 
testing, some autonomy protagonists place a lot of emphasis on the right to know 
and the right to (health) information: this information may not be withheld from 
people.5 In this approach, the acquisition of more information (of any kind) is simply 
equated with increasing autonomy (v) without further problematizing the nature of 
the information6, an assumption philosopher Riley immediately called into question. 
Hildt (2009) calls this a “narrow conception of autonomy”, an approach that tends 
to “uncritically broaden the use of genetic tests” (151). As Boles (diabetic) already 
announced in the inventory round: “I want to know everything” (Discussion).
 Secondly, Barnhill and King deem a certain level of understanding of this 
information necessary: you have to be able to understand the significance this 
information has in your life (vi) and you have to be able to comprehend what the 
consequences of your choice are (vii). Thirdly, the autonomy principle presumes a 
(psychological) capacity: that, subsequently, you are able to make a well-considered 
decision in accordance with you own values, and that you also do what you have 
decided, without being impeded or limited (by, for example, an addiction, social 
values, or influences from your environment) (viii). This description of the autonomy 
principle still leaves room to decide to not use the information about your (future) 
health state, while the sociotechnical imaginaries of P4 presume that the rational 
individual always use the test results for their health management (ix).
 Autonomy as described above, then, denotes a quality of individuals, one which 
they have to a larger or smaller extent, based on how many of these conditions have 
been fulfilled. In liberal ethics, it is often presumed that people do actively possess 
this quality to an adequate extent (as long as they are free to choose, and possess 
sufficient correct information). In the liberally oriented sociotechnical imaginaries of 
P4 medicine, then, many of the above-mentioned assumptions are (tacitly) endorsed 
(see Section 6.3.3; see also info report Appendix E). But “the view that people are 
5 Some advocates of the right to know even argue for a duty to know, which directly 
pressurizes the freedom - and, with that, the autonomy - of individuals. In one of 
the reports used in the vision assessment (see Section 6.3.3), such a duty to now is 
suggested. “When good treatment options exist [...] and the costs of treatment at a 
later stage [...] are much higher, the right to not know is subordinate to other interests. 
In these cases, there are often clear detrimental consequences if someone was to call 
upon his right not to know. The no-harm principle is the foremost limitation of the 
individual freedom. Health care is, after all, financed with public means. If treatment 
in a later stage is significantly more expensive, the person does not have the right of 
not-knowing. In many cases, liberals do not acknowledge the right of not-knowing,” (De 
Haan et al 2010: 42).
6 “In this approach the information gained by [predictive] genetic testing [and personal 
omics profiling] is prioritized, the tendency being to equate the acquisition of 
information with increased autonomy (Hildt 2009: 151; additions KD).”
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always autonomous should be considered a descriptive statement that is debatable” 
(Ten Have et al. 2009: 81). Critics of this liberal autonomy principle have, after all, 
pointed out that people are to some extent socially and culturally determined and. 
Furthermore people who have a chronic illness (such as diabetes) cannot always 
demonstrate autonomy.
 Autonomy as a demonstrable quality (descriptive) should, however, be 
distinguished from autonomy as a value (normative) to be pursued. Autonomy as 
a value does, after all, express the desirability of people forming their own lives 
according to their own values. The assumption that more autonomy is always 
desirable (x) cannot, however, always be assumed. Since an individual cannot not 
decide, “an autonomous individual [...] is constantly working on self-determination: 
he constantly has to choose whether or not to do something” (Ten Have et al. 
2009: 81). Deciding about everything is unfeasible. Furthermore, medical ethics has 
other important values, besides autonomy, which sometimes need to be balanced 
against each other.
With this short philosophical survey, I can make evident how the panel members 
in their various contributions to the deliberation at the LUX cast doubt on the 
propositional content of the aforementioned presuppositions of the liberal notion 
of autonomy. Hudd (research director of a patient organization), for example, called 
the availability of suitable treatment options into question (premise i), something 
he would repeat during the deliberation round. “All initiatives for being able to 
measure more, should go together with more developments to actually be able to 
do something with that data. And in that sense, [there is] a long road ahead. [...] 
Then you get the very undesirable situation in which you do know that something is 
wrong, but you are unable to do anything about it” (Discussion).
 According to Hirst (board member obesity association), premises vi and vii are 
problematic. “For a number of people, monitoring their own health will be feasible, 
but by now, research has shown on all fronts that there is a very large group of 
people who find that difficult or who are not capable of doing so.” Mr. Kidd (general 
practitioner) complements her argument. People cannot or will not deal with their 
health care problems (premise iv). “I am a General Practitioner and as such, I see 
highly overweight people on a daily basis, [who are] from lower social classes as well. 
People who are very hard to reach. They come to me during my office hours for other 
things, but this is one thing you can never really discuss properly. And how can you 
persuade those people to lose weight?”
 Dr. Goldberg (diabetologist) doubts whether people possess enough psychological 
capacity, and draws a parallel to smoking (premise viii). “My mother had diabetes, so 
I have a higher risk of getting it as well. [...] But does that really mean I will drastically 
change my behavior? So: does it help when you know something? And I think we 
see that every day, with smoking. No matter what is written on a pack, people do 
not change their behavior. So if you have a nice iPOP but are unable to adjust your 
behavior accordingly, it will be a lot more complicated.”
 Others think that new, widely accepted social norms to monitor your health will 
do the exact opposite and limit the freedom of individuals (premise ii). Sands (young 
liberal politician), for example, did call into question Stokes’ argumentation. Is the 
autonomy principle really unambiguously applicable to the situation (see Section 
3.4.2 on deontological argumentation)? Does the right to autonomy not also mean 
that you have a right of not-knowing, and that you have the right not to use the 
information (premise ix)? She hinted at an imposed duty to know for everyone, by 
making an analogy with people in the Netherlands who do not participate in the 
vaccination program for religious reasons: “Here in the Netherlands, you can choose, 
for example, to not have your children vaccinated. And we say of those people in the 
“black stockings-area” [geographical area of mainly protestant Christians]: they don’t 
let their children be inoculated. They are in general reviled. Will that not be the same 
for the iPOP in the future? If you don’t get an iPOP made, will you be doing wrong?” 
7 Foster (diabetes patient) talked about the “pressure in your life” when “you don’t 
live according to the new rules that are necessary with this affliction.”
In the discussion round, the differences of opinion were further explored. Despite 
the aforementioned objections, patient Boles emphasized the narrow perspective 
on autonomy by an appeal to the right to information (cf. Hildt 2009). “I would really 
like to have the right to do things myself. So that is that freedom of choice. [...] It 
won’t surprise you that I am a proponent of the right to self-determination, but I 
just feel that I have the right to know, and I also feel that I have the right to use it. 
[...] So, that autonomy. I just want to be in charge myself” (Discussion). She equates 
an increasing amount of information with increasing autonomy (premise v). And she 
sees autonomy as freedom of choice.
 This provokes another reaction from philosopher Riley. He explicitly positions 
himself as a philosopher (“As a philosopher I am required to say something about 
that, I think”), who sees it as his role to put the autonomy principle itself up for 
discussion. He criticizes this narrow “neoliberal” view of autonomy as freedom of 
7 In this matter, this liberal differed enormously from the other, who also explicitly 
proclaimed his affinity with the liberal body of thought. He says the right of not-
knowing is ultimately subordinate. See Hildt, who says that a right to know is 
interpreted by some as a duty to know (Hildt 2009).
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choice as a not really political autonomy (voice), since health care consumers have 
had little say in what health care products are offered. “You can only choose from 
what is on offer. And that is what we call autonomy? That is very, very narrow.” 
Furthermore, he emphasizes that autonomy as a value should not be overestimated 
(premise x). People’s happiness does not automatically increase with every new 
choice, as he substantiates with an argumentation by analogy: “As if our autonomy 
has increased now we can choose between very many different electricity companies 
and mobile phone providers. Well, I don’t know if anyone is really happy about that, 
but I rarely meet [those] people anyway.” 8
 As an ethicist, Webber also emphasizes the important of “clarifying the 
understanding of autonomy.” He makes a distinction between autonomy as freedom 
of choice and autonomy as self-control (“to have the control to direct your own 
life”). The ethicist assumes an intermediate position by endorsing philosopher Riley’s 
criticism on autonomy as freedom of choice, while also acknowledging that the iPOP 
could increase the self-control of people. Could, because “for very many people 
[this technology] will really not [offer] that [self-control]. You are only offering more 
information, more uncertainty.” According to Webber, not everyone will benefit from 
this new technology in equal measure, something which he finds, as he indicated 
earlier on in the discussion, unjust. I will discuss the justice issue more extensively in 
Section 7.4. Webber also brings the relationship between more (and more uncertain) 
information and more autonomy of the narrow conception up for discussion (premise 
v). “And then one really has to wonder if you could state in general terms [that] ‘this 
technology stimulates autonomy as [self]control’.”
In short: for many of the unexpressed premises of autonomy as a quality people 
have, the propositional content was disputed. Others asked critical questions which 
undermined the justificatory force of Stokes’ chosen topos. Does more unclear 
information not lead to less autonomy? Does autonomy not presuppose the right to 
not-knowing? Stokes still had not come into the discussion. With an intervention, I 
tried to make him choose a position in the ongoing discussion.
8 One could wonder to what extent the analogy between an energy providers and the 
making of health care choices applies (and, so, if Riley’s argumentation derails). As life 
scientist Davies later remarked in his interview after the debate, he feels that many 
people are willing to pore over information once it concerns something as important as 
their health, in order to make an autonomous choice on that basis.
ME: “You made a rather paradoxical remark by saying: ‘It increases the 
uncertainty’, but you still consider it desirable because it increases 
autonomy. What is your position in this discussion, then?”
STOKES: “Well, in the daily scientific practice I do see that that 
uncertainty really only increases when there is more information. 
With every question we solve, two more [questions] come up.
ME: “Yes, and how do people handle that? Or, when you say: ‘I see this in daily 
practice’, does that mean you see it with patients, or do you see it...?”
STOKES: “Yes. With patients, but also... Well, in all kinds of research subjects. The 
good thing about it is: it is not about me. So we have done a little experiment 
in the research group in which we asked: ‘We are now looking at the DNA of 
patients and we can read that they have got certain diseases. That’s all well 
and good. What would you do if it was you? Or if it was your mother? Then 
the realization suddenly dawned on us: ‘Wait a minute, this is not just about 
DNA anymore, this is about real patients.’ And then there is suddenly a lot of 
uncertainty. So the very certain statements we make.... that we try to make 
as scientists, those are suddenly very uncertain when we are talking about 
ourselves. And I think that is something that we have not solved yet, but 
that we will have to learn to deal with. Also as consumers or patients […]”
ME: “Once again, I am really trying to find out what your position is 
[in the discussion]. Is it: ‘Okay, we are going to have to learn to 
deal with that’ and do you see it as desirable anyway?”
[ excerpt 7.3 ]
I do not ask Stokes to specifically address the doubts and arguments of his 
antagonists. Although the discussion situation offers him ample opportunity to 
strategically maneuver into the discussion, he selects none of the many articulated 
topics (topical selection) to defend his point of view. Instead, he utilizes the space 
of my open intervention (“What is your position in the discussion, then?”) to 
reiterate his intended message as an expert: the uncertainty will increase. With a 
question, I try to broach his experiences in order to find out how he expects people 
to handle this increased uncertainty in practice. Stokes answers my question with an 
anecdote about the scientists themselves (“So we have done a little experiment...”). 
This story demonstrates the reflectiveness of scientists, who are also not always 
able to gain a comprehensive view of what this new scientific knowledge will mean 
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for its intended users.9 The experiment shows, after all, that the scientists find it 
hard to interpret their own uncertain test results. With this, Stokes compromises 
to premise viii: that people actually do what they have decided. At the same time, 
Stokes seems to put forward a habituation argument (see also Section 4.2.2.). His 
remark does come across as cautious (“We have not quite solved that yet”), but since 
he does not revoke his earlier advocacy, in my opinion Stokes aims to assert that 
more uncertainty is simply inevitable, which health care consumers will just have to 
get used to. So, although Stokes does not directly respond to the discussion about 
autonomy, he does seem to posit the habituation argument as a “standard answer 
that closes down the discussion before it even begins” (Swierstra et al. 2005).
 Hence, I try to move Stokes to take a position in the discussion a second time. To 
no avail. He starts an interview with diabetes patient Boles to find out what kinds of 
health information she would like to receive. After that, the discussion takes a turn, 
and Stokes does not engage in the discussion about autonomy anymore.
This analysis demonstrates, first of all, that the moral argumentation of life scientist 
Stokes that was expressed in the inventory round was critically discussed. The 
propositional content of many unexpressed premises, for example, proved unacceptable 
to some of the panel members. Furthermore, a number of critical questions were 
asked. Stokes, however, did not answer this doubt and these critical questions. This 
excerpt demonstrates that he chose an evasive or reserved discussion strategy, that he 
felt suited his chosen role as an expert. According to Stokes, experts often take position 
about issues that do no match their own expertise, which obfuscates the debate 
(Interview 2). Moreover, Stokes generally considers the dilemmas in ethical discussions 
as theoretical issues that cannot easily be substantiated in practice. “As far as I am 
concerned – especially as a technician – it is not very useful to enter into an extensive 
yes-no [discussion] about it” (Interview 2). That is striking. Although Stokes himself 
mentions a moral argument to support the benefits of P4 medicine, he suddenly 
performs ethical boundary work (see Section 4.4.1) here: he does consider it to be 
not his responsibility to participate in the discussion about these ethical questions. 
Neither does he give the impression that he is examining the articulated objections. He 
simply lets the matter drop. This is hardly consistent with his earlier advocacy during 
the preliminary interview and – to a lesser extent – on stage at the LUX.
9 “What you do generally see  – that’s why I used the anecdote – what you do generally 
see is that people adapt their opinion, their point of view, their actions, their 
theoretical actions as soon as it concerns themselves. And scientists are still thinking 
too little about ‘What would it be like if I got this conclusion?’” (Interview 2).
 Finally, my analysis demonstrates that my intervention was unsuccessful. 
Although I wanted Stokes to take position in the ongoing philosophical discussion, 
my intervention offered Stokes too much room to continue playing the role of expert.
7.4 Discussing side-effects
The script of the deliberation included a break (see Section 6.3.4). The break was 
mostly intended for me to be able to direct the course of the discussion. Before the 
break, the discussion about autonomy had eventually moved to the issue of whether 
or not health care consumers want the information this technology produces (see 
premise iv). 10 This difference of opiniondissolved as soon as life scientist Davies 
suggested a liberal solution with an appeal to autonomy. Everyone should be free to 
decide if they want to gather health information for prevention, a point of view that 
he would repeat after the break.11
 With a colleague who was observing, I decided to direct the discussion toward 
the expected social side effects or costs of the iPOP. Similar issues had already been 
articulated in the inventory round. Webber (ethicist), for example, had articulated the 
issue of a just distribution of benefits. And King (young social-democratic politician) 
called attention to the effect of P4 medicine on solidarity within the health insurance 
system. King feared that P4 technologies will hold people ever more responsible for 
their own health, even when they cannot always control it themselves.
KING: “I find that another of those [undesirable] developments [...]. 
It’s like ‘yes, you’ve got this disease, but didn’t you know you’d get 
it beforehand? It’s your own fault. We as a society won’t help you. 
You are responsible. You are autonomous.’ That is an element of the 
discussion that I find underexposed, and that is something I do fear.”
[ excerpt 7.4 ]
10 The two diabetes patients had divergent opinions about this. Although both 
supported having as much health information as possible, Foster (the other diabetes 
patient) responded to diabetes patient Boles who “on behalf of the group I guess 
I’m representing” said she wanted to know everything about herself. Foster called 
attention to “a large group of people who simply do not want to know that they 
have diabetes now. And if they have diabetes, they really don’t want anything else 
happening with it. They cannot bear it.”
11 Davies: “One person [...] will go wild with all available options, and another will 
completely trust his doctor. Perfect” (Discussion).
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These issues had, however, not been critically discussed yet. Right before the 
break, philosopher Riley had yet again called attention to them in reaction to Briggs 
(science communicator and liberal), who had after all used the topos of something 
that could be called the Luddite argument to position critics as anti-technology, like 
the Luddites. Briggs: “Is that almost a nostalgic longing for a kind of pre-technology 
era? [...] The problem with this discussion is of course that, to some extent, we 
don’t know what this new technology will yield. But if it will really give us tangible 
health improvement, yes, then I can only be in favor.” To which philosopher Riley 
immediately replied: “Then the question still stands: who gets it, who doesn’t, and 
at what cost?”
 In the last minutes of the break, I spoke to Webber and King to asked them to state 
their objections once more. Immediately after the deliberation continued, I prefaced 
my intervention to the public with a short elucidation. Since the iPOP individualizes 
the risk of diabetes (assuming the cause in the biology and the individual lifestyles 
of people), as Webber had already argued, the discussion may have been framed 
in terms of the consequences for individual health care consumers. I alluded to the 
possibility that some social issues were kept out of the discussion, since I suspected 
that the panel mainly consisted of highly educated people for whom being willing 
and able to use this technology is no issue.12 Then, I invited the ethicist and the young 
social-democratic politician to elucidate their views about the social costs once more.
 In this section, I will analyze how life scientist Davies maneuvered strategically 
in the discussion about unjust social-economical health differences. Ethicist Webber 
expects that an increase in these differences will be an undesirable consequence of 
using the iPOP. In my analysis, I limit myself to Davies’ performance since he actively 
participated in the discussion, while Stokes hardly took part in these discussions. 
The presented reconstruction and an analysis of Webber’s argumentation show that 
Davies strategically chose from the topics Webber raised in order to position himself 
as an advocate on stage at the LUX (topical selection), while he left other topics that 
he had commented on off stage unmentioned.
12 The questionnaire that was filled in after the debate demonstrates that virtually 
everyone in the panel was highly educated.
WEBBER: “What I mentioned early on [in the discussion] is something that has 
two sides. Not that that is a reason not to want this technology, by the way. Or 
to consider it undesirable. I just think that it does have a problematic aspect 
that should be duly considered. [...] Important factors that cause diseases 
[are] socially determined. [They are] also connected with lifestyle, but lifestyle 
cannot be separated from the way in which children, but adults as well, are 
formed by the environment in which they live. The moment you individualize 
[health] problems [in terms of] ‘your omics,’ you will often take no notice of 
other [social] factors. There is one group that specifically suffers from this 
[...]. This is the same group that also suffers most from the social factors of 
unhealthiness, and this is often the lower socio-economic class. This group is 
at a double disadvantage when we really focus on this technology, because 
as soon as you put this technology at the center of [...] a whole prevention 
program, I very well know who will use it most. Who can use it most. Those 
will be highly educated people, and they are the exact opposite group. 
So you could say: as soon as you consider the health differences between 
different groups in society, the social-economic health differences, as a social 
problem... the problem of justice. This really is about equal chances of a 
good life. Yes, then we’ve got a double problem. Because we aren’t paying 
attention, or less attention, to the factors that should be center stage, and the 
interventions that we’re bringing into society mostly help... groups that are 
better off to begin with. [This will] only reinforce the health differences.”
[ excerpt 7.5 ]
 
Webber puts the use of the iPOP in a social perspective. He puts Davies’ pragmatic 
argumentation – that the iPOP will lead to the desirable consequence of health 
benefits (Excerpt 7.1) – up for discussion. Figure 7.1 represents the argumentation 
structure of the sub-discussion between Webber en Davies (see below). It 
demonstrates Webber’s topical selection in the confrontation stage of the sub-
dissussion: the issues that he chooses to bring up for discussion.
 Webber (obviously) does not question the desirability of a lower disease burden 
for chronic illnesses such as diabetes. He had, however, cast doubt on the general 
validity of the propositional content that P4 and the iPOP will lead to health benefits 
for everyone (see previous section; see Inter-subjective Identification Procedure in 
Figure 7.1). Not, incidentally, that he considered the iPOP as a whole undesirable.
 He doubts the justificatory force of Davies’ pragmatic argumentation even more 
(see Inter-subjective Testing Procedure in Figure 7.1). I interpret some of Webber’s 
statements in this fragment as a sign that he finds that Davies has no satisfactory 
answer to some of the three sets of critical questions required for pragmatic 
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argumentation. As was described in Section 3.4.1, pragmatic argumentation is a 
topos to justify (or reject) an action by pointing out its desirable (or undesirable) 
consequences.
 The first critical question is the (technological) feasibility question. Webber 
does not choose feasibility as an issue to demonstrate the untenability of Davies’ 
argument, which indicates that he does not question the technological possibility 
of the iPOP. As reported, the scenario posited the iPOP as a given. The prepared 
intervention of the facilitator to prevent the discussion from falling into feasibility 
issues (see Chapter 5) proved unnecessary.
 Webber does suggest that the necessary means question should be answered 
negatively: aside from P4 medicine and the iPOP, the risks of obesity and type 2 
diabetes can be dealt with in other ways. People from lower socio-economic groups 
are, after all, more at risk for diabetes because of their unhealthy diets and habits, 
and the excessive offer of fattening foods in their social environments, claims Webber.
 This implies that adjusting this fattening or obesogenic environment (for 
example: fewer or no unhealthy foods in schools, supermarkets, etc., a tax on fat and 
sugars) is an important condition for health benefits for this group (Statement 3.1 in 
Figure 7.1). “This is the same group that also suffers most from the social factors of 
unhealthiness.”
 Reasoned this way, advocates of P4 medicine do not have a satisfactory answer 
to the best means question either. Is a wide deployment of the iPOP as a means of 
preventing diabetes (and other diseases of civilization) really the best solution to the 
problem, considering its social costs (best means question)? Since the P4 is not an 
indispensable measure in the prevention of diabetes, Davies (and other advocates 
who point out the desirable consequences) should demonstrate that it is the best 
measure, i.e. the measure that has most advantages to compensate for its possible 
disadvantages. Webber identifies such a disadvantage (social cost) of P4 medicine: 
(even) larger socio-economic health differences (standpoint).
 He defends the evaluative proposition of this standpoint (“Larger health 
differences are undesirable”) by appealing to the justice principle. Everyone should 
have an equal chance to a good or healthy life (Statement 4.1.1.1 in Figure 7.1). 
Then, he argues for the causal proposition (“P4 leads to larger health differences”) 
with a complex or multiple argument (Van Eemeren et al. 2002). First, Webber 
refers to medicalization as a cause of increasing health differences. According to the 
medicalization criticism, we lose sight of the social factors of a problem because the 
complaint is seen as a medical problem in the individual (cf. Ten Have et al. 2009: 
104). Under the medical purview, your own biological vulnerability and character are 
the main determining factors in your risk for obesity and diabetes (Statement 4.1.2.1 
in Figure 7.1). An adjustment of the living environment as a solution gets forgotten as 
a result of medicalization, when “you put the iPOP at the center of a full prevention 
program” (Statement 4.1 in Figure 7.1).
 Second, the undesirable consequence of increasing socio-economic health 
differences occurs as a result of the selective use of the iPOP technology. Thus, 
Webber involves the user context in his argumentation. Webber expects that exactly 
the group of people which benefits from an adjustment in their living environments 
(the lower socio-economic classes) will be less inclined to use the iPOP or less capable 
of using the iPOP (Statement 4.1.2.2 in Figure 7.1). Webber does not explicitly 
comment on whether or not the undesirable consequence of the growing health 
differences outweigh the advantages. His remark that it is “no reason not to want 
this technology”, suggests that it does not.
The discussion that follows is mostly about the best means to tackle the problem 
of lifestyles that are at risk of diabetes. Baron (young liberal politician) defends the 
iPOP technology and is convinced that “explaining [the knowledge] in simple terms” 
can remedy the unintended effect. McCann (GGD) appeals to his experience as a 
professional (“I work with this on a daily basis”) to claim that good, comprehensible 
information on its own does not work. You have to make it easy for people to make the 
right choice by changing the alluring environment (“Because the temptations there 
[in the supermarkets], they are enormous, aren’t they?”). He finds the adjustment of 
a fattening life environment necessary. Philosopher Riley adds another argument to 
the question of whether or not the iPOP is the best intervention. Most likely not, he 
answers, because “it would not surprise me if it was much more effective to shape 
the environment differently.” An environment that is lighter on sugar and fat and 
that invites more physical exercise. Not just because there’s a more equal chance to 
a good life (Webber’s justice argument), but because it attains more effects.
 At this point, Davies has not entered the discussion. I ask him to respond. When 
I asked him in the preliminary interview which ethical questions he expected the 
audience to articulate, Davies had, after all, personally identified with the problem 
of increasing socio-economic health differences. He said he was shocked when he 
recently heard of the existing difference in life expectancy between people with 
higher and lower educations. P4 technologies contribute to these differences, 
Davies feels, because he expects that low-skilled people will not be interested in 
the iPOP, or that they will not want to know their personal profiles. He told me he 
was afraid it would become a “white, highly educated, luxury thing to intervene in 
your health” (Interview 1). Although he interprets the cause somewhat differently 
from Webber (the lack of interest or the fear of knowing versus not being capable), 
in his preliminary interview he did take a standpoint that was similar to Webber’s: 
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that there is an “increasing gap between haves and have-nots” (Interview 1). In LUX, 
however, he takes a different position.
ME: “But Mr. Davies, if I may ask: What is your standpoint in this discussion? 
Because there is something being said about the functioning of this 
kind of technology [referring to the unintended consequences].”
DAVIES: “It is not without reason that TNO has a whole bunch of social scientists 
who are engaged in the design of cities, and the optimal ways of doing 
that. [...] I think we are [again]13 making a false contrast. The government 
should indeed be making choices about how to arrange society, but the 
knowledge we have about the individual’s biology and environment should 
not be neglected [...]. A society that is not obesogenic, yes, I don’t think 
anyone can be against that, but at the same time, you can still say ‘an iPOP 
approach can offer benefits.’ So I think it is a bit of a false contrast.”
McCANN: “But I think we all agree with that. In that sense, I think 
we all agree with that, with taking a broad approach. And then 
the issue lies more with: where does the money go?”
[ excerpt 7.6 ]
In the public sphere of LUX, Davies does not openly take the position that he expects 
the iPOP to contribute to increasing health differences, as he did in the preliminary 
interview. He does not respond to Webber’s statement that especially poorly 
educated people are less inclined to use the technology (Statement 4.1.2.2 in Figure 
7.1). Neither does he confirm nor deny that they are less capable of doing so (ibid.). 
He does not want to position himself as a concerned citizen, but as an advocate of 
P4 medicine “in order to not present the technology too negatively” (Interview 2). 
Because of that, he focuses his topical selection on the premises he can ward off. 
He does not select any of the other topics. This strategy allows him to, first of all, 
dispute the ethicist’s suggestion and the philosopher’s statement that environmental 
changes would be a better solution – either more just, or more effective – by 
13 With the “again,” Davies refers to a moment before the break. Davies: “I also think 
that.... Of course we get deluged with a flood of new technology and I agree with you 
that if we don’t make political choices to rearrange society, we will always be behind 
the facts on these matters. So, yes, we make implicit choices as a society. When things 
happen to us, we would do best to use the technology that seems best to us, that gives 
us most profit. That should not prevent us, I think, from doing those other things” 
(Discussion). 
emphasizing that “an iPOP approach [can] offer benefits”. Secondly, he defends 
himself against the “false contrast” that says a choice needs to be made and that the 
choice will be a one-sided technological solution (Webber’s Statement 4.2.1: “when 
you put the iPOP at the center of a full prevention program”). The risk of losing sight 
of social factors because of a medical purview is imaginary. The organization Davies 
works for does itself already embody a versatile approach: “It is not without reason 
that TNO has [...] social scientists”. In Webber’s premise, Davies sees the effects of 
future imaginaries that are overblown: “So people will say: ‘We’re throwing all of 
our money into this kind of thing’, which means other things cannot be afforded 
anymore” (Interview 2). According to Davies, a choice between iPOP technology or 
environmental measures is unnecessary. “You can do one thing [...] and still do the 
other thing, too” (Interview 2).
 Nevertheless, McCann (GGD) suggests that in reality, little money is invested in 
preventing diabetes via environmental adjustments. A little later  in the discussion, 
he answers his own question, “Where does the money go?” with a rhetorical 
question: “Do you know how much money is used for prevention [by adjustments in 
the environment], out of all the money that we have for health care? ….. Zero point 
seven percent” (Discussion). On stage at the LUX, Davies does not support McCann. 
Off stage in the interview after the discussion, however, Davies is willing to admit it: 
“Well, there is very little we do about prevention, that is true” (Interview 2).
The analysis shows that Davies’ initial reserved attitude changes in response to my 
intervention to direct the discussion towards the social costs of P4 technologies. 
More than in the earlier part of the debate, life scientist Davies reveals himself as 
an advocate. To defend P4 medicine from criticism, he uses topical selection as a 
strategic maneuver: he strategically chooses from the topics that are available in 
the discussion situation. Without publicly divulging his personal convictions, he can 
refute the statement that the adjustment of an obesogenic living environment is 
more effective than P4 medicine, and at the same time he can remove the suggestion 
that P4 medicine is the only solution to the problem. In this way, he tries to prevent 
that “this kind of collateral damage becomes an excuse to dismiss this technology” 
(Interview 2). Although these maneuvers are indeed allowed within the normative 
framework of pragma-dialecticians, this debating attitude can be criticized from the 
viewpoint of the deliberative democracy. I will discuss this mo re extensively in the 
conclusion.
So despite Davies’ initial reticence, he attempts to position himself more and more as 
an advocate over the course of the deliberation. But not everyone recognizes Davies’ 
advocacy. A member of the audience, for example, remarked afterwards that Davies’ 
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“role as a proponent did not appear clearly. But that did not really seem to be [his] 
intent. Maybe there were not enough proponents present in the end, and these two 
[Davies and Stokes] covered themselves because of that?” (Survey audience).
 The contribution Davies’ fellow scientist Nigel Havers made from the audience 
near the end of the deliberation indicates this as well. Havers felt, after all, that his 
fellow scientists on stage should have taken a stronger position as advocates. “I had 
expected more of them, honestly” (Interview Havers). As some panel members 
mainly emphasized the disadvantages of these technological developments, Havers 
decided to engage in the deliberation from the audience. To conclude this section, 
I will briefly analyze Havers’ contribution to the discussion in terms of strategic 
maneuvering. He made a historical analogy that enabled him to address the hotly 
discussed issue of privacy.
Havers, a colleague of Davies at TNO who was recently appointed professor of 
personalized health at a Dutch university hospital, was able to follow the whole 
discussion as a member of the audience. He came to LUX to get a sense of how 
citizens look at the new iPOP technology. He himself felt that the article by Chen 
et al. in Cell was very important. “A game changer” (Interview Havers). He noticed 
that the members of the panel who are not closely involved in the technological 
developments primarily perceive this innovation as as potentially harmful. Havers 
even found two of the young politicians (Sands and Baron) annoying. He thought their 
contributions were one-sided. “When you look at an issue, [...] you have to consider 
both its positive and its negative aspects. [...] I did not hear them saying: ‘Yes, but 
it could be beneficial as well.’ [...] Sometimes there were irrational comments like: 
‘Yes, but my employer can find out about this. You make agreements about that, and 
you can decently protect those [rights], as is currently happening with every patient. 
And I thought that was very unfair, and no one commented on that” (Interview 
Havers). With that, Havers appeals to the critics’ reasonableness. He expects a form 
of compliance from his fellow discussants – something that Gutmann and Thompson 
call the deliberative virtue of civic magnanimity: the acknowledgement of the value 
in your opponent’s statements (see Gutmann and Thompson 1996; see Section 
2.3.2).
 When I ask the audience for their last responses at the end of the deliberation, 
Havers is among the people who raise their hands immediately. With an analogy, 
Havers attempts to to stimulate the young politicians’ imagination to envision the 
usefulness of the iPOP , without directly challenging their views.
NICK HAVERS: “Yes, my names is Nick Havers. I work part-time at TNO, am a 
colleague of Davies, and I work part-time as a professor at University Medical 
Center Y. I have been working on molecular biomarkers for twenty years, so 
you can roughly imagine what my position in this discussion is. But I want to 
simplify this [discussion] for a moment, because we are talking about science 
and society etcetera, but in reality we are talking about a tool that helps 
you determine the route to your health. Well, I’d like to present a parallel 
with the GPS route planning software, since that does the same thing, really. 
That shows: when I want to go from here to Paris, I enter my direction, and I 
can go left, I can go right, etcetera. I can determine my best route to health. 
There is an inequality there. Some people cannot afford a TomTom, and some 
people can afford a live service subscription that tells you, while you are, 
where the traffic jams are, and then you can take another route. So there is 
a parallel there and yes, there was a lot of fear twenty years ago. ‘Oh, but 
everyone will be able to see where I am going. So if I go to the Red Light 
District in Amsterdam, that will be tracked, and then my wife will get to see...’ 
Etcetera. Well, that’s all nonsense, of course. So you could safeguard that.”
[ excerpt 7.7 ]
According to Havers, the discussion about the detrimental side effects has diverted 
our attention from the true intentions of the makers of the iPOP. Havers wants to 
“simplify” the discussion. To that purpose, he selects the analogy as argumentation 
scheme (topical selection). He compares the iPOP with GPS route planning software. 
On one hand, Havers underscores the useful function of both instruments: directing 
people to their destination. For the GPS route planning software, the travel 
destination is a geographical spot (Paris), for the iPOP it is health. On the other hand, 
the comparison is mainly intended to refute certain of the critics’ counter-arguments. 
The historical analogy with the GPS route planning software is intended, first of all, 
to demonstrate that the articulated fear of privacy violations is unfounded (“that 
is all nonsense”) because this fear proved unfounded with the GPS route planning 
software twenty years ago. In his reflection on his contribution after the deliberation, 
Havers uses the habituation argument (see Section 4.2.2) to emphasize that people 
will eventually get used to the iPOP, just as they did with the GPS route planning 
software. “In ten years, everyone will use it on their smartphones and no one will be 
questioning these things” (Interview Havers).
 Secondly, Havers also addresses the issue of an unfair distribution in his analogy. 
He does not, however, express moral judgments about the differences between 
people who do not have a GPS route planning software and other people who have a 
luxury version. In– contrast to the fear of privacy violations, Havers does not consider 
Webber’s claims about an unjust distribution of benefits nonsensical (and, therefore, 
he does not call them such), as it turned out in the interview after the discussion. “It 
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can reflect inequality. That is true” (Interview Havers). Havers presents the inequality 
as a given (“There is an inequality there”), as something that we have to accept.
 Leaving aside the question of whether or not an analogy between the GPS route 
planning software  and the iPOP holds true, the analogy proves to be an instrument 
for topical selection. With his comparison, Havers does address certain topics (privacy, 
equal distribution of benefits), while he leaves other articulated issues undiscussed. 
He does not, for example, comment on issues like the increasing responsibility for 
one’s own health, as was mentioned by young politician King (see Excerpt 7.4), or 
the provisional shortage of fitting treatments, as Hudd (research director patients’ 
advocate association) stated (see Section 7.3). At the same time, off stage, Havers 
admits he finds these objections convincing. “I had never realized that before, but 
the idea of ‘it’s your own fault’that’s is going to happen, of course” and “I would like 
to avoid falling ill, yes.[…] That’s an important bottleneck. [...] You do have to know 
what you can do to prevent that health risk. And there’s a big flaw, there” (Interview 
Havers).
 Havers’ comparison only addresses those counter-arguments which, in his 
opinion, paint too negative an image of this future technology. Furthermore, 
this strategic maneuver enables him to defend P4 technologies without publicly 
acknowledging the negative side effects (increased personal responsibility) or 
uncertain assumptions (personalized treatment). After my interview with Havers – 
after I had already turned off the recorder– I asked him to reflect on his views about 
the image of non-reflective scientists who support new technologies uncritically. 
Havers: “On the outside, that perception is rather correct. When you are enthusiastic 
about something, you emphasize the advantages, not the disadvantages. [...] You just 
don’t do that. When you subsequently ask the individual scientists, they will mention 
the disadvantages” (notes interview Havers).
7.5 Conclusions
The deliberative quality of this dialogue has considerably improved compared to the 
discussions about behavioral genetics. As was concluded in Chapter 5, two issues 
undermined the deliberative quality of those discussions. First of all, the burden of 
proof was allocated to the public instead of to the participating scientists as a result of 
a bias in the script (the ADHD discussion) and strategic maneuvers (not publicly taking 
position; the delinquency discussion). In Section 7.2 I argued that this allocation of 
the burden of proof fits into a dominant liberal discourse assigning a large measure 
of autonomy to science and technology developers. The advocates of upstream 
public engagement feel, however, that enactors do need to account for the so-called 
soft impacts that, after all, do frequently lead to public controversies. Therefore, the 
explicit objective was to critically and publicly examine the moral argumentation of 
life scientists who support new developments in medical technology and/or help 
develop these. Although Davies and Stokes no longer presented themselves as 
convinced advocates, my interventions prompted both life scientists to articulate 
their most important moral argumentation about the desirability of P4 medicine. I 
will discuss this more extensively later.
 Secondly, it turned out that issues about moral desirability, as far as they were 
articulated, were not critically discussed (confronted with a maximum of doubt) in 
the discussions about behavioral genetics. I have characterized all three discussions 
about behavioral genetics as a “struggle to represent the imagined consequences 
of technoscientific innovation and to render dominant their particular view of the 
future” (Bloomfield and Doolin 2010: 59). The expected undesirable consequences of 
these developments were not deemed feasible. To put it differently: the constructed 
future imaginaries of critics proved less plausible or even implausible whereas the 
future imaginaries concerning technological feasibility of scientists were deemed 
most plausible. Due to the scientific expertise that was ascribed to them, they had 
an advantage in this struggle about presented futures.
 The elaborate argumentative reconstruction of the deliberation at the LUX 
demonstrates that the argumentation the life scientists advanced to defend the moral 
desirability of P4 medicine was at the forefront of the discussion. Moreover, their 
reasons were critically discussed. I first reconstructed the argumentative discourse 
by making its unexpressed premises explicit with the aid of a short discussion of the 
philosophical literature on autonomy. Subsequently, I demonstrated that doubt was 
cast on the (partially unexpressed) propositional content of the premises of Stokes’ 
autonomy. This topos was also critically questioned. The same goes for Davies’ 
pragmatic argumentation. Are P4 technologies really the best way of solving the 
social problem of an ever-increasing number of diabetes patients? At what social 
cost? And do the benefits outweigh these costs? Even though the differences of 
opinion have not been solved and no consensus has been reached, the validity of the 
arguments used has been tested. The differences of opinion have also become a lot 
more clear, which is also an important goal of public deliberation (see Section 2.3.2).
 I also demonstrated that as a facilitator, you can successfully intervene during 
the deliberation. My interventions, first of all, contributed to both life scientist being 
staged as advocates. With his mitigation strategies, Dr. Davies initially positioned 
himself as a self-critical scientist emphasizing the dangers of P4 developments 
(“technology push”). But I continued to ask him about his views on its desirability. 
Furthermore, I asked both life scientists to react to the discussion as it had unfolded. 
When the discussion about autonomy was heading for the familiar liberal solution 
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(“everyone should know and decide for themselves whether or not they want to 
have an iPOP made”), I guided the discussion towards the articulated social side 
effects that had not yet been critically examined.
At the same time, the analysis in this chapter demonstrates how difficult it is for 
facilitators on stage to direct public discussion towards quality deliberation. Some 
interventions not apply, had a reverse effect, and sometimes interventions lacked 
when they were needed. It is not without reason that an analysis as presented in this 
chapter is needed to show which subtle strategic maneuvers the scientists deploy to 
be rhetorically effective without derailing, while they did reduce the dialectic quality 
of a critical discussion – solving a difference of opinions in a reasonable way.
 Subject positioning proved to be the salient strategic maneuver. As was described 
in Chapter 4, subject positioning refers to how people shape their social identity 
in interactions with others, as a compendium of personae which are “publicly 
presented in the episodes of interpersonal interaction in the everyday world” 
(Harré and Langenhove 1999: 24; see Section 4.3.2). Stokes, for example, positioned 
himself mainly as a technician who adopted a rather unresponsive attitude in the 
philosophical discussion about autonomy in the deliberation, by not picking from the 
topics that were made available to him in the discussion situation (topical selection). 
According to him, he did so in order not to obfuscate the discussion., In the interview 
afterwards he constructed a demarcation between issues in which, in his role as an 
expert, he does not have a responsibility of responding, and issues in which he does 
have to respond (boundary work). My intervention that was intended to make him 
take position in the philosophical discussion allowed Stokes to remain reserved.
As opposed to Stokes’, Davies’ social identity evolved during the discussion. Initially, 
he positioned himself as a socially responsible scientist who is capable of naming 
the undesirable aspects of technology developments, dissociating himself from the 
inventors of the iPOP by choosing suitable strategic maneuvers (footing, mitigation 
strategies and boundary work) to achieve his rhetorical objective. Although an 
intervention that was intended to nevertheless stage him as an advocate was 
successful, an intervention lacked when Davies defended P4 medicine in the discussion 
about social side effects without publicly sharing his personal convictions. In this 
case, too, topical selection proved to be an effective strategy to get the maximum 
defense of the technology in without either giving up his personal convictions to the 
audience, or disavowing them. This strategy also respected the dialectical conditions 
for a reasonable discussion. Only when his performance on stage was compared 
to the preparatory interview in the analysis after the discussion, it became evident 
how Davies’ public identity at the LUX differed from his more personal identity off 
stage. The same goes for Davies’ colleague Nick Havers, who chose the topos of the 
analogy with the main intention of refuting the most important arguments of the 
critics without openly having to acknowledge the points of criticism he agreed with, 
as became clear in his interview after the discussion.
 These contrasts between their off stage identities and the identities the life 
scientists constructed on stage indicate that they used the theatrical technique of 
stage management or impression management: disclosing controlled information 
about themselves, they attempted to create a public identity that matched the 
image they wanted others to have of them (see Introduction and Hilgartner 2000). 
As advocates, both Davies and Havers made the most of the room the discussion 
occasionally offered to refute some issues, while leaving the issues that they 
(later) admitted they could agree with undiscussed. And also Stokes presented 
himself differently in his role as a technician than as the missionary of new medical 
technology he had intended himself to be before the public deliberation.
 Although topical selection is a discussion strategy that tallies with reasonableness, 
this debating strategy can be criticized on the basis of the framework of the 
deliberative virtues of civic integrity and civic magnanimity, as defined by Gutmann 
and Thompson (see Section 2.3.2). According to Gutmann and Thompson, participants 
in a public deliberation have to develop these character traits in order to be able to 
discuss a moral disagreement in a reasonable manner (principle of accommodation). 
One of the three aspects of civic integrity is displaying a consistency of speech. An 
important aspect of civic magnanimity is sincerity and the pursuit of an economy of 
moral disagreement. The latter means that participants in the deliberation should 
strive to “minimize  rejection of the position they oppose” (Gutmann and Thompson 
1996: 85), and that they should also openly indicate the matters they do not disagree 
with.
How can this deliberative behavior be interpreted? It is possible that an instrumental 
view on technology incites a defensive attitude in the life scientists. Based on a 
fundamentally optimistic attitude towards NEST, they consider new technologies 
mainly as good instruments in themselves, losing sight of unintended consequences. 
This would explain scientists’ discussion strategy to refute as much criticism as 
possible.
 The dramaturgical setting may have partially determined the strategic behavior 
of the life scientists here. The evasive discussion behavior of Stokes was possibly 
reinforced by the informal dramaturgical setting of LUX. Participation in the 
deliberation was, after all, voluntary, it was an one-off event withno outcome (in 
the form of a report or a tangible decision) enforced. There is not much at stake at 
the LUX. Unless you, as a life scientist, decide for yourself to shape your scientific 
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practice differently because the deliberation gave you new insights, the conversation 
will have little concrete influence on the research practice.
 Furthermore, the critical discussion was mainly focused on spotlighting 
differences in opinion. During the inventory round, many panel members chose 
an issue that indicated why they considered P4 medicine to be undesirable. As 
Lucivero et al (2011) wrote, the claims on [moral] desirability [of NEST] often display 
a conservative stance towards the future. When new technological developments 
mostly evoke criticism, the inclination to defend yourself or, possibly, to withdraw 
from the discussion, increases.
8
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8.1 Introduction
“The official from the State Department of Environmental Protection [DEP] locked 
the door to the […] building and the five of us walked together out into the parking 
lot. After almost three and one-half hours of heated discussions with citizens in the 
meeting room, the fresh, cool air of the night was reinvigorating. I was thinking to 
myself, I’m glad that’s over with! when the DEP official aggressively said, ‘[…] The 
participation project was a complete failure. […]’ Between the lines I thought I heard 
him say, ‘Thanks for nothing.’
 […] In the van on the drive home we analyzed the event and looked for mistakes. 
We looked for people to blame. On the outset, there was plenty of blame to go 
around. If only the moderator had controlled the discussion a bit differently. If only 
that member of the research team did not argue with the expert. If only the state 
official had not given such a one-sided and lengthy presentation. If only we had pushed 
harder to have citizens from outside communities present. If only we had known 
about that other landfill siting debacle from last year. If only the citizens had been a 
little more patient, a little more open, and a little less hostile!” (Webler 1995: 35-6).
This ethnographic account of the world behind the scenes of a public participation 
event beautifully describes the struggle that facilitators of public deliberation can 
sometimes experience. To me, as a professional facilitator of public dialogue, Thomas 
Webler’s personal revelations are very recognizable despite the differences between 
discussions on waste disposal that Webler describes and upstream public deliberation 
on the moral desirability of new and emerging life sciences and biotechnologies that I 
have been studying. Indeed, my colleagues and I have often talked over the events of 
public discussions, fully frustrated, right after our performances on stage.
 But, as Webler rightly observes, before moderators, citizens, experts or others 
can be blamed, a mistake has to be identified. What is it that went wrong? As with 
Webler and his colleagues, the frustration and struggle I have experienced every 
once in a while were an important incentive to investigate the practice of facilitating 
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public deliberation. Webler et al. have developed a “yardstick” to evaluate the 
“right discourse in citizen participation” (ibid: 35). Although their reference to 
Habermas’ discourse ethics suggests differently, I demonstrated in Chapter 2 that 
in their approach the throughput quality of public deliberation still remains out of 
the picture: in the end, their rich framework has too little to offer for facilitators 
to evaluate the quality of argumentation and to direct public discussions towards 
deliberation.
 Therefore in this dissertation, I have investigated the following main question: 
How to facilitate quality face-to-face upstream public deliberation between life 
scientists and citizens on the ethical issues emerging from the new life sciences and 
biotechnologies? As I demonstrated in the Introduction of this book, this question 
has become most relevant because upstream public deliberation has by now gained 
considerable ground in the European science policy, as appears from the Horizon2020 
framework. At the same time, the quality of the outcome of public dialogue depends 
largely on what actually happens during the deliberation.
 In this conclusion section, it is time to consider what we can learn from the events 
during the upstream public deliberation sessions at the LUX. What my analyses 
discussed in Chapters 5, 6 and 7, demonstrate is that deliberation does not occur 
automatically. This observation will hardly come as a surprise for we all know out 
of our own experiences how difficult it can be to remain reasonable in discussions. 
As Webler says, “[n]othing that happened during the meeting was so unusual” 
(Webler 1995: 36). Even though empirical research (by argumentation researchers) 
shows that we subscribe to the normative framework of a reasonable discussion 
(cf. Van Eemeren et al. 2009), in the heat of the moment we do not always act as 
reasonable critics who demonstrate the deliberative virtue of magnanimity. We do 
not always assess the position of the ones we disagree with, distancing ourselves 
from our own. It is not uncommon that we push the boundaries of a reasonable 
discussion in order to be effective. “[P]eople are also, and perhaps even primarily, 
interested in resolving the difference of opinion effectively in favor of their case, i.e. 
in agreement with their own standpoint or the position of those they represent” 
(Van Eemeren 2010: 39). Sometimes our argumentation even derails. Even though 
the performances of life scientists were looked at through a magnifying glass in this 
study, of course they do not belong to the rare species of strategically maneuvering 
people.
 Psychologists have described and theoretically accounted for the mechanisms 
of several cognitive biases and logical errors humans are frequently entangled in. 
Apparently, we are not always the rational and clear thinkers whom deliberative 
democrats theoretically assume we are, as most of them are undoubtedly willing 
to admit. People are inclined to interpret the world as it confirms them in their own 
right (confirmation bias). They brilliantly invent reasons to let their ideas tally with 
the outside world again in their strive towards inner harmony (cognitive dissonance 
reduction). Or they tend to just think what the majority thinks (bandwagon effect, 
group think or herd behavior).
 However, this does not mean that we are completely at the mercy of our 
irrational psyche. Nor that Van Eemeren’s rules of a critical discussion are less correct 
or valuable. It does mean, however, that discussions can greatly benefit from the 
help of well-trained facilitators who stimulate critical thinking to become truly 
deliberative. These are facilitators who know how to apply the pragma-dialectical 
discussion rules in various contexts; who recognize recurring strategic maneuvers 
as expressions of persuasive rhetoric participants of deliberation employ to close 
down the discussion; who observe what character the actors in the play construct; 
who are – following Maarten Hajer – in their role as dramaturgist also aware that the 
deliberative setting that is staged, affects “what is said, what can be said and what 
can be said with influence” (Hajer 2005: 624).
 In these concluding remarks, I pass the most salient findings of this study in 
review. Firstly, I discuss in what ways the taxonomy of critical questions or stock 
topics that I have derived from pragma-dialectics and NEST-ethics is a helpful tool 
to confront the argumentations in discussions on the moral desirability of NEST 
with a maximum of doubt and to intervene in the discussion on site (Section 8.2). 
Next, I turn to the performative dimension of public deliberation. I discuss the 
staging techniques facilitators can utilize to counterbalance the theatrical techniques 
of persuasive rhetoric (particularly the construction of futures) and impression 
management (controlling the information in their public presentation) life scientists 
used to pre-empt discussion (Section 8.3). Then, I discuss how the public sphere 
itself, the fact that participants deliberate publicly, affects their very performance 
and what dramaturgical interventions can prevent plebiscitory reason which reflects 
the harmful effect of publicity (Section 8.4). Finally, I will conclude with some 
general remarks about future research and the necessity for training programs to 
professionalize facilitators of upstream public deliberation (Section 8.5).
8.2 Stock topics and deliberative quality
Facilitators whose ambition it is to facilitate quality upstream public engagement 
on the moral desirability of NEST first need a conception of deliberative quality. 
According to deliberative democrats, the quality of decisions on public moral issues 
depends on a legitimate decision-making process based on mutually justifiable 
reasons. In the context of NEST, this means that those involved in the process of 
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directing techno-scientific innovation trajectories (in the life sciences) owe affected 
publics justifications for their science policy. As a result, deliberation is all about 
the reasonableness of the process of argumentation. And the task of deliberative 
democrats is to “critically investigate the quality, substance and rationality” of these 
reasons and justifications (Chambers 2003: 309).
 Because deliberative democracy theory does not provide a detailed theory of 
how to assess or evaluate the discursive quality of argumentation that facilitators 
of upstream public deliberation can use to direct discussions towards deliberation, 
I developed a theoretical conception of deliberative quality. This conception had 
to a) enable a reconstruction, analysis and evaluation of argumentative discourse, 
particularly in the context of new and emerging science and technology and b) allow 
facilitators to intervene in face-to-face public deliberation on NEST.
 For that purpose I used the pragma-dialectical argumentation theory. In 
Chapter 3 I elaborated the pragma-dialectical model of critical discussion which 
provides a code of conduct for reasonably resolving a difference of opinion (see 
Table 3.1). When it comes to determining the quality of reasons, the argument 
scheme rule is at the heart of this normative framework. This rule stipulates that “a 
standpoint may not be regarded as conclusively defended if the defense does not 
take place by means of an appropriate argument scheme that is correctly applied” 
(Van Eemeren et al 2002: 183). This can only be the case when the protagonist has 
satisfactorily answered a set of critical questions pertaining to the argument scheme 
that is applied. Drawing on Swierstra and Rip’s NEST-ethics, which describes recurring 
argumentation patterns in NEST-ethical debates, I have derived sets of critical 
questions discussants need to satisfactorily answer in the context of discussions on 
the moral desirability of NEST. Together, these critical questions constitute a set of 
stock topics: “a taxonomy, a system of classifying the kinds of questions that can be 
at issue in a [NEST-ethical] controversy” (Jasinski 2001: 528).
 This taxonomy of stock topics has proven to be a helpful tool in three respects. 
Firstly, the taxonomy can serve as a diagnostic tool for assessing the quality of a 
certain public deliberation. In Chapter 5 I have used the tool to evaluate three face-
to-face upstream public deliberation sessions on behavioral genetics at a Dutch 
debating center (LUX). I concluded that in neither of these public discussions were 
the claims of life scientists critically discussed, since their argumentation was not 
confronted with a maximum of doubt. Most of the stock topics were not addressed. 
According to the literature reviewed afterwards, however, several critical questions 
could have been posed. At the LUX these questions were not satisfactorily answered, 
but they were in the first place, never raised.
 Secondly, the taxonomy is useful as a heuristic tool for systematically 
investigating, mapping and thus anticipating NEST-ethical issues as part of a critical 
vision assessment of new technologies. In Chapter 6, I described how I performed 
such a vision assessment as part of the preparatory work for an upstream public 
deliberation session on new and emerging biomedical technologies (esp. Integrative 
Personalized Omics Profile, or iPOP). An extensive argumentative reconstruction 
and analysis, including the explication of unexpressed premises, constituted the 
main source of information for a report sent out to the panelists to prepare them 
for the discussion.
 Thirdly, the stock topics are an important intervention tool for facilitators to direct 
the deliberative discourse on stage to improve its quality real time. As I have discussed 
in Chapter 7 critical questions helped to open up the discussion again. When the 
discussion about whether and how new biomedical technologies will contribute to 
the good life was closed down with an appeal to the principle of autonomy (“Since 
we will not be able to resolve our difference of opinion on this issue, people should 
be able to decide according to their own moral beliefs”), one of the critical questions 
pertaining to pragmatic argumentation opened up a critical discussion on unintended 
consequences and (in)justice that had not yet been systematically addressed.
 The pragma-dialectical model of critical discussion and the taxonomy of critical 
questions are also effective intervention tools when a deliberative session is spread 
out over a few meetings. Then, there is sufficient time for a meticulous reconstruction, 
analysis and assessment of the argumentative discourse of one session that can 
serve as an input for the next.
8.3 Directing deliberative performances
The pragma-dialectical argumentation theory provides a normative framework 
for resolving differences of opinion in a reasonable manner. Similarly, deliberative 
democrats prescribe deliberative behavior in terms of civic virtues. Together, the 
pragma-dialectical code of conduct and these virtues constitute a set of constraints for 
an appropriate deliberative interaction. However, in the unruly deliberative reality on 
the ground discussants do not only behave as virtuous and reasonable agents. They 
also attempt to make maximal use of the room that these deliberative constraints 
offer to pursue the aim of effectiveness: having others to accept their standpoints. 
Drawing on the dramaturgical perspective in the social sciences, I have indicated that 
participants in public deliberation can be considered as public performers or actors 
who employ a variety of theatrical techniques to be effective in trying “to manage 
and turn in their ‘best performance’, appropriate to their individual (or institutional) 
goals” (Harvey 2009: 150).
 One of these theatrical techniques is persuasive rhetoric (cf. Hilgartner 2000). 
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Pragma-dialecticians acknowledge that discussants also pursue rhetorical aims apart 
from resolving a difference of opinion. To make room for this rhetorical dimension, 
Van Eemeren introduced the concept of strategic maneuvering. This concept 
amounts to the delicate balancing act of discussants being effective (the rhetorical 
dimension of argumentative discourse) while also remaining reasonable (the 
dialectical dimension). Drawing on Discourse Analysis – and particularly Discourse 
Historical Approach (DHA) –I demonstrated in Chapter 4 that discussants dispose 
of more discursive strategies than using topoi or argument schemes in order to be 
effective. Language or discourse does not neutrally reflect reality. Instead, it is a form 
of social action: people can do things with words to be persuasive.
 In the case studies presented in Chapters 5, 6 and 7, I also studied how life 
scientists strategically maneuvered in upstream public deliberation on NEST-ethical 
issues and how these strategic maneuvers relate to the pragma-dialectical norms 
of critical discussion. One effective strategic maneuver that I have identified is the 
construction of futures. At the LUX, all kinds of futures were constructed: distal, 
bad, uncertain, beneficial to individuals, unlikely etc. Particularly the expectations 
concerning the technological feasibility of new and emerging life sciences and 
(biomedical) technologies proved effective in discussions on the moral desirability 
of NEST. Some represented the futures of critics who anticipated undesirable 
consequences of new technological developments as unfeasible. Others constructed 
a future with new technologies (e.g. genetic tests for autism) as implausible. In both 
cases, the effect was that difficult issues concerning the moral desirability of NEST 
were not discussed.
 In this struggle to construct plausible expectations, expertise about the future 
was claimed by or ascribed to a particular group of people. These appeals to authority 
with regard to the technological feasibility can be considered as derailments 
(argumentum ad verecundiam). Only time will  learn which socio-technical 
imaginaries will materialize. From the pragma-dialectical perspective on this kind of 
argumentation, discussants appealing to scientific expertise about techno-scientific 
futures – “This future is (un)feasible, because (I belong to the selected group of) 
experts (who) say so” – cannot satisfactorily answer a set of critical questions. Is 
the expert able to provide evidence for his claim about the future? Is his claim 
consistent with other experts’ assertions? How much certainty can be attached to 
this claim? As I demonstrated in Chapter 6, these critical questions are powerful tools 
for facilitators to anticipate discussions on technological feasibility and intervene in 
them if necessary.
Another theatrical technique is impression management. From the dramaturgical 
perspective, participants of public deliberation manage their public presentation: 
people present themselves to the public in such a way that they are perceived as 
they prefer, distinguishing between their “self” that remains hidden from the public 
view and their public identity or “persona.” To identify the dramatic personae of 
life scientists participating in upstream public engagement on NEST, using the 
pragma-dialectical argumentation theory is not sufficient. Argumentation theory 
focuses after all on the positions people express in their speech acts, on what is, 
directly or indirectly, said (or written; see Van Eemeren and Grootendorst 2004). 
Impression management is also about what people do not express front stage. To 
investigate how life scientists manage their impressions I additionally performed 
participant observation.
 In accordance with the concept of subject positioning, which presupposes a 
multitude of different identities in different social situations, participants of the 
upstream public deliberations at the LUX positioned themselves and (implicitly) 
others variously as: modest, sound, concerned fellow citizen, expert, spokesperson, 
responsible innovator, illiterate, techie or geek. From these various subject positions, 
one can conclude that there is not a single role that life scientists adopt when they 
participate in upstream public deliberation. In fact, their public identities can even 
change during a single deliberative session.
 Two public identities dominated the discussions at the LUX: the pure scientist 
(or technician) and the issue advocate (cf. Pielke 2007). Life scientists presenting 
themselves as pure scientist chose to refrain from publicly advancing their 
standpoint on the moral desirability of NEST. Others, on the other hand, presented 
themselves as issue advocates. However, sometimes life scientists demonstrated 
public reluctance to express their advocacy they had expressed privately. They 
presented themselves as modest or occasionally even as anti. As I described in 
Chapter 5 for example, the professor in forensic youth psychiatry (Dr. Lamb) warned 
against the high expectations of his academic colleagues (such as Adrian Raine). In 
the end Dr. Lamb even refrained from publicly advancing a standpoint on the moral 
desirability of improved risk assessment tools for criminals and citizens based on 
biological indicators. Perhaps this is understandable in view of the fierce Buikhuisen 
controversy in the Netherlands, but it complicated the discussion considerably.
 These performances by pure scientist and the reserve to act as issue advocate 
are in contrast with the literature on the sociology of expectations where it is claimed 
that promises and expectations tend to be exaggerated, particularly in early stages 
of technological innovation. Perhaps there is a cultural explanation for this reserve 
among Dutch life scientists because of a consensus-based, social policy making 
culture, often referred to as the polder model. What is more, these constructions 
of public identities as pure and modest scientists serve as immunization strategies, 
aimed at pre-empting critical discussions on moral desirability of NEST.
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 As a facilitator it is important to be aware of these strategies and to stage them 
as they present themselves behind the scenes, as I did with Dr. Davies in the public 
dialogue on P4 medicine (see Chapter 7). Whereas Dr. Davies presented himself as 
an issue advocate behind the scenes, on stage he initially distanced himself from the 
new technology, anticipating the possible public resistance towards the exaggerated 
expectations of P4 supporters. He even seemed to present himself as a critic or 
opponent, choosing a footing as animator instead of author of the imaginaries of 
P4 medicine and referring to these technological developments in terms of being 
“overrun in this tsunami of new technologies.” Having learned from the events in the 
deliberation on behavioral genetics and delinquency, I managed to elicit Dr. Davies’ 
argumentation expressing why he thinks developing P4 medicine is a good idea.
 This intervention would have impossible without a preparatory interview. The 
impression management thus illustrates the importance of these interviews where 
people feel comfortable and confident to express how they (really) think about 
particular issues in a relatively private environment.
8.4 The detrimental effects of publicity
As I described in the introduction section of this dissertation, some commentators 
have argued that the organization of upstream public deliberation itself has 
contributed to the public uneasiness with new and emerging science and technology. 
Therefore, I decided to include the effects of the organizational process on the quality 
of deliberation into my analysis. For this purpose, I borrowed the dramaturgical 
concepts of scripting, staging and setting as Maarten Hajer has introduced. Besides 
the theatrical techniques discussed in the previous section, the second aspect of the 
performative dimension of public dialogue is the effect of the dramaturgy on the 
performances of participants.
 In the previous chapters I showed for instance how the casting of characters in 
the play (as part of the scripting of public deliberation) influenced whose expertise is 
considered as more credible (see Section 5.4). I also demonstrated how the script of 
the public discussion on behavioral genetics and ADHD was biased (see Section 5.2). 
Furthermore, the staging between active panelists and passive audience proved to 
have an effect on the role perception of one of the panelists (see Section 7.4). And 
even  the technologies recording the discourse (microphones and video cameras) 
that were part of the laboratory setting turned out to be – putting it in terms of Actor 
Network Theory (ANT) – actants mediating the deliberation.
 But what affected the deliberation perhaps most significantly is the public sphere 
itself. The public indicated that speaking in public discouraged them to actively 
participate in the discussion on the behavioral genetics of ADHD. Furthermore, the 
observations described in the previous section corroborates the claim that publicity 
can have harmful effects on the quality of deliberation, as Simone Chambers has 
argued (Chambers 2004).
 Publicity is one of the three main procedural principles deliberative democracy 
theory hinges on (see Section 2.2). Deliberative democrats argue that the openness 
of the public sphere has salutary effects on public reason. Theoretically, it has 
a positive effect on the quality of reasoning since in public people are urged to 
carefully think over one’s position, to anticipate possible criticisms and to take 
other people’s view into account. Furthermore, publicity stimulates public reason 
because in pluralist societies, people are committed to arguing in favor of the general 
interest instead of their own, private needs and concerns. Nevertheless, publicity 
can also have a detrimental effect on the quality of reasoning in reality (Chambers, 
2004). In those cases, public reason turns to plebiscitory reason: even if people 
argue in favor of the res publica, the quality of the argumentation lags behind. “The 
public nature of the debate forces speakers to make general appeals, but there is 
little or no critical accountability to ensure that those appeals are well reasoned” 
(Chambers 2004: 398).
 Two of the strategies that characterize plebiscitory reason are more or less 
recognizable in the public performances of life scientists at the LUX. The first strategy 
is that public speakers say what people want to hear, a form of shallow reason or 
pandering, as Chambers describes this strategy pejoratively. Dr. Davies for instance 
anticipated public criticism towards the overblown future visions regarding P4 
medicine. That he was the first person to publicly express his views on the topic 
reinforced his mitigation strategies to tone down his future visions. In public, he 
articulated his concern that P4 medicine would possibly result in a technology push, 
while behind the scenes he said that he would enact the role of advocate to persuade 
the public of the benefits of a transition towards P4 medicine.
 The second strategy is image-maintaining. Publicly, speakers might not “want 
to ‘look’ weak by changing their mind and so are resistant to good argument” 
(ibid. 399). They do not want to lose face. The analysis of the deliberation on the 
iPOP at the LUX demonstrated that both Dr. Davies and Dr. Havers had difficulties to 
publicly agree with some arguments of their opponents. Dr. Davies did not publicly 
show his personal beliefs concerning the possibly increasing inequalities in health as 
a result of the use of P4 technologies, while Dr. Havers did not openly acknowledge 
the points of criticism of opponents he agreed with. “You simply do not do that,” 
Dr. Havers said.
 Again, this illustrates how important it is to a) critically examine the argumentation 
used in public deliberation mobilizing critical questions (to discourage pandering) and 
Behind the scenes of… life scientists on stage
8
CONCLUDING REMARKS
278 279
b) to investigate the opinions of participants of public deliberation using preparatory 
interviews (to catch sight of instances of image-maintaining). Most of all, facilitators 
have an important role to play in stimulating deliberative courage: that it is okay for 
participants to publicly change your mind and admitting that things are perhaps a bit 
different than initially thought.
8.5 Final remarks
My findings have demonstrated the value of qualitative research to cast light on the 
discursive as well as the performative dimensions of the throughput processes of 
public deliberation. Facilitating public deliberation is not only about applying the 
right democratic input criteria. The application of criteria is only to a certain extent 
helpful in the organizational process because concrete designs appear to reflect 
particular trade-offs between these criteria (see Section 6.4). As political scientist 
Ryfe writes: “Deliberative democrats mistakenly adopt an ‘if we build it they will 
come’ mentality. If we infuse a context with the right procedures and [if we] organize 
an encounter to conform to the right norms then deliberation ought to take place” 
(Ryfe 2005: 63; italics KD).
 The pragma-dialectical argumentation theory (combined with NEST-ethics and 
discourse analytical studies of controversies in new science and technology) has 
proven to be a useful tool for facilitators to realize and improve reasonableness in 
upstream public deliberation on NEST. Similarly, the dramaturgical perspective is 
valuable to sensitize social scientists as well as facilitators for the social dynamics 
during upstream public deliberation on NEST. More research on the argumentative 
discourse in public discussions on NEST will yield additional recurring strategic 
maneuvers than I have identified. Furthermore, new sets of critical questions can 
be developed to confront argumentation with a maximum of doubt. More social 
scientific research aimed at studying the social interaction during public deliberation 
will also reveal more features of the performative dimension of deliberation. I am 
also strongly in favor of broadening the scope of research. In this study, the focus 
was on participating life scientists. I think it would be valuable as well to closely 
investigate the roles of other important groups of participants in upstream public 
deliberation as well, for instance the role of ethicists who are frequently staged as 
experts in ethics.
 Ideally, the findings from this study and future research projects will be used to 
professionalize facilitators of upstream public deliberation on NEST. My experience 
as a facilitator is that intervening in the discourse is quite difficult in the chaotic, 
spontaneous and dynamic course of events that follow each other at a fast pace. It 
is for good reason that I needed a complete reconstruction afterwards to analyze 
the argumentative discourse. Therefore, it is important for professional facilitators 
to be trained in recognizing argumentative discourse in NEST-ethical discussions. 
Since deliberation is regarded as an important democratic condition among theorists 
in the field of deliberative democracy, facilitation is a large responsibility that can 
only be left to professionals. Perhaps, technology assessment institutes – such as 
the Rathenau Institute in the Netherlands – can play an active role here to develop 
intense training programs to instruct and train professional facilitators. Making 
use of video recordings of deliberative settings, argumentative discourse can be 
reconstructed, analyzed and evaluated and the social interaction can be analyzed.
 Of course, the frustration that Webler describes and that I am now familiar with 
will not disappear completely. Deliberation will to a certain degree always remain an 
utopia. At the same time, this is what makes this profession attractive and tempting. 
Never a dull moment…
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What is your gender?
 Female
 Male
What is your age?
 15 – 24
 25 – 39
 40 – 60
 Older than 60
How are you related to the issue of ADHD (more than one possibility)?
 Patient
 Parent of a child with ADHD
 Professional in education
 Professional in youth care
 Psychologist
 Psychiatrist
 Psychotherapist
 Genomics researcher
 Behavioral scientist
 Other . . . . . . . . . .
What was the reason for you to visit this public discussion? . . . . . . . . . .
Did you acquire new information? 
 Yes
 No 
If so, what information? . . . . . . . . . .
appendix b
Questionnaire: The preprogrammed human
What did you learn from this public discussion? . . . . . . . . . .
Did the public discussion meet your expectations?
 Yes
 No
If so, what? If not, why so? . . . . . . . . . .
What did you think of the facilitator? 
 Good
 Fair
 Moderate
 Inadequate
Remarks . . . . . . . . . .
What did you think of the setting? 
 Good
 Fair
 Moderate
 Inadequate
Remarks . . . . . . . . . .
What did you think of the interaction? 
 Good
 Fair
 Moderate
 Inadequate
Remarks . . . . . . . . . .
What did you think of the interview with prof. John Lush? 
 Good
 Fair
 Moderate
 Inadequate
Appendix B
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What did you think of the contribution of prof. John Lush? 
 Good
 Fair
 Moderate
 Inadequate
Remarks . . . . . . . . . .
What did you think of the quality of the discussion? 
 Good
 Fair
 Moderate
 Inadequate
Remarks . . . . . . . . . .
What should have been done differently (e.g. break, duration etc.)?
. . . . . . . . . .
Final remarks . . . . . . . . . .
Do you want to be kept informed about the next public discussions 
“The Preprogrammed Human”?
 Yes
 No
Can we call for a more detailed discussion? 
 Yes
 No
If so, how and when can we get in touch? . . . . . . . . . .
The preventive outpatient clinic (for Diabetes)
Scenario “An iPOP for everyone”1
International life sciences research keeps yielding an increasing amount of results. 
In recent years, international research consortia and companies have invested 
considerable amounts of money in systems biology studies of common diseases such 
as Type 2 Diabetes. The aim of this research is to find new entries to treatment, 
but above all, early detection and prevention. In the footsteps of the first scientific 
publication about iPOPs, in leading magazine Cell’s March 2012 issue2, affordable 
and validated methods have become available for sequencing the complete human 
hereditary material and for determining which omics profiles signify diseases in a 
“molecular” stadium. 
 Insurance companies, patient organizations such as the Diabetesvereniging 
Nederland (DVN, Dutch Diabetes Organization), hospitals and health centers have 
seized on the growing interest in individual disease prevention by founding so-
called preventive outpatient clinics. In this way, the patient organizations present 
themselves not just as representatives of their own constituent patient groups, 
but also as advocates who look after the interests of health care consumers and 
citizens who want to stay in good health. Insurance companies also want to answer 
the growing interest in the (commercial) offer of this type of test among the more 
‘risk aware’ consumers. The insurance companies do not want to give the wrong 
impression, and they let it be known that they take no interest in the results of medical 
tests and profiles. They trust the individual responsibility of the insured; that they, in 
case of a less favorable result, will take their own actions to ensure improvement. It 
1 Largely based on Genetica, genomics en gezondheidszorg (Van Rijswoud e.a. 2008), 
supplemented by interviews with experts.
2 Chen et al. 2012.
appendix c
Scenario public deliberation on iPOPs
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is solely about customer relations, and about answering the government’s demand 
for stimuli in prevention. 
 Depending on the type of insurance a person has, the patient will pay for the 
costs. Some insurance companies put this type of prevention in their supplemental 
options, and mostly stimulate the free lifestyle changes. On top of that, a number 
of insurance companies try to lure customers with a differentiation in premium, in 
which the basic insurance is offered with extra beneficial conditions to individuals 
with a low risk profile. 
 The Dutch ministry of health, welfare and sport stimulates these developments. 
Confronted with high health care costs, the ministry has increased its focus on three 
goals over the past few years. The so-called Triple Aims are a) to improve healthy 
behavior (in which individuals’ own responsibility for their own health will be 
addressed in increasing measure), b) specific health improvement for risk groups 
and c) decreasing collective health care costs.3 Spearheads of the government’s 
preventive policy are, among others, obesity and Type 2 Diabetes. In recent 
years most efforts were aimed at education and stimulating measures, but these 
policies have so far shown little effect. Due to the alarming increase of obesity and 
Type 2 Diabetes (at ever younger ages), the government decides to stimulate the 
development of prevention clinics. An implementation that is controlled as much 
as possible in public health care is to be preferred, in the minister’s opinion, over 
an uncontrolled market development in which commercial parties offer preventive 
screenings. In this way, it is also easier to guarantee equal access to these facilities.
 In the past, the government decided to forego systematic screenings of children 
for their genetic disposition towards obesity and diabetes (as was suggested 
by the medical field4) for ethical reasons. The fact that parents would receive 
information about their child’s health was considered too much of an infringement 
of the child’s right to decide later on what it does and does not want to know.5 
Parliamentary questions asked by the liberal political party VVD did not manage 
to sway the minister’s opinion.6 Although every parent is free to abstain from 
genetic screening in the neonatal heel prick, this implementation was seen as too 
proactive. Furthermore, doctors raised the objection that the difference between 
3 Innoveren voor gezondheid, TNO Zeist, 2013.
4 Diagnose Diabetes 2025, Virusscenario.
5 Het ‘Duizend Dollar Genoom’: een Ethische Verkenning, CEG, Den Haag, 2010.
6 Gen-ethische Grensverkenningen, Teldersstichting, Den Haag, 2010
life threatening but treatable diseases (such as PKU) and chronic diseases like 
Diabetes would become too complex for parents. The government does, however, 
think that the time of casual information and general measures has passed. General 
practitioners are urged to play an active role in talking to parents in a more direct 
manner about their responsibilities, and regional health services agree to approach 
parents and children more as individuals when it comes to child health care. 
 Apart from a place where general practitioners can be actively approached, 
the outpatient clinic for prevention is also a place where risk aware health care 
consumers can take responsibility for their own health. In this clinic, doctors and 
health coaches attend, educate and give out personalized lifestyle advice to patients 
and clients. Every adult can, for example, access their electronic patient file at the 
outpatient clinic and have it periodically screened for possible variants of which the 
medical meaning has recently been determined.7 To increase the possible impact 
of the genetic data, clients are also advised to convince their direct relatives to 
have their DNA sequenced.8 Beside genetic information, the outpatient clinics offer 
the opportunity for regular health checks. In case it turns out that the client has 
a genetic risk for Type 2 Diabetes, (future) patients have the option to procure a 
glucose meter so they can monitor their own blood sugar levels. So-called lab-on-
a-chip technologies enable clients to simply take a drop of blood from the fingertip 
and measure countless molecular biomarkers that indicate the early development of 
Diabetes (and other diseases).9 The test results are also sent to the attending doctor 
or health coach. Requisite for participation is that patients and clients make their 
data available for scientific research.10 In so-called digital communities, patients and 
clients can share their experiences with other patients and clients, in the Netherlands 
and in the rest of the world.
7 Hood and Flores 2012.
8 Ibid.
9 Iibd.
10 Innoveren voor Gezondheid, TNO Zeist, 2013.
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1 In advance
Direct cause
The article by Chen et al. (2012) in Cell, in which they introduce the concept of the 
iPOP and present the results of an experiment that had Stanford-researcher Michael 
Snyder go into a number of systems-biological readings over the course of 14 months: 
first a complete DNA sequence, then, based on that, regularly scheduled test panels 
to trace biomarkers that might indicate the presence of Type 2 Diabetes (and other 
(multifactorial) diseases).
Indirect cause
The developments in the field of P4 Medicine (specifically the “predictive” and 
“preventive” aspects) and the research in the field of life sciences about multifactorial 
(and) common diseases (like Type 2 Diabetes).
Main question for the public dialogue (for now; depends on where the focus lies 
in the preliminary talks): Can a wide application of iPOPs in (public) health care 
contribute to a responsible preventive care of Type 2 Diabetes?
appendix d
Interview guide Mr. Davies
2 Interview questions
Introduction
 ͳ Who is Mr. Davies? What does he do for TNO (specifically concerning P4 
Medicine and Diabetes)?
Questions about participation
 ͳ What is your reason/are your reasons for participating in this public dialogue?
 ͳ Why is it good to have this public dialogue?
 ͳ When would you consider this public dialogue a success?
 ͳ What function does this public dialogue serve, in your opinion?
 ͳ Which topics need to be discussed in this dialogue, in your opinion?
Questions about expectations
 ͳ What are your expectations concerning the future (uses of) the knowledge  
in the life sciences for preventive and predictive medicine?
 ͳ Why is the research in the life sciences that concerns multifactorial diseases 
(especially Type 2 Diabetes) valuable in relation to preventive and predictive 
medicine?
 ͳ What are your expectations regarding the “technological feasibility” of iPOPs (in 
particular, and the knowledge of the life sciences and its applications in general, 
to the care for Diabetes)? What will be possible? Under which technological 
conditions (specifications)?
 ͳ What are your expectations regarding the “social usability” of iPOPs (or other 
future applications)?
 ͳ What would make iPOPS (un)desirable? To which need do they cater? Who has 
this need, and how do you know?
 ͳ What do you think of the promises that are being made about P4 Medicine, 
NextGen Sequencing, iPOPS, etcetera (Francis Collins, Leroy Hood, Rui Chen/
Michael Snyder)?
 ͳ Which (ethical) issues are prompted by iPOPs or might in the future be 
prompted by iPOPs?
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Introduction
Below you can read the (provisional) results of the preliminary investigation for 
the public deliberation. This information was gathered in interviews and by doing 
desk research. I talked to experts (in ethics, the sociology of scientific knowledge, 
diabetology), researchers in the field of life sciences, and stakeholders (Dutch 
Diabetes Federation – NDF – and the Diabetes Association Netherlands. I have 
studied reports, scientific publications and opinion articles (you will find a list of 
references below; all sources are also made available to you in the Dropbox folder).
 I have attempted to present the contents of the information accurately and 
clearly, without oversupplying you. For the sake of openness, all references are made 
available to you, but this does not mean that you are expected to have read them all. 
For questions, remarks, corrections and additions, you can contact Koen Dortmans 
(contact information in the email).
Goal of the public deliberation
In the first public deliberation at the LUX (with a possible continuation on Dutch 
Diabetes Day 2014 - in March), the issue of P4 Medicine (and the iPOP as technology 
within the subject) will be explored. The word “issue” presupposes that there are 
uncertainties and differences of opinion. The preliminary investigation demonstrates 
that these uncertainties and differences of opinion do exist. The goal, given these 
insecurities (is P4 technologically feasible, what does the health care consumer feel 
about P4 Medicine, etcetera), is to examine these differences of opinion. To get the 
deliberation process about the pros and cons of P4Medicine started, this piece was 
written. It is an attempt to offer information about what P4 Medicine is, and which 
questions a transition to P4 Medicine in health care can incite. The goal has been to 
be as complete as possible, but some questions and issues must surely have been 
overlooked. These can of course be addressed during the deliberation.
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deliberation on iPOPs
Information in preparation of the Public Deliberation “An iPOP for everyone.
Is preventing diabetes better than curing it?” 
What is P4 Medicine?
The concept of P4 Medicine is attributed to Leroy Hood, an American biologist who 
makes many efforts in the area of systems biology in health care. Systems biology is 
a coordinating (holistic) view on the biology of humans and their health. It integrates 
various disciplines in the life sciences which commonly end in -omic and which each 
have a specific level of the biology of humans (DNA, cell, organ) as their object of 
study. Genomics is the field that studies the complete individual DNA and the genes 
of humans (and other living organisms). In transcriptomics, RNA molecules which 
come into being as a result of the process of transcription are studied, while in 
proteomics the produced proteins and in metabolomics the metabolites (products of 
the metabolism such as glucose) are studied. Elaborating the details of life sciences 
leads me to far afield. It is most important to know that the presence of, a change 
in, the amount of (or concentration of), or the chemical composition of all this 
molecular material might be early indications of divergent processes, which possibly 
indicate the early development of a disease. As such, all these sectors combined yield 
important information about the (non-)functioning of the organism, and because of 
that, about the illness and health of humans.
In March 2012, a number of researchers published a study in scientific magazine 
Cell (Chen et al. 2012), in which they made a so-called integrative Personalized 
Omics Profile (iPOP) of a human subject. The subject did not just have his full DNA-
material mapped (this process is also called sequencing), but other matters were 
also observed on a molecular level. Thus, it turned out that the subject had a genetic 
predisposition for type 2 diabetes (a number of genes that, when combined, increase 
the risk of getting diabetes). The history of disease in his family formed no cause to 
think that this person would have a predisposition for diabetes (whereas the DNA 
analysis did indicate the risk of heart disease that ran in his family). 
In an interview with Rui Chen, the first author of the article, he elucidated that the 
study was a  “proof of principle”, a manner of demonstrating that an iPOP could yield 
valuable information in the very early detection of diseases. As such, the iPOP forms 
an important prelude to “precision medicine” or “P4 Medicine”, write Chen and the 
subject in an opinion piece (Snyder and Chen 2012).  This form of proactive medicine 
(or health management), they write, is the expected new pattern that health care 
will follow. According to them, this proactive form of medicine has a number of 
advantages over the (current) limited reactive medicine, which is primarily based 
on diagnosing and treating diseases after symptoms have occurred. The existing, 
reactive health care “generally neglects preclinical pathophenotypes or risk factors; 
it generally disregards the underlying mechanisms of the symptoms; the disease 
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descriptions are often quite broad so that they may actually include multiple diseases 
with shared symptoms; the reductionist approach to identify therapeutic targets in 
traditional medicine may over-simplify the complex nature of most diseases,” they 
write (p. 73).
 The alternative, then, is a proactive form of medicine: P4 Medicine. This term 
refers to the four P’s. It is:
— Predictive
According to Leroy Hood, this is about completely mapping the individual DNA (DNA 
sequence) and about other tests that enable an assessment of various health risks. 
Hood estimates that this will happen for every individual within ten years (Hood and 
Flores 2012). Even better, he argues, would be to sequence whole families so that 
even more precise determinations become possible. It is about the identification of 
“actionable genetic variants”: variations in the hereditary material which indicate an 
increased risk of the development of a disease, which can be countered (by being 
actionable). In this manner, the subject in the iPOP study came to find out that he had 
an increased genetic risk of getting diabetes, a disorder which also further developed 
(during the study) after the subject contracted a virus (his blood sugar levels remained 
elevated after the virus). With more exercise and an adapted diet, the test subject 
managed to normalize his blood sugar levels, thus avoiding early-onset diabetes. 
Since the amount of knowledge about this type of risk factors grows rapidly, these 
risk assessments should be repeated every year, claims Hood. Moreover, the blood 
(the  “window for assessing health and disease”) will be periodically (Hood mentions 
a two year-term) examined for all kinds of biomolecules that indicate diseases in 
their early stages (for example, the detection of proteins in the blood in organs 
which are the first signs of a disease). These measurements will make it possible to 
compare the person to him or herself: the previously measured health states will 
form the basis from which to determine whether or not there are deviations in a 
newer, later state (a so-called longitudinal n=1 measurement, like the subject from 
the Cell study underwent).  All data will be stored and will – anonymously – be made 
available in databases which scientists elsewhere will have at their disposal in order 
to gather knowledge about the diseases and health of individuals. 
— Preventive
More knowledge about the early signals of disease and health will make the prevention 
of diseases or the occurrence of complications a possibility, as a result of which the 
disease burden will either not occur, or remain manageable. This can be done, the 
researchers of the Cell article write, by means of a lifestyle transformation (more 
exercising, eating fewer high-fat and high-calorie foods, quitting smoking, etcetera). 
Another option is the prescription of preventive drugs which are specifically attuned 
to the individual (Hood and Flores 2012). Hood expects that the management of 
health will, in this way, mostly come to take place outside of clinics and hospitals. 
Perhaps special centers in which professionals counsel individuals in managing their 
health will come into existence (see “How can P4 technologies be used in practice?” 
below).
— Personalized
Since every individual is (genetically) unique (even monozygotic twins do not have the 
exact same DNA material), the individual is compared to him or herself every time. 
As such, it is individually determined for each person which values are divergent in 
their specific case, and which interventions or treatments are suitable. Hood stresses 
the potential of the immensely large new data source, if each individual would 
constantly make their measured values available (on the condition that these data 
are anonymized and used responsibly). Hood expects that people will be willing to 
do this (as long as their privacy is warranted by legislation), in order to improve the 
health of their children and grandchildren (he assumes that there will be solidarity 
between generations).
— Participatory
The success of P4 Medicine depends to a large extent on the contributions of active 
patients and consumers. The participation contains two elements. Firstly, Hood 
determines that patients have become critical health care consumers who no longer 
“are passive recipients of the advice of expert advice”, but who are active, and 
who do not just ask for a more effective health care, but who also contribute to 
the transition towards a proactive health care (by, for example, making their health 
data available). “Today’s educated consumers are increasingly conscious of this fact 
and are beginning to demand that science-based healthcare address their their need 
for assistance in managing their own health,” writes Hood. (p. 619).  Secondly, the 
participation of health care consumers and patients consists of making their data 
available for scientific research in large databases.  In the TNO report Innovating 
for Health (“Innoveren voor gezondheid” 2013) the authors write that people “are 
responsible for making the enormous amount of data that becomes possible through 
personalized diagnosis available and for sharing it” (p. 60).
 A market of new machines, technologies and appliances will, according to Hood, 
follow to aid health care consumers in supplying information about the state of their 
health.  He also anticipates that the management of health will become a social 
activity. All kinds of new digital platforms, social networks and mobile applications 
will make it possible for people to communicate with each other about their lifestyles, 
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and to stimulate each other to change those lifestyles (for example to prevent Type 2 
Diabetes).
Which problem(s) will P4 Medicine (or P4 Health and Care) solve?
The TNO report offers an extensive analysis of the current state of affairs of Dutch 
society and medicine. The costs of health care keep rising disproportionately. On 
top of that, chronic diseases (such as diabetes) occur ever more often. According 
to Diagnosis Diabetes 2025 (Idenburg et al. 2012) over 1.4 million people will have 
been diagnosed with diabetes by 2025 (p. 10). Citizens have a personal responsibility 
to stay healthy and thus to contribute to the cost problem in that way, the authors 
of the TNO report state. These developments induce a new understanding of health: 
“the ability to adapt and self manage.” How will people be able to participate, 
notwithstanding their limitations? (“Participation society,” King Willem Alexander’s 
new buzzword.)
Given this situation, a so-called Triple Aim was formulated:
 ͳ Improvement of health care quality as experienced by the patient
 ͳ Improvement of the health/vitality of a defined population/specific target group
 ͳ Decrease of the costs per capita (or, at least, a check on the costs)
According to the authors of the TNO report, a transition to P4 Medicine would be 
the select route towards reaching these goals. This analysis takes the quality of 
health care and the control over health care costs as a point of departure. But when 
one also reads the prospect by Hood and Flores, it is hard to avoid the impression 
that P4 Medicine also serves an economic goal: P4 Medicine will then contribute 
to increasing economic growth through health care innovations and is, as such, 
important for the knowledge economy.
What is the technological feasibility of P4 Medicine?
Technological innovation, and especially “rolling it out” on a large scale, is an obstinate 
and, in part, social process (social factors determine the success of innovations to a 
large extent). The expectations about what is technologically feasible, as described 
in the studied sources and sounded out in the interviews, vary considerably. Just 
like with gene therapy before, expectations of what is possible and what is desirable 
are closely interwoven.  Some find that previous biological research has yielded 
little result, and feel that it will be extremely complicated (and even see this as a 
reason to not yet organize a public deliberation). Leroy Hood, on the other hand, 
anticipates the technological feasibility (and its practical applications) shortly (within 
10 years). The TNO report also speaks of “fundamental breakthroughs in genomics 
and biotechnology.” Some claim that this technology will come no matter what, that 
it cannot be stopped.
How can P4 Medicine technologies be used in practice?
On the one hand, there is a market-oriented solution in which everyone who wants 
to do so can pay for the technologies themselves (whether this is reimbursed by 
insurance companies or not) to better manage their health (see Hood and Flores 
2012). On the other hand, there is a government-directed solution, in which a (more 
or less) active government tries to reach as many people as possible with screening 
programs (see, for example, the “Virus scenario” in Diagnosis Diabetes 2025 
(Idenburg et al. 2012)).  Or a compromise in which an observant general practitioner 
fulfills an important function. As the authors of Genetics, Genomics, and Health Care 
(Van Rijnswoud et al. 2008) argue, each scenario comes with its own dilemmas.
How desirable is P4 Medicine?
The opinions about the desirability of P4 Medicine vary quite considerably as well. 
Some people are reserved or even skeptical. Its enthusiasts, on the other hand, focus 
their attention on the desirable consequences that investing in further scientific 
research and technology development will have. Hood and Flores in particular focus 
primarily on the benefits. The TNO report is more nuanced. P4 Health and Care (the 
term they use) is “a beautiful vision of the future.” “But many ethical and social 
questions, and question about health care policy, science policy and technology policy 
are still open” (p. 74). The mentioned (expected) advantages and disadvantages are 
listed below.
Which (expected) advantages does P4 Medicine have (to which positive or desirable 
consequences)?
 ͳ Prevention, early (or earlier) diagnosis, and a (more) effective treatment of 
diseases for individual health care consumers and specific target groups.
 ͳ A vital society with citizens who are able to develop themselves and contribute 
to productivity.
 ͳ Lower collective costs for health care (with an eventual export to developing 
countries so they can profit as well; see Hood and Flores 2012). 
 ͳ Economic growth through technological innovations (“economic opportunities”).
 ͳ P4 Medicine gives people more autonomy: more authority over their data, more 
control over their health and a more equal relationship to their doctors or health 
care managers.
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Which (expected) disadvantages will the transition to P4 Medicine have?
 ͳ P4 Health and Care could result in (more excessive) medicalization, in two 
definitions of the word: a) too many aspects of daily life will partially or entirely 
become about health and disease (at the expense of other values), b) emphasis 
will be put on disease as an individual problem, which will cause other (primarily 
social and environmental factors) to be relatively underexposed.
 ͳ The already present (socioeconomic) health differences might be magnified, 
since especially (highly) educated people will find their way to these 
technologies.
 ͳ How will the right of not-knowing be guaranteed (see, for example, Dondorp and 
De Wert 2010)?
 ͳ If people know their risk of contracting a disease or disorder (like diabetes), it 
might cause a psychological burden for them.
 ͳ Privacy and access to this immense quantity of data might be liable to suffer. 
 ͳ Empirical philosopher Annemarie Mol (2000) argues that appliances such as the 
glucose meter (and, similarly, a lab-on-chip which enables the study of a large 
number of proteins that might indicate disease through a simple prick in the 
fingertip; Hood and Flores 2012) do not only register a value, but do something 
as well.
What is required for a successful transition to P4 Medicine?
The success of a transition to P4 Medicine is based on a number of prerequisites, 
most of which are social factors. A number of important ones have been listed:
 ͳ An individual who does not just want to be active and participative about his or 
her health, but who is also willing and able to take on the (shared) responsibility 
for his or her health. 
 ͳ An individual who furthermore understands how things work, has discipline, and 
possesses the knowledge and skills to take action.
 ͳ Active participation of the individual (or the individual health care consumer) in 
scientific research by (willing to be) making their data available.
 ͳ There are successful interventions to achieve lifestyle adaptations and health 
gains exercise programs, medication, etcetera). A certain expectation (or, in 
terms of the health care market: a demand): that people in this way are willing 
to (continuously) engage with their health.
 ͳ Harmonization of systems and collaborating scientists (to store all different 
methodologies and research data and to save them in order to be able to 
compare them). 
 ͳ New relations between scientists, doctors, health care professionals, patients 
and consumers.
A number of questions
The issue P4 Medicine does in fact raise a number of questions that can be explored 
during the public deliberation. As a first step, a number of these are listed here:
 ͳ Are the aforementioned advantages and disadvantages realistic? Does P4 
medicine really deliver a reduction of health care costs? Are people not 
psychologically able enough to handle new information about their health?
 ͳ Is P4 medicine the best solution to the problem? What, in reality, is the 
problem that needs to be solved? What are the alternatives and what are their 
advantages and disadvantages?
 ͳ Are the assumptions that are made true: do people feel the need to be 
preventive?
 ͳ What will this technological innovation ask of patients, health care providers, 
citizens, the health care system, and society?
During the public deliberation, we will explore these questions (among other 
questions, some of which will be put on the agenda by you).
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“Script” Public deliberation “An iPOP for everyone?
Is preventing diabetes better than curing it?” Nijmegen, 2013
Goal
A critical exploration of the issues emerging from the potential future application 
of systems biological technologies (like iPOPs) in the (preventive) health care of 
diabetes. The aim of the report of the vision assessment [Appendix B] was to inform 
you in advance about the issue as well as possible. The short sketch of the future (the 
other attachment in the mail that contains this script [Appendix C]) is the starting 
point of the conversation: what issues does this vision of the future of preventive or 
P4 Health and Care raise according to you?
 The idea is to first collect these issues (without discussion), and then 
to discuss them in order of priority. On which topics do opinions differ and what 
does the difference of opinion consist of? This approach is intended to collect as 
many issues as possible and to further examine the most important ones first.  The 
proposal is that we end with making an inventory of issues that can be discussed in a 
possible future follow-up deliberation (for example during the National Diabetes Day 
in March 2014).
The discussion will primarily take place among the panel members on stage. 
Although the members of the audience will mostly have the role of observers, they 
can participate at fixed moments.
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Script of public deliberation on iPOPs
Participants
[…]
Schedule
12:00 PM Arrival panel members, short introductions, tuning the microphones
12:50 PM Arrival audience
01:00 PM A welcome by panel chairman Koen Dortmans
 The theme will be briefly introduced, the intention and schedule 
 are briefly discussed
01:10 PM Short presentation (on film):  introduction to the issue, 
 ending with a short sketch of the future (the other attachment in 
 the mail that accompanies this script)
01:20 PM The panel members are introduced briefly (by name and 
 occupation only) by the panel chairman and are asked to take 
 their seats on the stage
01:30 PM Inventory of the panel members’ issues
02:00 PM Discussion round 1: discussion based on the prioritized list of issues
03:00 PM Intermission
03:20 PM Discussion round 2: continuation of the discussion
04:45 PM Conclusion: which issues deserve further discussion?
05:00 PM End of the deliberation
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What is your name? . . . . . . . . . .
What is your level of education? . . . . . . . . . .
What was the reason for you to visit this public discussion? . . . . . . . . . .
What did you learn from this public dialogue? . . . . . . . . . .
Did you revise your opinion (compared to your opinion before the dialogue)?
 Yes
 No
If so, how? If not, why not? . . . . . . . . . .
What were your intentions c.q. what is it you wanted to do during the dialogue?
. . . . . . . . . .
Did the public discussion meet your expectations?
 Yes
 No
If so, what? If not, why so? . . . . . . . . . .
What did you think of the quality of the information you received to prepare 
yourself (e.g. neutrality, intelligibility, completeness etc.)? . . . . . . . . . .
Did you use the information that was disseminated before the dialogue?
 Yes
 No
If so, what? If not, why so? . . . . . . . . . .
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Questionnaire Panelists: An iPOP for everyone?
What do you think of the recording of the panelists’ statements in terms of 
“desirable” and “undesirable” issues? . . . . . . . . . .
What do you think of the future scenario that was used? . . . . . . . . . .
What did you think of the composition of the panel (e.g. size, who was absent, 
who was redundant etc.)? . . . . . . . . . .
What did you think of the interaction within the panel (e.g. respectful, 
dominant, fair etc.)? . . . . . . . . . .
What did you think of the contribution of Dr. Stokes? . . . . . . . . . .
What did you think of the contribution of Dr. Davies? . . . . . . . . . .
Who do you think was persuasive? . . . . . . . . . .
What did you think of the facilitation of the dialogue (e.g. too much/too little 
guidance; on/off topic; promoting participation; neutrality; framing; depth etc.)?
. . . . . . . . . .
What did you think of the setting (staging, attributes, microphones etc.)? . . . . . 
. . . . .
The dialogue was in the public sphere. Did this affect your contribution in any 
way?
 Yes
 No
If so, how? . . . . . . . . . .
The organizers chose to differentiate between an active panel discussion and a 
more passive audience. What do you think of that? . . . . . . . . . .
Do you think you had enough expertise to equally engage into the discussion? 
Please explain (what kind of expertise did you use, what expertise lacked etc.).
. . . . . . . . . .
What additional comments do you have? . . . . . . . . . .
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What is your gender?
 Female
 Male
What is your age? . . . . . . . . . .
What is your level of education? . . . . . . . . . .
How are you related to the issue of “new technologies in diabetes health care” 
(more than one possibility)?
 Patient
 Care professional
 Working at the Diabetes Association
 Working at the Diabetes Federation
 Working at the Diabetes Fund
 Working at a company (e.g. developing new biomedical technologies)
 Citizen, interested in the social issues concerning new technological
 developments
 Studying the social, legal and ethical aspects of life sciences
 Working at TNO on the development of new biomedical technologies
 Working at a Dutch university on the development of new biomedical
 technologies
 Working at a Dutch university in the field of life sciences
 Other . . . . . . . . . .
What was the reason for you to visit this public discussion? . . . . . . . . . .
What did you learn from this public dialogue? . . . . . . . . . .
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Questionnaire Public: An iPOP for everyone?
Did the public discussion meet your expectations?
 Yes
 No
If so, what? If not, why so? . . . . . . . . . .
What did you think of the composition of the panel (e.g. size, who was absent, 
who was redundant etc.)? . . . . . . . . . .
What did you think of the interaction within the panel (e.g. respectful, 
dominant, fair etc.)? . . . . . . . . . .
What did you think of the contribution of Dr. Stokes? . . . . . . . . . .
What did you think of the contribution of Dr. Davies? . . . . . . . . . .
Who do you think was persuasive? . . . . . . . . . .
What did you think of the facilitation of the dialogue (e.g. too much/too little 
guidance; on/off topic; promoting participation; neutrality; framing; depth 
etc.)? . . . . . . . . . .
What did you think of the setting (staging, attributes, microphones etc.)? . . . . . 
. . . . .
The dialogue was in the public sphere. Did this affect your contribution in any 
way?
 Yes
 No
If so, how? . . . . . . . . . .
The organizers chose to differentiate between an active panel discussion and a 
more passive audience. What do you think of that? . . . . . . . . . .
What do you think of the recording of the panelists’ statements in terms of 
“desirable” and “undesirable” issues? . . . . . . . . . .
What do you think of the future scenario that was used? . . . . . . . . . .
What additional comments do you have? . . . . . . . . . .
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“Citizens will participate in decisions on academic research.” Thus read the headline 
on the front page of a national Dutch newspaper on 25 November 2014. The article 
highlights one of the spearheads of the new science policy as presented by the 
Dutch Ministry of Education, Culture and Science. This new policy fits a broader 
trend within European science policy to engage the public with decisions on science 
and technology. Public engagement with science and technology is considered to 
be a necessary condition to achieve either instrumental ends (restoring public trust, 
increasing public acceptance) or substantive ends (improving the quality of health 
care) or simply the right thing to do from a normative and democratic perspective. 
However, simply increasing public participation is not the means to achieve these 
ends, as Chapter 1 of this dissertation demonstrates. Several lessons about the 
process of PEST have been drawn from past experiences. 
 First, the discussion of public issues was narrowly framed in terms of the (un)
desirable impacts of new science and technology. But public engagement also has 
to address a wider spectrum of issues concerning the moral desirability of purposes, 
needs and expected benefits of new and emerging science and technology (or NEST) 
as imagined or envisioned by scientists and technology developers. Secondly, it is 
important to involve the public as early as possible to anticipate potential benefits 
and harms of NEST; to openly discuss the research priorities that are set; and to assess 
the moral visions that drive scientific developments. In this way the contribution of 
participants can have an impact on technoscientific innovation trajectories. In short, 
public engagement has to move upstream. Thirdly, public engagement with science 
also needs a deliberative turn. According to deliberative democrats, decisions 
on public moral issues (e.g. emerging from new science and technology) are only 
legitimate when they are the result of a quality discussion where individual views 
and perspectives are justified with good reasons that are acceptable to the people 
who think differently. Finally, how public engagement is organized can contribute 
considerably to the public uneasiness with new science and technology. Facilitators 
wrongfully assume that correctly following protocols and guidelines for implementing 
public engagement methodologies (such as consensus conferences) automatically 
generates a legitimate outcome, thus neglecting the influence of the facilitation 
process itself on the outcome and quality of the deliberation.
 Public engagement has by now become a popular topic of academic analysis 
and evaluation. However, the problem is that scholars in the fields of Science and 
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Technology Studies (STS) and political sciences have paid scant attention to the 
deliberative process itself and the effects of facilitation on this process and its quality. 
On the one hand, evaluative research in STS is mainly concerned with providing 
normative conceptual frameworks for assessing the conditions of a valuable outcome 
of public engagement instead of assessing deliberation in action. On the other hand, 
the few studies that are focused on the deliberative process do not take the effect of 
settings on this process systematically into account.
 This dissertation on the contrary investigates both deliberation in action and the 
effect of settings on public dialogue. Both are crucial for the quality of facilitating 
upstream deliberation on the moral desirability of new and emerging life sciences 
and biotechnologies. The life sciences – the broad field of science that involve the 
scientific study of living organisms such as microorganisms, plants, animals, and 
human beings on a molecular level (DNA, RNA etc.) – have proven to be a research 
field that has sparked public controversy time and again (think of Dolly the Sheep, 
Bull Herman and genetically modified crops). As its title suggests, I compare public 
engagement with theater. This metaphor allows me to spotlight, firstly, engagement 
as public performance, i.e. the front stage performances of life scientists enacting 
public engagement as well as the interventions of facilitators directing the discussion 
process towards deliberation and, secondly, the dramaturgy of public engagement, 
i.e. the back stage process of how professional organizers of public engagement set 
the scenes of public deliberation in their role of dramaturgist.
 The metaphor of the theater also connects the two theoretical frameworks 
used in this study. In dramaturgical analysis in social sciences interaction among 
people – such as deliberating ethical issues of NEST – is studied in terms of public 
performances. Drawing on the work of social scientist Erving Goffman and STS 
scholar Stephen Hilgartner, this book is particularly focused on the theatrical 
techniques persuasive rhetoric and impression management life scientists who 
participate in public engagement with science, are expected to employ in upstream 
public deliberation. How do life scientists’ rhetorically perform in upstream public 
deliberation NEST-ethical issues? How do these performances relate to norms of a 
good discussion? How does the presentation of these life scientists on stage differ 
from their back stage presentation?
 The second theoretical framework draws a parallel between the process of 
facilitating public deliberation and dramaturgy, the process of scripting, staging and 
physical setting behind the scenes that affects the performances on stage and the 
quality of the discussion. How does the dramaturgy of upstream public deliberation 
affect the performances of participants and the quality of deliberation?
In Chapter 2 a discursive as well as a performative perspective on the quality of 
deliberation are developed that are both crucial in the off stage work of organizing 
public dialogue as well as the work of facilitating dialogue on stage.
 To develop the discursive perspective, the implicit link between STS literature 
on upstream public engagement and the conception of deliberative democracy of 
Gutmann and Thompson is explicated. Drawing on their theory, its central principle 
of reciprocity – amounting to a process of seeking mutually justifiable reasons – 
indicates a first direction for developing a conception of discursive quality: the quality 
of argumentation advanced to defend particular (science) policy. An important 
aspect of the work of facilitators of upstream public deliberation then is to critically 
investigate the quality of the reasons advanced to defend science policy, i.e. the 
input and direction of innovation trajectories. Therefore, the first research focus of 
this study is to develop a theoretical concept of argumentative quality which enables 
a reconstruction, analysis and evaluation of argumentative discourse, particularly in 
the context of new and emerging science and technology and which allows facilitators 
to intervene in face-to-face public deliberation on NEST.
 Drawing on Actor Network Theory (esp. the work of Gomart and Hajer), a 
performative perspective on quality public deliberation is developed. Methodologies 
or “technologies of community” used for facilitating upstream public deliberation 
on NEST (such as consensus conferences etc.) are not neutral instruments that 
produce an unbiased representation of consensus. Just like other technologies, these 
methodologies affect the outcome. The second research aim of this dissertation is to 
investigate the dramaturgical work implied in and its effects on public deliberation on 
NEST. For this purpose, the dramaturgical concepts of scripting, staging and setting 
are introduced that form a framework to analyze how the work behind the scenes 
affects the public deliberation process.
In Chapter 3, a notion of argumentative quality of public discussions over new 
and emerging science and technology (NEST) is developed on the basis of the so-
called pragma-dialectical argumentation theory. What does a good discussion 
entail? According to pragma-dialectics reasonableness is the main quality criterion. 
Quality then refers to a formal procedure that reasonable discussants agree to 
observe in order to resolve their difference of opinion by systematically testing 
standpoints (and their argumentative defense) for their acceptability. Within this 
formal procedure, I particularly focus on the elements for analyzing and assessing 
the quality of argumentation as a product (how a conclusion can be inferred from 
its premises). Pragma-dialecticians define three procedures that are important for 
systematically confronting argumentation as product with a “maximum of doubt.” 
Firstly, it is important to explicate unexpressed premises that remain implicit largely 
Behind the scenes of… life scientists on stage SUMMARY
330 331
for communicative efficiency reasons. Secondly, the explicated propositional content 
of every individual statement must be acceptable. If not, the protagonist needs 
to advance argumentation in a sub-discussion to defend this claim. Thirdly, the 
justificatory force of every argumentation needs to be critically tested. The critical 
testing procedure is successfully completed when protagonists, defending a claim 
by advancing argumentation, have satisfactorily answered all critical questions, 
pertaining to a correctly applied argument scheme. These critical questions are first 
and foremost a measure for deliberative quality (diagnostic tool). But these questions 
also constitute a heuristic in order to fulfill another quality aspect of deliberation: 
inclusiveness (heuristic tool). What are the issues to be addressed? Futhermore, 
these critical questions are an important intervention tool for facilitators, responsible 
for leading the critical testing procedure, to direct the deliberative discourse on stage 
to improve its quality real time.
 The pragma-dialectical procedure of reasonable discussion is applied to ethical 
argumentation patterns within the context of public discussions on NEST, as described 
in the literature. As an illustration I use the Dutch public and political debate on 
cisgenesis, a technique to modify crops developed as an answer to the public unease 
with genetic modification. From this particular case, a comprehensive set of critical 
questions is developed that together form the stock topics to be addressed in NEST-
ethical discussions. 
Apart from the dialectical aim of resolving their difference of opinion following 
the procedure of reasonable discussion, discussants also – or perhaps first and 
foremost – want to be rhetorically effective: to have others accept their claims and 
argumentation. In Chapter 4 the concept of strategic maneuvering is elaborated, that 
pragma-dialecticians introduced to refine and extend their argumentation theory 
so as to include the rhetorical dimension of argumentative discourse. Strategic 
maneuvering is defined as keeping the delicate balance between the rhetorical aim 
for effectiveness in argumentative discourse and the dialectical aim of maintaining 
reasonableness. When argumentation violates the pragma-dialectical procedure 
of critical discussion, i.e. when discussants pursue effectiveness at the expense of 
reasonableness, their strategic maneuvering is derailing.
 The concept of strategic maneuvering draws attention, first, to how discussants 
make a selection from the available issues or argument schemes to defend their 
claims (topical selection); secondly, how standpoints and arguments correspond to 
what particular publics (or audiences) or the public in general perceive as plausible 
(audience demand); thirdly, how discussants choose a suitable presentation 
(presentational devices) to have their standpoint accepted.
 The concept of strategic maneuvering is used in this study to analyze the 
persuasive rhetoric that both advocates and opponents of NEST employ as theatrical 
technique to be effective in public discussions on new science and technology. Since 
pragma-dialectics is not specifically concerned with public discussions on NEST, 
scientific literature is reviewed that has discursive strategies used in NEST-ethical 
discussions as its focus. Methodologically, these studies use discourse analysis which 
is, as will be argued, useful because of it is focused on a) the rhetorical function 
of constructed versions of the (social) world and b) other discursive strategies than 
argumentation (in the pragma-dialectical sense) alone.
 The literature review demonstrates that both proponents and opponents draw 
on a repertoire of strategic maneuvers in order to be effective in public deliberations 
on controversial science and technology: boundary work or conceptual demarcations 
between science and non-science, science and society, basic and applied science, 
facts and values, ethical and unethical science, settled and unsettled ethical issues, 
natural and unnatural etc.; subject positioning to construct public identities of 
selves and others as e.g fundamentalist, unrealistic or myopic; and expectations to 
represent futures as e.g. distant, good, uncertain and rumbling.
The dramaturgical perspective on public deliberation, with its concepts of scripting, 
staging and setting (Chapter 2), combined with the concept of strategic maneuvering 
and its derailments with respect to the pragma-dialectical rules of reasonable 
discussion applied to public discussion on NEST-ethical issues (developed in Chapter 
3 and 4) constitute the analytical framework to describe, reconstruct, analyze and 
assess face-to-face upstream public deliberation events on the moral desirability of 
new and emerging life sciences and biotechnologies. In Chapter 5 a series of three 
deliberative events on behavioral genomics is analyzed. How do participants of these 
public discussions strategically maneuver, how do these maneuvers affect the quality 
of the deliberation and how does the dramaturgy of these upstream public dialogues 
scripted as public inquiries into the ethical and social issues concerning behavioral 
genomics, influence the performance of participants?
 Life scientists mainly select pragmatic argumentation to be effective in this 
struggle about the moral desirability of behavioral genomics research. Pragmatic 
argumentation is an argument scheme used to justify the desirability of a certain 
action to indicate the desirable consequences this action entails. This argumentation 
reflects a public reason because it indicates the beneficial social consequences. 
However, their argumentation were not confronted with a maximum of doubt, 
i.e. not critically tested, because, firstly, the burden of proof was allocated to the 
public. Participating life scientists staged as advocates of NEST, publicly presented 
themselves as sound and modest professionals toning down future expectations 
regarding their behavioral genomics research. The public on the other hand – staged 
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as participants critically assessing the new science and technology – rather adopted 
a role of a health care consumer merely interested in being informed about the 
state-of-the art in behavioral genomics. What is more, a bias that lurked in the script 
reinforced the public’s hesitance to participate in a discussion in the public sphere: 
the attempt to involve the public in the setting of the agenda of issues, the burden 
of proof was allocated to them instead of to the participating scientists. This reflects 
a dominant liberal discourse assigning a large measure of autonomy to science and 
technology developers.
 Secondly, some strategic maneuvers proved effective in closing down discussion 
on the moral desirability of behavioral genomics research. Demarcating between 
insiders (scientists contributing to behavioral genomics research) and outsiders (the 
public/society) and between the production of factual scientific knowledge and its 
socially determined use (boundary work) as well as appeals to scientific authority 
about the technological feasibility rendered the constructed future imaginaries of 
critics less plausible or even implausible. Due to the scientific expertise ascribed to 
them, the life scientists had an advantage in this struggle about presented futures. 
When futures are represented as unfeasible, the moral desirability of these futures 
need not be discussed.
Chapter 6 is a detailed description of the dramaturgical work performed behind the 
scenes of an upstream public deliberation event on new knowledge and technologies 
in another field within the life sciences: P4 medicine and particularly, the moral 
desirability of integrative personalized omics profiles or iPOPs in the preventive care 
for type 2 diabetes. 
 Firstly, the chapter includes the description of the discursive work of a critical 
vision assessment to prevent the pitfalls diagnosed in Chapter 5. Based on interviews 
and literature review, the technological feasibility of sociotechnical imaginaries 
concerning P4 Medicine are mapped and critally assessed using a set of critical 
questions experts must answer satisfactorily derived from the pragma-dialectical 
evaluation of argumentations from expert opinion. Furthermore, an analysis of 
how P4-technologies are envisioned to function in social practices (social usability) 
informed the development of a future scenario that was the point of departure of the 
public discussion. In addition the argumentation advocates advance to defend the 
moral desirability of P4 Medicine and iPOPs is systematically and critically assessed 
using the stock topics derived in Chapter 3 as a heuristic tool to make explicit which 
values and moral justifications are embedded in expectations and to anticipate moral 
desirability issues.
 Secondly, the thick description of the dramaturgical work behind the scenes 
demonstrates how the framing of the issue; the provision of information; the 
contingent process of casting participants; and the distinction between an actively 
deliberating mini-public and a more passive audience considerably affected the 
performance of participants. Thus, the ethnography casts a light on the practical 
entanglements facilitators of upstream public deliberation face: the tradeoffs as a 
result of  the application of abstract normative criterions concerning input legitimacy 
(inclusiveness, independence and early involvement) and throughput legitimacy 
(dialectical quality of the deliberation) of public participation. It is argued that an 
understanding of the “normative surfeit” of this practice with its countless choices, 
compromises and tensions in the practice of the organization of a dialogue, is 
essential for the sensitization facilitators to improve their work as dramaturgists of 
public deliberation.
Chapter 7 turns the spotlight to the staged performances of life scientists 
participating in the public deliberation on the moral desirability of iPOP-technologies. 
An elaborate argumentative reconstruction of the deliberation demonstrates that, 
partly due to the facilitator’s successful discursive interventions, firstly, the burden 
of proof was allocated to the advocates and, secondly, how their deontological and 
consequentialist topoi, reflecting a liberal bioethics, were critically questioned. 
Although no consensus was reached, differences of opinion about the moral 
desirability of P4 Medicine have become clearer, which is also an important aim of 
public deliberation. 
 However, the analysis of the strategic maneuvering also shows that all three 
participating life scientists employed the theatrical technique of impression 
management to position themselves as advocates on stage without having to 
publicly divulge their personal convictions that prove to correspond to the views 
of their opponents backstage. Although the dialectical dimension of a reasonable 
discussion was respected, their impression management does not fully accord with 
the deliberative virtue of civic magnanimity. According to this principle, discussants 
should strive to “minimize rejection of the position they oppose” and that means 
they should also openly indicate the matters they do not disagree with. 
 In addition, it is argued that the informal dramaturgical setting and the voluntary 
participation in the deliberation with no enforced outcome together with the 
instrumental view on technology are possible explanantion for the life scientists’ 
strategic discussion behavior. For the fundamentally optimistic attitude towards 
NEST that is implied in the sociotechnical imaginaries of P4 Medicine might reinforce 
the often conservative stance towards a technological future.
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“Burgers gaan meebeslissen over onderzoek,” zo kopte dagblad NRC op 25 november 
2014. Daarmee belichtte de krant het nieuwe initiatief van de Nederlandse minister 
van onderwijs om een dialoog te starten tussen wetenschap en maatschappij om 
zo tot een Nationale Wetenschapsagenda te komen. De minister sluit daarmee aan 
bij een brede Europese ontwikkeling in het wetenschapsbeleid om het publiek te 
betrekken bij beslissingen over wetenschap en techniek (in de literatuur aangeduid 
met het Engelstalige begrip public engagement with science and technology; 
hierna kortweg en oververtaald public engagement genoemd). De dialoog tussen 
wetenschappelijke onderzoekers en de maatschappij wordt beschouwd als een 
noodzakelijke voorwaarde voor het bereiken van instrumentele doelen (bijv. 
herstel van publiek vertrouwen, vergroten van publieke acceptatie) of substantiële 
doelen (bijv. verbetering van de kwaliteit van zorg) of simpelweg het juiste om te 
doen vanuit normatief en democratisch oogpunt. Het simpelweg vergroten van 
publieksparticipatie is echter niet zonder meer de oplossing gebleken om deze 
doelen te bereiken, zo laat Hoofdstuk 1 uit dit proefschrift zien. Uit het verleden is 
lering getrokken uit het proces rond public engagement.
 Ten eerste werd het onderwerp van discussie van publieke kwesties beperkt tot 
de (on)wenselijke gevolgen van nieuwe wetenschap en technologie. Maar public 
engagement moet ook een breder spectrum van kwesties aansnijden betreffende 
de morele wenselijkheid van de doelen, behoeften en verwachte voordelen van 
nieuwe en opkomende wetenschap en technologie (in de literatuur aangeduid 
als new and emerging science and technology, afgekort tot NEST). Ten tweede 
is het belangrijk om het publiek zo vroeg mogelijk te betrekken om zo te kunnen 
anticiperen op eventuele voordelen en risico’s van NEST. Bovendien kunnen zo 
de gekozen onderzoeksprioriteiten openlijk besproken worden en de normatief 
geladen toekomstvisies van wetenschappelijke ontwikkelingen beoordeeld worden. 
Alleen zo kan de bijdrage van deelnemers aan het publieke debat impact hebben 
op wetenschapsgedreven innovatietrajecten. De publieksdialoog moet kortom 
stroomopwaarts (of upstream) plaatsvinden. Ten derde heeft public engagement 
een deliberatieve wending nodig. Volgens deliberatieve democraten zijn besluiten 
over publieke morele kwesties (zoals opgeroepen door nieuwe wetenschap en 
technologie) alleen legitiem als ze voortkomen uit een kwalitatieve discussie waar 
individuele perspectieven gerechtvaardigd worden met goede argumenten die ook 
acceptabel zijn voor de mensen die anders tegen de kwestie aankijken. Tenslotte 
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blijkt de manier waarop public engagement wordt georganiseerd het publieke 
onbehagen ten aanzien van nieuwe wetenschap en technologie aanzienlijk te 
kunnen vergroten. Organisatoren van public engagement (of facilitators) nemen 
soms ten onrechte aan dat implementeren van public engagement methoden (zoals 
consensus conferenties) automatisch leiden tot een legitieme uitkomst. Zij zien dan 
echter de invloed over het hoofd van het facilitatieproces zelf op de uitkomst en de 
kwaliteit van de deliberatie.
 Public engagement is inmiddels een populair onderwerp is geworden van 
academische studie. Het probleem is echter dat onderzoekers in wetenschap- en 
technologiestudies (in het Engels aangeduid met Science and Technology Studies, 
of STS) en in de politieke wetenschappen maar weinig aandacht besteed hebben 
aan het deliberatieve proces zelf en de effecten van het facilitatieproces op de 
kwaliteit ervan. Aan de ene kant heeft onderzoek binnen STS vooral betrekking 
op het definiëren van normatieve conceptuele kaders voor het evalueren van de 
voorwaarden van een waardevolle uitkomst van public engagement. Binnen deze 
kaders is echter geen plaats voor het beoordelen van deliberatieve actie. Aan de 
andere kant nemen de weinige studies die het deliberatieve proces wel als focus 
hebben het effect van de setting op dit proces niet systematisch in ogenschouw.
 Dit proefschrift onderzoekt juist deliberatie in actie en het effect van settings 
op de kwaliteit van publieksdialoog. Beide zijn een cruciaal onderdeel van het 
faciliteren van kwalitateitsdeliberatie over de wenselijkheid van nieuwe en 
opkomende levenswetenschappen en biotechnologieën. De levenswetenschappen 
– het brede wetenschappelijke veld dat de studie van levende organismen zoals 
micro-organismen, planten, dieren en mensen veelal op een moleculaire basis 
(DNA, RNA etc.) omvat – is een onderzoeksveld gebleken dat keer op keer publieke 
controverse heeft losgemaakt (denk aan Dolly het schaap, stier Herman of genetisch 
gemodificeerde gewassen).
 Zoals de titel van dit boek aangeeft, vergelijk ik public engagement met 
theater. De theatermetafoor maakt het mogelijk enerzijds om zowel de publieke 
optredens van levenswetenschappers als de interventies van facilitators gericht op 
het realiseren van deliberatie te belichten. Anderzijds brengt deze metafoor het 
proces van professionele organisatoren van public engagement in hun rol achter de 
schermen voor het voetlicht.
 De theatermetafoor verbindt tevens de twee gebruikte theoretische kaders 
die in deze studie worden gebruikt. In dramaturgische analyse binnen de sociale 
wetenschappen wordt interactie tussen mensen – zoals het delibereren over ethische 
kwesties opgeroepen door nieuwe wetenschap en technologie – bestudeerd in 
termen van publieke performances. Voortbouwend op het werk van socioloog Erving 
Goffman en de STS-er Stephen Hilgartner, richt dit boek zich specifiek op retorische 
overtuigingskracht en de management van impressies die levenswetenschappers 
naar verwachting zullen als theatrale technieken aanwenden tijdens hun deelname 
aan upstream publieke deliberatie. Hoe geven levenswetenschappers hun optreden 
aan upstream publieke deliberatie over NEST-ethische kwesties retorisch vorm? 
Voldoen deze performances aan de eisen van een goede discussie? In welke mate 
verschilt hun presentatie op het podium van hun voorkomen achter de schermen?
 Het tweede theoretische kader trekt een parallel tussen het facilitatieproces en 
dramaturgie, het proces van het schrijven van een script en het in scene zetten van 
een theatrale interactie (de mis-en-scène) achter de schermen dat de kwaliteit van 
de discussie en de optredens op het podium beïnvloedt. Op welke manier beïnvloedt 
de dramaturgie van upstream publieke deliberatie de optredens van deelnemers en 
de kwaliteit van de deliberatie?
In Hoofdstuk 2 worden een zogenoemd discursief en een performatief perspectief op 
de kwaliteit van deliberatie ontwikkeld die respectievelijk hun licht laten schijnen op 
het facilitatieproces op het podium en op het organisatiewerk achter de schermen.
 Voor het ontwikkelen van het discursieve perspectief, wordt eerst de impliciete 
verwantschap van de literatuur in de wetenschap- en technologiestudies (STS) en 
het concept van deliberatieve democratie van Gutmann en Thompson verduidelijkt. 
Gebruikmakend van hun theorie, wijst het centrale principe van wederkerigheid 
– dat neerkomt op het proces van het zoeken naar argumenten die wederzijds 
acceptabel zijn – in een eerste richting voor het ontwikkelen van een opvatting van 
discursieve kwaliteit: de kwaliteit van argumentatie gebruikt voor de verdediging van 
wetenschapsbeleid. Een belangrijk aspect van het werk van facilitators van upstream 
publieke deliberatie is dan ook om op kritische wijze de kwaliteit van de argumenten 
te onderzoeken die gebruikt worden om de richting van innovatietrajecten te 
rechtvaardigen. Daarom is de eerste focus van deze studie het ontwikkelen van een 
theoretisch begrip van argumentatieve kwaliteit die zowel de reconstructie, analyse 
en evaluatie van argumentatie in de context van nieuwe wetenschap en technologie. 
Dit theoretische begrip van argumentatieve kwaliteit moet tevens de mogelijkheid 
bieden voor facilitators om publieke deliberatie over NEST mogelijk te maken.
 Gebruikmakend van Actor Netwerk Theorie (en in het bijzonder het werk van 
Gomart en Hajer), wordt een performatief perspectief op de kwaliteit van publieke 
deliberatie ontwikkeld. Methoden die gebruikt worden voor het faciliteren van 
upstream publieke deliberatie (zoals consensus conferenties) zijn geen neutrale 
hulpmiddelen die een waardevrije representatie van consensus opleveren. Net 
als andere technologieën, hebben deze methoden invloed op de uitkomst. Het 
tweede onderzoeksdoel van dit proefschrift is dan ook om het dramaturgische werk 
te onderzoeken dat verricht wordt bij publieke deliberatie over NEST. Om dit doel 
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te bereiken, worden de dramaturgische begrippen script, mis-en-scène en setting 
geïntroduceerd die samen een kader vormen om het werk achter de schermen van 
het publieke deliberatieproces te analyseren.
In Hoofdstuk 3 wordt een begrip van argumentatieve kwaliteit van publieksdiscussies 
over NEST ontwikkeld gebaseerd op de zogenoemde pragma-dialectische 
argumentatietheorie. Wat betekent een goede discussie eigenlijk? Volgens pragma-
dialectici vormt redelijkheid het belangrijkste criterium. Kwaliteit verwijst naar 
een formele procedure die redelijke discussianten stilzwijgend respecteren om 
hun meningsverschil op te lossen door systematisch de aanvaardbaarheid van hun 
standpunten (en hun argumentatie) te testen. Binnen deze formele procedure zoom 
ik in het bijzonder in op de elementen voor het analyseren en evalueren van de 
kwaliteit van het product van argumentatie (hoe een conclusie logisch voortkomt 
uit zijn premissen). Pragma-dialectici definiëren drie procedures die noodzakelijk 
zijn voor het systematisch onderwerpen van argumentatie aan optimale twijfel. Ten 
eerste is het belangrijk om de onuitgesproken vooronderstellingen die veelal impliciet 
blijven vanwege efficiënte in communicatie te expliciteren. Ten tweede moet de 
inhoud van iedere afzonderlijke uitspraak aanvaardbaar zijn. Mocht dat niet het geval 
zijn, dan moet de protagonist in een sub-discussie argumentatie aanvoeren om deze 
uitspraak te verdedigen. Ten derde moet de argumentatie kritisch getest worden. De 
kritische testprocedure is pas helemaal afgerond wanneer protagonisten een set van 
kritische vragen op bevredigende wijze heeft beantwoord die horen bij het correct 
toegepaste argumentatieschema. Deze kritische vragen zijn eerst en vooral een maat 
voor de deliberatieve kwaliteit en vormen zo een diagnostisch gereedschap. Maar 
deze vragen zijn ook een heuristisch middel om te voldoen aan een andere belangrijk 
kwaliteitskenmerk van deliberatie: inclusiviteit. Wat zijn de kwesties die ter sprake 
moeten komen? Tenslotte vormen de kritische vragen een belangrijk gereedschap 
voor facilitators, die verantwoordelijkheid dragen voor de uitvoering van de kritische 
testprocedure,  om de deliberatie op het podium te verbeteren.
 De pragma-dialectische procedure wordt toegepast op de ethische 
argumentatiepatronen binnen de context van publieksdiscussies over NEST, zoals 
beschreven in de literatuur. Bij wijze van illustratie pas ik het theoretische kader toe 
op het publieke en politieke debat in Nederland over cisgenese, een methode om 
gewassen te modificeren ontwikkeld als antwoord op de maatschappelijke onvrede 
over genetische modificatie. Uit deze casus, wordt een omvattende lijst van kritische 
vragen afgeleid die samen de stock topics vormen die in NEST-ethische discussie ter 
sprake gebracht moeten worden.
Behalve het dialectische doel om een verschil van mening op te lossen door het 
volgen van de procedure van een redelijke discussie, proberen deelnemers aan een 
discussie – misschien zelfs wel in de eerste plaats – om retorisch doelmatig te zijn: om 
anderen hun claims en argumentatie te laten accepteren. In Hoofdstuk 4 wordt het 
begrip strategisch manoeuvreren uiteengezet, dat pragma-dialectici introduceerden 
om hun argumentatietheorie te verfijnen zodat ook de retorische dimensie van 
argumentatie in de analyse meegenomen kan worden. Strategisch manoeuvreren 
wordt gedefinieerd als het bewaren van het delicate evenwicht tussen het retorische 
doel van effectiviteit en het dialectische doel om redelijk te blijven. Als argumentatie 
in strijd is met de pragma-dialectische procedure van kritische discussie, oftewel als 
deelnemers aan een discussie doelmatigheid nastreven ten koste van redelijkheid, 
dan kan gezegd worden dat hun strategisch manoeuvreren ontspoort.
 Het concept strategisch manoeuvreren werpt ten eerste een licht op hoe 
deelnemers aan een discussie een keuze maken uit beschikbare geschilpunten en 
argumentatieschema’s om hun standpunten te onderbouwen (in de literatuur 
aangeduid als topical selection); ten tweede op hoe standpunten en argumenten 
afgestemd zijn op wat specifieke publieksgroepen of het algemene publiek plausibel 
vinden (aangeduid als audience demand); en ten derde op hoe discussiedeelnemers 
een geschikte presentatie kiezen (aangeduid als presentational devices) om hun 
standpunt geaccepteerd te krijgen.
 Het begrip strategisch manoeuvreren wordt in deze studie gebruikt voor de 
analyse van de persuasieve retoriek die zowel voor- als tegenstanders van nieuwe 
wetenschap en technologie bezigen als theatrale techniek om effectief te zijn 
in publieke debatten. Omdat pragma-dialectici zich niet specifiek bezig hebben 
gehouden met publieksdiscussies over NEST, is wetenschappelijke literatuur 
onderzocht die zich concentreert op discursieve strategieën in NEST-ethische 
discussies. Methodologisch gezien, maken deze studies gebruik van discourse-
analyse dat, zoals beargumenteerd wordt, bruikbaar is omdat het aandacht heeft 
voor a) de retorische functie van de verschillende versies om de (sociale) wereld 
te construeren en b) voor andere discursieve strategieën dan argumentatie zoals 
pragma-dialectici dat definiëren.
 De literatuurstudie maakt duidelijk dat zowel voor- als tegenstanders de 
beschikking hebben over een repertoire aan strategische manoeuvres om effectief 
te zijn in publieke deliberaties over controversiële wetenschap en technologie: a) 
grenzenwerk dat gedefinieerd kan worden als het conceptueel onderscheiden van 
wetenschap en niet-wetenschap, van wetenschap en samenleving, van fundamenteel 
en toegepast onderzoek, van feiten en waarden, van moreel aanvaardbare en moreel 
onaanvaardbaar wetenschappelijk onderzoek, van beslechte en controversiële 
kwesties, van natuurlijk en onnatuurlijk etc.; b) identiteitswerk, oftewel het 
construeren van publieke identiteiten van zichzelf en anderen als bijvoorbeeld 
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fundamentalistisch, onrealistisch, kortzichtig; c) toekomstwerk, oftewel het 
representeren van toekomsten als ververwijderd, goed, onzeker, of impactvol.
 Het dramaturgische perspectief op publieksdeliberatie, met de begrippen script, 
mis-en-scène en setting (Hoofdstuk 2) en het begrip strategisch manoeuvreren 
(en het ontsporen daarvan) toegepast op NEST-ethische discussies (ontwikkeld in 
Hoofdstuk 3 en 4) vormen samen het analytische kader om face-to-face upstream 
publieksdeliberatie over de morele wenselijkheid van nieuwe levenswetenschappen 
en biotechnologieën te beschrijven, te reconstrueren, analyseren en te evalueren. 
In Hoofdstuk 5 wordt een reeks van drie publieke discussie over gedragsgenetica 
geanalyseerd. Hoe manoeuvreren de deelnemers aan deze discussies strategisch? 
Welke invloed hebben deze manoeuvres op de kwaliteit van van de deliberatie? En 
wat is de invloed van de dramaturgie van deze upstream publieksdialogen, gescript als 
publieke onderzoeken naar de ethische en maatschappelijk kwesties met betrekking 
tot de genomics van menselijk gedrag, op het optreden van de deelnemers?
 Levenswetenschappers kozen in deze discussies veelal voor pragmatische 
argumentatie, een redeneerpatroon om de wenselijkheid van een handeling te 
rechtvaardigen door te wijzen op wenselijke gevolgen van dat handelen. Deze 
argumentatie weerspiegelt een publieke rede omdat het wijst op de voordelige 
gevolgen voor de hele maatschappij. Hun argumentatie werd echter niet maximaal 
betwijfeld oftewel niet kritisch getest. Ten eerste kwam de bewijslast bij het publiek 
te liggen. Deelnemende levenswetenschappers die ten tonele gevoerd werden 
als pleitbezorgers van het nieuwe onderzoek naar de genetica van gedrag, wisten 
zich publiekelijk te presenteren als verantwoorde en bescheiden professionals die 
de toekomstverwachtingen rond hun onderzoek temperden. Het publiek – dat 
de rol moest innemen van actieve deelnemer die de nieuwe wetenschappelijke 
ontwikkelingen kritisch onder de loep zou nemen – nam daarentegen juist de rol 
aan van een zorgconsument die slechts geïnformeerd wil worden over de nieuwste 
ontwikkelingen in het vakgebied. Bovendien bevatte het script een zekere tendens 
die de publieke aarzeling om deel te nemen aan de discussie in de publieke sfeer 
nog vergrootte: in een poging om het publiek actief te betrekken bij het bepalen van 
de gespreksonderwerpen, kreeg het de bewijslast toegewezen. Dit weerspiegelt een 
dominant liberaal discours, waarin wetenschappers en technologieontwikkelaars 
een grote mate van autonomie toebedeeld krijgen.
 Ten tweede bleken sommige strategische manoeuvres effectief om de discussie 
over de morele wenselijkheid van genomicsonderzoek naar menselijk gedrag kort te 
sluiten. Het maken van conceptuele onderscheidingen, zoals tussen wetenschappers 
die bijdragen aan hun wetenschapsgebied en buitenstaanders (het publiek/
de maatschappij) en tussen de productie van wetenschappelijke kennis en het 
maatschappelijke gebruik ervan werkten in het voordeel van de wetenschappers. Net 
als hun appel op wetenschappelijke autoriteit met betrekking tot de technologische 
haalbaarheid die de toekomstvisies van critici minder geloofwaardig of zelfs 
ongeloofwaardig maakten. Als gevolg van de wetenschappelijke expertise die hen 
werd toegeschreven, hadden de levenswetenschappers duidelijk een voordeel in 
de twist over de verschillende toekomstvisies. En als een toekomst als onhaalbaar 
wordt gerepresenteerd, is een discussie over de morele wenselijkheid van zo’n 
toekomstbeeld onnodig.
Hoofdstuk 6 bevat een gedetailleerde beschrijving van het dramaturgische werk 
uitgevoerd achter de schermen van een upstream publieksdeliberatie over nieuwe 
kennis en nieuwe technologieën in een andere veld binnen de levenswetenschappen: 
P4 gezondheid en zorg (in het Engels aangeduid als P4 Medicine) en meer in het 
bijzonder, de morele wenselijkheid van integratieve personalized omics profielen 
(afgekort tot iPOPs) voor de preventie van diabetes type 2.
 Het hoofdstuk beschrijft ten eerste het discursieve werk van een kritische 
beoordeling van de toekomstvisies teneinde de valkuilen beschreven in Hoofdstuk 
5 te voorkomen. Gebruikmakend van interviews en een literatuurstudie, worden 
de technologische haalbaarheid van sociotechnische toekomstvisies rond P4 
Medicine in kaart gebracht en vervolgens beoordeeld door gebruik te maken van 
een reeks kritische vragen die wetenschappers bevredigend moeten beantwoorden. 
Deze kritische vragen zijn afgeleid van de pragma-dialectische evaluatie van 
wetenschappelijke autoriteitsargumentatie. Bovendien werd een toekomstscenario 
ontwikkeld dat het vertrekpunt van discussie vormde, op basis van een analyse 
van hoe in deze toekomstvisies de implementatie van deze nieuwe technologieën 
in praktijken vervat ligt. Ook werd de argumentatie die pleitbezorgers naar voren 
brengen om de morele wenselijkheid van P4 Medicine en de iPOPs systematisch 
en kritisch getest. Daarvoor werd gebruikt gemaakt van de reeks kritische vragen 
afgeleid in Hoofdstuk 3 als een heuristisch middel om de waarden en morele 
rechtvaardigingen te expliciteren die in deze toekomstvisies besloten liggen. Dit 
instrument kon de facilitator tevens gebruiken om te anticiperen op controversiële 
kwesties rond morele wenselijkheid.
 Hoofdstuk 6 is ten tweede een etnografische beschrijving van het dramaturgische 
werk achter de schermen: het framen van de kwestie; het verschaffen van informatie 
aan de deelnemers; het contingente proces van het uitnodigen en vastleggen van 
deelnemers; en de besluiten rond de mis-en-scène die alle een effect te hebben op de 
optredens van de deelnemers. Deze etnografie werpt aldus een licht op de praktische 
verwikkelingen waar facilitators van upstream publieksdeliberatie in verzeild kunnen 
raken: de keuzes die zij moeten maken als gevolg van het toepassen van abstracte 
normatieve criteria die publieksparticipatie legitiem zouden maken (inclusiviteit, 
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onafhankelijkheid, vroege betrokkenheid, kwaliteit van deliberatie etc.). Hoofdstuk 
6 werkt het argument uit dat een diepgaand begrip van deze normatieve overdaad 
van de praktijk van het organiseren van publieksdialoog met zijn ontelbare keuzes, 
compromissen en spanningen onontbeerlijk is om organisatoren gevoelig te maken 
zodat ze zo hun werk als dramaturgen van publieksdeliberatie kunnen verbeteren.
Hoofdstuk 7 richt het toneellicht wederom op de optredens op de bühne 
waar levenswetenschappers deelnemen aan de publieke deliberatie over de 
morele wenselijkheid van iPOP-technologieën. Een uitgebreide argumentatieve 
reconstructie van de deliberatie maakt duidelijk dat – deels dankzij de succesvolle 
discursieve interventies van de facilitator – ten eerste de bewijslast duidelijk bij de 
pleitbezorgers van NEST kwam te liggen en ten tweede dat hun argumentatie – die 
een liberale bio-ethiek weerspiegelen – kritisch is getest. Hoewel geen consensus 
werd bereikt onder de deelnemers, zijn de verschillen van mening over de morele 
wenselijkheid van P4 Medicine duidelijker geworden, hetgeen ook een duidelijk doel 
is van publieke deliberatie.
 De analyse van het strategisch manoeuvreren maakt echter ook duidelijk dat alle 
deelnemende levenswetenschappers gebruik maakten van de theatrale techniek van 
impressiemanagement. Ze konden zich publiekelijk presenteren als pleitbezorgers 
van deze nieuwe technologieën zonder aan het publiek prijs te hoeven geven dat 
hun persoonlijke overtuigingen achter de schermen wel degelijk overeenkomsten 
vertoonden met critici. Ook al werden de dialectische regels van de kritische 
discussie gerespecteerd, hun impressiemanagement staat op gespannen voet met 
de deliberatieve deugd van grootmoedigheid. Deze burgerschapsdeugd schrijft 
voor dat deelnemers aan een discussie ernaar moeten streven om de positie van 
tegenstanders of andersdenkend zo min mogelijk af te wijzen. Dat betekent dat het 
ook belangrijk is om openlijk toe te geven waar je het met je tegenstanders over eens 
bent.
 Tot slot wordt beargumenteerd dat de informele dramaturgische setting en de 
vrijwillige deelname aan de deliberatie die geen concrete uitkomst verlangde samen 
met een instrumentele kijk op technologie een mogelijke verklaring kunnen zijn 
voor het strategische discussiegedrag van levenswetenschappers. De fundamenteel 
optimistische attitude tegenover nieuwe technologieën die in de sociotechnische 
toekomstvisies van P4 Medicine besloten liggen zou immers wel eens de toch al zo 
vaak getoonde conservatieve houding tegenover toekomstige technologieën kunnen 
versterken.
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